
<html lang="en"     class="pb-page"  data-request-id="2b6dc491-8a60-430a-9736-ba1dab75a22e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.0c01431;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2021.64.issue-1;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="3,4-Dihydropyrimidin-2(1H)-ones as Antagonists of the Human A2B Adenosine Receptor: Optimization, Structure–Activity Relationship Studies, and Enantiospecific Recognition" /></meta><meta name="dc.Creator" content="María  Majellaro" /></meta><meta name="dc.Creator" content="Willem  Jespers" /></meta><meta name="dc.Creator" content="Abel  Crespo" /></meta><meta name="dc.Creator" content="María J.  Núñez" /></meta><meta name="dc.Creator" content="Silvia  Novio" /></meta><meta name="dc.Creator" content="Jhonny  Azuaje" /></meta><meta name="dc.Creator" content="Rubén  Prieto-Díaz" /></meta><meta name="dc.Creator" content="Claudia  Gioé" /></meta><meta name="dc.Creator" content="Belma  Alispahic" /></meta><meta name="dc.Creator" content="José  Brea" /></meta><meta name="dc.Creator" content="María I.  Loza" /></meta><meta name="dc.Creator" content="Manuel  Freire-Garabal" /></meta><meta name="dc.Creator" content="Carlota  Garcia-Santiago" /></meta><meta name="dc.Creator" content="Carlos  Rodríguez-García" /></meta><meta name="dc.Creator" content="Xerardo  García-Mera" /></meta><meta name="dc.Creator" content="Olga  Caamaño" /></meta><meta name="dc.Creator" content="Christian  Fernandez-Masaguer" /></meta><meta name="dc.Creator" content="Javier F.  Sardina" /></meta><meta name="dc.Creator" content="Angela  Stefanachi" /></meta><meta name="dc.Creator" content="Abdelaziz  El Maatougui" /></meta><meta name="dc.Creator" content="Ana  Mallo-Abreu" /></meta><meta name="dc.Creator" content="Johan  Åqvist" /></meta><meta name="dc.Creator" content="Hugo  Gutiérrez-de-Terán" /></meta><meta name="dc.Creator" content="Eddy  Sotelo" /></meta><meta name="dc.Description" content="We present and thoroughly characterize a large collection of 3,4-dihydropyrimidin-2(1H)-ones as A2BAR antagonists, an emerging strategy in cancer (immuno) therapy. Most compounds selectively bind A..." /></meta><meta name="Description" content="We present and thoroughly characterize a large collection of 3,4-dihydropyrimidin-2(1H)-ones as A2BAR antagonists, an emerging strategy in cancer (immuno) therapy. Most compounds selectively bind A..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 29, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01431" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01431" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01431" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01431" /></link>
        
    
    

<title>3,4-Dihydropyrimidin-2(1H)-ones as Antagonists of the Human A2B Adenosine Receptor: Optimization, Structure–Activity Relationship Studies, and Enantiospecific Recognition | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01431" /></meta><meta property="og:title" content="3,4-Dihydropyrimidin-2(1H)-ones as Antagonists of the Human A2B Adenosine Receptor: Optimization, Structure–Activity Relationship Studies, and Enantiospecific Recognition" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0025.jpeg" /></meta><meta property="og:description" content="We present and thoroughly characterize a large collection of 3,4-dihydropyrimidin-2(1H)-ones as A2BAR antagonists, an emerging strategy in cancer (immuno) therapy. Most compounds selectively bind A2BAR, with a number of potent and selective antagonists further confirmed by functional cyclic adenosine monophosphate experiments. The series was analyzed with one of the most exhaustive free energy perturbation studies on a GPCR, obtaining an accurate model of the structure–activity relationship of this chemotype. The stereospecific binding modeled for this scaffold was confirmed by resolving the two most potent ligands [(±)-47, and (±)-38 Ki = 10.20 and 23.6 nM, respectively] into their two enantiomers, isolating the affinity on the corresponding (S)-eutomers (Ki = 6.30 and 11.10 nM, respectively). The assessment of the effect in representative cytochromes (CYP3A4 and CYP2D6) demonstrated insignificant inhibitory activity, while in vitro experiments in three prostate cancer cells demonstrated that this pair of compounds exhibits a pronounced antimetastatic effect." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01431"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01431">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01431&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01431&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01431&amp;href=/doi/10.1021/acs.jmedchem.0c01431" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 458-480</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01374" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01441" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">3,4-Dihydropyrimidin-2(1<i>H</i>)-ones as Antagonists of the Human A<sub>2B</sub> Adenosine Receptor: Optimization, Structure–Activity Relationship Studies, and Enantiospecific Recognition</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">María Majellaro</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">María Majellaro</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro Singular de Investigación en Química Biolóxica y Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div><div class="loa-info-affiliations-info">Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa++Majellaro">María Majellaro</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Willem Jespers</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Willem Jespers</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Cell and Molecular Biology, Uppsala University, SE-75124 Uppsala, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Willem++Jespers">Willem Jespers</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4951-9220" title="Orcid link">http://orcid.org/0000-0002-4951-9220</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Abel Crespo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Abel Crespo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro Singular de Investigación en Química Biolóxica y Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div><div class="loa-info-affiliations-info">Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Abel++Crespo">Abel Crespo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">María J. Núñez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">María J. Núñez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">SNL, Departamento de Farmacología, Facultade de Medicina, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa+J.++N%C3%BA%C3%B1ez">María J. Núñez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Silvia Novio</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Silvia Novio</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">SNL, Departamento de Farmacología, Facultade de Medicina, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Silvia++Novio">Silvia Novio</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jhonny Azuaje</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jhonny Azuaje</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro Singular de Investigación en Química Biolóxica y Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div><div class="loa-info-affiliations-info">Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jhonny++Azuaje">Jhonny Azuaje</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rubén Prieto-Díaz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rubén Prieto-Díaz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro Singular de Investigación en Química Biolóxica y Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div><div class="loa-info-affiliations-info">Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rub%C3%A9n++Prieto-D%C3%ADaz">Rubén Prieto-Díaz</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2539-3106" title="Orcid link">http://orcid.org/0000-0003-2539-3106</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Claudia Gioé</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Claudia Gioé</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro Singular de Investigación en Química Biolóxica y Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div><div class="loa-info-affiliations-info">Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Claudia++Gio%C3%A9">Claudia Gioé</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Belma Alispahic</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Belma Alispahic</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Cell and Molecular Biology, Uppsala University, SE-75124 Uppsala, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Belma++Alispahic">Belma Alispahic</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">José Brea</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">José Brea</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#dfafbaafb0f1bdadbabe9faaacbcf1baac"><span class="__cf_email__" data-cfemail="730316031c5d11011612330600105d1600">[email protected]</span></a>. Phone: +34 881815459. Fax: +34-8818115474.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jos%C3%A9++Brea">José Brea</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">María I. Loza</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">María I. Loza</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa+I.++Loza">María I. Loza</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Manuel Freire-Garabal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Manuel Freire-Garabal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">SNL, Departamento de Farmacología, Facultade de Medicina, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Manuel++Freire-Garabal">Manuel Freire-Garabal</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Carlota Garcia-Santiago</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carlota Garcia-Santiago</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">SNL, Departamento de Farmacología, Facultade de Medicina, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carlota++Garcia-Santiago">Carlota Garcia-Santiago</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Carlos Rodríguez-García</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carlos Rodríguez-García</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro Singular de Investigación en Química Biolóxica y Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div><div class="loa-info-affiliations-info">Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carlos++Rodr%C3%ADguez-Garc%C3%ADa">Carlos Rodríguez-García</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xerardo García-Mera</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xerardo García-Mera</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xerardo++Garc%C3%ADa-Mera">Xerardo García-Mera</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Olga Caamaño</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Olga Caamaño</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Olga++Caama%C3%B1o">Olga Caamaño</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christian Fernandez-Masaguer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christian Fernandez-Masaguer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christian++Fernandez-Masaguer">Christian Fernandez-Masaguer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Javier F. Sardina</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Javier F. Sardina</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro Singular de Investigación en Química Biolóxica y Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Javier+F.++Sardina">Javier F. Sardina</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6758-0068" title="Orcid link">http://orcid.org/0000-0002-6758-0068</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Angela Stefanachi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Angela Stefanachi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari ALDO MORO, via Orabona 4, 70125 Bari, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Angela++Stefanachi">Angela Stefanachi</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9430-7972" title="Orcid link">http://orcid.org/0000-0002-9430-7972</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Abdelaziz El Maatougui</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Abdelaziz El Maatougui</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro Singular de Investigación en Química Biolóxica y Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div><div class="loa-info-affiliations-info">Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Abdelaziz++El+Maatougui">Abdelaziz El Maatougui</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ana Mallo-Abreu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ana Mallo-Abreu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro Singular de Investigación en Química Biolóxica y Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div><div class="loa-info-affiliations-info">Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ana++Mallo-Abreu">Ana Mallo-Abreu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Johan Åqvist</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Johan Åqvist</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Cell and Molecular Biology, Uppsala University, SE-75124 Uppsala, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Johan++%C3%85qvist">Johan Åqvist</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2091-0610" title="Orcid link">http://orcid.org/0000-0003-2091-0610</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hugo Gutiérrez-de-Terán</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hugo Gutiérrez-de-Terán</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Cell and Molecular Biology, Uppsala University, SE-75124 Uppsala, Sweden</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#335b46545c1d5446475a5641415649735a505e1d46461d4056"><span class="__cf_email__" data-cfemail="670f120008490012130e021515021d270e040a491212491402">[email protected]</span></a>. Phone: +46 18 471 5056. Fax: +46 18 536971.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hugo++Guti%C3%A9rrez-de-Ter%C3%A1n">Hugo Gutiérrez-de-Terán</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0459-3491" title="Orcid link">http://orcid.org/0000-0003-0459-3491</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Eddy Sotelo</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eddy Sotelo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro Singular de Investigación en Química Biolóxica y Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div><div class="loa-info-affiliations-info">Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#781d560b170c1d1417380d0b1b561d0b"><span class="__cf_email__" data-cfemail="94f1bae7fbe0f1f8fbd4e1e7f7baf1e7">[email protected]</span></a>. Phone: +34 881815732, +34 881814942. Fax: +34-881815704.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eddy++Sotelo">Eddy Sotelo</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5571-2812" title="Orcid link">http://orcid.org/0000-0001-5571-2812</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01431&amp;href=/doi/10.1021%2Facs.jmedchem.0c01431" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 458–480</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 29, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 August 2020</li><li><span class="item_label"><b>Published</b> online</span>29 December 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 January 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01431" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01431</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D458%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMar%25C3%25ADa%2BMajellaro%252C%2BWillem%2BJespers%252C%2BAbel%2BCrespo%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D1%26contentID%3Dacs.jmedchem.0c01431%26title%3D3%252C4-Dihydropyrimidin-2%25281H%2529-ones%2Bas%2BAntagonists%2Bof%2Bthe%2BHuman%2BA2B%2BAdenosine%2BReceptor%253A%2BOptimization%252C%2BStructure%25E2%2580%2593Activity%2BRelationship%2BStudies%252C%2Band%2BEnantiospecific%2BRecognition%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D480%26publicationDate%3DJanuary%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01431"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">906</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">1</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01431" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;3,4-Dihydropyrimidin-2(1H)-ones as Antagonists of the Human A2B Adenosine Receptor: Optimization, Structure–Activity Relationship Studies, and Enantiospecific Recognition&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;Majellaro&quot;},{&quot;first_name&quot;:&quot;Willem&quot;,&quot;last_name&quot;:&quot;Jespers&quot;},{&quot;first_name&quot;:&quot;Abel&quot;,&quot;last_name&quot;:&quot;Crespo&quot;},{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;J. Núñez&quot;},{&quot;first_name&quot;:&quot;Silvia&quot;,&quot;last_name&quot;:&quot;Novio&quot;},{&quot;first_name&quot;:&quot;Jhonny&quot;,&quot;last_name&quot;:&quot;Azuaje&quot;},{&quot;first_name&quot;:&quot;Rubén&quot;,&quot;last_name&quot;:&quot;Prieto-Díaz&quot;},{&quot;first_name&quot;:&quot;Claudia&quot;,&quot;last_name&quot;:&quot;Gioé&quot;},{&quot;first_name&quot;:&quot;Belma&quot;,&quot;last_name&quot;:&quot;Alispahic&quot;},{&quot;first_name&quot;:&quot;José&quot;,&quot;last_name&quot;:&quot;Brea&quot;},{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;I. Loza&quot;},{&quot;first_name&quot;:&quot;Manuel&quot;,&quot;last_name&quot;:&quot;Freire-Garabal&quot;},{&quot;first_name&quot;:&quot;Carlota&quot;,&quot;last_name&quot;:&quot;Garcia-Santiago&quot;},{&quot;first_name&quot;:&quot;Carlos&quot;,&quot;last_name&quot;:&quot;Rodríguez-García&quot;},{&quot;first_name&quot;:&quot;Xerardo&quot;,&quot;last_name&quot;:&quot;García-Mera&quot;},{&quot;first_name&quot;:&quot;Olga&quot;,&quot;last_name&quot;:&quot;Caamaño&quot;},{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;Fernandez-Masaguer&quot;},{&quot;first_name&quot;:&quot;Javier&quot;,&quot;last_name&quot;:&quot;F. Sardina&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;Stefanachi&quot;},{&quot;first_name&quot;:&quot;Abdelaziz&quot;,&quot;last_name&quot;:&quot;El Maatougui&quot;},{&quot;first_name&quot;:&quot;Ana&quot;,&quot;last_name&quot;:&quot;Mallo-Abreu&quot;},{&quot;first_name&quot;:&quot;Johan&quot;,&quot;last_name&quot;:&quot;Åqvist&quot;},{&quot;first_name&quot;:&quot;Hugo&quot;,&quot;last_name&quot;:&quot;Gutiérrez-de-Terán&quot;},{&quot;first_name&quot;:&quot;Eddy&quot;,&quot;last_name&quot;:&quot;Sotelo&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;458-480&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01431&quot;},&quot;abstract&quot;:&quot;We present and thoroughly characterize a large collection of 3,4-dihydropyrimidin-2(1H)-ones as A2BAR antagonists, an emerging strategy in cancer (immuno) therapy. Most compounds selectively bind A2BAR, with a number of potent and selective antagonists further confirmed by functional cyclic adenosine monophosphate experiments. The series was analyzed with one of the most exhaustive free energy perturbation studies on a GPCR, obtaining an accurate model of the structure–activity relationship of this chemotype. The stereospecific binding modeled for this scaffold was confirmed by resolving the two most potent ligands [(±)-47, and (±)-38 Ki = 10.20 and 23.6 nM, respectively] into their two enantiomers, isolating the affinity on the corresponding (S)-eutomers (Ki = 6.30 and 11.10 nM, respectively). The assessment of the effect in representative cytochromes (CYP3A4 and CYP2D6) demonstrated insignificant inhibitory activity, while in vitro experiments in three prostate cancer cells demonstrated that this pair of co&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01431&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01431" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01431&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01431" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01431&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01431" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01431&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01431&amp;href=/doi/10.1021/acs.jmedchem.0c01431" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01431" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01431" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (10 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01431%26sid%3Dliteratum%253Aachs%26pmid%3D33372800%26genre%3Darticle%26aulast%3DMajellaro%26date%3D2021%26atitle%3D3%252C4-Dihydropyrimidin-2%25281H%2529-ones%2Bas%2BAntagonists%2Bof%2Bthe%2BHuman%2BA2B%2BAdenosine%2BReceptor%253A%2BOptimization%252C%2BStructure%25E2%2580%2593Activity%2BRelationship%2BStudies%252C%2Band%2BEnantiospecific%2BRecognition%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D1%26spage%3D458%26epage%3D480%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=291308" title="Nucleic acids">Nucleic acids</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/jmcmar.2021.64.issue-1/20210114/jmcmar.2021.64.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0025.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We present and thoroughly characterize a large collection of 3,4-dihydropyrimidin-2(1<i>H</i>)-ones as A<sub>2B</sub>AR antagonists, an emerging strategy in cancer (immuno) therapy. Most compounds selectively bind A<sub>2B</sub>AR, with a number of potent and selective antagonists further confirmed by functional cyclic adenosine monophosphate experiments. The series was analyzed with one of the most exhaustive free energy perturbation studies on a GPCR, obtaining an accurate model of the structure–activity relationship of this chemotype. The stereospecific binding modeled for this scaffold was confirmed by resolving the two most potent ligands [(±)-<b>47</b>, and (±)-<b>38</b><i>K</i><sub>i</sub> = 10.20 and 23.6 nM, respectively] into their two enantiomers, isolating the affinity on the corresponding (<i>S</i>)-eutomers (<i>K</i><sub>i</sub> = 6.30 and 11.10 nM, respectively). The assessment of the effect in representative cytochromes (CYP3A4 and CYP2D6) demonstrated insignificant inhibitory activity, while in vitro experiments in three prostate cancer cells demonstrated that this pair of compounds exhibits a pronounced antimetastatic effect.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41737" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41737" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Since its identification and cloning in the early 1990s, A<sub>2B</sub> remains the most enigmatic of the four adenosine receptors (ARs).<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Initially, this receptor was seen as a low-affinity (adenosine binds with an EC<sub>50</sub> = 24 μM) version of the A<sub>2A</sub>AR, with which it is often co-expressed in many tissues. These observations lead to the initial idea that the A<sub>2B</sub>AR was a receptor with scarce physiological relevance,<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3−5)</a> which was later ruled out due to the characterization of distinctive intracellular signaling pathways, body distribution, and physiological roles between these two subtypes of ARs.<a onclick="showRef(event, 'ref6 ref7 ref8 ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9 ref10 ref11 ref12">(6−12)</a> High levels of A<sub>2B</sub>AR have been detected in neurons,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> astrocytes,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and various immune cells,<a onclick="showRef(event, 'ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18">(15−18)</a> and it has been confirmed that its expression is heavily affected by environmental cues such as inflammation, cell stress, injury, and hypoxia.<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19−21)</a> Accordingly, the A<sub>2B</sub>AR is involved in diverse and relevant biological processes (e.g. vascular tone, cardiac myocyte contractility, penile erection, glucose homeostasis, pulmonary inflammation, inflammation, and pain).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Paradoxically, the reason for the initial low interest in A<sub>2B</sub>AR (namely its low affinity for adenosine) potentially turns this receptor into an excellent therapeutic target for highly relevant related pathologies,<a onclick="showRef(event, 'ref12 ref22'); return false;" href="javascript:void(0);" class="ref ref12 ref22">(12,22)</a> since it becomes activated under very specific pathological conditions (i.e. micromolar adenosine concentrations).</div><div class="NLM_p">The relevance of the A<sub>2B</sub>AR in cancer progression has been recognized recently, with increasing evidence demonstrating its protumorigenic role in multiple types of cancer cells.<a onclick="showRef(event, 'ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25">(23−25)</a> Growing evidence supports that the A<sub>2B</sub>AR promotes tumor progression in many ways, eliciting key roles during tumor proliferation, angiogenesis, chemoresistance, metastasis, and immune suppression.<a onclick="showRef(event, 'ref26 ref27 ref28 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28 ref29 ref30 ref31">(26−31)</a> Consistent with this, high levels of A<sub>2B</sub>AR are generally associated with worse prognosis in several cancer types.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Comparative analysis has shown that the A<sub>2B</sub>AR is particularly highly expressed in human prostate cancer tissues as compared to prostatic healthy tissues.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Recent studies employing <b>PSB603</b><a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, compound 1), a selective sub-nanomolar A<sub>2B</sub>AR antagonist, documented its antitumor effect in PCa cells<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and also the suppression of tumor growth and metastasis by inhibiting induction of regulatory T cells.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Moreover, data emerging from the study of the adenosine check point in cancer immunotherapy are progressively demonstrating highly relevant functions for the A<sub>2B</sub>AR.<a onclick="showRef(event, 'ref25 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref25 ref28 ref29">(25,28,29)</a> Accordingly, A<sub>2B</sub>AR antagonists are emerging as promising anticancer agents that can take advantage of the central roles of adenosine in the tumor microenvironment.<a onclick="showRef(event, 'ref25 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref25 ref28 ref29">(25,28,29)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of representative A<sub>2B</sub>AR antagonists.<a onclick="showRef(event, 'ref34 ref35 ref36 ref37 ref38 ref39 ref40 ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36 ref37 ref38 ref39 ref40 ref41 ref42 ref43">(34−43)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The elucidation of the functional roles and therapeutic potential of the A<sub>2B</sub>AR has been partially hampered by the limited availability of potent and specific ligands and molecular probes.<a onclick="showRef(event, 'ref44 ref45 ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref44 ref45 ref46 ref47 ref48">(44−48)</a> While some compounds have reached clinical trials,<a onclick="showRef(event, 'ref25 ref46'); return false;" href="javascript:void(0);" class="ref ref25 ref46">(25,46)</a> the chemical space explored by the current A<sub>2B</sub>AR agonists is still limited,<a onclick="showRef(event, 'ref44 ref45 ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref44 ref45 ref46 ref47 ref48">(44−48)</a> and the best characterized A<sub>2B</sub>AR antagonists are mainly xanthine congeners (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref34 ref35 ref36 ref37 ref38 ref39 ref40 ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36 ref37 ref38 ref39 ref40 ref41 ref42 ref43">(34−43)</a> Hence, novel prototypic structures providing unexplored topologies, physicochemical features, and alternative binding modes are in demand.<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46,47)</a> In this scenario, we recently documented novel series of potent A<sub>2B</sub>AR antagonists assembled by a Biginelli multicomponent approach (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, cpds <b>9–12</b>).<a onclick="showRef(event, 'ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43">(41−43)</a> The chiral center in these chemotypes imposes critical topological features, differentiating themselves from classical A<sub>2B</sub>AR ligands and modifying their biological profile from quantitative and qualitative points of view. Thus, in addition to its low nanomolar affinities and selectivity, their antagonistic effect is mediated by a previously unexplored stereospecific recognition at the A<sub>2B</sub>AR.<a onclick="showRef(event, 'ref42 ref43 ref49'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref49">(42,43,49)</a></div><div class="NLM_p last">In this work, we report an exhaustive exploration of the structural determinants governing the A<sub>2B</sub>AR antagonistic effect of the 3,4-dihydropyrimidin-2(1<i>H</i>)-one (DHPM) scaffold (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, cmpd <b>11</b>), discovered by our group together with the analogous series of 3,4-dihydropyrimidin-2(1<i>H</i>)-thiones (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, cmpd <b>12</b>).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> A large library, consisting of 160 derivatives, was conceived to assess the contribution of the diverse positions in the heterocyclic core, with particular emphasis in the exploration of bioisosteric replacements for the ester function at position 5. The study also included the elucidation of the structure–activity relationship (SAR) and assessment of the initially proposed enantiospecific recognition at the A<sub>2B</sub>AR by computational modeling using intensive free energy perturbation (FEP) calculations. The impact of the stereochemistry at position 4 in these series was confirmed by separation of the two most potent ligands (<b>38</b> and <b>47</b>) into their enantiomers, followed by pharmacological evaluation confirming the enantiospecific binding to the A<sub>2B</sub>AR. Finally, a preliminary exploration of the antitumoral potential of ligands <b>38</b> and <b>47</b> demonstrated a potent antimigratory effect in three cellular models of PCa.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35626" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35626" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Design</h3><div class="NLM_p">Our early report, documenting the original A<sub>2B</sub>AR antagonistic effect of 34 DHPMs, included a preliminary exploration of some SAR trends and the proposal of a binding mode for this scaffold.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> In subsequent studies, we focused on the evaluation of different points of variability around the DHPM scaffold. The definition of the optimal substituents in R<sub>4</sub><a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> was soon followed by scaffold hoping, investigating the effect of fusing other heterocycles at positions 2 and 3 of the pyrimidin-2-one core (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, panel A)<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and the impact of bioisosteric replacements at either position 2 or 3 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, panel A).<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41,42)</a> The SAR data accumulated in these studies was rationalized on the basis of the A<sub>2B</sub>AR stereoselective binding mode originally proposed by us<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> and constituted the basis to guide the design of 136 new DHPMs, herein synthesized and characterized, which we have now divided into nine series (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, panel B). The integrated synthesis, binding data, SAR, and computational studies of the complete ligand library are described in this manuscript. Three initial subsets (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, panel B, series <b>I–III</b>) were conceived to complement the SAR exploration of our original report,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> by modification of the substituents at positions 1, 2, 4, and 5 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, panel B). The diversity of space explored was envisaged to assess distinctive structural features (e.g. electronic, steric, or lipo/hydrophilic) within the heterocyclic core (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). These include the replacement of 3,4-dihydropyrimidin-2(1<i>H</i>)-one/thione (series <b>I/II</b>, respectively, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> panel B) and the methylation of N<sub>1</sub> (series <b>III</b>). Since the introduction of aryl, alkyl, or cycloalkyl groups at R<sub>4</sub> produced inactive compounds,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> we maintained the original set of pentagonal heteroaryl group (e.g. 2-furyl, 3-furyl and 2-thienyl, and 3-thienyl) characteristics of the ligands with highest A<sub>2B</sub>AR affinity. For these three early subsets (<b>I–III</b>), seven alkyl residues (Me, Et, Pr, <i>i</i>-Pr, <i>i</i>-Bu, <i>t</i>-Bu, and Bn) were explored in the ester function (R<sub>5</sub>). Series <b>IV–IX</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> panel B) were designed to complete the evaluation of the influence of R<sub>5</sub> on the A<sub>2B</sub>AR affinity and AR selectivity profiles. The design of each subset was conceived to analyze different bioisosteric replacements (subsets <b>IV</b>, <b>V</b>, <b>VI</b>, and <b>VII</b>). We then moved to evaluate the effect of cycle creation with series <b>VIII</b>. Finally, as the biological evaluation of series <b>IV–VIII</b> unequivocally identified an aliphatic ester as the optimum group in R<sub>5</sub>, a new subset (<b>IX</b>) was designed to expand the diversity of the alkoxy group in the ester on this position (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, panel B).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. General structure of previously explored chemotypes (panel A) and novel series herein documented (panel B, series <b>I–IX</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry</h3><div class="NLM_p">The library, consisting of 160 AR ligands (cpds <b>16–99</b> and <b>105–180</b>), was assembled by following different experimental protocols based on the highly reliable Biginelli three-component reaction.<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51,52)</a> The experimental conditions of the synthetic pathways are depicted in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<named-content content-type="anchor" rid="sch2" type="simple"></named-content><a class="ref internalNav" href="#sch3" aria-label="3">3</a>. In a typical experiment, the urea derivative (<b>13a–c</b>) was combined with a pentagonal heterocyclic aldehyde (<b>14a–d</b>), a methylene-activated carbonyl compound [e.g. keto-esters (<b>15a–n</b>), diketones (<b>100a–d</b>), keto-amides (<b>101a–d</b>), keto-thioesters (<b>102a–b</b>), keto-phosphonate (<b>103</b>) or keto-1,3-oxazole (<b>104</b>)], and the appropriate catalyst. The reaction mixture was heated at 80 °C during variable reaction times (6–24 h). Due to the reactivity differences among the methylene-activated carbonyl compounds (<b>15</b>, <b>100</b>, <b>101</b>, <b>102</b>, <b>103</b>, and <b>104</b>) and being aware that the efficiency of the Biginelli reaction is dependent of the catalyst employed,<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51,52)</a> the optimal catalyst for each series was identified during preliminary experiments (<a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Targeted pyrimidine derivatives (<b>16–99</b> and <b>105–180</b>) were obtained in variable yields (37–90%) after appropriate purification (i.e. chromatographic methods or recrystallization).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 3,4-Dihydropyrimidin-2-one/thione Series <b>I–III</b> (Cpds <b>16–99</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 3,4-Dihydropyrimidin-2-one Series <b>IV–VI</b> (Cpds <b>105–144</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 3,4-Dihydropyrimidin-2-one Series <b>VII–IX</b> (Cpds <b>145–180</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The synthesized compounds were organized in nine subsets (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, panel B); the structures are depicted in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<named-content content-type="anchor" rid="tbl2" type="simple"></named-content><named-content content-type="anchor" rid="tbl3" type="simple"></named-content><named-content content-type="anchor" rid="tbl4" type="simple"></named-content><named-content content-type="anchor" rid="tbl5" type="simple"></named-content><named-content content-type="anchor" rid="tbl6" type="simple"></named-content><named-content content-type="anchor" rid="tbl7" type="simple"></named-content><a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>. Within the first three series (<b>I</b>, <b>II</b>, and <b>III</b>), 8 out of the 28 compounds within each subset correspond to previously reported compounds (denoted with an asterisk in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and the corresponding references included in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01431/suppl_file/jm0c01431_si_002.pdf" class="ext-link">Supporting Information</a>). Series <b>IV–IX</b> contained 16, 16, 8, 4, 4, and 28 new ligands, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Tables <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). As in previous studies,<a onclick="showRef(event, 'ref41 ref42 ref43 ref49'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43 ref49">(41−43,49)</a> all ligands were tested as racemic mixtures and this data constituted the basis to explore the SAR. Thereafter, the most appealing A<sub>2B</sub>AR antagonists were separated into its enantiomers, their configuration was established by circular dichroism (CD), and then, its binding affinity at all four Ars was evaluated for each stereoisomer. A full account of the synthesis, structural, and characterization data for all compounds is provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01431/suppl_file/jm0c01431_si_001.csv" class="ext-link">Supporting Information</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structure and Binding Data for the 3,4-Dihydropyridin-2(1<i>H</i>)-ones <b>16–43</b> at the hARs (Subset <b>I</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0015.gif" alt="" id="GRAPHIC-d7e1170-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center"><i>K</i><sub>i</sub> (nM) or % at 1 μM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center">R<sub>5</sub></th><th class="colsep0 rowsep0" align="center">hA<sub>1</sub><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">hA<sub>2A</sub><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">hA<sub>2B</sub><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">hA<sub>3</sub><a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">34%</td><td class="colsep0 rowsep0" align="left">25%</td><td class="colsep0 rowsep0" align="left">2159 ± 232</td><td class="colsep0 rowsep0" align="left">13%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">15%</td><td class="colsep0 rowsep0" align="left">31%</td><td class="colsep0 rowsep0" align="left">585 ± 89</td><td class="colsep0 rowsep0" align="left">2%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="left"><i>n</i>-Pr</td><td class="colsep0 rowsep0" align="left">43%</td><td class="colsep0 rowsep0" align="left">55%</td><td class="colsep0 rowsep0" align="left">206 ± 11</td><td class="colsep0 rowsep0" align="left">3%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (<b>SYAF014</b>)</td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">18%</td><td class="colsep0 rowsep0" align="left">23%</td><td class="colsep0 rowsep0" align="left">40.8 ± 2.3</td><td class="colsep0 rowsep0" align="left">4%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Bu</td><td class="colsep0 rowsep0" align="left">27%</td><td class="colsep0 rowsep0" align="left">36%</td><td class="colsep0 rowsep0" align="left">199 ± 11</td><td class="colsep0 rowsep0" align="left">13%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="left"><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="left">4%</td><td class="colsep0 rowsep0" align="left">7%</td><td class="colsep0 rowsep0" align="left">44%</td><td class="colsep0 rowsep0" align="left">7%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left">36%</td><td class="colsep0 rowsep0" align="left">26%</td><td class="colsep0 rowsep0" align="left">887 ± 30</td><td class="colsep0 rowsep0" align="left">3%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">3-furyl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">8%</td><td class="colsep0 rowsep0" align="left">3%</td><td class="colsep0 rowsep0" align="left">42%</td><td class="colsep0 rowsep0" align="left">2%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (<b>SYAF101</b>)</td><td class="colsep0 rowsep0" align="left">3-furyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">21%</td><td class="colsep0 rowsep0" align="left">24%</td><td class="colsep0 rowsep0" align="left">39.6 ± 1.1</td><td class="colsep0 rowsep0" align="left">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">3-furyl</td><td class="colsep0 rowsep0" align="left"><i>n</i>-Pr</td><td class="colsep0 rowsep0" align="left">50%</td><td class="colsep0 rowsep0" align="left">45%</td><td class="colsep0 rowsep0" align="left">1192 ± 107</td><td class="colsep0 rowsep0" align="left">11%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="left">3-furyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">25%</td><td class="colsep0 rowsep0" align="left">26%</td><td class="colsep0 rowsep0" align="left">1486 ± 62</td><td class="colsep0 rowsep0" align="left">3%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">3-furyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Bu</td><td class="colsep0 rowsep0" align="left">3088 ± 88</td><td class="colsep0 rowsep0" align="left">31%</td><td class="colsep0 rowsep0" align="left">326 ± 7</td><td class="colsep0 rowsep0" align="left">16%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b><a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></td><td class="colsep0 rowsep0" align="left">3-furyl</td><td class="colsep0 rowsep0" align="left"><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="left">11%</td><td class="colsep0 rowsep0" align="left">9%</td><td class="colsep0 rowsep0" align="left">4436 ± 182</td><td class="colsep0 rowsep0" align="left">2%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">3-furyl</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left">41%</td><td class="colsep0 rowsep0" align="left">24%</td><td class="colsep0 rowsep0" align="left">6650 ± 210</td><td class="colsep0 rowsep0" align="left">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b><a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></td><td class="colsep0 rowsep0" align="left">2-thienyl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">6%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">19%</td><td class="colsep0 rowsep0" align="left">3%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="left">2-thienyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">33%</td><td class="colsep0 rowsep0" align="left">41%</td><td class="colsep0 rowsep0" align="left">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">2-thienyl</td><td class="colsep0 rowsep0" align="left"><i>n</i>-Pr</td><td class="colsep0 rowsep0" align="left">43%</td><td class="colsep0 rowsep0" align="left">30%</td><td class="colsep0 rowsep0" align="left">1519 ± 117</td><td class="colsep0 rowsep0" align="left">32%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="left">2-thienyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">37%</td><td class="colsep0 rowsep0" align="left">19%</td><td class="colsep0 rowsep0" align="left">44%</td><td class="colsep0 rowsep0" align="left">14%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">2-thienyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Bu</td><td class="colsep0 rowsep0" align="left">25%</td><td class="colsep0 rowsep0" align="left">12%</td><td class="colsep0 rowsep0" align="left">2130 ± 88</td><td class="colsep0 rowsep0" align="left">11%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b><a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></td><td class="colsep0 rowsep0" align="left">2-thienyl</td><td class="colsep0 rowsep0" align="left"><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="left">26%</td><td class="colsep0 rowsep0" align="left">10%</td><td class="colsep0 rowsep0" align="left">38%</td><td class="colsep0 rowsep0" align="left">7%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b><a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></td><td class="colsep0 rowsep0" align="left">2-thienyl</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left">45%</td><td class="colsep0 rowsep0" align="left">30%</td><td class="colsep0 rowsep0" align="left">1916 ± 110</td><td class="colsep0 rowsep0" align="left">8%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b><a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></td><td class="colsep0 rowsep0" align="left">3-thienyl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">7%</td><td class="colsep0 rowsep0" align="left">2%</td><td class="colsep0 rowsep0" align="left">36%</td><td class="colsep0 rowsep0" align="left">3%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (<b>SYAF080</b>)</td><td class="colsep0 rowsep0" align="left">3-thienyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">16%</td><td class="colsep0 rowsep0" align="left">34%</td><td class="colsep0 rowsep0" align="left">23.6 ± 1.0</td><td class="colsep0 rowsep0" align="left">11%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">3-thienyl</td><td class="colsep0 rowsep0" align="left"><i>n</i>-Pr</td><td class="colsep0 rowsep0" align="left">44%</td><td class="colsep0 rowsep0" align="left">48%</td><td class="colsep0 rowsep0" align="left">201 ± 3</td><td class="colsep0 rowsep0" align="left">6%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (<b>SYAF020</b>)</td><td class="colsep0 rowsep0" align="left">3-thienyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">26%</td><td class="colsep0 rowsep0" align="left">25%</td><td class="colsep0 rowsep0" align="left">56.6 ± 1.3</td><td class="colsep0 rowsep0" align="left">5%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">3-thienyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Bu</td><td class="colsep0 rowsep0" align="left">56%</td><td class="colsep0 rowsep0" align="left">37%</td><td class="colsep0 rowsep0" align="left">1188 ± 110</td><td class="colsep0 rowsep0" align="left">21%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b><a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></td><td class="colsep0 rowsep0" align="left">3-thienyl</td><td class="colsep0 rowsep0" align="left"><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="left">15%</td><td class="colsep0 rowsep0" align="left">5%</td><td class="colsep0 rowsep0" align="left">47%</td><td class="colsep0 rowsep0" align="left">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">3-thienyl</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left">57%</td><td class="colsep0 rowsep0" align="left">21%</td><td class="colsep0 rowsep0" align="left">44%</td><td class="colsep0 rowsep0" align="left">25%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>ISAM-140</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">20%</td><td class="colsep0 rowsep0" align="left">25%</td><td class="colsep0 rowsep0" align="left">3.49 ± 0.2</td><td class="colsep0 rowsep0" align="left">2%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>ZM241385</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">683 ± 4</td><td class="colsep0 rowsep0" align="left">1.9 ± 0.1</td><td class="colsep0 rowsep0" align="left">65.7 ± 1.7</td><td class="colsep0 rowsep0" align="left">863 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>DPCPX</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2.20 ± 0.2</td><td class="colsep0 rowsep0" align="left">157 ± 2.9</td><td class="colsep0 rowsep0" align="left">73.24 ± 2.0</td><td class="colsep0 rowsep0" align="left">1722 ± 11</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last"><i>n</i> = 3 for <i>K</i><sub>i</sub> values, or <i>n</i> = 2 for percentage displacement of specific binding.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]DPCPX binding in adenosine A<sub>1</sub> receptors expressed in human CHO cells.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Displacement of specific [3]ZM2421385 binding in adenosine A<sub>2A</sub> receptors expressed in human HeLa cells.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]DPCPX binding in human HEK-293 cells.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]NECA binding in adenosine A<sub>3</sub> receptors expressed in human HeLa cells.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Structure and Binding Data for the 3,4-Dihydropyridin-2(1<i>H</i>)-thiones <b>44–71</b> at the hARs (Subset <b>II</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0016.gif" alt="" id="GRAPHIC-d7e2160-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center"><i>K</i><sub>i</sub> (nM) or % at 1 μM<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center">R<sub>5</sub></th><th class="colsep0 rowsep0" align="center">hA<sub>1</sub><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">hA<sub>2A</sub><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">hA<sub>2B</sub><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">hA<sub>3</sub><a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b><a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></td><td class="colsep0 rowsep0" align="center">2-furyl</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center">11%</td><td class="colsep0 rowsep0" align="center">20%</td><td class="colsep0 rowsep0" align="center">984 ± 52</td><td class="colsep0 rowsep0" align="center">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="center">2-furyl</td><td class="colsep0 rowsep0" align="center">Et</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">32%</td><td class="colsep0 rowsep0" align="center">608 ± 31</td><td class="colsep0 rowsep0" align="center">5%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="center">2-furyl</td><td class="colsep0 rowsep0" align="center"><i>n</i>-Pr</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">2%</td><td class="colsep0 rowsep0" align="center">46%</td><td class="colsep0 rowsep0" align="center">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (<b>SYAF030</b>)</td><td class="colsep0 rowsep0" align="center">2-furyl</td><td class="colsep0 rowsep0" align="center"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="center">15%</td><td class="colsep0 rowsep0" align="center">18%</td><td class="colsep0 rowsep0" align="center">10.2 ± 0.5</td><td class="colsep0 rowsep0" align="center">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="center">2-furyl</td><td class="colsep0 rowsep0" align="center"><i>i</i>-Bu</td><td class="colsep0 rowsep0" align="center">7%</td><td class="colsep0 rowsep0" align="center">30%</td><td class="colsep0 rowsep0" align="center">18%</td><td class="colsep0 rowsep0" align="center">10%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="center">2-furyl</td><td class="colsep0 rowsep0" align="center"><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="center">3%</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">9%</td><td class="colsep0 rowsep0" align="center">9%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="center">2-furyl</td><td class="colsep0 rowsep0" align="center">Bn</td><td class="colsep0 rowsep0" align="center">32%</td><td class="colsep0 rowsep0" align="center">12%</td><td class="colsep0 rowsep0" align="center">41%</td><td class="colsep0 rowsep0" align="center">4%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="center">3-furyl</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center">25%</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">48%</td><td class="colsep0 rowsep0" align="center">3%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="center">3-furyl</td><td class="colsep0 rowsep0" align="center">Et</td><td class="colsep0 rowsep0" align="center">18%</td><td class="colsep0 rowsep0" align="center">25%</td><td class="colsep0 rowsep0" align="center">43.1 ± 1.6</td><td class="colsep0 rowsep0" align="center">15%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="center">3-furyl</td><td class="colsep0 rowsep0" align="center"><i>n</i>-Pr</td><td class="colsep0 rowsep0" align="center">4%</td><td class="colsep0 rowsep0" align="center">2%</td><td class="colsep0 rowsep0" align="center">45%</td><td class="colsep0 rowsep0" align="center">3%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="center">3-furyl</td><td class="colsep0 rowsep0" align="center"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="center">18%</td><td class="colsep0 rowsep0" align="center">33%</td><td class="colsep0 rowsep0" align="center">194 ± 12</td><td class="colsep0 rowsep0" align="center">23%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="center">3-furyl</td><td class="colsep0 rowsep0" align="center"><i>i</i>-Bu</td><td class="colsep0 rowsep0" align="center">12%</td><td class="colsep0 rowsep0" align="center">35%</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="center">3-furyl</td><td class="colsep0 rowsep0" align="center"><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="center">18%</td><td class="colsep0 rowsep0" align="center">15%</td><td class="colsep0 rowsep0" align="center">1893 ± 88</td><td class="colsep0 rowsep0" align="center">19%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="center">3-furyl</td><td class="colsep0 rowsep0" align="center">Bn</td><td class="colsep0 rowsep0" align="center">25%</td><td class="colsep0 rowsep0" align="center">16%</td><td class="colsep0 rowsep0" align="center">36%</td><td class="colsep0 rowsep0" align="center">20%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="center">2-thienyl</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">10%</td><td class="colsep0 rowsep0" align="center">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="center">2-thienyl</td><td class="colsep0 rowsep0" align="center">Et</td><td class="colsep0 rowsep0" align="center">2%</td><td class="colsep0 rowsep0" align="center">23%</td><td class="colsep0 rowsep0" align="center">3247 ± 101</td><td class="colsep0 rowsep0" align="center">4%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b><a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></td><td class="colsep0 rowsep0" align="center">2-thienyl</td><td class="colsep0 rowsep0" align="center"><i>n</i>-Pr</td><td class="colsep0 rowsep0" align="center">7%</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">3%</td><td class="colsep0 rowsep0" align="center">10%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="center">2-thienyl</td><td class="colsep0 rowsep0" align="center"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="center">23%</td><td class="colsep0 rowsep0" align="center">15%</td><td class="colsep0 rowsep0" align="center">1572 ± 93</td><td class="colsep0 rowsep0" align="center">20%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b><a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></td><td class="colsep0 rowsep0" align="center">2-thienyl</td><td class="colsep0 rowsep0" align="center"><i>i</i>-Bu</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">2%</td><td class="colsep0 rowsep0" align="center">12%</td><td class="colsep0 rowsep0" align="center">4%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63</b></td><td class="colsep0 rowsep0" align="center">2-thienyl</td><td class="colsep0 rowsep0" align="center"><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="center">22%</td><td class="colsep0 rowsep0" align="center">7%</td><td class="colsep0 rowsep0" align="center">26%</td><td class="colsep0 rowsep0" align="center">22%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64</b><a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></td><td class="colsep0 rowsep0" align="center">2-thienyl</td><td class="colsep0 rowsep0" align="center">Bn</td><td class="colsep0 rowsep0" align="center">34%</td><td class="colsep0 rowsep0" align="center">63%</td><td class="colsep0 rowsep0" align="center">45%</td><td class="colsep0 rowsep0" align="center">24%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>65</b></td><td class="colsep0 rowsep0" align="center">3-thienyl</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center">3%</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">38%</td><td class="colsep0 rowsep0" align="center">3%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>66</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="center">3-thienyl</td><td class="colsep0 rowsep0" align="center">Et</td><td class="colsep0 rowsep0" align="center">23%</td><td class="colsep0 rowsep0" align="center">28%</td><td class="colsep0 rowsep0" align="center">1103 ± 94</td><td class="colsep0 rowsep0" align="center">2%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>67</b></td><td class="colsep0 rowsep0" align="center">3-thienyl</td><td class="colsep0 rowsep0" align="center"><i>n</i>-Pr</td><td class="colsep0 rowsep0" align="center">5%</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">26%</td><td class="colsep0 rowsep0" align="center">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="center">3-thienyl</td><td class="colsep0 rowsep0" align="center"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="center">16%</td><td class="colsep0 rowsep0" align="center">20%</td><td class="colsep0 rowsep0" align="center">315 ± 7</td><td class="colsep0 rowsep0" align="center">3%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="center">3-thienyl</td><td class="colsep0 rowsep0" align="center"><i>i</i>-Bu</td><td class="colsep0 rowsep0" align="center">8%</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">15%</td><td class="colsep0 rowsep0" align="center">2%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>70</b></td><td class="colsep0 rowsep0" align="center">3-thienyl</td><td class="colsep0 rowsep0" align="center"><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="center">16%</td><td class="colsep0 rowsep0" align="center">22%</td><td class="colsep0 rowsep0" align="center">26%</td><td class="colsep0 rowsep0" align="center">16%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>71</b></td><td class="colsep0 rowsep0" align="center">3-thienyl</td><td class="colsep0 rowsep0" align="center">Bn</td><td class="colsep0 rowsep0" align="center">3%</td><td class="colsep0 rowsep0" align="center">16%</td><td class="colsep0 rowsep0" align="center">10%</td><td class="colsep0 rowsep0" align="center">2%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>ISAM-140</b></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">20%</td><td class="colsep0 rowsep0" align="center">25%</td><td class="colsep0 rowsep0" align="center">3.49 ± 0.2</td><td class="colsep0 rowsep0" align="center">2%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>ZM241385</b></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">683 ± 4</td><td class="colsep0 rowsep0" align="center">1.9 ± 0.1</td><td class="colsep0 rowsep0" align="center">65.7 ± 1.7</td><td class="colsep0 rowsep0" align="center">863 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>DPCPX</b></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">2.20 ± 0.2</td><td class="colsep0 rowsep0" align="center">157 ± 2.9</td><td class="colsep0 rowsep0" align="center">73.24 ± 2.0</td><td class="colsep0 rowsep0" align="center">1722 ± 11</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last"><i>n</i> = 3 for <i>K</i><sub>i</sub> values, or <i>n</i> = 2 for percentage displacement of specific binding.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]DPCPX binding in adenosine A<sub>1</sub> receptors expressed in human CHO cells.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Displacement of specific [3]ZM2421385 binding in adenosine A<sub>2A</sub> receptors expressed in human HeLa cells.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]DPCPX binding in human HEK-293 cells.</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]NECA binding in adenosine A<sub>3</sub> receptors expressed in human HeLa cells.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Structure and Binding Data for the 3,4-Dihydropyridin-2(1<i>H</i>)-ones <b>72–99</b> at the hARs (Subset <b>III</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0017.gif" alt="" id="GRAPHIC-d7e3124-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center"><i>K</i><sub>i</sub> (nM) or % at 1 μM<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center">R<sub>5</sub></th><th class="colsep0 rowsep0" align="center">hA<sub>1</sub><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">hA<sub>2A</sub><a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">hA<sub>2B</sub><a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">hA<sub>3</sub><a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>72</b></td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">45%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">31%</td><td class="colsep0 rowsep0" align="left">9%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>73</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">17%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">6544 ± 101</td><td class="colsep0 rowsep0" align="left">25%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>74</b></td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="left"><i>n</i>-Pr</td><td class="colsep0 rowsep0" align="left">3%</td><td class="colsep0 rowsep0" align="left">2%</td><td class="colsep0 rowsep0" align="left">23%</td><td class="colsep0 rowsep0" align="left">8%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>75</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">29%</td><td class="colsep0 rowsep0" align="left">37%</td><td class="colsep0 rowsep0" align="left">1151 ± 23</td><td class="colsep0 rowsep0" align="left">18%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>76</b></td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Bu</td><td class="colsep0 rowsep0" align="left">13%</td><td class="colsep0 rowsep0" align="left">3%</td><td class="colsep0 rowsep0" align="left">4%</td><td class="colsep0 rowsep0" align="left">23%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>77</b></td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="left"><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="left">44%</td><td class="colsep0 rowsep0" align="left">20%</td><td class="colsep0 rowsep0" align="left">26%</td><td class="colsep0 rowsep0" align="left">54%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>78</b></td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left">1736 ± 89</td><td class="colsep0 rowsep0" align="left">37%</td><td class="colsep0 rowsep0" align="left">41%</td><td class="colsep0 rowsep0" align="left">11%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>79</b></td><td class="colsep0 rowsep0" align="left">3-furyl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">15%</td><td class="colsep0 rowsep0" align="left">5%</td><td class="colsep0 rowsep0" align="left">7%</td><td class="colsep0 rowsep0" align="left">7%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>80</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="left">3-furyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">17%</td><td class="colsep0 rowsep0" align="left">24%</td><td class="colsep0 rowsep0" align="left">4259 ± 95</td><td class="colsep0 rowsep0" align="left">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>81</b></td><td class="colsep0 rowsep0" align="left">3-furyl</td><td class="colsep0 rowsep0" align="left"><i>n</i>-Pr</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">2%</td><td class="colsep0 rowsep0" align="left">16%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>82</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="left">3-furyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">23%</td><td class="colsep0 rowsep0" align="left">2%</td><td class="colsep0 rowsep0" align="left">37%</td><td class="colsep0 rowsep0" align="left">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>83</b></td><td class="colsep0 rowsep0" align="left">3-furyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Bu</td><td class="colsep0 rowsep0" align="left">4%</td><td class="colsep0 rowsep0" align="left">4%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">16%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>84</b></td><td class="colsep0 rowsep0" align="left">3-furyl</td><td class="colsep0 rowsep0" align="left"><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="left">21%</td><td class="colsep0 rowsep0" align="left">16%</td><td class="colsep0 rowsep0" align="left">16%</td><td class="colsep0 rowsep0" align="left">12%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>85</b></td><td class="colsep0 rowsep0" align="left">3-furyl</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left">51%</td><td class="colsep0 rowsep0" align="left">37%</td><td class="colsep0 rowsep0" align="left">49%</td><td class="colsep0 rowsep0" align="left">25%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>86</b><a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></td><td class="colsep0 rowsep0" align="left">2-thienyl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">30%</td><td class="colsep0 rowsep0" align="left">49%</td><td class="colsep0 rowsep0" align="left">17%</td><td class="colsep0 rowsep0" align="left">15%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>87</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="left">2-thienyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">11%</td><td class="colsep0 rowsep0" align="left">2%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>88</b></td><td class="colsep0 rowsep0" align="left">2-thienyl</td><td class="colsep0 rowsep0" align="left"><i>n</i>-Pr</td><td class="colsep0 rowsep0" align="left">9%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">4%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>89</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="left">2-thienyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">22%</td><td class="colsep0 rowsep0" align="left">24%</td><td class="colsep0 rowsep0" align="left">28%</td><td class="colsep0 rowsep0" align="left">17%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>90</b></td><td class="colsep0 rowsep0" align="left">2-thienyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Bu</td><td class="colsep0 rowsep0" align="left">9%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">2%</td><td class="colsep0 rowsep0" align="left">5%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>91</b></td><td class="colsep0 rowsep0" align="left">2-thienyl</td><td class="colsep0 rowsep0" align="left"><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="left">18%</td><td class="colsep0 rowsep0" align="left">12%</td><td class="colsep0 rowsep0" align="left">24%</td><td class="colsep0 rowsep0" align="left">22%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>92</b></td><td class="colsep0 rowsep0" align="left">2-thienyl</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left">50%</td><td class="colsep0 rowsep0" align="left">3%</td><td class="colsep0 rowsep0" align="left">50%</td><td class="colsep0 rowsep0" align="left">18%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>93</b></td><td class="colsep0 rowsep0" align="left">3-thienyl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">24%</td><td class="colsep0 rowsep0" align="left">13%</td><td class="colsep0 rowsep0" align="left">26%</td><td class="colsep0 rowsep0" align="left">22%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>94</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="left">3-thienyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">32%</td><td class="colsep0 rowsep0" align="left">23%</td><td class="colsep0 rowsep0" align="left">53%</td><td class="colsep0 rowsep0" align="left">3%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>95</b></td><td class="colsep0 rowsep0" align="left">3-thienyl</td><td class="colsep0 rowsep0" align="left"><i>n</i>-Pr</td><td class="colsep0 rowsep0" align="left">2%</td><td class="colsep0 rowsep0" align="left">3%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">11%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>96</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="left">3-thienyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">35%</td><td class="colsep0 rowsep0" align="left">22%</td><td class="colsep0 rowsep0" align="left">51%</td><td class="colsep0 rowsep0" align="left">14%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>97</b></td><td class="colsep0 rowsep0" align="left">3-thienyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Bu</td><td class="colsep0 rowsep0" align="left">8%</td><td class="colsep0 rowsep0" align="left">2%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">4%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>98</b></td><td class="colsep0 rowsep0" align="left">3-thienyl</td><td class="colsep0 rowsep0" align="left"><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="left">18%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">35%</td><td class="colsep0 rowsep0" align="left">14%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>99</b></td><td class="colsep0 rowsep0" align="left">3-thienyl</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left">46%</td><td class="colsep0 rowsep0" align="left">30%</td><td class="colsep0 rowsep0" align="left">4521 ± 79</td><td class="colsep0 rowsep0" align="left">14%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>ISAM-140</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">20%</td><td class="colsep0 rowsep0" align="left">25%</td><td class="colsep0 rowsep0" align="left">3.49 ± 0.2</td><td class="colsep0 rowsep0" align="left">2%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>ZM241385</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">683 ± 4</td><td class="colsep0 rowsep0" align="left">1.9 ± 0.1</td><td class="colsep0 rowsep0" align="left">65.7 ± 1.7</td><td class="colsep0 rowsep0" align="left">863 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>DPCPX</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2.20 ± 0.2</td><td class="colsep0 rowsep0" align="left">157 ± 2.9</td><td class="colsep0 rowsep0" align="left">73.24 ± 2.0</td><td class="colsep0 rowsep0" align="left">1722 ± 11</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last"><i>n</i> = 3 for <i>K</i><sub>i</sub> values, or <i>n</i> = 2 for percentage displacement of specific binding.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]DPCPX binding in adenosine A<sub>1</sub> receptors expressed in human CHO cells.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Displacement of specific [3]ZM2421385 binding in adenosine A<sub>2A</sub> receptors expressed in human HeLa cells.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]DPCPX binding in human HEK-293 cells.</p></div><div class="footnote" id="t3fn5"><sup><sup>e</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]NECA binding in adenosine A<sub>3</sub> receptors expressed in human HeLa cells.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Structure and Binding Data for the 3,4-Dihydropyridin-2(1<i>H</i>)-ones <b>105–120</b> at the hARs (Subset <b>IV</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0018.gif" alt="" id="GRAPHIC-d7e4076-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center"><i>K</i><sub>i</sub> (nM) or % at 1 μM<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center">R<sub>5</sub></th><th class="colsep0 rowsep0" align="center">hA<sub>1</sub><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">hA<sub>2A</sub><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">hA<sub>2B</sub><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">hA<sub>3</sub><a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>105</b><a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">30%</td><td class="colsep0 rowsep0" align="left">21%</td><td class="colsep0 rowsep0" align="left">38%</td><td class="colsep0 rowsep0" align="left">14%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>106</b></td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="left"><i>c</i>-Pr</td><td class="colsep0 rowsep0" align="left">2%</td><td class="colsep0 rowsep0" align="left">2%</td><td class="colsep0 rowsep0" align="left">1062 ± 29</td><td class="colsep0 rowsep0" align="left">7%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>107</b></td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="left"><i>n</i>-Pr</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">6%</td><td class="colsep0 rowsep0" align="left">807 ± 12</td><td class="colsep0 rowsep0" align="left">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>108</b></td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Bu</td><td class="colsep0 rowsep0" align="left">16%</td><td class="colsep0 rowsep0" align="left">6%</td><td class="colsep0 rowsep0" align="left">240 ± 5</td><td class="colsep0 rowsep0" align="left">31%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>109</b></td><td class="colsep0 rowsep0" align="left">3-furyl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">6%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">15%</td><td class="colsep0 rowsep0" align="left">2%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>110</b></td><td class="colsep0 rowsep0" align="left">3-furyl</td><td class="colsep0 rowsep0" align="left"><i>c</i>-Pr</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">10%</td><td class="colsep0 rowsep0" align="left">16%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>111</b></td><td class="colsep0 rowsep0" align="left">3-furyl</td><td class="colsep0 rowsep0" align="left"><i>n</i>-Pr</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">2%</td><td class="colsep0 rowsep0" align="left">22%</td><td class="colsep0 rowsep0" align="left">2%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>112</b></td><td class="colsep0 rowsep0" align="left">3-furyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Bu</td><td class="colsep0 rowsep0" align="left">23%</td><td class="colsep0 rowsep0" align="left">20%</td><td class="colsep0 rowsep0" align="left">1008 ± 25</td><td class="colsep0 rowsep0" align="left">18%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>113</b><a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></td><td class="colsep0 rowsep0" align="left">2-thienyl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">11%</td><td class="colsep0 rowsep0" align="left">2%</td><td class="colsep0 rowsep0" align="left">2%</td><td class="colsep0 rowsep0" align="left">3%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>114</b></td><td class="colsep0 rowsep0" align="left">2-thienyl</td><td class="colsep0 rowsep0" align="left"><i>c</i>-Pr</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">15%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>115</b></td><td class="colsep0 rowsep0" align="left">2-thienyl</td><td class="colsep0 rowsep0" align="left"><i>n</i>-Pr</td><td class="colsep0 rowsep0" align="left">2%</td><td class="colsep0 rowsep0" align="left">23%</td><td class="colsep0 rowsep0" align="left">9%</td><td class="colsep0 rowsep0" align="left">2%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>116</b></td><td class="colsep0 rowsep0" align="left">2-thienyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Bu</td><td class="colsep0 rowsep0" align="left">19%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">43%</td><td class="colsep0 rowsep0" align="left">18%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>117</b><a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></td><td class="colsep0 rowsep0" align="left">3-thienyl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">9%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">24%</td><td class="colsep0 rowsep0" align="left">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>118</b></td><td class="colsep0 rowsep0" align="left">3-thienyl</td><td class="colsep0 rowsep0" align="left"><i>c</i>-Pr</td><td class="colsep0 rowsep0" align="left">2%</td><td class="colsep0 rowsep0" align="left">4%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>119</b></td><td class="colsep0 rowsep0" align="left">3-thienyl</td><td class="colsep0 rowsep0" align="left"><i>n</i>-Pr</td><td class="colsep0 rowsep0" align="left">6%</td><td class="colsep0 rowsep0" align="left">11%</td><td class="colsep0 rowsep0" align="left">9%</td><td class="colsep0 rowsep0" align="left">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>120</b></td><td class="colsep0 rowsep0" align="left">3-thienyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Bu</td><td class="colsep0 rowsep0" align="left">37%</td><td class="colsep0 rowsep0" align="left">19%</td><td class="colsep0 rowsep0" align="left">1002 ± 11</td><td class="colsep0 rowsep0" align="left">14%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>ISAM-140</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">20%</td><td class="colsep0 rowsep0" align="left">25%</td><td class="colsep0 rowsep0" align="left">3.49 ± 0.2</td><td class="colsep0 rowsep0" align="left">2%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>ZM241385</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">683 ± 4</td><td class="colsep0 rowsep0" align="left">1.9 ± 0.1</td><td class="colsep0 rowsep0" align="left">65.7 ± 1.7</td><td class="colsep0 rowsep0" align="left">863 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>DPCPX</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2.20 ± 0.2</td><td class="colsep0 rowsep0" align="left">157 ± 2.9</td><td class="colsep0 rowsep0" align="left">73.24 ± 2.0</td><td class="colsep0 rowsep0" align="left">1722 ± 11</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last"><i>n</i> = 3 for <i>K</i><sub>i</sub> values, or <i>n</i> = 2 for percentage displacement of specific binding.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]DPCPX binding in adenosine A<sub>1</sub> receptors expressed in human CHO cells.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Displacement of specific [3]ZM2421385 binding in adenosine A<sub>2A</sub> receptors expressed in human HeLa cells.</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]DPCPX binding in human HEK-293 cells.</p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]NECA binding in adenosine A<sub>3</sub> receptors expressed in human HeLa cells.</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Structure and Binding Data for the 3,4-Dihydropyridin-2(1<i>H</i>)-ones <b>121–136</b> at the hARs (Subset <b>V</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0019.gif" alt="" id="GRAPHIC-d7e4721-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center"><i>K</i><sub>i</sub> (nM) or % at 1 μM<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center">R<sub>5</sub>, R<sub>5′</sub></th><th class="colsep0 rowsep0" align="center">hA<sub>1</sub><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">hA<sub>2A</sub><a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">hA<sub>2B</sub><a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">hA<sub>3</sub><a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>121</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="center">2-furyl</td><td class="colsep0 rowsep0" align="center">H, H</td><td class="colsep0 rowsep0" align="center">2%</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">2%</td><td class="colsep0 rowsep0" align="center">2%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>122</b></td><td class="colsep0 rowsep0" align="center">2-furyl</td><td class="colsep0 rowsep0" align="center">H, Et</td><td class="colsep0 rowsep0" align="center">2%</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">3%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>123</b></td><td class="colsep0 rowsep0" align="center">2-furyl</td><td class="colsep0 rowsep0" align="center">H, <i>i</i>-Pr</td><td class="colsep0 rowsep0" align="center">3%</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">2%</td><td class="colsep0 rowsep0" align="center">4%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>124</b></td><td class="colsep0 rowsep0" align="center">2-furyl</td><td class="colsep0 rowsep0" align="center">Et, Et</td><td class="colsep0 rowsep0" align="center">11%</td><td class="colsep0 rowsep0" align="center">9%</td><td class="colsep0 rowsep0" align="center">31%</td><td class="colsep0 rowsep0" align="center">19%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>125</b></td><td class="colsep0 rowsep0" align="center">3-furyl</td><td class="colsep0 rowsep0" align="center">H, H</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">3%</td><td class="colsep0 rowsep0" align="center">6%</td><td class="colsep0 rowsep0" align="center">2%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>126</b></td><td class="colsep0 rowsep0" align="center">3-furyl</td><td class="colsep0 rowsep0" align="center">H, Et</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">2%</td><td class="colsep0 rowsep0" align="center">2%</td><td class="colsep0 rowsep0" align="center">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>127</b></td><td class="colsep0 rowsep0" align="center">3-furyl</td><td class="colsep0 rowsep0" align="center">H, <i>i</i>-Pr</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">3%</td><td class="colsep0 rowsep0" align="center">3%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>128</b></td><td class="colsep0 rowsep0" align="center">3-furyl</td><td class="colsep0 rowsep0" align="center">Et, Et</td><td class="colsep0 rowsep0" align="center">15%</td><td class="colsep0 rowsep0" align="center">6%</td><td class="colsep0 rowsep0" align="center">12%</td><td class="colsep0 rowsep0" align="center">37%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>129</b></td><td class="colsep0 rowsep0" align="center">2-thienyl</td><td class="colsep0 rowsep0" align="center">H, H</td><td class="colsep0 rowsep0" align="center">2%</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">3%</td><td class="colsep0 rowsep0" align="center">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>130</b></td><td class="colsep0 rowsep0" align="center">2-thienyl</td><td class="colsep0 rowsep0" align="center">H, Et</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">4%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>131</b></td><td class="colsep0 rowsep0" align="center">2-thienyl</td><td class="colsep0 rowsep0" align="center">H, <i>i</i>-Pr</td><td class="colsep0 rowsep0" align="center">2%</td><td class="colsep0 rowsep0" align="center">22%</td><td class="colsep0 rowsep0" align="center">40%</td><td class="colsep0 rowsep0" align="center">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>132</b></td><td class="colsep0 rowsep0" align="center">2-thienyl</td><td class="colsep0 rowsep0" align="center">Et, Et</td><td class="colsep0 rowsep0" align="center">13%</td><td class="colsep0 rowsep0" align="center">15%</td><td class="colsep0 rowsep0" align="center">22%</td><td class="colsep0 rowsep0" align="center">31%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>133</b></td><td class="colsep0 rowsep0" align="center">3-thienyl</td><td class="colsep0 rowsep0" align="center">H, H</td><td class="colsep0 rowsep0" align="center">2%</td><td class="colsep0 rowsep0" align="center">18%</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>134</b></td><td class="colsep0 rowsep0" align="center">3-thienyl</td><td class="colsep0 rowsep0" align="center">H, Et</td><td class="colsep0 rowsep0" align="center">3%</td><td class="colsep0 rowsep0" align="center">17%</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>135</b></td><td class="colsep0 rowsep0" align="center">3-thienyl</td><td class="colsep0 rowsep0" align="center">H, <i>i</i>-Pr</td><td class="colsep0 rowsep0" align="center">8%</td><td class="colsep0 rowsep0" align="center">1%</td><td class="colsep0 rowsep0" align="center">3%</td><td class="colsep0 rowsep0" align="center">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>136</b></td><td class="colsep0 rowsep0" align="center">3-thienyl</td><td class="colsep0 rowsep0" align="center">Et, Et</td><td class="colsep0 rowsep0" align="center">11%</td><td class="colsep0 rowsep0" align="center">9%</td><td class="colsep0 rowsep0" align="center">11%</td><td class="colsep0 rowsep0" align="center">35%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>ISAM-140</b></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">20%</td><td class="colsep0 rowsep0" align="center">25%</td><td class="colsep0 rowsep0" align="center">3.49 ± 0.2</td><td class="colsep0 rowsep0" align="center">2%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>ZM241385</b></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">683 ± 4</td><td class="colsep0 rowsep0" align="center">1.9 ± 0.1</td><td class="colsep0 rowsep0" align="center">65.7 ± 1.7</td><td class="colsep0 rowsep0" align="center">863 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>DPCPX</b></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">2.20 ± 0.2</td><td class="colsep0 rowsep0" align="center">157 ± 2.9</td><td class="colsep0 rowsep0" align="center">73.24 ± 2.0</td><td class="colsep0 rowsep0" align="center">1722 ± 11</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last"><i>n</i> = 3 for <i>K</i><sub>i</sub> values, or <i>n</i> = 2 for percentage displacement of specific binding.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]DPCPX binding in adenosine A<sub>1</sub> receptors expressed in human CHO cells.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Displacement of specific [3]ZM2421385 binding in adenosine A<sub>2A</sub> receptors expressed in human HeLa cells.</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]DPCPX binding in human HEK-293 cells.</p></div><div class="footnote" id="t5fn5"><sup><sup>e</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]NECA binding in adenosine A<sub>3</sub> receptors expressed in human HeLa cells.</p></div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Structure and Binding Data for the 3,4-Dihydropyridin-2(1<i>H</i>)-ones <b>137–144</b> at the hARs (Subset <b>VI</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0020.gif" alt="" id="GRAPHIC-d7e5351-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center"><i>K</i><sub>i</sub> (nM) or % at 1 μM<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center">R<sub>5</sub></th><th class="colsep0 rowsep0" align="center">hA<sub>1</sub><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">hA<sub>2A</sub><a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">hA<sub>2B</sub><a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">hA<sub>3</sub><a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>137</b></td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">6%</td><td class="colsep0 rowsep0" align="left">2%</td><td class="colsep0 rowsep0" align="left">29%</td><td class="colsep0 rowsep0" align="left">14%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>138</b></td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">5%</td><td class="colsep0 rowsep0" align="left">2%</td><td class="colsep0 rowsep0" align="left">22%</td><td class="colsep0 rowsep0" align="left">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>139</b></td><td class="colsep0 rowsep0" align="left">3-furyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">3%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>140</b></td><td class="colsep0 rowsep0" align="left">3-furyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">9%</td><td class="colsep0 rowsep0" align="left">2%</td><td class="colsep0 rowsep0" align="left">637 ± 28</td><td class="colsep0 rowsep0" align="left">3%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>141</b></td><td class="colsep0 rowsep0" align="left">2-thienyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">6%</td><td class="colsep0 rowsep0" align="left">8%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>142</b></td><td class="colsep0 rowsep0" align="left">2-thienyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>143</b></td><td class="colsep0 rowsep0" align="left">3-thienyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">11%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">17%</td><td class="colsep0 rowsep0" align="left">2%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>144</b></td><td class="colsep0 rowsep0" align="left">3-thienyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">24%</td><td class="colsep0 rowsep0" align="left">2%</td><td class="colsep0 rowsep0" align="left">14%</td><td class="colsep0 rowsep0" align="left">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>ISAM-140</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">20%</td><td class="colsep0 rowsep0" align="left">25%</td><td class="colsep0 rowsep0" align="left">3.49 ± 0.2</td><td class="colsep0 rowsep0" align="left">2%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>ZM241385</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">683 ± 4</td><td class="colsep0 rowsep0" align="left">1.9 ± 0.1</td><td class="colsep0 rowsep0" align="left">65.7 ± 1.7</td><td class="colsep0 rowsep0" align="left">863 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>DPCPX</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2.20 ± 0.2</td><td class="colsep0 rowsep0" align="left">157 ± 2.9</td><td class="colsep0 rowsep0" align="left">73.24 ± 2.0</td><td class="colsep0 rowsep0" align="left">1722 ± 11</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last"><i>n</i> = 3 for <i>K</i><sub>i</sub> values, or <i>n</i> = 2 for percentage displacement of specific binding.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]DPCPX binding in adenosine A<sub>1</sub> receptors expressed in human CHO cells.</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">Displacement of specific [3]ZM2421385 binding in adenosine A<sub>2A</sub> receptors expressed in human HeLa cells.</p></div><div class="footnote" id="t6fn4"><sup><sup>d</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]DPCPX binding in human HEK-293 cells.</p></div><div class="footnote" id="t6fn5"><sup><sup>e</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]NECA binding in adenosine A<sub>3</sub> receptors expressed in human HeLa cells.</p></div></div></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Structure and Binding Data for the 3,4-Dihydropyridin-2(1<i>H</i>)-ones <b>145–152</b> at the hARs (Series <b>VII</b> and <b>VIII</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0021.gif" alt="" id="GRAPHIC-d7e5775-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center"><i>K</i><sub>i</sub> (nM) or % at 1 μM<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center">hA<sub>1</sub><a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">hA<sub>2A</sub><a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">hA<sub>2B</sub><a class="ref internalNav" href="#t7fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">hA<sub>3</sub><a class="ref internalNav" href="#t7fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>145</b></td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="left">3%</td><td class="colsep0 rowsep0" align="left">4%</td><td class="colsep0 rowsep0" align="left">2%</td><td class="colsep0 rowsep0" align="left">4%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>146</b></td><td class="colsep0 rowsep0" align="left">3-furyl</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">8%</td><td class="colsep0 rowsep0" align="left">3%</td><td class="colsep0 rowsep0" align="left">2%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>147</b></td><td class="colsep0 rowsep0" align="left">2-thienyl</td><td class="colsep0 rowsep0" align="left">2%</td><td class="colsep0 rowsep0" align="left">5%</td><td class="colsep0 rowsep0" align="left">7%</td><td class="colsep0 rowsep0" align="left">5%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>148</b></td><td class="colsep0 rowsep0" align="left">3-thienyl</td><td class="colsep0 rowsep0" align="left">4%</td><td class="colsep0 rowsep0" align="left">3%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>149</b></td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="left">27%</td><td class="colsep0 rowsep0" align="left">23%</td><td class="colsep0 rowsep0" align="left">905 ± 39</td><td class="colsep0 rowsep0" align="left">4%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>150</b></td><td class="colsep0 rowsep0" align="left">3-furyl</td><td class="colsep0 rowsep0" align="left">21%</td><td class="colsep0 rowsep0" align="left">14%</td><td class="colsep0 rowsep0" align="left">801 ± 13</td><td class="colsep0 rowsep0" align="left">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>151</b></td><td class="colsep0 rowsep0" align="left">2-thienyl</td><td class="colsep0 rowsep0" align="left">21%</td><td class="colsep0 rowsep0" align="left">7%</td><td class="colsep0 rowsep0" align="left">45%</td><td class="colsep0 rowsep0" align="left">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>152</b></td><td class="colsep0 rowsep0" align="left">3-thienyl</td><td class="colsep0 rowsep0" align="left">34%</td><td class="colsep0 rowsep0" align="left">20%</td><td class="colsep0 rowsep0" align="left">1126 ± 45</td><td class="colsep0 rowsep0" align="left">2%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>ISAM-140</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">20%</td><td class="colsep0 rowsep0" align="left">25%</td><td class="colsep0 rowsep0" align="left">3.49 ± 0.2</td><td class="colsep0 rowsep0" align="left">2%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>ZM241385</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">683 ± 4</td><td class="colsep0 rowsep0" align="left">1.9 ± 0.1</td><td class="colsep0 rowsep0" align="left">65.7 ± 1.7</td><td class="colsep0 rowsep0" align="left">863 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>DPCPX</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2.20 ± 0.2</td><td class="colsep0 rowsep0" align="left">157 ± 2.9</td><td class="colsep0 rowsep0" align="left">73.24 ± 2.0</td><td class="colsep0 rowsep0" align="left">1722 ± 11</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last"><i>n</i> = 3 for <i>K</i><sub>i</sub> values, or <i>n</i> = 2 for percentage displacement of specific binding.</p></div><div class="footnote" id="t7fn2"><sup><sup>b</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]DPCPX binding in adenosine A<sub>1</sub> receptors expressed in human CHO cells.</p></div><div class="footnote" id="t7fn3"><sup><sup>c</sup></sup><p class="last">Displacement of specific [3]ZM2421385 binding in adenosine A<sub>2A</sub> receptors expressed in human HeLa cells.</p></div><div class="footnote" id="t7fn4"><sup><sup>d</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]DPCPX binding in human HEK-293 cells.</p></div><div class="footnote" id="t7fn5"><sup><sup>e</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]NECA binding in adenosine A<sub>3</sub> receptors expressed in human HeLa cells.</p></div></div></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Structure and Binding Data for the 3,4-Dihydropyridin-2(1<i>H</i>)-ones <b>153–180</b> at the hARs (Subset <b>IX</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0022.gif" alt="" id="GRAPHIC-d7e6148-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0023.gif" alt="" id="gr14" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup><sup>a</sup></sup><p class="last"><i>n</i> = 3 for <i>K</i><sub>i</sub> values, or <i>n</i> = 2 for percentage displacement of specific binding.</p></div><div class="footnote" id="t8fn2"><sup><sup>b</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]DPCPX binding in adenosine A<sub>1</sub> receptors expressed in human CHO cells.</p></div><div class="footnote" id="t8fn3"><sup><sup>c</sup></sup><p class="last">Displacement of specific [3]ZM2421385 binding in adenosine A<sub>2A</sub> receptors expressed in human HeLa cells.</p></div><div class="footnote" id="t8fn4"><sup><sup>d</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]DPCPX binding in human HEK-293 cells.</p></div><div class="footnote" id="t8fn5"><sup><sup>e</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]NECA binding in adenosine A<sub>3</sub> receptors expressed in human HeLa cells.</p></div></div><div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Biological Evaluation</h3><div class="NLM_p last">The affinities for the four human AR (hAR) subtypes (A<sub>1</sub>, A<sub>2A</sub>, A<sub>2B</sub>, and A<sub>3</sub>) of the 160 3,4-dihydropyrimidin-2-one/thiones obtained (<b>16–99</b> and <b>105–180</b>) were evaluated in vitro (radioligand binding assays)<a onclick="showRef(event, 'ref41 ref42 ref43 ref49'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43 ref49">(41−43,49)</a> and reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>. hARs expressed in transfected Chinese hamster ovary (CHO) (A<sub>1</sub>AR), HeLa (A<sub>2A</sub>AR and A<sub>3</sub>AR), and HEK-293 (A<sub>2B</sub>AR) cells were employed. [<sup>3</sup>H]DPCPX for A<sub>1</sub>AR and A<sub>2B</sub>AR, [<sup>3</sup>H]ZM241385 for A<sub>2A</sub>AR, and [<sup>3</sup>H]NECA for A<sub>3</sub>AR were used as radiotracers during binding assays. The affinity data obtained for the racemic mixture of each compound is provided in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>. The biological data are expressed as <i>K</i><sub>i</sub> ± standard error of the mean (SEM) (nM, <i>n</i> = 3) or as percentage inhibition of specific binding at 1 μM (<i>n</i> = 2, average) for those compounds that did not fully displace specific radioligand binding. <i>K</i><sub>i</sub> values were obtained by fitting the data with nonlinear regression using Prism 2.1 software (GraphPad, San Diego, CA). The binding affinity obtained for representative AR antagonists (<b>ISAM-140</b>, <b>ZM241385</b>, and <b>DPCPX</b>), using the binding protocols herein employed, was included in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a> for comparative purposes.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Functional Experiments</h3><div id="sec2_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Cyclic Adenosine Monophosphate Assays</h4><div class="NLM_p">The two most potent compounds of the series (<b>38</b> and <b>47</b>) were evaluated in cyclic adenosine monophosphate (cAMP) assays to determinate their ability to inhibit NECA-stimulated (100 nM) cAMP production.<a onclick="showRef(event, 'ref41 ref42 ref43 ref49'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43 ref49">(41−43,49)</a> The log concentration–response curves of c-AMP accumulation for selected antagonists to hA<sub>2B</sub>ARs are presented in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>. These experiments demonstrated that compounds <b>38</b> and <b>47</b> inhibit NECA-induced c-AMP accumulation, unequivocally validating their antagonism at hA<sub>2B</sub>ARs. Analysis of the <i>K</i><sub>i</sub> and <i>K</i><sub>B</sub> values shows low nanomolar range data obtained during binding (<i>K</i><sub>i</sub> = 23.6 and 10.2 nM, respectively) and functional experiments (<i>K</i><sub>B</sub> = 25.2 and 4.7 nM, respectively).</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Radioligand binding and functional assays. (Left) Concentration–response curves of <b>47</b> (▲) and <b>38</b> (■) at hA<sub>2B</sub> ARs labeled with 22 nM [<sup>3</sup>H]DPCPX. (Right) Concentration–response curves of <b>47</b> (▲) and <b>38</b> (■) over 100 nM NECA-elicited cAMP formation. Points represent the mean ± SD (vertical bars) of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Enantiospecific Binding to the A<sub>2B</sub>AR</h4><div class="NLM_p">As indicated above, all compounds here reported were obtained and tested as racemates (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). However, both our initial molecular models<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> and results from the FEP calculations (see previous section) indicate that only one enantiomer should bind the orthosteric site of the receptor. The importance of the stereogenic center at the heterocyclic core during the recognition at the A<sub>2B</sub>AR binding pocket was also inferred during our early SAR exploration of the DHPM scaffold.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> It was observed that aromatization of the 3,4-dihydropyrimidin-2(1<i>H</i>)-one/thione nucleus abolished the A<sub>2B</sub>AR affinity for ligands <b>38</b> and <b>47</b>.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> In addition, in our recent studies with other structurally related scaffolds,<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42,43)</a> the most attractive ligands were separated and the corresponding active stereoisomer correlated with these predictions. Following this line of reasoning, we proceeded to the enantiomeric separation and assignment of the most attractive compounds within series <b>I–IX</b> [(±)-<b>38</b> and (±)-<b>47</b>], followed by their biological evaluation.</div><div class="NLM_p"><a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> shows the results of our joint approach using chiral high-performance liquid chromatography (HPLC) and CD spectroscopy. As recently documented by our own results with structurally related Biginelli-like systems<a onclick="showRef(event, 'ref42 ref49'); return false;" href="javascript:void(0);" class="ref ref42 ref49">(42,49)</a> as well as for other pharmacologically active 3,4-dihydropyrimidin-2-ones/thiones,<a onclick="showRef(event, 'ref61 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref61 ref62 ref63">(61−63)</a> the sign of the distinctive CD activity of the enamide group (around 300 nm) allows the unequivocal assignment of the absolute configuration of each enantiomer (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Semipreparative HPLC separation of the selected racemic ligands [(±)-<b>38</b> and (±)-<b>47</b>] on a chiral stationary phase (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> and <a class="ref internalNav" href="#sec4" aria-label="Experimental Sectio">Experimental Sectio</a>n) afforded each enantiomer with excellent stereochemical purity (97 and 99% respectively). At this wavelength, enantiomers showing a negative Cotton effect (red line) contain the pentagonal heterocycle (furan or thiophene) backward [which corresponds to (4<i>S</i>)-<b>38</b> and (4<i>S</i>)-<b>47</b>, respectively] while the stereoisomers giving a positive Cotton effect (blue line) contain the heterocyclic core forward [which corresponds to (4<i>R</i>)-<b>38</b> and (4R)-<b>47</b>, respectively].</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Chiral HPLC traces, CD spectra, and absolute configuration for (±)-<b>38</b> and (±)-<b>47</b> and its enantiomers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The biological profiles of the isolated enantiomers [(<i>R</i>)-<b>38</b>, (<i>S</i>)-<b>38</b>, (<i>R</i>)-<b>47</b>, and (<i>S</i>)-<b>47</b>] were then evaluated at the four hARs, and the resulting data (<a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>) are compared to the corresponding racemic mixtures [(±)-<b>38</b> and (±)-<b>47</b>]. With this analysis, we could confirm that the A<sub>2B</sub>AR affinity exhibited by the racemic mixture of <b>38</b> and <b>47</b> is exclusively due to the (<i>S</i>)-<b>38</b> and (<i>S</i>)-<b>47</b> enantiomers (<i>K</i><sub>i</sub> = 11.1 and 6.30 nM). In both cases, the eutomer [the (<i>S</i>) stereoisomer] is nearly twofold more potent than the racemic mixture [<b>38</b>, (<i>K</i><sub>i</sub> = 23.6 nM), <b>47</b>, (<i>K</i><sub>i</sub> = 10.2 nM)], whereas (<i>R</i>)-stereoisomers are devoid of any affinity at the four ARs (<a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>). To provide a further structural rationale, we calculated the energetic difference between both enantiomers of compound <b>47</b> via direct FEP simulations between the compound pair, starting from the binding model proposed in each case (see <a href="/doi/suppl/10.1021/acs.jmedchem.0c01431/suppl_file/jm0c01431_si_002.pdf" class="ext-link">Figure S4</a>). The simulations agree with the experimental data, indicating stark binding preference for the most potent eutomer (ΔΔ<i>G</i> = 6.04 ± 1.06 kcal/mol). These data constitute a remarkable example of A<sub>2B</sub>AR antagonists that exhibit enantiospecific recognition profiles, which is satisfactorily explained with the binding mode hypothesis behind the design of this series, in agreement with our observations for structurally related Biginelli-based scaffolds.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Structure and Binding Data for the Enantiomers of the 3,4-Dihydropyridin-2(1<i>H</i>)-ones/thiones <b>38</b> and <b>47</b> at the hARs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0024.gif" alt="" id="GRAPHIC-d7e6643-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char="."><i>K</i><sub>i</sub> (nM) or % at 1 μM</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center">R<sub>5</sub></th><th class="colsep0 rowsep0" align="center" char=".">hA<sub>1</sub><a class="ref internalNav" href="#t9fn1" aria-label="a">a</a> (%)</th><th class="colsep0 rowsep0" align="center" char=".">hA<sub>2A</sub><a class="ref internalNav" href="#t9fn2" aria-label="b">b</a> (%)</th><th class="colsep0 rowsep0" align="center">hA<sub>2B</sub><a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">hA<sub>3</sub><a class="ref internalNav" href="#t9fn4" aria-label="d">d</a> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>38</b></td><td class="colsep0 rowsep0" align="left">3-thienyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="left">23.6 ± 1.0</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>38</b></td><td class="colsep0 rowsep0" align="left">3-thienyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="left">19%</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>38</b></td><td class="colsep0 rowsep0" align="left">3-thienyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="left">11.1 ± 1.4</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>47</b></td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="left">10.2 ± 0.5</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>47</b></td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="left">12%</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>47</b></td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="left">6.30 ± 1.1</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup><sup>a</sup></sup><p class="last"><i>n</i> = 3 for <i>K</i><sub>i</sub> values, or <i>n</i> = 2 for percentage displacement of specific binding.</p></div><div class="footnote" id="t9fn2"><sup><sup>b</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]DPCPX binding in adenosine A<sub>1</sub> receptors expressed in human CHO cells.</p></div><div class="footnote" id="t9fn3"><sup><sup>c</sup></sup><p class="last">Displacement of specific [3]ZM2421385 binding in adenosine A<sub>2A</sub> receptors expressed in human HeLa cells.</p></div><div class="footnote" id="t9fn4"><sup><sup>d</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]DPCPX binding in human HEK-293 cells.</p></div><div class="footnote" id="t9fn5"><sup><sup>e</sup></sup><p class="last">Displacement of specific [<sup>3</sup>H]NECA binding in adenosine A<sub>3</sub> receptors expressed in human HeLa cells.</p></div></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> SAR Analysis and Molecular Modeling</h3><div class="NLM_p">The biological evaluation of the nine series of DHPMs (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>) allowed us to identify eight potent (<i>K</i><sub>i</sub> < 100 nM) and specific A<sub>2B</sub>AR ligands, for example, compounds <b>19</b>, <b>24</b>, <b>38</b>, and <b>40</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), <b>47</b> and <b>52</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), and <b>154</b> and <b>155</b> (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>). Additionally, a dozen of DHPMs exhibited moderate (<i>K</i><sub>i</sub> 100–500 nM) A<sub>2B</sub>AR affinity (e.g. compounds <b>18</b>, <b>20</b>, <b>27</b>, <b>39</b>, <b>54</b>, <b>68</b>, <b>108</b>, <b>158</b>, <b>161</b>, <b>162</b>, <b>165</b>, and <b>176</b>), while still retaining the excellent selectivity profile characteristic of these series. The most interesting DHPMs contained an exocyclic carbonyl group at position 2 and no substituent at positions 1 and 3 (series <b>I</b>, <b>IV–IX</b>), while the most potent A<sub>2B</sub>AR antagonist (<b>47</b>, <i>K</i><sub>i</sub> = 10.2 nM) belongs to the bioisosteric 3,4-dihydropyrimidin-2(1<i>H</i>)-thione series <b>II</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The first part of the SAR analysis is focused on the first three subsets (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, series <b>I–III</b>), exploring precisely the effect of the O/S bioisosteric replacement at position 2 of the DHPM scaffold (series II) as well as methylation on N<sub>1</sub> (series <b>III</b>). All these series maintain a substituted ester group (position 5), and the impact of bioisosteric replacement of this functionality is further analyzed in subsets <b>IV–VIII</b>. It will be deduced that collectively, the most appealing A<sub>2B</sub>AR affinities within series <b>I–VIII</b> are indeed within the first subset of DHPMs (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, compounds <b>16–43</b>). This motivated an expansion of the diversity of the alkyl residues at the ester group (subset <b>IX</b>), which will be analyzed in depth through the last section of this SAR study. The effect of all these structural modifications on binding affinity will be systematically assessed by FEP calculations, performed on the basis of the binding mode previously proposed and here refined for the A<sub>2B</sub>AR.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><div class="NLM_p">The first general SAR observation is the systematic drop in affinity to negligible values due to methylation on position N<sub>1</sub> of the pyrimidine scaffold observed along subset <b>III</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, <b>72–99</b>). Notably, this effect is not compensated by any substituents explored at either R<sub>4</sub> or R<sub>5</sub>. Within the first subsets, the effect of the pentagonal heterocycle at position 4 also shows some clear tendencies: 2-furyl-, 3-furyl-, and 3-thienyl-substituted ligands exert higher affinities as compared to the 2-thienyl substituted ligands. This is clearly exemplified in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, showing a comparison of the most active compound within each series (<b>I–III</b>). In this case, however, the effect is variable depending on the substituent at R<sub>5</sub>. In general, the exploration of the R<sub>5</sub> chain on the ester group reveals a size dependency, that is, from the smallest to the largest substitution (Me to Bn), with optimal affinities observed for medium sized substituents (Et, <i>i</i>-Pr).</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Proposed binding mode of the 3,4-dihydropyrimidin-2(1<i>H</i>)-one/thione scaffold (left) and graphical analysis of the SAR from tables <b>I–III</b> (right). The bars represent the p<i>K</i><sub>i</sub> value on the A<sub>2B</sub>AR for the highest affinity compound within each of the R<sub>4</sub> (top graph) or R<sub>5</sub> (bottom graph) substituents, as extracted from each of the three subsets (blue: subset <b>I</b>, compounds <b>16–43</b> in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>; orange, subset <b>II</b>, compounds <b>44–71</b> in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>; gray, subset <b>III</b>, compounds <b>72–99</b> in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The observed SAR trends generally support the binding orientation previously proposed for this chemotype, here illustrated in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> for the DHPM scaffold after further refinement (see below).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> This model resulted from a docking exploration of compound <b>38</b> (subset <b>I</b>) using a homology model of the hA<sub>2B</sub>AR based on the X-ray structure of the A<sub>2A</sub>AR<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> and retained two key interactions conserved in most AR antagonists: a hydrogen bond with the AR-conserved residue N254<sup>6.55</sup>, achieved via the oxygen atom at position 2 of the ligand, and the π–π stacking of the core ring with F173<sup>EL2</sup>. These interactions are complemented by an enantiospecific shape complementarity between the L-shape formed by the pyrimidinone core and the ring at R<sub>4</sub> and the A<sub>2B</sub>AR specific residue V250<sup>6.51</sup>, providing a possible source of selectivity versus other AR members (containing a bigger Leu).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> A similar binding orientation was found for the structural analogues bicyclic and tricyclic scaffolds,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> including a related series consisting of trifluorinated pyrimidine-based A<sub>2B</sub>AR antagonists<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> as well as for the monocyclic cyanoimino derivatives.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> In the last two cases, the stereospecific recognition hypothesized with molecular modeling was experimentally confirmed by enantiomeric separation of the most potent compounds by chiral HPLC followed by structural characterization by CD and X-ray determination of the most potent compounds.<a onclick="showRef(event, 'ref42 ref49'); return false;" href="javascript:void(0);" class="ref ref42 ref49">(42,49)</a> It thus seemed reasonable to retain the equivalent active stereoisomer for modeling purposes of the current series, something that we would later evaluate by a similar experimental separation and evaluation of the stereoisomers of the most potent compounds here identified (see below). The binding orientation described for <b>38</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> was used to create an analogous complex with the prototype compound <b>19</b>, which was here subject to a molecular dynamics (MD) equilibration. The resulting refined binding model importantly considers the role of water-mediated interactions and led to a slight shift of the position of the ligand, allowing for a second hydrogen bond between N254<sup>6.55</sup> and the NH at position 1 (see <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>), in analogy to the dual hydrogen bond observed between this residue and most co-crystallized AR ligands. This refined position was then used for a first series of FEP simulations, designed to evaluate if the proposed binding model could successfully explain the pronounced detrimental effect on methylation at N<sub>1</sub> (comparison between subsets <b>I</b> and <b>III</b>, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) as well as the role of the carbonyl/thiocarbonyl bioisosteric substitution at position 2, (i.e., comparison between equivalent ligand pairs of subsets <b>I</b> and <b>II</b>, see <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). The FEP calculations covered all compound pairs between the two series to be compared, where at least one of the molecules involved showed measurable A<sub>2B</sub> binding affinities (<i>K</i><sub>i</sub> < 1 μM), thus yielding 10 and 12 pair comparisons for subsets <b>I</b> → <b>III</b> and <b>I</b> → <b>II</b>.</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of methylation on R<sub>1</sub>. The binding modes considered are depicted in panels (A,B) for the compound pair <b>19</b> (R<sub>1</sub> = NH) and <b>75</b> (R<sub>1</sub> = N–CH<sub>3</sub>). Panel (C) depicts the result of the FEP simulations, performed on each binding pose for 10 pairs of compounds. Color code corresponds to the binding pose, blue for pose A, and orange for pose B. * = no detectable binding.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The calculations of binding affinity differences between subsets <b>I</b> and <b>III</b> yielded excellent agreement with the experimental results (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, compare gray and blue bars) with a mean absolute error (MAE) of 0.71 kcal/mol over the 10 pair comparisons. According to the binding mode proposed (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A), the reason for the systematic reduction in affinity observed upon N<sub>1</sub>-methylation can be found in the destabilization of the hydrogen bond with conserved N254<sup>6.55</sup>. However, given the relative symmetry of the 3,4-dihydropyrimidinone scaffold, one cannot rule out the possibility of an alternate binding mode adopted by the methylated DHPM scaffold. This would meanwhile place the substituent at R<sub>5</sub> in the same extracellular binding crevice, as previously explored,<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42,43)</a> while satisfying the double hydrogen bond with N254<sup>6.55</sup> as illustrated in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B. To further analyze this possibility, we performed the corresponding FEP transformations using the alternative binding mode. The results, depicted in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C in orange bars, systematically predicted incorrect increases in binding affinity for the methylated compounds in subset <b>III</b>, in stark contrast with the experimental results (MAE = 3.59 kcal/mol). Thus, the simulations clearly support the stereospecific binding mode previously proposed<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> and here refined (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). Consequently, we retained this binding mode as the starting point to explore the differences in affinity due to the thiocarbonyl substitution in position 2 (subset <b>II</b>). This single heteroatom substitution has a more spurious effect along the two subsets to be compared (<b>I</b> and <b>II</b>), as illustrated by a 4-fold increase in binding affinity observed between <b>19</b> and <b>47</b>, while the best compound in series <b>I</b> (<b>38</b>) dramatically loses affinity (50 fold) when transformed into the corresponding thienyl derivative <b>66</b>. On average, for the 12 compound pairs considered, the experimental effect of this bioisosteric substitution is milder than in the previous case of N<sub>1</sub> methylation (ΔΔ<i>G</i><sub>avg,exp</sub> = 0.94 ± 1.35 kcal/mol). According to our binding model, the replacement of an oxygen by a bigger sulfur atom at position 2 produces a slight shift in the position of the ligand, which can lead to suboptimal accommodation of the remaining substituents, depending on the nature of R<sub>4</sub> and R<sub>5</sub>. Encouragingly, this trend is also correctly reproduced by our theoretical calculations, and in most cases, the stabilizing or destabilizing effect of the bioisosteric replacement is correctly predicted (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>, ΔΔ<i>G</i><sub>avg,calc</sub> = 0.68 ± 0.87 kcal/mol, MAE = 1.17 kcal/mol).</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Binding mode of compounds <b>19</b> (subset <b>I</b>, orange) and <b>47</b> (subset <b>II</b>, blue), before and after the corresponding FEP transformation in the A<sub>2B</sub>AR model (top). It can be appreciated by the shift in the binding orientation due to the heteroatom change. Experimental and calculated binding free energies between this and analogous compound pairs in subsets <b>I</b> and <b>II</b> are depicted in the bar graph (bottom). *No detectable binding.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The next cycle of FEP simulations was conceived to explore the effects of the different substitutions at R<sub>5</sub> (subsets <b>IV–IX</b>) on the A<sub>2B</sub>AR affinity. This substituent would sit on a narrow region between TM2 and TM3 in the extracellular side of the binding cavity (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). The ester (subsets <b>I–III</b> and <b>IX</b>) or bioisosteric analogues (series <b>IV–VIII</b>) would displace the water molecules that eventually fill this region, which were initially occupying this pocket by analogy with the high-resolution crystal structure of the A<sub>2A</sub>AR.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> In this way, the alkyl chain on the functionalized ester (or by analogy on most of the bioisosteres), would sit in a relatively small and hydrophobic cavity defined by residues Ala64<sup>2.61</sup>, Ile67<sup>2.64</sup>, Ala82<sup>3.29</sup>, and Val85<sup>3.32</sup>. Indeed, on the basis of this binding mode, we could recently explain the succinct effect of fluorination in the functionalized ester substituents at R<sub>5</sub>.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The limited size of this pocket also correlates with the SAR observation that larger hydrophilic changes result in loss of binding (in particular series <b>VII</b>). To assess these qualitative observations, we performed FEP calculations transforming R<sub>5</sub> between three reference compounds in series <b>I</b>, namely <b>19</b> (R<sub>4</sub> = 2-furyl, R<sub>5</sub> = CO<sub>2</sub>–<i>i</i>-Pr, <i>K</i><sub>i</sub> = 40.8 nM), <b>24</b> (R<sub>4</sub> = 3-furyl, R<sub>5</sub> = CO<sub>2</sub>–Et, <i>K</i><sub>i</sub> = 39.6 nM), and <b>38</b> (R<sub>4</sub> = 3-thienyl, R<sub>5</sub> = CO<sub>2</sub>–Et, <i>K</i><sub>i</sub> = 23.6 nM) and their counterparts in series <b>IV–IX</b>. In other words, each parent compound in series <b>I</b> was compared to an array of 19 compounds which differ on R<sub>5</sub>, while maintaining the corresponding R<sub>4</sub> substituent in each case (see Tables S1–S3 in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01431/suppl_file/jm0c01431_si_002.pdf" class="ext-link">Supporting Information</a>). The replacement of the ester function to different bioisosteres, namely ketone (subset <b>IV</b>), amide (subset <b>V</b>), thioamide (subset <b>VI</b>), phosphate (series <b>VII</b>), or oxazolyl (subset <b>VIII</b>) functions, results in all cases in a moderate to complete loss of experimental affinity (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Tables <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>), which is correctly modeled by the corresponding FEP transformations in all cases (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01431/suppl_file/jm0c01431_si_002.pdf" class="ext-link">Tables S1–S3</a>). The mildest reduction in affinity is observed in subset <b>IV</b>, where a ketone in R<sub>5</sub> in combination with 2-furyl in R<sub>4</sub> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, compounds <b>105–108</b>) yields compounds that can be almost as active as their counterparts in subset <b>I</b> (R<sub>5</sub> = CO<sub>2</sub>R, e.g. compare compound <b>20</b> with <b>108</b>), something that is well captured by the FEP calculations (see <a href="/doi/suppl/10.1021/acs.jmedchem.0c01431/suppl_file/jm0c01431_si_002.pdf" class="ext-link">Supporting Information S1</a>). The systematic drop in affinity observed when an amide function replaces the ester in R<sub>5</sub> (subset <b>V</b>) is also correctly reproduced in our models, with calculated loss in affinity close to or higher than the experimental threshold of the binding experiment (e.g. ΔΔ<i>G</i><sub>exp</sub> ≥ 3.27 kcal/mol, see <a href="/doi/suppl/10.1021/acs.jmedchem.0c01431/suppl_file/jm0c01431_si_002.pdf" class="ext-link">Tables S1–S3</a>), indicating that this function does not fit on the designated binding site. The same applies for the phosphate and oxazolyl containing compounds (series <b>VII</b> and <b>VIII</b>), and in the former case, the ligand cannot even be accommodated in the binding site to run any FEP calculation.</div><div class="NLM_p">Finally, the extensive exploration of the alkoxy substituent on the ester function resulted in a broad range of effects in affinity, as illustrated <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>, showing a bar plot representation of the experimental affinities within subsets <b>I</b> and <b>IX</b>. This effect is, in most cases, correctly reproduced and rationalized by FEP simulations, particularly in the 3-furyl (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01431/suppl_file/jm0c01431_si_002.pdf" class="ext-link">Supporting Information S2</a>) and 3-thienyl (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01431/suppl_file/jm0c01431_si_002.pdf" class="ext-link">Supporting Information S3</a>) containing compounds. The structural reason of the observed effects can be traced back to the presence of two buried water molecules adjacent to the hydrophobic pocket (see <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B,C), which were previously characterized as highly stable.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Indeed, along the MD simulations associated to the FEP calculations, the compounds with bulkier alkyl chains at R<sub>5</sub> = CO<sub>2</sub>R trend to selectively displace one or the two water molecules (depicted as water 2 and 3 in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>) as compared to compounds with optimized R chains, which only displace the unstable water 1 (see <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). The overall agreement of our FEP calculations and experiment is very reasonable, with a MAE of 1.15 kcal/mol for all perturbations with measurable experimental binding affinities, which fall well within values previously reported by others on homology models with much smaller datasets and provide a better signal for the described SAR observations than more intuitive relationships, such as correlation of affinity shifts with MW or SASA of the substituent in R<sub>5</sub> (data not shown). Altogether, the experimental data and computational modelling suggest a combined effect due to the optimal shape complementarity and specific water displacement elicited by the R<sub>5</sub> substituent, which is also dependent on the positioning of the heteroatom within the ring at R<sub>4</sub>.</div><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Proposed binding mode of the 3,4-dihydropyrimidin-2-one scaffold (left) and graphical analysis of the SAR from tables <b>I</b> and <b>IX</b> (right). The bars represent the p<i>K</i><sub>i</sub> value for each of the R<sub>5</sub> substituents, for the three groups of R<sub>4</sub> with the highest affinity [2-furyl (blue), 3-furyl (orange), and 3-thienyl (gray)]. Binding mode of <b>19</b> (B, in pink) and <b>157</b> (C, in blue), binding site waters (from apo MD simulations) are depicted in spheres. Water 1 is replaced by both compounds; however, waters 2 and 3 are not displaced by <b>19</b> (<b>SYAF014</b>). These waters are buried deeply in the binding site and overlay with structural waters from the A<sub>2A</sub>AR crystal structure (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EIY">4EIY</a>). It is likely that these waters are favorably accommodated in the binding site and hence should not be displaced by any compound, in agreement with the decrease in affinity of <b>157</b> compared to <b>19</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Preliminary ADME Exploration</h3><div class="NLM_p">With the aim to early identify metabolic liabilities of herein explored series, the inhibitory activity of (±)-<b>38</b> and (±)-<b>47</b> at two prototypical cytochrome P450 isoforms (CYP3A4 and CYP2D6) was assessed.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> The selected subfamilies (CYP3A4 and CYP2D6) are abundant in the liver, shows broad substrate specificity, and are responsible for the metabolization of numerous drugs.<a onclick="showRef(event, 'ref69 ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref69 ref70 ref71">(69−71)</a> This data would enable to anticipate potential side effects and to examine the tendency for drug–drug interactions. The assays (done in duplicates) use fluorescence-based detection and employed 7-benzyloxy-4-(trifluoromethyl)-coumarin (IC<sub>50</sub> = 0.008 μM), ketoconazole (IC<sub>50</sub> = 0.027 μM), and quinidine (IC<sub>50</sub> = 0.0073 μM) as references for CYP3A4 and CYP2D6. The obtained data is presented in <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>. As observed, at the evaluated concentrations (1 and 10 μM), ligands (±)-<b>38</b> and (±)-<b>47</b> do not show substantial interaction with the studied cytochrome isoforms (CYP3A4 and CYP2D6). The ADME profile (in vitro) of the novel potent A<sub>2B</sub> antagonists herein identified (<b>38</b> and <b>47</b>) was completed by evaluating its stability in human microsomes. The obtained data revealed that both ligands exhibited satisfactory microsomal stability, with 65 and 77% of (±)-<b>38</b> and (±)-<b>47</b> remaining unaltered after 60 min of exposure to human microsomes. The emerging ADME data highlight the attractiveness of the identified lead compounds.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Inhibition Data of (±)-<b>38</b> and (±)-<b>47</b> on CYP3A4 and CYP2D6<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">CYP3A4 (BFC) % inhibition</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">CYP3A4 (DBF) % inhibition</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">CYP2D6 % inhibition</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center" char=".">(1 μM) (%)</th><th class="colsep0 rowsep0" align="center" char=".">(10 μM) (%)</th><th class="colsep0 rowsep0" align="center" char=".">(1 μM) (%)</th><th class="colsep0 rowsep0" align="center" char=".">(10 μM) (%)</th><th class="colsep0 rowsep0" align="center" char=".">(1 μM) (%)</th><th class="colsep0 rowsep0" align="center" char=".">(10 μM) (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>38</b></td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">44</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>47</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup><sup>a</sup></sup><p class="last">Presented data are the mean ± SD of three (<i>n</i> = 3) experiments. The percentage of inhibition (at 1 and 10 μM) is described due to the negligible effect of the compounds at both cytochromes.</p></div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Evaluation of the Antimetastatic Effect</h3><div class="NLM_p">It is well accepted that A<sub>2B</sub>AR activation has to play a crucial role in promoting cell migration and motility<a onclick="showRef(event, 'ref32 ref72'); return false;" href="javascript:void(0);" class="ref ref32 ref72">(32,72)</a> and also in early events of the multistep process of cell invasion and metastasis.<a onclick="showRef(event, 'ref25 ref30 ref73'); return false;" href="javascript:void(0);" class="ref ref25 ref30 ref73">(25,30,73)</a> In addition, adenosine binding to A<sub>2B</sub>AR on tumor cells enhance their metastatic capabilities, while A<sub>2B</sub>AR activation enhances tumor chemotaxis and metastasis in animal models of melanoma and breast cancer.<a onclick="showRef(event, 'ref9 ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref9 ref74 ref75">(9,74,75)</a> These precedents aimed us to briefly investigate a potential antimetastatic effect of the most appealing ligands identified in this work on three representative PCa cell lines (LNCaP, PC-3, and DU145). The selected ligands were tested as racemates [(±)-<b>38</b> and (±)-<b>47</b>]. Elected cell lines are derived from PCa metastasis (isolated from the lymph nodes, bone, and brain, respectively) and represent states with different metastatic potential and androgen responses. To rule out the potential cytotoxic effect of (±)-<b>38</b> or (±)-<b>47</b> in LNCaP, PC-3, and DU145, the cell growth inhibitory activity of these ligands was preliminarily evaluated. Both compounds were tested (10 and 100 μM) following described protocols (MTT assays) using cisplatin as the control.<a onclick="showRef(event, 'ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref76 ref77">(76,77)</a> These experiments unequivocally confirmed that (±)-<b>38</b> or (±)-<b>47</b> do not exhibit a cytotoxic effect at the tested concentrations. The transwell migration assay<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> was used as a marker of A<sub>2B</sub>AR antimetastatic activity. The cytopathic changes induced by selected compounds in the PC-3 cell line were analyzed using confocal microscopy.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> For the sake of comparison, the prototypic A<sub>2B</sub>AR antagonist <b>PSB603</b><a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> was also included in the study. <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a> shows the results of the transwell migration assay after 72 h of exposure to (±)-<b>38</b>, (±)-<b>47</b>, and <b>PSB603</b> (at their respective <i>K</i><sub>i</sub> values) compared to untreated cells (controls). As observed, the optimized 3,4-dihydropyridine derivatives (±)-<b>38</b> and (±)-<b>47</b> significantly (<i>p</i> < 0.05) decreased PC-3, DU145, and LNCaP cells migration in comparison to controls (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A). Moreover, the antimigratory effect of this pair of ligands is indeed superior to that observed for <b>PSB603</b> (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A). Interestingly, the antimetastatic effect was in all cases lightly superior on PC-3 cells compared to DU145 and LNCaP. Here, the antimigratory activity of ligand (±)-<b>47</b> was clearly superior to ligand (±)-<b>38</b> (50 vs 35% in PC-3 migration assay), which correlates with the observed structural and affinity differences between the two ligands.</div><figure id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Migration of PC-3, DU145 and LNCaP cells. (A) A<sub>2B</sub>AR antagonists (±)-<b>38</b> and (±)-<b>47</b> inhibited PC-3, LNCaP, and DU145 cell migration, in comparison to the controls (CTL) and <b>PSB603</b>. Results are expressed as mean ± SE, from at least three separate experiments, each conducted in triplicates. *A<sub>2B</sub>AR antagonists’ treatment was significantly different compared with control treatment (<i>p</i> < 0.05); ▲A<sub>2B</sub>AR antagonist (±)-<b>38</b> and A<sub>2B</sub>AR antagonist (±)-<b>47</b> were significantly different compared with A<sub>2B</sub>AR antagonist <b>PSB603</b> (<i>p</i> < 0.05). (B) Representative microphotographs of PC-3 cells (40×) which migrated through the chamber membranes: (B<sub>1</sub>) control, (B<sub>2</sub>), A<sub>2B</sub>AR antagonist <b>PSB603</b>, (B<sub>3</sub>) A<sub>2B</sub>AR antagonist (±)-<b>38</b>, (B<sub>4</sub>) A<sub>2B</sub>AR antagonist (±)-<b>47</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Cytopathic changes are considered an indicator of tumor progression,<a onclick="showRef(event, 'ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref80 ref81">(80,81)</a> and these changes are usually employed to evaluate the anti-invasive effect of antitumoral compounds.<a onclick="showRef(event, 'ref79 ref80 ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref79 ref80 ref81 ref82">(79−82)</a> It is already known that migration is comparatively faster in PC-3 cells that have an elongated shape compared to rounded ones.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Changes in the morphology may be driven by modification in the actin cytoskeleton organization and this, in turn, can target cell motility.<a onclick="showRef(event, 'ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref81 ref82">(81,82)</a> As a complement of the previous data, it was decided to study the cytopathic changes induced by the herein developed pyrimidin-2-ones [(±)-<b>38</b> and (±)-<b>47</b>] and the reference ligand <b>PSB603</b> in PC-3 cells using confocal laser scanning microscopy.<a onclick="showRef(event, 'ref79 ref80 ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref79 ref80 ref81 ref82">(79−82)</a></div><div class="NLM_p">As depicted in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>, PC-3 cells treated with ligands (±)-<b>38</b> or (±)-<b>47</b> exhibited a rounded shape as the predominant phenotype and showed actin skeleton reorganization. Similarly, cells treated with <b>PSB603</b> showed similar changes. In contrast, untreated PC-3 cells (control) showed an elongated morphology and ellipsoid nuclei with eu- and hetero-chromatin; actin filaments localized mainly beneath the plasma membrane and carboxyfluorescein diacetate succinimidyl ester (CFDA-SE) stained homogenously the cytoplasm (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). The excellent antimigratory effect of (±)-<b>47</b> and (±)-<b>38</b> supports the antimetastatic effect observed. These experiments additionally evidenced their superior efficacy on PC-3 cell lines and the higher antimetastatic profile of (±)-<b>47</b>. The outstanding antimigratory effect documented herein for optimized ligands suggests that they could be attractive pharmacological tools to explore potential applications of A<sub>2B</sub>AR antagonists in the implementation of novel approaches to cancer treatment.</div><figure id="fig10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Cytopathic changes of PC-3 cells observed by confocal laser scanning microscopy. Blue (DAPI), green (CFDA-SE), and red (phalloidin–ATTO 647N) and merge of three channels. Cells treated with (±)-<b>47</b> (10.2 nM) or (±)-<b>38</b> (23.6 nM) showed predominantly rounded shape phenotype with DNA condensation. Untreated PC-3 cells showed an elongated phenotype with cytoplasmic projections when compared with A<sub>B2</sub>AR antagonist-treated PC-3 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05247" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05247" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have disclosed a large library of 3,4-dihydropyrimidin-2(1<i>H</i>)-ones as potent and selective A<sub>2B</sub>AR ligands and confirmed its functional (antagonistic) behavior through cAMP assays. The biological dataset enabled the comprehensive examination of the most prominent features of the SAR and SSR in this series. The SAR trends were complemented and interpreted with a comprehensive computational modeling analysis based on rigorous FEP simulations, starting from the receptor-driven docking model that initially guided the design of these series. The combined use of preparative chiral HPLC and CD enabled to obtain experimental evidences supporting the stereospecific interaction between the different stereoisomers of the most attractive hA<sub>2B</sub>AR antagonists identified herein. An exploratory ADME study of optimized A<sub>2B</sub> antagonists evidenced the insignificant inhibitory effect at CYP3A4 and CYP2D6 and to corroborate its microsomal stability. The antimetastatic effect of 3,4-dihydropyrimidin-2(1<i>H</i>)-ones <b>47</b> and <b>38</b> was preliminarily validated in vitro in two androgen-insensitive (PC-3 and DU145) and one androgen-sensitive (LNCaP) prostate cancer cells. These results support a promising future for A<sub>2B</sub>AR antagonists in the context of emerging therapeutic approaches for cancer treatment.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50117" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50117" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Chemistry</h3><div class="NLM_p">Unless otherwise indicated, all starting materials, reagents, and solvents were purchased and used without further purification. After extraction from aqueous phases, the organic solvents were dried over anhydrous sodium sulfate. The reactions were monitored by thin-layer chromatography (TLC) on 2.5 mm Merck silica gel GF 254 strips, and the purified compounds each showed a single spot; unless stated otherwise, UV light and/or iodine vapor were used to detect compounds. The Biginelli reactions were performed in coated Kimble vials on a PLS (6 × 4) organic synthesizer with orbital stirring. The purity and identity of all tested compounds were established by a combination of HPLC, elemental analysis, mass spectrometry, and NMR spectroscopy as described below. Purification of isolated products was carried out by column chromatography (Kieselgel 0.040–0.063 mm, E. Merck) or medium pressure liquid chromatography on a CombiFlash Companion (Teledyne ISCO) with RediSep pre-packed normal-phase silica gel (35–60 μm) columns followed by recrystallization. Melting points were determined on a Gallenkamp melting point apparatus and are uncorrected. The NMR spectra were recorded on Bruker AM300 and XM500 spectrometers. Chemical shifts are given as δ values against tetramethylsilane as the internal standard, and <i>J</i> values are given in Hz. Mass spectra were obtained on a Varian MAT-711 instrument. High-resolution mass spectra were obtained on an Autospec Micromass spectrometer. Analytical HPLC was performed on an Agilent 1100 system using an Agilent Zorbax SB-Phenyl, 2.1 mm × 150 mm, 5 μm column with gradient elution using the mobile phases (A) H<sub>2</sub>O containing 0.1% CF<sub>3</sub>COOH and (B) MeCN and a flow rate of 1 mL/min. The purity of all tested compounds was determined to be >95%. The structural and spectroscopic data obtained for all compounds described is provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01431/suppl_file/jm0c01431_si_002.pdf" class="ext-link">Supporting Information</a>.</div><div class="NLM_p last">The chiral resolution of selected racemic ligands [(±)-<b>38</b> and (±)-<b>47</b>] was performed using a Water Breeze 2 (binary pump 1525, detector UV/visible 2489, 7725i Manual Injector Kit 1500 Series) with a 250 mm × 10 mm Lux 5 μm amylose-2 (Phenomenex) using a linear gradient of the mobile phase (<i>n</i>-hexane/<i>i</i>-propanol) at 25 °C. A detailed description of the experimental protocols and relevant parameters (retention times and stereochemical purities) is provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01431/suppl_file/jm0c01431_si_002.pdf" class="ext-link">Supporting Information</a>. All single stereoisomers were isolated, and their stereochemical purity was analyzed by chiral HPLC (>97% for each stereoisomer) and then characterized by NMR in CDCl<sub>3</sub>. CD spectra were recorded on a Jasco-815 system equipped with a Peltier-type thermostatic accessory (CDF-426S, Jasco). Measurements were carried out at 20 °C using a 1 mm quartz cell in a volume of 300–350 mL. Compounds (0.1 mg) were dissolved in MeOH (1.0 mL). The instrument settings were bandwidth, 1.0 nm; data pitch, 1.0 nm; speed, 500 nm/min; accumulation, 10; and wavelengths, 400–190 nm.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Procedure for the Biginelli Synthesis of 3,4-Dihydropyrimidin-2(1<i>H</i>)-ones (<b>16–43</b>) and 3,4-Dihydropyrimidin-2(1<i>H</i>)-thiones (<b>44–71</b>)</h3><div class="NLM_p last">A mixture of urea <b>13a</b> or thiourea <b>13b</b> (7.5 mmol), aldehyde <b>14a–d</b> (5 mmol), the β-ketoester <b>15a–g</b> (5 mmol), and ZnCl<sub>2</sub> (0.5 mmol) in 3 mL of tetrahydrofuran (THF) in coated Kimble vials was stirred with orbital stirring at 80 °C for 12 h. After completion of the reaction, as indicated by TLC, the reaction mixture was poured onto crushed ice and stirred for 5–10 min. The solid separated was filtered under suction, washed with ice-cold water (20 mL), and then purified either by recrystallization or column chromatography on a silica gel.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> General Procedure for the Biginelli Synthesis of 3,4-Dihydropyrimidin-2(1<i>H</i>)-ones (<b>72–99</b>)</h3><div class="NLM_p last">A mixture of methylurea <b>13c</b> (7.5 mmol), aldehyde <b>14a–d</b> (5 mmol), the β-ketoester <b>15a–g</b> (5 mmol), and H<sub>3</sub>BO<sub>3</sub> (0.5 mmol) in 3 mL of THF in coated Kimble vials was stirred with orbital stirring at 80 °C for 12 h. After completion of the reaction, as indicated by TLC, the reaction mixture was poured onto crushed ice and stirred for 5–10 min. The solid separated was filtered under suction, washed with ice-cold water (20 mL), and then purified either by recrystallization or column chromatography on a silica gel.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> General Procedure for the Biginelli Synthesis of 3,4-Dihydropyrimidin-2(1<i>H</i>)-ones (<b>105–120</b>)</h3><div class="NLM_p last">A mixture of the urea <b>13a</b> (7.5 mmol), aldehyde <b>14a–d</b> (5 mmol), the 1,3-diketone <b>100a–d</b> (5 mmol), and AcOH (0.5 mmol) in 3 mL of THF in coated Kimble vials was stirred with orbital stirring at 80 °C for 12 h. After completion of the reaction, as indicated by TLC, the reaction mixture was poured onto crushed ice and stirred for 5–10 min. The solid separated was filtered under suction, washed with ice-cold water (20 mL), and then purified either by recrystallization or column chromatography on a silica gel.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> General Procedure for the Biginelli Synthesis of 3,4-Dihydropyrimidin-2(1<i>H</i>)-ones (<b>121–136</b>)</h3><div class="NLM_p last">A mixture of the urea <b>13a</b> (7.5 mmol), aldehyde <b>14a–d</b> (5 mmol), the ketoamide <b>101a–d</b> (5 mmol), and ZnCl<sub>2</sub> (0.5 mmol) in 3 mL of THF in coated Kimble vials was stirred with orbital stirring at 80 °C for 12 h. After completion of the reaction, as indicated by TLC, the reaction mixture was poured onto crushed ice and stirred for 5–10 min. The solid separated was filtered under suction, washed with ice-cold water (20 mL), and then purified either by recrystallization or column chromatography on a silica gel.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> General Procedure for the Biginelli Synthesis of 3,4-Dihydropyrimidin-2(1<i>H</i>)-ones (<b>137–144</b>)</h3><div class="NLM_p last">A mixture of the urea <b>13a</b> (7.5 mmol), aldehyde <b>14a–d</b> (5 mmol), the ketothioester <b>102a–b</b> (5 mmol) and CeCl<sub>3</sub> (0.5 mmol) in 3 mL of THF in coated Kimble vials was stirred with orbital stirring at 80 °C for 12 h. After completion of the reaction, as indicated by TLC, the reaction mixture was poured onto crushed ice and stirred for 5–10 min. The solid separated was filtered under suction, washed with ice-cold water (20 mL), and then purified either by recrystallization or column chromatography on a silica gel.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> General Procedure for the Biginelli Synthesis of 3,4-Dihydropyrimidin-2(1<i>H</i>)-ones (<b>145–148</b>)</h3><div class="NLM_p last">A mixture of the urea <b>13a</b> (7.5 mmol), aldehyde <b>14a–d</b> (5 mmol), diethyl (2-oxopropyl)phosphonate <b>103</b> (5 mmol), and chloroacetic acid (0.5 mmol) in 3 mL of THF in coated Kimble vials was stirred with orbital stirring at 90 °C for 12 h. After completion of the reaction, as indicated by TLC, the reaction mixture was poured onto crushed ice and stirred for 5–10 min. The solid separated was filtered under suction, washed with ice-cold water (20 mL), and then purified either by recrystallization or column chromatography on a silica gel.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> General Procedure for the Biginelli Synthesis of 3,4-Dihydropyrimidin-2(1<i>H</i>)-ones (<b>149–152</b>)</h3><div class="NLM_p last">A mixture of the urea <b>13a</b> (7.5 mmol), aldehyde <b>14a–d</b> (5 mmol), 1-(5-methyloxazol-2-yl)propan-2-one <b>104</b> (5 mmol), and SnCl<sub>2</sub> (0.5 mmol) in 3 mL of THF in coated Kimble vials was stirred with orbital stirring at 80 °C for 12 h. After completion of the reaction, as indicated by TLC, the reaction mixture was poured onto crushed ice and stirred for 5–10 min. The solid separated was filtered under suction, washed with ice-cold water (20 mL), and then purified either by recrystallization or column chromatography on a silica gel.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> General Procedure for the Biginelli Synthesis of 3,4-Dihydropyrimidin-2(1<i>H</i>)-ones (<b>153–180</b>)</h3><div class="NLM_p last">A mixture of the urea <b>13a</b> (7.5 mmol), aldehyde <b>14a–d</b> (5 mmol), the β-ketoester <b>15h–n</b> (5 mmol), and ZnCl<sub>2</sub> (0.5 mmol) in 3 mL of THF in coated Kimble vials was stirred with orbital stirring at 80 °C for 12 h. After completion of the reaction, as indicated by TLC, the reaction mixture was poured onto crushed ice and stirred for 5–10 min. The solid separated was filtered under suction, washed with ice-cold water (20 mL), and then purified either by recrystallization or column chromatography on a silica gel.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Pharmacological Characterization</h3><div class="NLM_p last">Radioligand binding competition assays were performed in vitro using hARs expressed in transfected HeLa [hA<sub>2A</sub>AR (9 pmol/mg protein) and hA<sub>3</sub>AR (3 pmol/mg protein)], HEK-293 [hA<sub>2B</sub>AR (1.5 pmol/mg protein)], and CHO [hA<sub>1</sub>AR (1.5 pmol/mg protein)] cells as described previously.<a onclick="showRef(event, 'ref41 ref42 ref43 ref49'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43 ref49">(41−43,49)</a> A brief description is given below. A<sub>1</sub>AR competition binding experiments were carried out in membranes from CHO-A<sub>1</sub> cells labeled with 1 nM [<sup>3</sup>H]DPCPX (<i>K</i><sub>D</sub> = 0.7 nM). Nonspecific binding was determined in the presence of 10 μM R-PIA. The reaction mixture was incubated at 25 °C for 60 min. A<sub>2A</sub>AR competition binding experiments were carried out in membranes from HeLa-A<sub>2A</sub> cells labeled with 3 nM [<sup>3</sup>H]ZM241385 (<i>K</i><sub>D</sub> = 2 nM). Nonspecific binding was determined in the presence of 50 μM NECA. The reaction mixture was incubated at 25 °C for 30 min. A<sub>2B</sub>AR competition binding experiments were carried out in membranes from HEK-293-A<sub>2B</sub> cells (Euroscreen, Gosselies, Belgium) labeled with 25 nM [<sup>3</sup>H]DPCPX (<i>K</i><sub>D</sub> = 21 nM). Nonspecific binding was determined in the presence of 400 μM NECA. The reaction mixture was incubated at 25 °C for 30 min. A<sub>3</sub>AR competition binding experiments were carried out in membranes from HeLa-A<sub>3</sub> cells labeled with 10 nM [<sup>3</sup>H]NECA (<i>K</i><sub>D</sub> = 8.7 nM). Nonspecific binding was determined in the presence of 100 μM R-PIA. The reaction mixture was incubated at 25 °C for 180 min. After the incubation time, membranes were washed and filtered, and radioactivity was detected in a MicroBeta Trilux reader (PerkinElmer).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Functional Experiments</h3><div class="NLM_p last">cAMP assays were performed at human A<sub>2B</sub>ARs using a cAMP enzyme immunoassay kit (Amersham Biosciences). HEK-293 cells were seeded (10,000 cells/well) in 96-well culture plates and incubated at 37 °C in an atmosphere with 5% CO<sub>2</sub> in Eagle’s medium nutrient mixture F-12 (EMEM F-12), containing 10% fetal calf serum and 1% <span class="smallcaps smallerCapital">l</span>-glutamine. Cells were washed 3× with 200 μL of assay medium (EMEM-F12 and 25 mM <i>N</i>-(2-hydroxyethyl)piperazine-<i>N</i>′-ethanesulfonic acid pH = 7.4) and preincubated with assay medium containing 30 μM rolipram and test compounds at 37 °C for 15 min. 10 μM NECA was incubated for 15 min at 37 °C (total incubation time 30 min). Reaction was stopped with lysis buffer supplied in the kit, and the enzyme immunoassay was carried out for detection of intracellular cAMP at 450 nm in an Ultra Evolution detector (Tecan).</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Data Analysis</h3><div class="NLM_p last">IC<sub>50</sub> values were obtained by fitting the data with nonlinear regression using Prism 5.0 software (GraphPad, San Diego, CA). For those compounds that showed either little affinity or poor solubility, a percentage inhibition of specific binding is reported. Results are the mean of three experiments (<i>n</i> = 3) each performed in duplicates.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> In Vitro Migration Assay</h3><div class="NLM_p last">The effects of (±)-<b>38</b>, (±)-<b>47</b>, and <b>PSB603</b> (23.6, 10.2, and 0.53 nM respectively) on PC-3, DU145, and LNCaP cell migration tests were assessed by using 24-well transwell cell culture chambers (6.5 mm diameter, 8.0 μm pore size, polycarbonate membrane) (Sigma-Aldrich, Madrid, MD, Spain) with Millicell Cell Culture Insert (Merck Millipore Madrid, MD, Spain).<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> In the upper chamber, 10<sup>5</sup> cells were seeded in 100 μL serum-free fetal bovine serum (FBS), while the lower chamber was filled with 600 μL of complete medium with 10% FBS. After 24 h of incubation, cells in the upper chamber were carefully removed with a cotton swab and cells that had migrated through the membrane and had stuck to the lower surface of the membrane were fixed with 4% paraformaldehyde (2 min) and stained with crystal violet stain (Sigma-Aldrich, Madrid, MD, Spain) (15 min). Stained cells were counted by photographing the membrane in five randomly selected fields using a microscope equipped with a digital camera (Olympus, Tokyo, Japan). At least three chambers from three different experiments were analyzed. Prostate adenocarcinoma cell lines PC-3, DU145, and LNCaP. PCa cells were cultured in RPMI 1640 supplemented with 10% FBS (Life Technologies, Madrid, MD, Spain), 100 U/mL penicillin, and 100 mg/mL streptomycin (penicillin–streptomycin solution 30-2300; LGC Standards Barcelona, CAT, Spain). All cells were maintained at 37 °C in a 5% CO<sub>2</sub> humidified incubator, grown to confluence, and thereafter seeded into well culture plates at assay-specific densities.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Migration Assay</h3><div class="NLM_p last">As an indicator of the antimetastatic effect, we assessed PC-3, DU145, and LNCaP cell migration by using 24-well transwell cell culture chambers (6.5 mm diameter, 8.0 μm pore size, polycarbonate membrane) (cat. no. C6932; Sigma-Aldrich, Madrid, MD, Spain) with Millicell Cell Culture Insert (cat. no. PI8P01250; Merck Millipore Madrid, MD, Spain).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> In the upper chamber, 10<sup>5</sup> cells were seeded in 100 μL serum-free FBS, while the lower chamber was filled with 600 μL of complete medium with 10% FBS. After 24 h of incubation, cells in the upper chamber were carefully removed with a cotton swab and cells that had migrated through the membrane and had stuck to the lower surface of the membrane were fixed with 4% paraformaldehyde (2 min) and stained with crystal violet stain (cat. no. C6158; Sigma-Aldrich, Madrid, MD, Spain) (15 min). Stained cells were counted by photographing the membrane in five randomly selected fields using a microscope equipped with a digital camera (Olympus, Tokyo, Japan). At least three chambers from three different experiments were analyzed. Migration was evaluated after 72 h of cell culture without or with each of the treatments tested.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Cell Morphological Changes by Scanning Confocal Microscopy</h3><div class="NLM_p last">PC-3 cells were seeded in glass coverslips into incubation chambers (24 h at 37 °C and 5% CO<sub>2</sub>) in order to obtain full adherence. Thereafter, the medium was replaced with fresh complete medium containing antagonists <b>38</b> and <b>47</b>, or vehicles and plates were incubated for 72 h at 37 °C. Then, PC-3 cells were fluorescently stained for F-actin (phalloidin–ATTO 647N 1:500, cat. no. 65906; Sigma-Aldrich, Madrid, MD, Spain), nuclei (4′,6-diamidino-2-phenylindole, DAPI), and cytoplasm (CFDA-SE, cat. no. 1351201EDU; Bio-Rad Laboratories, Madrid, MD, Spain). The culture medium was replaced by PBS solution containing fluorescent dye CFDA-SE at 1 mM, and the cells were incubated 15 min. Subsequently, CFDA-SE solution was removed; cells were washed with PBS, fixed with 70% ethanol for 5 min, washed again with PBS, and finally, stained for with phalloidin–ATTO for 1 h. Then, the cells were washed with 0.9% sodium chloride (NaCl, cat. no. S7653; Sigma-Aldrich Madrid, MD, Spain) and stained with DAPI at 1 mg/mL for 10 min. Finally, slides were embedded in a VectaShield antifade mounting medium (cat. no. H-1000; Vector Laboratories, Burlingame CA, U.S.A.). The cells were analyzed with a Leica confocal microscope (Leica TCS SP5 II microscope).<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a></div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Receptor Modeling and Ligand Docking</h3><div class="NLM_p last">Our computational strategy for the structure-based design of AR ligands involves a combination of homology modeling, ligand–receptor docking, and free energy calculations, as recently reviewed.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Homology modeling of and docking to the hA<sub>2B</sub>AR: a 3D structure of the inactive form of the receptor was generated at the beginning of this project.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Briefly, the process consisted of the following sequential steps: (i) manual curation of the sequence alignment with the template A<sub>2A</sub>AR (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EML">3EML</a>),<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> (ii) generation and selection of homology models and loop refinement procedures with Modeler,<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> (iii) assessment of Asn/Gln/His rotamers and side chain protonation states with the MolProbity web server (<a href="http://molprobity.biochem.duke.edu/" class="extLink">http://molprobity.biochem.duke.edu/</a>), and (iv) use of tools from the Schrödinger Suite for energetic structural refinements.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> The previously described binding mode of <b>SYAF014</b><a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> in the A<sub>2B</sub>AR model was used as a starting point to manually dock all reported compounds within the series.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> MD and FEP Calculations</h3><div class="NLM_p last">The hA<sub>2B</sub>AR model obtained in the previous stage was inserted in the membrane and equilibrated under periodic boundary conditions using the PyMemDyn protocol described elsewhere.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Shortly, the starting structure is automatically embedded in a pre-equilibrated membrane consisting of 1-palmitoyl-2-oleoyl phosphatidylcholine lipids, with the TM bundle aligned to its vertical axis. This hexagonal-prism shaped box is then soaked with bulk water and energy minimized with GROMACS 4.6.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> using the OPLS-AA force field<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> for protein and ligands, combined with the Berger parameters for the lipids.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> The same setup is used for a 2.5 ns MD equilibration, where initial restraints on protein and ligand atoms are gradually released as described in detail in our original protocol.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> The equilibrated binding site is then transferred to the MD software Q<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> for FEP calculations under spherical boundary conditions, using the automated QligFEP protocol.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> A 25 Å sphere centered on the center of geometry of the ligand is considered for these MD simulations. Protein atoms in the boundary of the sphere (22–25 Å outer shell) had a positional restraint of 20 kcal/mol/Å<sup>2</sup>, while solvent atoms were subject to polarization and radial restrains using the surface constrained all-atom solvent<a onclick="showRef(event, 'ref90 ref92'); return false;" href="javascript:void(0);" class="ref ref90 ref92">(90,92)</a> model to mimic the properties of bulk water at the sphere surface. Atoms lying outside the simulation sphere are tightly constrained (200 kcal/mol/Å<sup>2</sup> force constant) and excluded from the calculation of nonbonded interactions. Long range electrostatic interactions beyond a 10 Å cut off were treated with the local reaction field method,<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> except for the atoms undergoing the FEP transformation where no cut-off was applied. Solvent bonds and angles were constrained using the SHAKE algorithm.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> All titratable residues outside the sphere were neutralized, and histidine residues were assigned a hydrogen atom on the δ nitrogen. Residue parameters were translated from the OPLS-AA/M force field,<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> and the parameters for the ligand and lipids were inherited from the previous MD stage. The simulation sphere was warmed up from 0.1 to 298 K, during a first equilibration period of 0.61 ns, where an initial restraint of 25 kcal/mol/Å<sup>2</sup> imposed on all heavy atoms was slowly released for all complexes. Thereafter, the system was subject to 10 parallel replicates of unrestrained MD, where the FEP protocol is applied for each ligand transformation. Each of these MD replicates starts with a 0.25 ns unbiased equilibration period, with different initial velocities. Thereafter, the FEP protocol follows, which consists of 21 FEP λ-windows, distributed using a sigmoidal function and consisting of 10 ps each for every investigated ligand pair. In order to fulfil a thermodynamic cycle and calculate relative binding free energies, parallel FEP transformations are run in a sphere of water for each ligand pair. In these water simulations, the same parameters apply (i.e., sphere size, simulation time, etc.), and the relative binding free energy difference was estimated by solving the thermodynamic cycle utilizing the Bennett acceptance ratio.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a></div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> CYP3A4 and CYP2D6 Inhibition</h3><div class="NLM_p last">The inhibitory activity of ligands (±)-<b>38</b> and (±)-<b>47</b> was assessed by following a published protocol.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Incubations were conducted in a 200 μL of volume in 96 well microtiter plates (COSTAR 3915). Addition of the cofactor-buffer mixture (KH<sub>2</sub>PO<sub>4</sub> buffer, 1.3 mM NADP, 3.3 mM MgCl<sub>2</sub>, 3.3 mM glucose-6-phosphate, and 0.4 U/mL glucose-6-phosphate dehydrogenase), supersomes control, and standard inhibitor (ketoconazole from Sigma-Aldrich) previously diluted and compounds to plates were carried out by a liquid handling station (Zephyr Caliper). The plate was then preincubated at 37 °C for 5 min, and the reaction initiated by the addition of prewarmed enzyme/substrate (E/S) mix. The E/S mix contained buffer (KH<sub>2</sub>PO<sub>4</sub>), c-DNA-expressed P450 in insect cell microsomes, substrate (DBF: dibenzylfluorescein), and other components to give the final assay concentrations in a reaction volume of 200 μL. Reactions were terminated after various times (a specific time for each cytochrome) by the addition of STOP solution [ACN/Tris-HCl 0.5 M 80:20 and NaOH 2 N for CYP3A4 (DBF)]. Fluorescence per well was measured using a fluorescence plate reader (Tecan Infinite M1000 Pro), and the percentage of inhibition was calculated.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Human Microsomal Stability</h3><div class="NLM_p last">The human microsomes employed were purchased from Tebu-Xenotech. The A<sub>2B</sub> antagonists [(±)-<b>38</b> and (±)-<b>47</b>] were incubated with the microsomes at 37 °C in a 50 mM phosphate buffer (pH = 7.4) containing 3 mM MgCl<sub>2</sub>, 1 mM NADP, 10 mM glucose-6-phosphate, and 1 U/mL glucose-6-phosphate-dehydrogenase. Samples (75 μL) were taken from each well at 0, 10, 20, 40, and 60 min and transferred to a plate containing 4 °C 75 μL acetonitrile, and 30 μL of 0.5% formic acid in water was added for improving the chromatographic conditions. The plate was centrifuged (46,000<i>g</i>, 30 min), and supernatants were taken and analyzed in an UPLC–MS/MS (Xevo-TQD, Waters) by employing a BEH C18 column and an isocratic gradient of 0.1% formic acid in water/0.1% formic acid acetonitrile (60:40). The metabolic stability of the compounds was calculated from the logarithm of the remaining compounds at each of the time points studied.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i47"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01431" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31067" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31067" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01431?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01431</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01431/suppl_file/jm0c01431_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Peak summary report (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01431/suppl_file/jm0c01431_si_002.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Computational chemistry; general information; general procedure for Biginelli synthesis; spectroscopic and analytical data for all compounds described; and analytical HPLC chromatograms of AF80 (38) and AF80 (47) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01431/suppl_file/jm0c01431_si_003.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01431/suppl_file/jm0c01431_si_001.csv">jm0c01431_si_001.csv (7.67 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01431/suppl_file/jm0c01431_si_002.pdf">jm0c01431_si_002.pdf (1.24 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01431/suppl_file/jm0c01431_si_003.pdf">jm0c01431_si_003.pdf (697.88 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01431" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20746" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20746" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">José Brea</span> - <span class="hlFld-Affiliation affiliation">Centro
Singular de Investigación en Medicina Molecular y Enfermedades
Crónicas (CIMUS), Universidade de
Santiago de Compostela, 15782 Santiago de Compostela, Spain</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e8988d9887c68a9a8d89a89d9b8bc68d9b"><span class="__cf_email__" data-cfemail="eb9b8e9b84c589998e8aab9e9888c58e98">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hugo Gutiérrez-de-Terán</span> - <span class="hlFld-Affiliation affiliation">Department
of Cell and Molecular Biology, Uppsala University, SE-75124 Uppsala, Sweden</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0459-3491" title="Orcid link">http://orcid.org/0000-0003-0459-3491</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e8809d8f87c68f9d9c818d9a9a8d92a8818b85c69d9dc69b8d"><span class="__cf_email__" data-cfemail="234b56444c0d4456574a4651514659634a404e0d56560d5046">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eddy Sotelo</span> - <span class="hlFld-Affiliation affiliation">Centro
Singular de Investigación en Química Biolóxica
y Materiais Moleculares (CIQUS), Universidade
de Santiago de Compostela, 15782 Santiago de Compostela, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago
de Compostela, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5571-2812" title="Orcid link">http://orcid.org/0000-0001-5571-2812</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#472269342833222b2807323424692234"><span class="__cf_email__" data-cfemail="bbde95c8d4cfded7d4fbcec8d895dec8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María Majellaro</span> - <span class="hlFld-Affiliation affiliation">Centro
Singular de Investigación en Química Biolóxica
y Materiais Moleculares (CIQUS), Universidade
de Santiago de Compostela, 15782 Santiago de Compostela, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago
de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Willem Jespers</span> - <span class="hlFld-Affiliation affiliation">Department
of Cell and Molecular Biology, Uppsala University, SE-75124 Uppsala, Sweden</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4951-9220" title="Orcid link">http://orcid.org/0000-0002-4951-9220</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Abel Crespo</span> - <span class="hlFld-Affiliation affiliation">Centro
Singular de Investigación en Química Biolóxica
y Materiais Moleculares (CIQUS), Universidade
de Santiago de Compostela, 15782 Santiago de Compostela, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago
de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María J. Núñez</span> - <span class="hlFld-Affiliation affiliation">SNL,
Departamento de Farmacología, Facultade de Medicina, Universidade de Santiago de Compostela, 15782 Santiago
de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Silvia Novio</span> - <span class="hlFld-Affiliation affiliation">SNL,
Departamento de Farmacología, Facultade de Medicina, Universidade de Santiago de Compostela, 15782 Santiago
de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jhonny Azuaje</span> - <span class="hlFld-Affiliation affiliation">Centro
Singular de Investigación en Química Biolóxica
y Materiais Moleculares (CIQUS), Universidade
de Santiago de Compostela, 15782 Santiago de Compostela, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago
de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rubén Prieto-Díaz</span> - <span class="hlFld-Affiliation affiliation">Centro
Singular de Investigación en Química Biolóxica
y Materiais Moleculares (CIQUS), Universidade
de Santiago de Compostela, 15782 Santiago de Compostela, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago
de Compostela, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2539-3106" title="Orcid link">http://orcid.org/0000-0003-2539-3106</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claudia Gioé</span> - <span class="hlFld-Affiliation affiliation">Centro
Singular de Investigación en Química Biolóxica
y Materiais Moleculares (CIQUS), Universidade
de Santiago de Compostela, 15782 Santiago de Compostela, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago
de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Belma Alispahic</span> - <span class="hlFld-Affiliation affiliation">Department
of Cell and Molecular Biology, Uppsala University, SE-75124 Uppsala, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María I. Loza</span> - <span class="hlFld-Affiliation affiliation">Centro
Singular de Investigación en Medicina Molecular y Enfermedades
Crónicas (CIMUS), Universidade de
Santiago de Compostela, 15782 Santiago de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manuel Freire-Garabal</span> - <span class="hlFld-Affiliation affiliation">SNL,
Departamento de Farmacología, Facultade de Medicina, Universidade de Santiago de Compostela, 15782 Santiago
de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carlota Garcia-Santiago</span> - <span class="hlFld-Affiliation affiliation">SNL,
Departamento de Farmacología, Facultade de Medicina, Universidade de Santiago de Compostela, 15782 Santiago
de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carlos Rodríguez-García</span> - <span class="hlFld-Affiliation affiliation">Centro
Singular de Investigación en Química Biolóxica
y Materiais Moleculares (CIQUS), Universidade
de Santiago de Compostela, 15782 Santiago de Compostela, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago
de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xerardo García-Mera</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago
de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Olga Caamaño</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago
de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian Fernandez-Masaguer</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago
de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Javier F. Sardina</span> - <span class="hlFld-Affiliation affiliation">Centro
Singular de Investigación en Química Biolóxica
y Materiais Moleculares (CIQUS), Universidade
de Santiago de Compostela, 15782 Santiago de Compostela, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6758-0068" title="Orcid link">http://orcid.org/0000-0002-6758-0068</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela Stefanachi</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia-Scienze del Farmaco, Università
degli Studi di Bari ALDO MORO, via Orabona 4, 70125 Bari, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9430-7972" title="Orcid link">http://orcid.org/0000-0002-9430-7972</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Abdelaziz El Maatougui</span> - <span class="hlFld-Affiliation affiliation">Centro
Singular de Investigación en Química Biolóxica
y Materiais Moleculares (CIQUS), Universidade
de Santiago de Compostela, 15782 Santiago de Compostela, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago
de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ana Mallo-Abreu</span> - <span class="hlFld-Affiliation affiliation">Centro
Singular de Investigación en Química Biolóxica
y Materiais Moleculares (CIQUS), Universidade
de Santiago de Compostela, 15782 Santiago de Compostela, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago
de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Johan Åqvist</span> - <span class="hlFld-Affiliation affiliation">Department
of Cell and Molecular Biology, Uppsala University, SE-75124 Uppsala, Sweden</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2091-0610" title="Orcid link">http://orcid.org/0000-0003-2091-0610</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>M.M., W.J., and A.C. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i49">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34275" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34275" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was financially supported by the Consellería de Cultura, Educación e Ordenación Universitaria of the Galician Government: (grant: ED431B2017/70), Centro singular de Investigación de Galicia accreditation 2016–2019 (ED431G/09), Xunta de Galicia (ED431C 2018/21) and the European Regional Development Fund (ERDF), the Swedish Research Council (grant: 521-2014-2118), and by the Swedish strategic research program eSSENCE. The computations were performed on resources provided by the Swedish National Infrastructure for Computing (SNIC).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">ARs</td><td class="NLM_def"><p class="first last">adenosine receptors</p></td></tr><tr><td class="NLM_term">hA<sub>2B</sub>R</td><td class="NLM_def"><p class="first last">human A<sub>2B</sub> adenosine receptors</p></td></tr><tr><td class="NLM_term">hA<sub>2A</sub>R</td><td class="NLM_def"><p class="first last">human A<sub>2A</sub> adenosine receptors</p></td></tr><tr><td class="NLM_term">CHO cells</td><td class="NLM_def"><p class="first last">Chinese hamster ovary cells</p></td></tr><tr><td class="NLM_term">c-AMP</td><td class="NLM_def"><p class="first last">cyclic adenosine monophosphate</p></td></tr><tr><td class="NLM_term">FEP</td><td class="NLM_def"><p class="first last">free energy perturbation</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">MAE</td><td class="NLM_def"><p class="first last">mean absolute error</p></td></tr><tr><td class="NLM_term">MD</td><td class="NLM_def"><p class="first last">molecular dynamics</p></td></tr><tr><td class="NLM_term">MPLC</td><td class="NLM_def"><p class="first last">medium pressure liquid chromatography</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance spectroscopy</p></td></tr><tr><td class="NLM_term">PCa</td><td class="NLM_def"><p class="first last">prostate cancer</p></td></tr><tr><td class="NLM_term">PC-3 and DU145</td><td class="NLM_def"><p class="first last">androgen-independent human prostate cancer cell line cell lines</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr><tr><td class="NLM_term">LNCaP</td><td class="NLM_def"><p class="first last">androgen-dependent human prostate cancer cell line cell line</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationships</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">SCAAS</td><td class="NLM_def"><p class="first last">surface constrained all-atom solvent</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i51">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34078" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34078" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 96 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rivkees, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reppert, S. M.</span></span> <span> </span><span class="NLM_article-title">RFL9 Encodes an A2b-Adenosine Receptor</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1598</span>– <span class="NLM_lpage">1604</span>, <span class="refDoi"> DOI: 10.1210/mend.6.10.1333049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1210%2Fmend.6.10.1333049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1333049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADyaK3sXhvF2qug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1992&pages=1598-1604&author=S.+A.+Rivkeesauthor=S.+M.+Reppert&title=RFL9+Encodes+an+A2b-Adenosine+Receptor&doi=10.1210%2Fmend.6.10.1333049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">RFL9 encodes an A2b-adenosine receptor</span></div><div class="casAuthors">Rivkees, Scott A.; Reppert, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1598-604</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    </div><div class="casAbstract">The authors recently reported the cloning of a cDNA (designated RFL9) that encodes a novel A2-adenosine receptor subtype.  Here, the pharmacol. properties of RFL9 were characterized in stably transfected CHO cells by examg. cAMP responses to drug treatments.  The pharmacol. profile of cAMP responses in RFL9-transfected cells was similar to that expected for A2b-adenosine receptors and distinct from that of CHO cells transfected with the A2a-adenosine receptor.  When RFL9-transfected cells were compared with VA 13 fibroblasts, the human cell line in which endogenous A2b-adenosine receptors were originally characterized, the dose-response curves of cAMP responses to drug treatments were highly correlated.  Northern blot anal. of RNA prepd. from VA 13 fibroblasts revealed specific hybridizing transcripts when probed for RFL9, but no hybridizing signal for A2a-adenosine receptor mRNA.  Using degenerate oligonucleotide primers designed to detect adenosine receptors by PCR reaction, only 1 cDNA fragment homologous to the rat A2b-adenosine receptor was isolated from VA 13 cells.  These results strongly suggest that RFL9 encodes the proposed A2b-adenosine receptor subtype.  The identification of the cDNA for an A2b-adenosine receptor will allow more rigorous characterization of its anatomical distribution and functional properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGcZ6WQ3bIxbVg90H21EOLACvtfcHk0lgkLpjDxNOtDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhvF2qug%253D%253D&md5=1dbb93e3006dea720c62f570aec7b676</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1210%2Fmend.6.10.1333049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fmend.6.10.1333049%26sid%3Dliteratum%253Aachs%26aulast%3DRivkees%26aufirst%3DS.%2BA.%26aulast%3DReppert%26aufirst%3DS.%2BM.%26atitle%3DRFL9%2520Encodes%2520an%2520A2b-Adenosine%2520Receptor%26jtitle%3DMol.%2520Endocrinol.%26date%3D1992%26volume%3D6%26spage%3D1598%26epage%3D1604%26doi%3D10.1210%2Fmend.6.10.1333049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furlong, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selbie, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shine, J.</span></span> <span> </span><span class="NLM_article-title">Molecular Cloning and Expression of an Adenosine A2b Receptor from Human Brain</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>187</i></span>,  <span class="NLM_fpage">86</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(05)81462-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2FS0006-291X%2805%2981462-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1325798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADyaK3sXksVWitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=1992&pages=86-93&author=K.+D.+Pierceauthor=T.+J.+Furlongauthor=L.+A.+Selbieauthor=J.+Shine&title=Molecular+Cloning+and+Expression+of+an+Adenosine+A2b+Receptor+from+Human+Brain&doi=10.1016%2FS0006-291X%2805%2981462-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning and expression of an adenosine A2b receptor from human brain</span></div><div class="casAuthors">Pierce, Kerrie D.; Furlong, Timothy J.; Selbie, Lisa A.; Shine, John</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">86-93</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">A novel receptor cDNA was isolated from a human hippocampal cDNA library.  The encoded polypeptide contains structural features consistent with its classification as a G protein-coupled receptor and shares 45% homol. with the human A1 and A2a adenosine receptors.  Chinese hamster ovary K1 cells expressing this receptor showed marked stimulation of adenylate cyclase when treated with 1 mM adenosine.  There was no response to ligands selective for A1 and A2a receptors but the general adenosine agonist N-ethylcarboxyamidoadenosine (NECA) caused a 10-fold increase in cAMP accumulation with an EC50 of approx. 0.9 μM.  This effect was inhibited by the adenosine receptor antagonist theophylline.  Specific binding of A1 and A2a selective agonists and NECA was not detected.  It is proposed that the novel receptor is a human brain adenosine A2b receptor subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYMoxdq7h-XrVg90H21EOLACvtfcHk0lj-mK2oozSdDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXksVWitrY%253D&md5=508a77e25ebb1a3513d044122228dd6b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2805%2981462-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252805%252981462-7%26sid%3Dliteratum%253Aachs%26aulast%3DPierce%26aufirst%3DK.%2BD.%26aulast%3DFurlong%26aufirst%3DT.%2BJ.%26aulast%3DSelbie%26aufirst%3DL.%2BA.%26aulast%3DShine%26aufirst%3DJ.%26atitle%3DMolecular%2520Cloning%2520and%2520Expression%2520of%2520an%2520Adenosine%2520A2b%2520Receptor%2520from%2520Human%2520Brain%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1992%26volume%3D187%26spage%3D86%26epage%3D93%26doi%3D10.1016%2FS0006-291X%2805%2981462-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beukers, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Den Dulk, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Tilburg, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span> <span> </span><span class="NLM_article-title">Why Are A2B Receptors Low-Affinity Adenosine Receptors? Mutation of Asn273 to Tyr Increases Affinity of Human A2B Receptor for 2-(1-Hexynyl)adenosine</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1349</span>– <span class="NLM_lpage">1356</span>, <span class="refDoi"> DOI: 10.1124/mol.58.6.1349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1124%2Fmol.58.6.1349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=11093773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovFeqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2000&pages=1349-1356&author=M.+W.+Beukersauthor=H.+Den+Dulkauthor=E.+W.+Van+Tilburgauthor=J.+Brouwerauthor=A.+P.+Ijzerman&title=Why+Are+A2B+Receptors+Low-Affinity+Adenosine+Receptors%3F+Mutation+of+Asn273+to+Tyr+Increases+Affinity+of+Human+A2B+Receptor+for+2-%281-Hexynyl%29adenosine&doi=10.1124%2Fmol.58.6.1349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Why are A2B receptors low-affinity adenosine receptors? Mutation of Asn273 to Tyr increases affinity of human A2B receptor for 2-(1-hexynyl)adenosine</span></div><div class="casAuthors">Beukers, Margot W.; den Dulk, Hans; Van Tilburg, Erica W.; Brouwer, Jaap; Ijerman, Adriaan P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1349-1356</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Adenosine A2B receptors are known as low-affinity receptors due to their modest-to-negligible affinity for adenosine and prototypic agonists.  Despite numerous synthetic efforts, 5'-N-ethylcarboxamidoadenosine (NECA) still is the ref. agonist, albeit nonselective for this receptor.  In the authors' search for higher affinity agonists, the authors developed decision schemes to select amino acids for mutation to the corresponding residues in the most homologous, higher affinity, human A2A receptor.  One scheme exploited knowledge on sequence alignments and modeling data and yielded three residues, V11, L58, and F59, mutation of which did not affect agonist affinity.  The second scheme combined knowledge on sequence alignments and mutation data and pointed to Ala 12 and Asn 273.  Mutation of Ala 12 to threonine did not affect the affinity for NECA, (R)-N6-(phenylisopropyl)adenosine (R-PIA), and 2Cl Ado.  The affinity of the N273Y mutant for NECA and R-PIA and for the antagonists xanthine amine congener (XAC), ZM241385, and SCH58261 was also unaltered.  However, this mutant had a slightly increased affinity for a 2-substituted adenosine deriv., CGS21680.  This prompted the authors to investigate other 2-substituted adenosines, with selectivity and high affinity for A2A receptors.  All four compds. tested had improved affinity for the N273Y receptor.  Of these, 2-(1-hexynyl)adenosine had submicromolar affinity for the N273Y receptor, 0.18±0.10 μM, with a 61-fold affinity gain over the wt receptor.  In addn., the non-NECA analog (S)-PHP adenosine had an affinity of 1.7±0.5 μM for the wt receptor.  The high affinity of (S)-PHP adenosine for the wt receptor suggests that further modifications at the 2-position may yield agonists with even higher affinity for A2B receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTiX-Z-7VU-LVg90H21EOLACvtfcHk0lj-mK2oozSdDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovFeqs78%253D&md5=9325abaf777165625a71c5f5b0d6aa2c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1124%2Fmol.58.6.1349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.58.6.1349%26sid%3Dliteratum%253Aachs%26aulast%3DBeukers%26aufirst%3DM.%2BW.%26aulast%3DDen%2BDulk%26aufirst%3DH.%26aulast%3DVan%2BTilburg%26aufirst%3DE.%2BW.%26aulast%3DBrouwer%26aufirst%3DJ.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3DWhy%2520Are%2520A2B%2520Receptors%2520Low-Affinity%2520Adenosine%2520Receptors%253F%2520Mutation%2520of%2520Asn273%2520to%2520Tyr%2520Increases%2520Affinity%2520of%2520Human%2520A2B%2520Receptor%2520for%25202-%25281-Hexynyl%2529adenosine%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D58%26spage%3D1349%26epage%3D1356%26doi%3D10.1124%2Fmol.58.6.1349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fredholm, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irenius, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kull, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulte, G.</span></span> <span> </span><span class="NLM_article-title">Comparison of the Potency of Adenosine as an Agonist at Human Adenosine Receptors Expressed in Chinese Hamster Ovary Cells</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">448</span>, <span class="refDoi"> DOI: 10.1016/S0006-2952(00)00570-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2FS0006-2952%2800%2900570-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=11226378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsVOiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=443-448&author=B.+B.+Fredholmauthor=E.+Ireniusauthor=B.+Kullauthor=G.+Schulte&title=Comparison+of+the+Potency+of+Adenosine+as+an+Agonist+at+Human+Adenosine+Receptors+Expressed+in+Chinese+Hamster+Ovary+Cells&doi=10.1016%2FS0006-2952%2800%2900570-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells</span></div><div class="casAuthors">Fredholm, B. B.; Irenius, E.; Kull, B.; Schulte, G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">443-448</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The potency of adenosine and inosine as agonists at human adenosine receptors was examd. in a functional assay using changes in cAMP formation in intact Chinese hamster ovary (CHO) cells stably transfected with the human A1, A2A, A2B, and A3 receptors.  Adenosine increased cAMP formation in cells expressing the A2A (EC50: 0.7 μM) and A2B (EC50: 24 μM) receptors and inhibited forskolin (0.3-3 μM)-stimulated cAMP formation in cells expressing the A1 (EC50: 0.31 μM) and A3 receptors (EC50: 0.29 μM).  The potency of adenosine at the A2A and A2B receptors was not altered by the presence of the uptake inhibitor nitrobenzylthioinosine (NBMPR), whereas it was increased about 6-fold by NBMPR at the A1 and A3 receptors.  In the presence of NBMPR, inosine was a potent agonist (EC50: 7 and 0.08 μM at the A1 and A3 receptors, resp.), but with low efficacy esp. at the A3 receptors.  No effect of inosine was seen at the A2 receptors.  Caffeine, theophylline, and paraxanthine shifted the dose-response curve for adenosine at the A1, A2A, and A2B receptors.  These results indicate that adenosine is the endogenous agonist at all human adenosine receptors and that physiol. levels of this nucleoside can activate A1, A2A, and A3 receptors on cells where they are abundantly expressed, whereas pathophysiol. conditions are required to stimulate A2B receptors to produce cAMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8KNx0HlJjOrVg90H21EOLACvtfcHk0lj-mK2oozSdDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsVOiu7c%253D&md5=dd9a7630a12458fcca188164c702cc13</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2800%2900570-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252800%252900570-0%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DIrenius%26aufirst%3DE.%26aulast%3DKull%26aufirst%3DB.%26aulast%3DSchulte%26aufirst%3DG.%26atitle%3DComparison%2520of%2520the%2520Potency%2520of%2520Adenosine%2520as%2520an%2520Agonist%2520at%2520Human%2520Adenosine%2520Receptors%2520Expressed%2520in%2520Chinese%2520Hamster%2520Ovary%2520Cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2001%26volume%3D61%26spage%3D443%26epage%3D448%26doi%3D10.1016%2FS0006-2952%2800%2900570-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fredholm, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors-An Update</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1124/pr.110.003285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1124%2Fpr.110.003285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=21303899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslGisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=1-34&author=B.+B.+Fredholmauthor=A.+P.+Ijzermanauthor=K.+A.+Jacobsonauthor=J.+Lindenauthor=C.+E.+M%C3%BCller&title=International+Union+of+Basic+and+Clinical+Pharmacology.+LXXXI.+Nomenclature+and+Classification+of+Adenosine+Receptors-An+Update&doi=10.1124%2Fpr.110.003285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors - an update</span></div><div class="casAuthors">Fredholm, Bertil B.; IJzerman, Adriaan P.; Jacobson, Kenneth A.; Linden, Joel; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-34</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  In the 10 years since our previous International Union of Basic and Clin. Pharmacol. report on the nomenclature and classification of adenosine receptors, no developments have led to major changes in the recommendations.  However, there have been so many other developments that an update is needed.  The fact that the structure of one of the adenosine receptors has recently been solved has already led to new ways of in silico screening of ligands.  The evidence that adenosine receptors can form homo- and hetero-multimers has accumulated, but the functional significance of such complexes remains unclear.  The availability of mice with genetic modification of all the adenosine receptors has led to a clarification of the functional roles of adenosine, and to excellent means to study the specificity of drugs.  There are also interesting assocns. between disease and structural variants in one or more of the adenosine receptors.  Several new selective agonists and antagonists have become available.  They provide improved possibilities for receptor classification.  There are also developments hinting at the usefulness of allosteric modulators.  Many drugs targeting adenosine receptors are in clin. trials, but the established therapeutic use is still very limited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNqbDC-UZ5sbVg90H21EOLACvtfcHk0ljdvv49zPqQxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslGisrY%253D&md5=e184c127e06b800bbcf15402ed27f02a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.003285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.003285%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DInternational%2520Union%2520of%2520Basic%2520and%2520Clinical%2520Pharmacology.%2520LXXXI.%2520Nomenclature%2520and%2520Classification%2520of%2520Adenosine%2520Receptors-An%2520Update%26jtitle%3DPharmacol.%2520Rev.%26date%3D2011%26volume%3D63%26spage%3D1%26epage%3D34%26doi%3D10.1124%2Fpr.110.003285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koupenova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliades, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toselli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravid, K.</span></span> <span> </span><span class="NLM_article-title">A New Role for the A2b Adenosine Receptor in Regulating Platelet Function</span>. <i>J. Thromb. Haemostasis</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">817</span>– <span class="NLM_lpage">827</span>, <span class="refDoi"> DOI: 10.1111/j.1538-7836.2010.03769.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1111%2Fj.1538-7836.2010.03769.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=20102488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVGksbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=817-827&author=D.+Yangauthor=H.+Chenauthor=M.+Koupenovaauthor=S.+H.+Carrollauthor=A.+Eliadesauthor=J.+E.+Freedmanauthor=P.+Toselliauthor=K.+Ravid&title=A+New+Role+for+the+A2b+Adenosine+Receptor+in+Regulating+Platelet+Function&doi=10.1111%2Fj.1538-7836.2010.03769.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A new role for the A2b adenosine receptor in regulating platelet function</span></div><div class="casAuthors">Yang, D.; Chen, H.; Koupenova, M.; Carroll, S. H.; Eliades, A.; Freedman, J. E.; Toselli, P.; Ravid, K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-827</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background: Activation of platelets is a crit. component of atherothrombosis and plays a central role in the progression of unstable cardiovascular syndromes.  Adenosine, acting through adenosine receptors, increases intracellular cAMP levels and inhibits platelet aggregation.  The A2a adenosine receptor has already been recognized as a mediator of adenosine-dependent effects on platelet aggregation, and here we present a new role for the A2b adenosine receptor (A2bAR) in this process.  Methods and Results: As compared with platelets from wild-type controls, platelets derived from A2bAR knockout mice have significantly greater ADP receptor activation-induced aggregation.  Although mouse megakaryocytes and platelets express low levels of the A2bAR transcript, this gene is highly upregulated following injury and systemic inflammation in vivo.  Under these conditions, A2bAR-mediated inhibition of platelet aggregation significantly increases.  Our studies also identify a novel mechanism by which the A2bAR could regulate platelet aggregation; namely, ablation of the A2bAR leads to upregulated expression of the P2Y1 ADP receptor, whereas A2bAR-mediated or direct elevation of cAMP has the opposite effect.  Thus, the A2bAR regulates platelet function beyond mediating the immediate effect of adenosine on aggregation.  Conclusions: Taken together, these investigations show for the first time that the platelet A2bAR is upregulated under stress in vivo, plays a significant role in regulating ADP receptor expression, and inhibits agonist-induced platelet aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN-oGDZCyD2LVg90H21EOLACvtfcHk0ljdvv49zPqQxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVGksbs%253D&md5=882c8143d7bb1fe14a7b8f4300d07b0c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2010.03769.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2010.03769.x%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DKoupenova%26aufirst%3DM.%26aulast%3DCarroll%26aufirst%3DS.%2BH.%26aulast%3DEliades%26aufirst%3DA.%26aulast%3DFreedman%26aufirst%3DJ.%2BE.%26aulast%3DToselli%26aufirst%3DP.%26aulast%3DRavid%26aufirst%3DK.%26atitle%3DA%2520New%2520Role%2520for%2520the%2520A2b%2520Adenosine%2520Receptor%2520in%2520Regulating%2520Platelet%2520Function%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2010%26volume%3D8%26spage%3D817%26epage%3D827%26doi%3D10.1111%2Fj.1538-7836.2010.03769.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koupenova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCrann, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopeikina, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravid, K.</span></span> <span> </span><span class="NLM_article-title">The A2b Adenosine Receptor Protects against Vascular Injury</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">792</span>– <span class="NLM_lpage">796</span>, <span class="refDoi"> DOI: 10.1073/PNAS.0705563105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1073%2FPNAS.0705563105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=18184815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVSjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=792-796&author=D.+Yangauthor=M.+Koupenovaauthor=D.+J.+McCrannauthor=K.+J.+Kopeikinaauthor=H.+M.+Kaganauthor=B.+M.+Schreiberauthor=K.+Ravid&title=The+A2b+Adenosine+Receptor+Protects+against+Vascular+Injury&doi=10.1073%2FPNAS.0705563105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The A2b adenosine receptor protects against vascular injury</span></div><div class="casAuthors">Yang, Dan; Koupenova, Milka; McCrann, Donald J.; Kopeikina, Katherine J.; Kagan, Herbert M.; Schreiber, Barbara M.; Ravid, Katya</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">792-796</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The A2b adenosine receptor (A2bAR) is highly abundant in bone marrow macrophages and vascular smooth muscle cells (VSMC).  To examine the functional significance of this receptor expression, we applied a femoral artery injury model to A2bAR knockout (KO) mice and showed that the A2bAR prevents vascular lesion formation in an injury model that resembles human restenosis after angioplasty.  While considering related mechanisms, we noted higher levels of TNF-α, an up-regulator of CXCR4, and of VSMC proliferation in the injured KO mice.  In accordance, CXCR4, which is known to attract progenitor cells during tissue regeneration, is up-regulated in lesions of the KO mice.  In addn., aortic smooth muscle cells derived from A2bAR KO mice display greater proliferation in comparison with controls.  Bone marrow transplantation expts. indicated that the majority of the signal for lesion formation in the null mice originates from bone marrow cells.  Thus, this study highlights the significance of the A2bAR in regulating CXCR4 expression in vivo and in protecting against vascular lesion formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJnXsJjGPbcLVg90H21EOLACvtfcHk0ljrsCfieaNbUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVSjs7Y%253D&md5=edc8e50d8d5160ba8f0c21691cf806d5</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2FPNAS.0705563105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252FPNAS.0705563105%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DD.%26aulast%3DKoupenova%26aufirst%3DM.%26aulast%3DMcCrann%26aufirst%3DD.%2BJ.%26aulast%3DKopeikina%26aufirst%3DK.%2BJ.%26aulast%3DKagan%26aufirst%3DH.%2BM.%26aulast%3DSchreiber%26aufirst%3DB.%2BM.%26aulast%3DRavid%26aufirst%3DK.%26atitle%3DThe%2520A2b%2520Adenosine%2520Receptor%2520Protects%2520against%2520Vascular%2520Injury%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D792%26epage%3D796%26doi%3D10.1073%2FPNAS.0705563105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koupenova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makitalo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. Hilaire, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toselli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamperti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavras, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravid, K.</span></span> <span> </span><span class="NLM_article-title">The A2B Adenosine Receptor Protects against Inflammation and Excessive Vascular Adhesion</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">1913</span>– <span class="NLM_lpage">1923</span>, <span class="refDoi"> DOI: 10.1172/JCI27933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1172%2FJCI27933" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=16823489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvV2lur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2006&pages=1913-1923&author=D.+Yangauthor=Y.+Zhangauthor=H.+G.+Nguyenauthor=M.+Koupenovaauthor=A.+K.+Chauhanauthor=M.+Makitaloauthor=M.+R.+Jonesauthor=C.+St.+Hilaireauthor=D.+C.+Seldinauthor=P.+Toselliauthor=E.+Lampertiauthor=B.+M.+Schreiberauthor=H.+Gavrasauthor=D.+D.+Wagnerauthor=K.+Ravid&title=The+A2B+Adenosine+Receptor+Protects+against+Inflammation+and+Excessive+Vascular+Adhesion&doi=10.1172%2FJCI27933"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The A2B adenosine receptor protects against inflammation and excessive vascular adhesion</span></div><div class="casAuthors">Yang, Dan; Zhang, Ying; Nguyen, Hao G.; Koupenova, Milka; Chauhan, Anil K.; Makitalo, Maria; Jones, Matthew R.; St. Hilaire, Cynthia; Seldin, David C.; Toselli, Paul; Lamperti, Edward; Schreiber, Barbara M.; Gavras, Haralambos; Wagner, Denisa D.; Ravid, Katya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1913-1923</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Adenosine has been described as playing a role in the control of inflammation, but it has not been certain which of its receptors mediate this effect.  Here, we generated an A2B adenosine receptor-knockout/reporter gene-knock-in (A2BAR-knockout/reporter gene-knock-in) mouse model and showed receptor gene expression in the vasculature and macrophages, the ablation of which causes low-grade inflammation compared with age-, sex-, and strain-matched control mice.  Augmentation of proinflammatory cytokines, such as TNF-α, and a consequent downregulation of IκB-α are the underlying mechanisms for an obsd. upregulation of adhesion mols. in the vasculature of these A2BAR-null mice.  Intriguingly, leukocyte adhesion to the vasculature is significantly increased in the A2BAR-knockout mice.  Exposure to an endotoxin results in augmented proinflammatory cytokine levels in A2BAR-null mice compared with control mice.  Bone marrow transplantations indicated that bone marrow (and to a lesser extent vascular) A2BARs regulate these processes.  Hence, we identify the A2BAR as a new crit. regulator of inflammation and vascular adhesion primarily via signals from hematopoietic cells to the vasculature, focusing attention on the receptor as a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwUPBsNqSZV7Vg90H21EOLACvtfcHk0ljrsCfieaNbUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvV2lur4%253D&md5=aa57093195cd8aac440709eb86067f7d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1172%2FJCI27933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI27933%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DNguyen%26aufirst%3DH.%2BG.%26aulast%3DKoupenova%26aufirst%3DM.%26aulast%3DChauhan%26aufirst%3DA.%2BK.%26aulast%3DMakitalo%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DM.%2BR.%26aulast%3DSt.%2BHilaire%26aufirst%3DC.%26aulast%3DSeldin%26aufirst%3DD.%2BC.%26aulast%3DToselli%26aufirst%3DP.%26aulast%3DLamperti%26aufirst%3DE.%26aulast%3DSchreiber%26aufirst%3DB.%2BM.%26aulast%3DGavras%26aufirst%3DH.%26aulast%3DWagner%26aufirst%3DD.%2BD.%26aulast%3DRavid%26aufirst%3DK.%26atitle%3DThe%2520A2B%2520Adenosine%2520Receptor%2520Protects%2520against%2520Inflammation%2520and%2520Excessive%2520Vascular%2520Adhesion%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2006%26volume%3D116%26spage%3D1913%26epage%3D1923%26doi%3D10.1172%2FJCI27933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morello, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miele, L.</span></span> <span> </span><span class="NLM_article-title">Targeting the Adenosine A2b Receptor in the Tumor Microenvironment Overcomes Local Immunosuppression by Myeloid-Derived Suppressor Cells</span>. <i>Oncoimmunology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">e27989</span> <span class="refDoi"> DOI: 10.4161/onci.27989</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.4161%2Fonci.27989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=25101221" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&author=S.+Morelloauthor=L.+Miele&title=Targeting+the+Adenosine+A2b+Receptor+in+the+Tumor+Microenvironment+Overcomes+Local+Immunosuppression+by+Myeloid-Derived+Suppressor+Cells&doi=10.4161%2Fonci.27989"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.4161%2Fonci.27989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fonci.27989%26sid%3Dliteratum%253Aachs%26aulast%3DMorello%26aufirst%3DS.%26aulast%3DMiele%26aufirst%3DL.%26atitle%3DTargeting%2520the%2520Adenosine%2520A2b%2520Receptor%2520in%2520the%2520Tumor%2520Microenvironment%2520Overcomes%2520Local%2520Immunosuppression%2520by%2520Myeloid-Derived%2520Suppressor%2520Cells%26jtitle%3DOncoimmunology%26date%3D2014%26volume%3D3%26doi%3D10.4161%2Fonci.27989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vecchio, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C. Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, L. T.</span></span> <span> </span><span class="NLM_article-title">Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>357</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1124/jpet.115.230003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1124%2Fjpet.115.230003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=26791603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvVeksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2016&pages=36-44&author=E.+A.+Vecchioauthor=C.+Y.+R.+Tanauthor=K.+J.+Gregoryauthor=A.+Christopoulosauthor=P.+J.+Whiteauthor=L.+T.+May&title=Ligand-Independent+Adenosine+A2B+Receptor+Constitutive+Activity+as+a+Promoter+of+Prostate+Cancer+Cell+Proliferation&doi=10.1124%2Fjpet.115.230003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand-independent adenosine A2B receptor constitutive activity as a promoter of prostate cancer cell proliferation</span></div><div class="casAuthors">Vecchio, Elizabeth A.; Tan, Christina Y. R.; Gregory, Karen J.; Christopoulos, Arthur; White, Paul J.; May, Lauren T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-44</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Aberrant ligand-independent G protein-coupled receptor constitutive activity has been implicated in the pathophysiol. of a no. of cancers.  The adenosine A2B receptor (A2BAR) is dynamically upregulated under pathol. conditions assocd. with a hypoxic microenvironment, including solid tumors.  This, in turn, may amplify ligand-independent A2BAR signal transduction.  The contribution of A2BAR constitutive activity to disease progression is currently unknown yet of fundamental importance, as the preferred therapeutic modality for drugs designed to reduce A2BAR constitutive activity would be inverse agonism as opposed to neutral antagonism.  The current study investigated A2BAR constitutive activity in a heterologous expression system and a native 22Rv1 human prostate cancer cell line exposed to hypoxic conditions (2% O2).  The A2BAR inverse agonists, ZM241385 [4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-ylamino]ethyl)phenol] or PSB-603 (8-(4-(4-(4-chlorophenyl)piperazide-1-sulfonyl)phenyl)-1-propylxanthine), mediated a concn.-dependent decrease in baseline cAMP levels in both cellular systems.  Proliferation of multiple prostate cancer cell lines was also attenuated in the presence of PSB-603.  Importantly, both the decrease in baseline cAMP accumulation and the redn. of proliferation were not influenced by the addn. of adenosine deaminase, demonstrating that these effects are not dependent on stimulation of A2BARs by the endogenous agonist adenosine.  Our study is the first to reveal that wild-type human A2BARs have high constitutive activity in both model and native cells.  Furthermore, our findings demonstrate that this ligand-independent A2BAR constitutive activity is sufficient to promote prostate cancer cell proliferation in vitro.  More broadly, A2BAR constitutive activity may have wider, currently unappreciated implications in pathol. conditions assocd. with a hypoxic microenvironment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXgR2SqHb3o7Vg90H21EOLACvtfcHk0lhkjouZKdLYsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvVeksbw%253D&md5=47cef2c343e8efedf7b9497f704e6a33</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.230003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.230003%26sid%3Dliteratum%253Aachs%26aulast%3DVecchio%26aufirst%3DE.%2BA.%26aulast%3DTan%26aufirst%3DC.%2BY.%2BR.%26aulast%3DGregory%26aufirst%3DK.%2BJ.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DWhite%26aufirst%3DP.%2BJ.%26aulast%3DMay%26aufirst%3DL.%2BT.%26atitle%3DLigand-Independent%2520Adenosine%2520A2B%2520Receptor%2520Constitutive%2520Activity%2520as%2520a%2520Promoter%2520of%2520Prostate%2520Cancer%2520Cell%2520Proliferation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D357%26spage%3D36%26epage%3D44%26doi%3D10.1124%2Fjpet.115.230003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnston-Cox, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenstein, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koupenova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravid, K.</span></span> <span> </span><span class="NLM_article-title">The Macrophage A2b Adenosine Receptor Regulates Tissue Insulin Sensitivity</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e98775</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0098775</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1371%2Fjournal.pone.0098775" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=24892847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGqsr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=H.+Johnston-Coxauthor=A.+S.+Eisensteinauthor=M.+Koupenovaauthor=S.+Carrollauthor=K.+Ravid&title=The+Macrophage+A2b+Adenosine+Receptor+Regulates+Tissue+Insulin+Sensitivity&doi=10.1371%2Fjournal.pone.0098775"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The macrophage A2b adenosine receptor regulates tissue insulin sensitivity</span></div><div class="casAuthors">Johnston-Cox, Hillary; Eisenstein, Anna S.; Koupenova, Milka; Carroll, Shannon; Ravid, Katya</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e98775/1-e98775/13, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">High fat diet (HFD)-induced type 2 diabetes continues to be an epidemic with significant risk for various pathologies.  Previously, we identified the A2b adenosine receptor (A2bAR), an established regulator of inflammation, as a regulator of HFD-induced insulin resistance.  In particular, HFD was assocd. with vast upregulation of liver A2bAR in control mice, and while mice lacking this receptor showed augmented liver inflammation and tissue insulin resistance.  As the A2bAR is expressed in different tissues, here, we provide the first lead to cellular mechanism by demonstrating that the receptor's influence on tissue insulin sensitivity is mediated via its expression in macrophages.  This was shown using a newly generated transgenic mouse model expressing the A2bAR gene in the macrophage lineage on an otherwise A2bAR null background.  Reinstatement of macrophage A2bAR expression in A2bAR null mice fed HFD restored insulin tolerance and tissue insulin signaling to the level of control mice.  The mol. mechanism for this effect involves A2bAR-mediated changes in cyclic adenosine monophosphate in macrophages, reducing the expression and release of inflammatory cytokines, which downregulate insulin receptor-2.  Thus, our results illustrate that macrophage A2bAR signaling is needed and sufficient for relaying the protective effect of the A2bAR against HFD-induced tissue inflammation and insulin resistance in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDs57NNj6wULVg90H21EOLACvtfcHk0lhkjouZKdLYsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGqsr%252FP&md5=c80ec59afda6fc6a4cdac9f590553726</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0098775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0098775%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston-Cox%26aufirst%3DH.%26aulast%3DEisenstein%26aufirst%3DA.%2BS.%26aulast%3DKoupenova%26aufirst%3DM.%26aulast%3DCarroll%26aufirst%3DS.%26aulast%3DRavid%26aufirst%3DK.%26atitle%3DThe%2520Macrophage%2520A2b%2520Adenosine%2520Receptor%2520Regulates%2520Tissue%2520Insulin%2520Sensitivity%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0098775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span> <span> </span><span class="NLM_article-title">Adenosine A2B Receptor: From Cell Biology to Human Diseases</span>. <i>Front. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">37</span>, <span class="refDoi"> DOI: 10.3389/fchem.2016.00037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.3389%2Ffchem.2016.00037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=27606311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVCmtrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&pages=37&author=Y.+Sunauthor=P.+Huang&title=Adenosine+A2B+Receptor%3A+From+Cell+Biology+to+Human+Diseases&doi=10.3389%2Ffchem.2016.00037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2B receptor: from cell biology to human diseases</span></div><div class="casAuthors">Sun, Ying; Huang, Pingbo</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Chemistry (Lausanne, Switzerland)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37/1-37/11</span>CODEN:
                <span class="NLM_cas:coden">FCLSAA</span>;
        ISSN:<span class="NLM_cas:issn">2296-2646</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Extracellular adenosine is a ubiquitous signaling mol. that modulates a wide array of biol. processes.  Recently, significant advances have been made in our understanding of A2B adenosine receptor (A2BAR).  In this review, we first summarize some of the general characteristics of A2BAR, and then we describe the multiple binding partners of the receptor, such as newly identified α-actinin-1 and p105, and discuss how these assocd. proteins could modulate A2BAR's functions, including certain seemingly paradoxical functions of the receptor.  Growing evidence indicates a crit. role of A2BAR in cancer, renal disease, and diabetes, in addn. to its importance in the regulation of vascular diseases, and lung disease.  Here, we also discuss the role of A2BAR in cancer, renal disease, and diabetes and the potential of the receptor as a target for treating these three diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhaEqMALVWUbVg90H21EOLACvtfcHk0lhkjouZKdLYsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVCmtrvL&md5=5216d780e9ceb31511d6810fef526d12</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3389%2Ffchem.2016.00037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffchem.2016.00037%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DP.%26atitle%3DAdenosine%2520A2B%2520Receptor%253A%2520From%2520Cell%2520Biology%2520to%2520Human%2520Diseases%26jtitle%3DFront.%2520Chem.%26date%3D2016%26volume%3D4%26spage%3D37%26doi%3D10.3389%2Ffchem.2016.00037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corset, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen-Ba-Charvet, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forcet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyse, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chédotal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehlen, P.</span></span> <span> </span><span class="NLM_article-title">Netrin-1-Mediated Axon Outgrowth and CAMP Production Requires Interaction with Adenosine A2b Receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>407</i></span>,  <span class="NLM_fpage">747</span>– <span class="NLM_lpage">750</span>, <span class="refDoi"> DOI: 10.1038/35037600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1038%2F35037600" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=11048721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsFWku74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2000&pages=747-750&author=V.+Corsetauthor=K.+T.+Nguyen-Ba-Charvetauthor=C.+Forcetauthor=E.+Moyseauthor=A.+Ch%C3%A9dotalauthor=P.+Mehlen&title=Netrin-1-Mediated+Axon+Outgrowth+and+CAMP+Production+Requires+Interaction+with+Adenosine+A2b+Receptor&doi=10.1038%2F35037600"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Netrin-1-mediated axon outgrowth and cAMP production requires interaction with adenosine A2b receptor</span></div><div class="casAuthors">Corset, Veronique; Nguyen-Ba-Charvet, Kim Tuyen; Forcet, Christelle; Moyse, Emmanuel; Chedotal, Alain; Mehlen, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">407</span>
        (<span class="NLM_cas:issue">6805</span>),
    <span class="NLM_cas:pages">747-750</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The netrins, a family of laminin-related secreted proteins, are crit. in controlling axon elongation and pathfinding.  The DCC (for deleted in colorectal cancer) protein was proposed as a receptor for netrin-1 in the light of many observations including the inhibition of netrin-1-mediated axon outgrowth and attraction in the presence of an anti-DCC antiserum, the similitude of nervous system defects in DCC and netrin-1 knockout mice and the results of receptor swapping expts.  Previous studies have failed to show a direct interaction of DCC with netrin-1 (ref.10), suggesting the possibility of an addnl. receptor or coreceptor.  Here we show that DCC interacts with the membrane-assocd. adenosine A2b receptor, a G-protein-coupled receptor that induces cAMP accumulation on binding adenosine.  We show that A2b is actually a netrin-1 receptor and induces cAMP accumulation on binding netrin-1.  Finally, we show that netrin-1-dependent outgrowth of dorsal spinal cord axons directly involves A2b.  Together our results indicate that the growth-promoting function of netrin-1 may require a receptor complex contg. DCC and A2b.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWTieJp7rtDLVg90H21EOLACvtfcHk0lhkjouZKdLYsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsFWku74%253D&md5=23b775be990bb35322e434e236ac8195</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2F35037600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35037600%26sid%3Dliteratum%253Aachs%26aulast%3DCorset%26aufirst%3DV.%26aulast%3DNguyen-Ba-Charvet%26aufirst%3DK.%2BT.%26aulast%3DForcet%26aufirst%3DC.%26aulast%3DMoyse%26aufirst%3DE.%26aulast%3DCh%25C3%25A9dotal%26aufirst%3DA.%26aulast%3DMehlen%26aufirst%3DP.%26atitle%3DNetrin-1-Mediated%2520Axon%2520Outgrowth%2520and%2520CAMP%2520Production%2520Requires%2520Interaction%2520with%2520Adenosine%2520A2b%2520Receptor%26jtitle%3DNature%26date%3D2000%26volume%3D407%26spage%3D747%26epage%3D750%26doi%3D10.1038%2F35037600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peakman, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, S. J.</span></span> <span> </span><span class="NLM_article-title">Adenosine A<sub>2B</sub>-receptor-mediated Cyclic AMP Accumulation in Primary Rat Astrocytes</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">198</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.1994.tb14043.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1111%2Fj.1476-5381.1994.tb14043.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=8012696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADyaK2cXht1GrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=1994&pages=191-198&author=M.-C.+Peakmanauthor=S.+J.+Hill&title=Adenosine+A2B-receptor-mediated+Cyclic+AMP+Accumulation+in+Primary+Rat+Astrocytes&doi=10.1111%2Fj.1476-5381.1994.tb14043.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2B-receptor-mediated cyclic AMP accumulation in primary rat astrocytes</span></div><div class="casAuthors">Peakman, Marie Claire; Hill, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">191-8</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">The effects of adenosine receptor agonists and antagonists on the accumulation of cAMP have been investigated in primary cultures of rat astrocytes.  Adenosine A2-receptor stimulation caused a concn.-dependent increase in the accumulation of [3H]-cAMP in cells prelabeled with [3H]-adenine.  The rank order of agonist potencies was 5'-N-ethylcarboxamidoadenosine (NECA; EC50 = 1 μM) > adenosine (EC50 = 5 μM) > 2-chloroadenosine (EC50 = 20 μM) >> CGS 21680 (EC50 > 10 μM).  The presence of 0.5 μM dipyridamole, an adenosine uptake blocker, had no effect on the potency of adenosine.  The response to 10 μM NECA was antagonized in a concn.-dependent manner by the non-selective adenosine receptor antagonists, xanthine amine congener (apparent KD = 12 nM), PD 115,199 (apparent KD = 134 nM) and 8-cyclopentyl-1,3-dipropylxanthine, had no significant effect on the responses to NECA or 2-chloroadenosine at concns. ≤1 μM.  Stimulation of A1-receptors with the selective agonist, N6-cyclopentyladenosine, did not alter the basal accumulation of [3H]-cAMP but inhibited a forskolin-mediated elevation of [3H]-cAMP accumulation by a maximal value of 42%.  This inhibition was fully reversed in the presence of 0.1 μM, 8-cyclopentyl-1,3-dipropylxanthine.  The time course for NECA-mediated [3H]-cAMP accumulation was investigated.  The results suggest that there is a substantial efflux of cAMP from the cells in addn. to the rapid and sustained elevation of intracellular cAMP (5 fold over basal) which was also obsd.  These data indicate that rat astrocytes in primary culture express an A2B-adenosine receptor coupled pos. to adenylyl cyclase.  Furthermore, the presence of A1-receptors neg. coupled to adenylyl cyclase appears to have no significant effect on the A2B-receptor-mediated cAMP responses to NECA and 2-chloroadenosine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-zban9p9AwbVg90H21EOLACvtfcHk0lh6XQHslA391Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXht1GrsbY%253D&md5=40c90aa0d78e7cb0c27e2661ba6ca95e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1994.tb14043.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1994.tb14043.x%26sid%3Dliteratum%253Aachs%26aulast%3DPeakman%26aufirst%3DM.-C.%26aulast%3DHill%26aufirst%3DS.%2BJ.%26atitle%3DAdenosine%2520A2B-receptor-mediated%2520Cyclic%2520AMP%2520Accumulation%2520in%2520Primary%2520Rat%2520Astrocytes%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D111%26spage%3D191%26epage%3D198%26doi%3D10.1111%2Fj.1476-5381.1994.tb14043.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovarova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chason, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koller, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilley, S. L.</span></span> <span> </span><span class="NLM_article-title">Enhanced Mast Cell Activation in Mice Deficient in the A2b Adenosine Receptor</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>204</i></span>,  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1084/jem.20061372</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1084%2Fjem.20061372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=17200408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=204&publication_year=2007&pages=117-128&author=X.+Huaauthor=M.+Kovarovaauthor=K.+D.+Chasonauthor=M.+Nguyenauthor=B.+H.+Kollerauthor=S.+L.+Tilley&title=Enhanced+Mast+Cell+Activation+in+Mice+Deficient+in+the+A2b+Adenosine+Receptor&doi=10.1084%2Fjem.20061372"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced mast cell activation in mice deficient in the A2b adenosine receptor</span></div><div class="casAuthors">Hua, Xiaoyang; Kovarova, Martina; Chason, Kelly D.; Nguyen, MyTrang; Koller, Beverly H.; Tilley, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">204</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">117-128</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Antigen-mediated crosslinking of IgE bound to mast cells via the high affinity receptor for IgE triggers a signaling cascade that results in the release of intracellular calcium stores, followed by an influx of extracellular calcium.  The collective increase in intracellular calcium is crit. to the release of the granular contents of the mast cell, which include the mediators of acute anaphylaxis.  We show that the sensitivity of the mast cell to antigen-mediated degranulation through this pathway can be dramatically influenced by the A2b adenosine receptor.  Loss of this Gs-coupled receptor on mouse bone marrow-derived mast cells results in decreased basal levels of cAMP and an excessive influx of extracellular calcium through store-operated calcium channels following antigen activation.  Mice lacking the A2b receptor display increased sensitivity to IgE-mediated anaphylaxis.  Collectively, these findings show that the A2b adenosine receptor functions as a crit. regulator of signaling pathways within the mast cell, which act in concert to limit the magnitude of mast cell responsiveness when antigen is encountered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWkx7Pzlq4GLVg90H21EOLACvtfcHk0lh6XQHslA391Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGjtrs%253D&md5=2596326ac056edc83bc37fd48dcd9a46</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1084%2Fjem.20061372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20061372%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DX.%26aulast%3DKovarova%26aufirst%3DM.%26aulast%3DChason%26aufirst%3DK.%2BD.%26aulast%3DNguyen%26aufirst%3DM.%26aulast%3DKoller%26aufirst%3DB.%2BH.%26aulast%3DTilley%26aufirst%3DS.%2BL.%26atitle%3DEnhanced%2520Mast%2520Cell%2520Activation%2520in%2520Mice%2520Deficient%2520in%2520the%2520A2b%2520Adenosine%2520Receptor%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2007%26volume%3D204%26spage%3D117%26epage%3D128%26doi%3D10.1084%2Fjem.20061372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eckle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faigle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laucher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eltzschig, H. K.</span></span> <span> </span><span class="NLM_article-title">A2B Adenosine Receptor Dampens Hypoxia-Induced Vascular Leak</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">2024</span>– <span class="NLM_lpage">2035</span>, <span class="refDoi"> DOI: 10.1182/blood-2007-10-117044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1182%2Fblood-2007-10-117044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=18056839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVeisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=2024-2035&author=T.+Eckleauthor=M.+Faigleauthor=A.+Grenzauthor=S.+Laucherauthor=L.+F.+Thompsonauthor=H.+K.+Eltzschig&title=A2B+Adenosine+Receptor+Dampens+Hypoxia-Induced+Vascular+Leak&doi=10.1182%2Fblood-2007-10-117044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A2B adenosine receptor dampens hypoxia-induced vascular leak</span></div><div class="casAuthors">Eckle, Tobias; Faigle, Marion; Grenz, Almut; Laucher, Stefanie; Thompson, Linda F.; Eltzschig, Holger K.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2024-2035</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Extracellular adenosine has been implicated in adaptation to hypoxia and previous studies demonstrated a central role in vascular responses.  Here, we examd. the contribution of individual adenosine receptors (ARs: A1AR/A2AAR/A2BAR/A3AR) to vascular leak induced by hypoxia.  Initial profiling studies revealed that siRNA-mediated repression of the A2BAR selectively increased endothelial leak in response to hypoxia in vitro.  In parallel, vascular permeability was significantly increased in vascular organs of A2BAR-/--mice subjected to ambient hypoxia (8% oxygen, 4 h; eg, lung: 2.1 ± 0.12-fold increase).  By contrast, hypoxia-induced vascular leak was not accentuated in A1AR-/--, A2AAR-/--, or A3AR-/--deficient mice, suggesting a degree of specificity for the A2BAR.  Further studies in wild type mice revealed that the selective A2BAR antagonist PSB1115 resulted in profound increases in hypoxia-assocd. vascular leakage while A2BAR agonist (BAY60-6583 [2-[6-amino-3,5-dicyano-4-[4-(cyclopropylmethoxy)-phenyl]pyridin-2-ylsulfanyl]acetamide]) treatment was assocd. with almost complete reversal of hypoxia-induced vascular leakage (eg, lung: 2.0 ± 0.21-fold redn.).  Studies in bone marrow chimeric A2BAR mice suggested a predominant role of vascular A2BARs in this response, while hypoxia-assocd. increases in tissue neutrophils were, at least in part, mediated by A2BAR expressing hematopoietic cells.  Taken together, these studies provide pharmacol. and genetic evidence for vascular A2BAR signaling as central control point of hypoxia-assocd. vascular leak.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpha1gIw4tRgbVg90H21EOLACvtfcHk0lh6XQHslA391Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVeisLk%253D&md5=c909fd42970de5e4a9a82d6eccc3c392</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-10-117044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-10-117044%26sid%3Dliteratum%253Aachs%26aulast%3DEckle%26aufirst%3DT.%26aulast%3DFaigle%26aufirst%3DM.%26aulast%3DGrenz%26aufirst%3DA.%26aulast%3DLaucher%26aufirst%3DS.%26aulast%3DThompson%26aufirst%3DL.%2BF.%26aulast%3DEltzschig%26aufirst%3DH.%2BK.%26atitle%3DA2B%2520Adenosine%2520Receptor%2520Dampens%2520Hypoxia-Induced%2520Vascular%2520Leak%26jtitle%3DBlood%26date%3D2008%26volume%3D111%26spage%3D2024%26epage%3D2035%26doi%3D10.1182%2Fblood-2007-10-117044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Addi, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefort, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Communi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledent, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macours, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilley, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boeynaems, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robaye, B.</span></span> <span> </span><span class="NLM_article-title">Modulation of Murine Dendritic Cell Function by Adenine Nucleotides and Adenosine: Involvement of the A2B Receptor</span>. <i>Eur. J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1610</span>– <span class="NLM_lpage">1620</span>, <span class="refDoi"> DOI: 10.1002/eji.200737781</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1002%2Feji.200737781" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=18465770" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2008&pages=1610-1620&author=A.+B.+Addiauthor=A.+Lefortauthor=X.+Huaauthor=F.+Libertauthor=D.+Communiauthor=C.+Ledentauthor=P.+Macoursauthor=S.+L.+Tilleyauthor=J.-M.+Boeynaemsauthor=B.+Robaye&title=Modulation+of+Murine+Dendritic+Cell+Function+by+Adenine+Nucleotides+and+Adenosine%3A+Involvement+of+the+A2B+Receptor&doi=10.1002%2Feji.200737781"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Feji.200737781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Feji.200737781%26sid%3Dliteratum%253Aachs%26aulast%3DAddi%26aufirst%3DA.%2BB.%26aulast%3DLefort%26aufirst%3DA.%26aulast%3DHua%26aufirst%3DX.%26aulast%3DLibert%26aufirst%3DF.%26aulast%3DCommuni%26aufirst%3DD.%26aulast%3DLedent%26aufirst%3DC.%26aulast%3DMacours%26aufirst%3DP.%26aulast%3DTilley%26aufirst%3DS.%2BL.%26aulast%3DBoeynaems%26aufirst%3DJ.-M.%26aulast%3DRobaye%26aufirst%3DB.%26atitle%3DModulation%2520of%2520Murine%2520Dendritic%2520Cell%2520Function%2520by%2520Adenine%2520Nucleotides%2520and%2520Adenosine%253A%2520Involvement%2520of%2520the%2520A2B%2520Receptor%26jtitle%3DEur.%2520J.%2520Immunol.%26date%3D2008%26volume%3D38%26spage%3D1610%26epage%3D1620%26doi%3D10.1002%2Feji.200737781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xaus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirabet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloberas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lluis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celada, A.</span></span> <span> </span><span class="NLM_article-title">IFN-γ Up-Regulates the A2B Adenosine Receptor Expression in Macrophages: A Mechanism of Macrophage Deactivation</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">3607</span>– <span class="NLM_lpage">3614</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10092821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADyaK1MXhvFSjuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=1999&pages=3607-3614&author=J.+Xausauthor=M.+Mirabetauthor=J.+Lloberasauthor=C.+Solerauthor=C.+Lluisauthor=R.+Francoauthor=A.+Celada&title=IFN-%CE%B3+Up-Regulates+the+A2B+Adenosine+Receptor+Expression+in+Macrophages%3A+A+Mechanism+of+Macrophage+Deactivation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">IFN-γ up-regulates the A2B adenosine receptor expression in macrophages: a mechanism of macrophage deactivation</span></div><div class="casAuthors">Xaus, Jordi; Mirabet, Maribel; Lloberas, Jorge; Soler, Concepcio; Lluis, Carme; Franco, Rafael; Celada, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3607-3614</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Adenosine is a potent endogenous anti-inflammatory agent released by cells in metabolically unfavorable conditions, such as hypoxia or ischemia.  Adenosine modulates different functional activities in macrophages.  Some of these activities are believed to be induced through the uptake of adenosine into the macrophages, while others are due to the interaction with specific cell surface receptors.  In murine bone marrow-derived macrophages, the use of different radioligands for adenosine receptors suggests the presence of A2B and A3 adenosine receptor subtypes.  The presence of A2B receptors was confirmed by flow cytometry using specific Abs.  The A2B receptor is functional in murine macrophages, as indicated by the fact that agonists of A2B receptors, but not agonists for A1, A2A, or A3, lead to an increase in cAMP levels.  IFN-γ up-regulates the surface protein and gene expression of the A2B adenosine receptor by induction of de novo synthesis.  The up-regulation of A2B receptors correlates with an increase in cAMP prodn. in macrophages treated with adenosine receptor agonist.  The stimulation of A2B receptors by adenosine or its analogs inhibits the IFN-γ-induced expression of MHC class II genes and also the IFN-γ-induced expression of nitric oxide synthase and of proinflammatory cytokines.  Therefore, the up-regulation of the A2B adenosine receptor expression induced by IFN-γ could be a feedback mechanism for macrophage deactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMbFXIDoX68LVg90H21EOLACvtfcHk0ljw5Z45HfAqnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvFSjuro%253D&md5=b032792b6d7ef790c0d1fa137827bedc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXaus%26aufirst%3DJ.%26aulast%3DMirabet%26aufirst%3DM.%26aulast%3DLloberas%26aufirst%3DJ.%26aulast%3DSoler%26aufirst%3DC.%26aulast%3DLluis%26aufirst%3DC.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DCelada%26aufirst%3DA.%26atitle%3DIFN-%25CE%25B3%2520Up-Regulates%2520the%2520A2B%2520Adenosine%2520Receptor%2520Expression%2520in%2520Macrophages%253A%2520A%2520Mechanism%2520of%2520Macrophage%2520Deactivation%26jtitle%3DJ.%2520Immunol.%26date%3D1999%26volume%3D162%26spage%3D3607%26epage%3D3614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westerman, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faigle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eltzschig, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colgan, S. P.</span></span> <span> </span><span class="NLM_article-title">HIF-dependent Induction of Adenosine A2B Receptor in Hypoxia</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2242</span>– <span class="NLM_lpage">2250</span>, <span class="refDoi"> DOI: 10.1096/fj.06-6419com</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1096%2Ffj.06-6419com" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=17077301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFyktLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=2242-2250&author=T.+Kongauthor=K.+A.+Westermanauthor=M.+Faigleauthor=H.+K.+Eltzschigauthor=S.+P.+Colgan&title=HIF-dependent+Induction+of+Adenosine+A2B+Receptor+in+Hypoxia&doi=10.1096%2Ffj.06-6419com"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">HIF-dependent induction of adenosine A2B receptor in hypoxia</span></div><div class="casAuthors">Kong, Tianqing; Westerman, Karen A.; Faigle, Marion; Eltzschig, Holger K.; Colgan, Sean P.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2242-2250</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Adenosine has been widely assocd. with hypoxia of many origins, including those assocd. with inflammation and tumorogenesis.  A no. of recent studies have implicated metabolic control of adenosine generation at sites of tissue hypoxia.  Here, we examine adenosine receptor control and amplification of signaling through transcriptional regulation of endothelial and epithelial adenosine receptors.  Initial studies confirmed previous findings indicating selective induction of human adenosine A2B receptor (A2BR) by hypoxia.  Anal. of the cloned human A2BR promoter identified a functional hypoxia-responsive region, including a functional binding site for hypoxia-inducible factor (HIF) within the A2BR promoter.  Further studies examg. HIF-1α DNA binding and HIF-1α gain and loss of function confirmed strong dependence of A2BR induction by HIF-1α in vitro and in vivo mouse models.  Addnl. studies in endothelia overexpressing full-length A2BR revealed functional phenotypes of increased barrier function and enhanced angiogenesis.  Taken together, these results demonstrate transcriptional coordination of A2BR by HIF-1α and amplified adenosine signaling during hypoxia.  These findings may provide an important link between hypoxia and metabolic conditions assocd. with inflammation and angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrepOsJmxWH5LVg90H21EOLACvtfcHk0ljw5Z45HfAqnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFyktLfJ&md5=4c994b176904887886214a1f60f57512</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1096%2Ffj.06-6419com&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.06-6419com%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DT.%26aulast%3DWesterman%26aufirst%3DK.%2BA.%26aulast%3DFaigle%26aufirst%3DM.%26aulast%3DEltzschig%26aufirst%3DH.%2BK.%26aulast%3DColgan%26aufirst%3DS.%2BP.%26atitle%3DHIF-dependent%2520Induction%2520of%2520Adenosine%2520A2B%2520Receptor%2520in%2520Hypoxia%26jtitle%3DFASEB%2520J.%26date%3D2006%26volume%3D20%26spage%3D2242%26epage%3D2250%26doi%3D10.1096%2Ffj.06-6419com" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hart, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schittenhelm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eltzschig, H. K.</span></span> <span> </span><span class="NLM_article-title">Cutting Edge: A2B Adenosine Receptor Signaling Provides Potent Protection during Intestinal Ischemia/Reperfusion Injury</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>182</i></span>,  <span class="NLM_fpage">3965</span>– <span class="NLM_lpage">3968</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.0802193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.4049%2Fjimmunol.0802193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=19299692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVSjtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2009&pages=3965-3968&author=M.+L.+Hartauthor=B.+Jacobiauthor=J.+Schittenhelmauthor=M.+Hennauthor=H.+K.+Eltzschig&title=Cutting+Edge%3A+A2B+Adenosine+Receptor+Signaling+Provides+Potent+Protection+during+Intestinal+Ischemia%2FReperfusion+Injury&doi=10.4049%2Fjimmunol.0802193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Cutting Edge: A2B Adenosine Receptor Signaling Provides Potent Protection during Intestinal Ischemia/Reperfusion Injury</span></div><div class="casAuthors">Hart, Melanie L.; Jacobi, Barbara; Schittenhelm, Jens; Henn, Martina; Eltzschig, Holger K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3965-3968</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Gastrointestinal ischemia/reperfusion (IR) injury significantly contributes to the morbidity and mortality of crit. illness.  In this study, we hypothesized a protective role for extracellular adenosine signaling in intestinal IR injury.  Initial profiling studies of mucosal scrapings following murine IR demonstrated selective induction of the A2B adenosine receptor (A2BAR) transcript.  Moreover, gene-targeted mice for the A2BAR showed more profound intestinal IR injury compared with controls.  In contrast, A2AAR-/- mice exhibited no differences in intestinal injury compared with littermate controls.  In addn., selective inhibition of the A2BAR resulted in enhanced intestinal inflammation and injury during IR.  Furthermore, A2BAR agonist treatment (BAY 60-6583) protected from intestinal injury, inflammation, and permeability dysfunction in wild-type mice, whereas the therapeutic effects of BAY 60-6583 were abolished following targeted A2BAR gene deletion.  Taken together, these studies demonstrate the A2BAR as a novel therapeutic target for protection during gastrointestinal IR injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeBKjh09rg8LVg90H21EOLACvtfcHk0ljw5Z45HfAqnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVSjtrk%253D&md5=e8d66aaf5f902c4ee2e69efacf16ebf8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0802193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0802193%26sid%3Dliteratum%253Aachs%26aulast%3DHart%26aufirst%3DM.%2BL.%26aulast%3DJacobi%26aufirst%3DB.%26aulast%3DSchittenhelm%26aufirst%3DJ.%26aulast%3DHenn%26aufirst%3DM.%26aulast%3DEltzschig%26aufirst%3DH.%2BK.%26atitle%3DCutting%2520Edge%253A%2520A2B%2520Adenosine%2520Receptor%2520Signaling%2520Provides%2520Potent%2520Protection%2520during%2520Intestinal%2520Ischemia%252FReperfusion%2520Injury%26jtitle%3DJ.%2520Immunol.%26date%3D2009%26volume%3D182%26spage%3D3965%26epage%3D3968%26doi%3D10.4049%2Fjimmunol.0802193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haskó, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csóka, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Németh, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vizi, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacher, P.</span></span> <span> </span><span class="NLM_article-title">A2B Adenosine Receptors in Immunity and Inflammation</span>. <i>Trends Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1016/j.it.2009.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.it.2009.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=19427267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1ynt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=263-270&author=G.+Hask%C3%B3author=B.+Cs%C3%B3kaauthor=Z.+H.+N%C3%A9methauthor=E.+S.+Viziauthor=P.+Pacher&title=A2B+Adenosine+Receptors+in+Immunity+and+Inflammation&doi=10.1016%2Fj.it.2009.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A2B adenosine receptors in immunity and inflammation</span></div><div class="casAuthors">Hasko, Gyoergy; Csoka, Balazs; Nemeth, Zoltan H.; Vizi, E. Sylvester; Pacher, Pal</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">263-270</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A2B adenosine receptors are increasingly recognized as important orchestrators of inflammation.  A2B receptor activation promotes the inflammatory response of mast cells, epithelial cells, smooth muscle cells and fibroblasts, thereby contributing to the pathophysiol. of asthma and colitis.  A2B receptor stimulation limits endothelial cell inflammatory responses and permeability and suppresses macrophage activation thereby preventing tissue injury after episodes of hypoxia and ischemia.  A2B receptor stimulation also promotes the prodn. of angiogenic cytokines by endothelial cells, mast cells and dendritic cells, aiding granuloma tissue formation and inflammatory resoln., but can also contribute to tumor growth.  A2B receptors are, thus, potentially important pharmacol. targets in treating immune system dysfunction and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk5JA17dyrT7Vg90H21EOLACvtfcHk0liJrapgmQ_Njg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1ynt7s%253D&md5=4aebd9d9b7d823dcc0a89f94b539d127</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2009.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2009.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DHask%25C3%25B3%26aufirst%3DG.%26aulast%3DCs%25C3%25B3ka%26aufirst%3DB.%26aulast%3DN%25C3%25A9meth%26aufirst%3DZ.%2BH.%26aulast%3DVizi%26aufirst%3DE.%2BS.%26aulast%3DPacher%26aufirst%3DP.%26atitle%3DA2B%2520Adenosine%2520Receptors%2520in%2520Immunity%2520and%2520Inflammation%26jtitle%3DTrends%2520Immunol.%26date%3D2009%26volume%3D30%26spage%3D263%26epage%3D270%26doi%3D10.1016%2Fj.it.2009.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aherne, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kewley, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eltzschig, H. K.</span></span> <span> </span><span class="NLM_article-title">The Resurgence of A2B Adenosine Receptor Signaling</span>. <i>Biochim. Biophys. Acta, Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1808</i></span>,  <span class="NLM_fpage">1329</span>– <span class="NLM_lpage">1339</span>, <span class="refDoi"> DOI: 10.1016/j.bbamem.2010.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.bbamem.2010.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=20546702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFSrsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1808&publication_year=2011&pages=1329-1339&author=C.+M.+Aherneauthor=E.+M.+Kewleyauthor=H.+K.+Eltzschig&title=The+Resurgence+of+A2B+Adenosine+Receptor+Signaling&doi=10.1016%2Fj.bbamem.2010.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The resurgence of A2B adenosine receptor signaling</span></div><div class="casAuthors">Aherne, Carol M.; Kewley, Emily M.; Eltzschig, Holger K.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1808</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1329-1339</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Since its discovery as a low-affinity adenosine receptor (AR), the A2B receptor (A2BAR), has proven enigmatic in its function.  The previous discovery of the A2AAR, which shares many similarities with the A2BAR but demonstrates significantly greater affinity for its endogenous ligand, led to the original perception that the A2BAR was not of substantial physiol. relevance.  In addn., lack of specific pharmacol. agents targeting the A2BAR made its initial characterization challenging.  However, the importance of this receptor was reconsidered when it was obsd. that the A2BAR is highly transcriptionally regulated by factors implicated in inflammatory hypoxia.  Moreover, the notion that during ischemia or inflammation extracellular adenosine is dramatically elevated to levels sufficient for A2BAR activation, indicated that A2BAR signaling may be important to dampen inflammation particularly during tissue hypoxia.  In addn., the recent advent of techniques for murine genetic manipulation along with development of pharmacol. agents with enhanced A2BAR specificity has provided invaluable tools for focused studies on the explicit role of A2BAR signaling in different disease models.  Currently, studies performed with combined genetic and pharmacol. approaches have demonstrated that A2BAR signaling plays a tissue protective role in many models of acute diseases e.g. myocardial ischemia, or acute lung injury.  These studies indicate that the A2BAR is expressed on a wide variety of cell types and exerts tissue/cell specific effects.  This is an important consideration for future studies where tissue or cell type specific targeting of the A2BAR may be used as therapeutic approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyVvyCnJhXUrVg90H21EOLACvtfcHk0liJrapgmQ_Njg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFSrsro%253D&md5=3dc9fe6ec9d65ab132d4b8425450657c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2010.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2010.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DAherne%26aufirst%3DC.%2BM.%26aulast%3DKewley%26aufirst%3DE.%2BM.%26aulast%3DEltzschig%26aufirst%3DH.%2BK.%26atitle%3DThe%2520Resurgence%2520of%2520A2B%2520Adenosine%2520Receptor%2520Signaling%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2011%26volume%3D1808%26spage%3D1329%26epage%3D1339%26doi%3D10.1016%2Fj.bbamem.2010.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mittal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barkauskas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalimutho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stannard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caramia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haibe-Kains, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, M. J.</span></span> <span> </span><span class="NLM_article-title">Adenosine 2B Receptor Expression on Cancer Cells Promotes Metastasis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">4372</span>– <span class="NLM_lpage">4382</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-16-0544</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1158%2F0008-5472.CAN-16-0544" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=27221704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gmt7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=4372-4382&author=D.+Mittalauthor=D.+Sinhaauthor=D.+Barkauskasauthor=A.+Youngauthor=M.+Kalimuthoauthor=K.+Stannardauthor=F.+Caramiaauthor=B.+Haibe-Kainsauthor=J.+Staggauthor=K.+K.+Khannaauthor=S.+Loiauthor=M.+J.+Smyth&title=Adenosine+2B+Receptor+Expression+on+Cancer+Cells+Promotes+Metastasis&doi=10.1158%2F0008-5472.CAN-16-0544"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine 2B Receptor Expression on Cancer Cells Promotes Metastasis</span></div><div class="casAuthors">Mittal, Deepak; Sinha, Debottam; Barkauskas, Deborah; Young, Arabella; Kalimutho, Murugan; Stannard, Kimberley; Caramia, Franco; Haibe-Kains, Benjamin; Stagg, John; Khanna, Kum Kum; Loi, Sherene; Smyth, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4372-4382</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Adenosine plays an important role in inflammation and tumor development, progression, and responses to therapy.  We show that an adenosine 2B receptor inhibitor (A2BRi) decreases both exptl. and spontaneous metastasis and combines with chemotherapy or immune checkpoint inhibitors in mouse models of melanoma and triple-neg. breast cancer (TNBC) metastasis.  Decreased metastasis upon A2BR inhibition is independent of host A2BR and lymphocytes and myeloid cells.  Knockdown of A2BR on mouse and human cancer cells reduces their metastasis in vivo and decreases their viability and colony-forming ability, while transiently delaying cell-cycle arrest in vitro.  The prometastatic activity of adenosine is partly tumor A2BR dependent and independent of host A2BR expression.  In humans, TNBC cell lines express higher A2BR than luminal and Her2+ breast cancer cell lines, and high expression of A2BR is assocd. with worse prognosis in TNBC.  Collectively, high A2BR on mouse and human tumors promotes cancer metastasis and is an ideal candidate for therapeutic intervention.  Cancer Res; 76(15); 4372-82. 2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxwJQYAF4O6LVg90H21EOLACvtfcHk0liJrapgmQ_Njg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gmt7jO&md5=cc697ab12211e6cfd4d6d20fdec04bf5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-16-0544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-16-0544%26sid%3Dliteratum%253Aachs%26aulast%3DMittal%26aufirst%3DD.%26aulast%3DSinha%26aufirst%3DD.%26aulast%3DBarkauskas%26aufirst%3DD.%26aulast%3DYoung%26aufirst%3DA.%26aulast%3DKalimutho%26aufirst%3DM.%26aulast%3DStannard%26aufirst%3DK.%26aulast%3DCaramia%26aufirst%3DF.%26aulast%3DHaibe-Kains%26aufirst%3DB.%26aulast%3DStagg%26aufirst%3DJ.%26aulast%3DKhanna%26aufirst%3DK.%2BK.%26aulast%3DLoi%26aufirst%3DS.%26aulast%3DSmyth%26aufirst%3DM.%2BJ.%26atitle%3DAdenosine%25202B%2520Receptor%2520Expression%2520on%2520Cancer%2520Cells%2520Promotes%2520Metastasis%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D4372%26epage%3D4382%26doi%3D10.1158%2F0008-5472.CAN-16-0544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iannone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miele, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiolino, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morello, S.</span></span> <span> </span><span class="NLM_article-title">Blockade of A2b Adenosine Receptor Reduces Tumor Growth and Immune Suppression Mediated by Myeloid-Derived Suppressor Cells in a Mouse Model of Melanoma</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1400</span>– <span class="NLM_lpage">1409</span>, <span class="refDoi"> DOI: 10.1593/neo.131748</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1593%2Fneo.131748" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=24403862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWls73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=1400-1409&author=R.+Iannoneauthor=L.+Mieleauthor=P.+Maiolinoauthor=A.+Pintoauthor=S.+Morello&title=Blockade+of+A2b+Adenosine+Receptor+Reduces+Tumor+Growth+and+Immune+Suppression+Mediated+by+Myeloid-Derived+Suppressor+Cells+in+a+Mouse+Model+of+Melanoma&doi=10.1593%2Fneo.131748"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of A2b adenosine receptor reduces tumor growth and immune suppression mediated by myeloid-derived suppressor cells in a mouse model of melanoma</span></div><div class="casAuthors">Iannone, Raffaella; Miele, Lucio; Maiolino, Piera; Pinto, Aldo; Morello, Silvana</div><div class="citationInfo"><span class="NLM_cas:title">Neoplasia (Ann Arbor, MI, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1400-1409, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEOPFL</span>;
        ISSN:<span class="NLM_cas:issn">1522-8002</span>.
    
            (<span class="NLM_cas:orgname">Neoplasia Press Inc.</span>)
        </div><div class="casAbstract">The A2b receptor (A2bR) belongs to the adenosine receptor family.  Emerging evidence suggest that A2bR is implicated in tumor progression in some murine tumor models, but the therapeutic potential of targeting A2bR in melanoma has not been examd.  This study first shows that melanoma-bearing mice treated with Bay 60-6583, a selective A2bR agonist, had increased melanoma growth.  This effect was assocd. with higher levels of immune regulatory mediators interleukin-10 (IL-10) and monocyte chemoattractant protein 1 (MCP-1) and accumulation of tumor-assocd. CD11b pos. Gr1 pos. cells (CD11b+Gr1+) myeloid-derived suppressor cells (MDSCs).  Depletion of CD11b+Gr1+ cells completely reversed the protumor activity of Bay 60-6583.  Conversely, pharmacol. blockade of A2bR with PSB1115 reversed immune suppression in the tumor microenvironment, leading to a significant melanoma growth delay.  PSB1115 treatment reduced both levels of IL-10 and MCP-1 and CD11b+Gr1+ cell no. in melanoma lesions.  These effects were assocd. with higher frequency of tumor-infiltrating CD8 pos. (CD8+) T cells and natural killer T (NKT) cells and increased levels of T helper 1 (Th1)-like cytokines.  Adoptive transfer of CD11b+Gr1+ cells abrogated the antitumor activity of PSB1115.  These data suggest that the antitumor activity of PSB1115 relies on its ability to lower accumulation of tumor-infiltrating MDSCs and restore an efficient antitumor T cell response.  The antitumor effect of PSB1115 was not obsd. in melanoma-bearing nude mice.  Furthermore, PSB1115 enhanced the antitumor efficacy of dacarbazine.These data indicate that A2bR antagonists such as PSB1115 should be investigated as adjuvants in the treatment of melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCc_1YKSaS8rVg90H21EOLACvtfcHk0liT-FK-5iG8gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWls73K&md5=0b4cb56ad530f6cca9027d845a7577cc</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1593%2Fneo.131748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.131748%26sid%3Dliteratum%253Aachs%26aulast%3DIannone%26aufirst%3DR.%26aulast%3DMiele%26aufirst%3DL.%26aulast%3DMaiolino%26aufirst%3DP.%26aulast%3DPinto%26aufirst%3DA.%26aulast%3DMorello%26aufirst%3DS.%26atitle%3DBlockade%2520of%2520A2b%2520Adenosine%2520Receptor%2520Reduces%2520Tumor%2520Growth%2520and%2520Immune%2520Suppression%2520Mediated%2520by%2520Myeloid-Derived%2520Suppressor%2520Cells%2520in%2520a%2520Mouse%2520Model%2520of%2520Melanoma%26jtitle%3DNeoplasia%26date%3D2013%26volume%3D15%26spage%3D1400%26epage%3D1409%26doi%3D10.1593%2Fneo.131748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span> <span> </span><span class="NLM_article-title">A2B Adenosine Receptor and Cancer</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5139</span>, <span class="refDoi"> DOI: 10.3390/ijms20205139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.3390%2Fijms20205139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BB3cXovF2gtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=5139&author=Z.-G.+Gaoauthor=K.+A.+Jacobson&title=A2B+Adenosine+Receptor+and+Cancer&doi=10.3390%2Fijms20205139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A2B adenosine receptor and cancer</span></div><div class="casAuthors">Gao, Zhan-Guo; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5139</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  There are four subtypes of adenosine receptors (ARs), named A1, A2A, A2B and A3, all of which are G protein-coupled receptors (GPCRs).  Locally produced adenosine is a suppressant in anti-tumor immune surveillance.  The A2BAR, coupled to both Gαs and Gαi G proteins, is one of the several GPCRs that are expressed in a significantly higher level in certain cancer tissues, in comparison to adjacent normal tissues.  There is growing evidence that the A2BAR plays an important role in tumor cell proliferation, angiogenesis, metastasis, and immune suppression.  Thus, A2BAR antagonists are novel, potentially attractive anticancer agents.  Several antagonists targeting A2BAR are currently in clin. trials for various types of cancers.  In this review, we first describe the signaling, agonists, and antagonists of the A2BAR.  We further discuss the role of the A2BAR in the progression of various cancers, and the rationale of using A2BAR antagonists in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJLj5N04AxZrVg90H21EOLACvtfcHk0liT-FK-5iG8gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXovF2gtLg%253D&md5=cd00c1fcfc81f12134a0753be8a61c8e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3390%2Fijms20205139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms20205139%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.-G.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DA2B%2520Adenosine%2520Receptor%2520and%2520Cancer%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2019%26volume%3D20%26spage%3D5139%26doi%3D10.3390%2Fijms20205139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mousavi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panjehpour, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izadpanahi, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aghaei, M.</span></span> <span> </span><span class="NLM_article-title">Expression of Adenosine Receptor Subclasses in Malignant and Adjacent Normal Human Prostate Tissues</span>. <i>Prostate</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">747</span>, <span class="refDoi"> DOI: 10.1002/pros.22955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1002%2Fpros.22955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=25704103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtlChs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=735-747&author=S.+Mousaviauthor=M.+Panjehpourauthor=M.+H.+Izadpanahiauthor=M.+Aghaei&title=Expression+of+Adenosine+Receptor+Subclasses+in+Malignant+and+Adjacent+Normal+Human+Prostate+Tissues&doi=10.1002%2Fpros.22955"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of adenosine receptor subclasses in malignant and adjacent normal human prostate tissues</span></div><div class="casAuthors">Mousavi, Samira; Panjehpour, Mojtaba; Izadpanahi, Mohammad Hossein; Aghaei, Mahmoud</div><div class="citationInfo"><span class="NLM_cas:title">Prostate (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">735-747</span>CODEN:
                <span class="NLM_cas:coden">PRSTDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-4137</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">BACKGROUND : Adenosine, a purine nucleoside plays important roles in the pathogenesis of cancer initiation and promotion via interaction with four adenosine receptors.  In the present study we examd. the differential expression pattern of adenosine receptors in the malignant and adjacent normal human prostate tissues.  METHODS : Prostate cancer tissue samples and adjacent normal tissues were obtained from 20 patients undergoing radical prostatectomy and histopathol. diagnosis was confirmed for each sample.  Total RNA was extd. and reverse transcribed into cDNA and the mRNA expression levels of adenosine receptors were investigated by Taq-man real-time RT-PCR expt.  Quant. protein anal. was done by Western blotting expt.  Moreover, the mRNA and protein expression levels of adenosine receptors were measured after androgen treatment.  RESULT : Taq-man real-time RT-PCR measurements show different expression levels of adenosine receptor transcripts.  A2B adenosine receptor was predominantly expressed in tumor tissues (2.4-fold) followed by significantly expression of A3 (1.6-fold) and A2A adenosine receptors (1.5-fold) compared to adjacent normal tissues.  The presence of adenosine receptors at protein levels in prostate cancer tissues compared with normal tissues was shown the following rank order: A2B > A3 > A2A > A1.  Androgen receptor regulates adenosine receptors mRNA and protein expression in AR-pos. LNCaP cells, which was not seen in AR-neg. PC-3 cells.  CONCLUSION : These results indicated for the first time, the differential mRNA expression profile and protein levels of adenosine receptors in the human prostate cancer.  Interestingly, the A2B adenosine receptor followed by A3 is highly expressed in prostate tumor samples in comparison with the adjacent normal tissues.  The findings support the possible key role of A2B adenosine receptor in promoting cancer cell growth and suggest that A2B may be a novel target for prostate cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc-kyXeidoIrVg90H21EOLACvtfcHk0liT-FK-5iG8gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtlChs7c%253D&md5=888f50cad93ee10a1f6e7e65a7415f02</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fpros.22955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.22955%26sid%3Dliteratum%253Aachs%26aulast%3DMousavi%26aufirst%3DS.%26aulast%3DPanjehpour%26aufirst%3DM.%26aulast%3DIzadpanahi%26aufirst%3DM.%2BH.%26aulast%3DAghaei%26aufirst%3DM.%26atitle%3DExpression%2520of%2520Adenosine%2520Receptor%2520Subclasses%2520in%2520Malignant%2520and%2520Adjacent%2520Normal%2520Human%2520Prostate%2520Tissues%26jtitle%3DProstate%26date%3D2015%26volume%3D75%26spage%3D735%26epage%3D747%26doi%3D10.1002%2Fpros.22955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novio, S.</span>; <span class="NLM_string-name">Nuñez-Iglesias, M. J.</span>; <span class="NLM_string-name">Freire-Garabal, M.</span></span> <span> </span><span class="NLM_article-title">Adenosine Signaling Pathways as Potential Therapeutic Targets in Prostate Cancer Disease</span>.  <i>Molecular Oncology: Underlying Mechanisms and Translational Advancements</i>; <span class="NLM_publisher-name">Springer International Publishing</span>: <span class="NLM_publisher-loc">Madrid</span>, <span class="NLM_year">2017</span>; pp  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">107</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1007%2F978-3-319-53082-6_4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=93-107&author=S.+Novio&author=M.+J.+Nu%C3%B1ez-Iglesias&author=M.+Freire-Garabal&title=Molecular+Oncology%3A+Underlying+Mechanisms+and+Translational+Advancements"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-53082-6_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-319-53082-6_4%26sid%3Dliteratum%253Aachs%26aulast%3DNovio%26aufirst%3DS.%26atitle%3DAdenosine%2520Signaling%2520Pathways%2520as%2520Potential%2520Therapeutic%2520Targets%2520in%2520Prostate%2520Cancer%2520Disease%26btitle%3DMolecular%2520Oncology%253A%2520Underlying%2520Mechanisms%2520and%2520Translational%2520Advancements%26pub%3DSpringer%2520International%2520Publishing%26date%3D2017%26spage%3D93%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turcotte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stagg, J.</span></span> <span> </span><span class="NLM_article-title">Targeting A2 Adenosine Receptors in Cancer</span>. <i>Immunol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.1038/icb.2017.8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1038%2Ficb.2017.8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=28174424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVSgtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2017&pages=333-339&author=D.+Allardauthor=M.+Turcotteauthor=J.+Stagg&title=Targeting+A2+Adenosine+Receptors+in+Cancer&doi=10.1038%2Ficb.2017.8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting A2 adenosine receptors in cancer</span></div><div class="casAuthors">Allard, David; Turcotte, Martin; Stagg, John</div><div class="citationInfo"><span class="NLM_cas:title">Immunology & Cell Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">333-339</span>CODEN:
                <span class="NLM_cas:coden">ICBIEZ</span>;
        ISSN:<span class="NLM_cas:issn">0818-9641</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tumor cells use various ways to evade anti-tumor immune responses.  Adenosine, a potent immunosuppressive metabolite, is often found elevated in the extracellular tumor microenvironment.  Therefore, targeting adenosine-generating enzymes (CD39 and CD73) or adenosine receptors has emerged as a novel means to stimulate anti-tumor immunity.  In particular, the A2 (A2a and A2b) adenosine receptors exhibit similar immunosuppressive and pro-angiogenic functions, yet have distinct biol. roles in cancer.  In this review, we describe the common and distinct biol. consequences of A2a and A2b adenosine receptor signaling in cancer.  We discuss recent pre-clin. studies and summarize the different mechanisms-of-action of adenosine-targeting drugs.  We also review the rationale for combining inhibitors of the adenosine pathway with other anticancer therapies such immune checkpoint inhibitors, tumor vaccines, chemotherapy and adoptive T cell therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfxdUqQmLeObVg90H21EOLACvtfcHk0liLRoLZaQ5KdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVSgtL8%253D&md5=c017e871d31f34803f9bca71303570aa</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Ficb.2017.8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Ficb.2017.8%26sid%3Dliteratum%253Aachs%26aulast%3DAllard%26aufirst%3DD.%26aulast%3DTurcotte%26aufirst%3DM.%26aulast%3DStagg%26aufirst%3DJ.%26atitle%3DTargeting%2520A2%2520Adenosine%2520Receptors%2520in%2520Cancer%26jtitle%3DImmunol.%2520Cell%2520Biol.%26date%3D2017%26volume%3D95%26spage%3D333%26epage%3D339%26doi%3D10.1038%2Ficb.2017.8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sorrentino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morello, S.</span></span> <span> </span><span class="NLM_article-title">Role of Adenosine in Tumor Progression: Focus on A2B Receptor as Potential Therapeutic Target</span>. <i>J. Cancer Metastasis Treat.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">127</span>, <span class="refDoi"> DOI: 10.20517/2394-4722.2017.29</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.20517%2F2394-4722.2017.29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkslCisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=127&author=C.+Sorrentinoauthor=S.+Morello&title=Role+of+Adenosine+in+Tumor+Progression%3A+Focus+on+A2B+Receptor+as+Potential+Therapeutic+Target&doi=10.20517%2F2394-4722.2017.29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Role of adenosine in tumor progression: focus on A2B receptor as potential therapeutic target</span></div><div class="casAuthors">Sorrentino, Claudia; Morello, Silvana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cancer Metastasis and Treatment</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127-138</span>CODEN:
                <span class="NLM_cas:coden">JCMTCU</span>;
        ISSN:<span class="NLM_cas:issn">2454-2857</span>.
    
            (<span class="NLM_cas:orgname">OAE Publishing Inc.</span>)
        </div><div class="casAbstract">Adenosine receptors are a family of G-coupled receptors which mediate the anti-inflammatory and immune-suppressive effects of adenosine in a damaged tissue.  A large no. of evidence indicate that the accumulation of adenosine under hypoxic conditions favors tumor progression, helping cancer cells to evade immune responses.  Tumor cells and/or lymphoid and myeloid cells can express the adenosine-generating enzyme CD73 and/or A2A receptor, which in turn strongly suppresses an effective T-cell-mediated response, while promotes the activity of suppressive cells such as Treg and myeloid-derived suppressor cells.  CD73 inhibitors and A2A antagonists, either as single agents, or in combination with immune-checkpoints inhibitors such as anti PD-1 monoclonal antibodies, are currently in Phase I clin. trial in cancer patients.  Recent studies show that A2B receptor plays an important role in mediating the pro-tumor effects of adenosine, since its selective blockade can inhibit tumor growth in some murine tumor models.  Targeting A2B receptor reduces immunosuppression induced by myeloid cells and inhibits the stromal cells activity within the tumor microenvironment, limiting tumor angiogenesis and metastatic processes.  Here, the authors review the current data on involvement of A2B receptor in regulating tumor progression and discuss the development of A2B receptor inhibitors as potential therapeutic agents in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4x_7esAsf_LVg90H21EOLACvtfcHk0liLRoLZaQ5KdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkslCisLs%253D&md5=fa3c6d881e962ae9f9f61eb99ecc0a54</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.20517%2F2394-4722.2017.29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.20517%252F2394-4722.2017.29%26sid%3Dliteratum%253Aachs%26aulast%3DSorrentino%26aufirst%3DC.%26aulast%3DMorello%26aufirst%3DS.%26atitle%3DRole%2520of%2520Adenosine%2520in%2520Tumor%2520Progression%253A%2520Focus%2520on%2520A2B%2520Receptor%2520as%2520Potential%2520Therapeutic%2520Target%26jtitle%3DJ.%2520Cancer%2520Metastasis%2520Treat.%26date%3D2017%26volume%3D3%26spage%3D127%26doi%3D10.20517%2F2394-4722.2017.29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sepúlveda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuentes, E.</span></span> <span> </span><span class="NLM_article-title">Role of Adenosine A2b Receptor Overexpression in Tumor Progression</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">92</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2016.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.lfs.2016.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=27729268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslCkurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2016&pages=92-99&author=C.+Sep%C3%BAlvedaauthor=I.+Palomoauthor=E.+Fuentes&title=Role+of+Adenosine+A2b+Receptor+Overexpression+in+Tumor+Progression&doi=10.1016%2Fj.lfs.2016.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Role of adenosine A2b receptor overexpression in tumor progression</span></div><div class="casAuthors">Sepulveda, Cesar; Palomo, Ivan; Fuentes, Eduardo</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">92-99</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The adenosine A2b receptor is a G-protein coupled receptor.  Its activation occurs with high extracellular adenosine concn., for example in inflammation or hypoxia.  These conditions are generated in the tumor environment.  Studies show that A2b receptor is overexpressed in various tumor lines and biopsies from patients with different cancers.  This suggests that A2b receptor can be used by tumor cells to promote progression.  Thus A2b participates in different events, such as angiogenesis and metastasis, besides exerting immunomodulatory effects that protect tumor cells.  Therefore, adenosine A2b receptor appears as an interesting therapeutic target for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4zsCypv39ubVg90H21EOLACvtfcHk0liLRoLZaQ5KdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslCkurfJ&md5=23f5235b7c2f663665e5db2521e064b8</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2016.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2016.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DSep%25C3%25BAlveda%26aufirst%3DC.%26aulast%3DPalomo%26aufirst%3DI.%26aulast%3DFuentes%26aufirst%3DE.%26atitle%3DRole%2520of%2520Adenosine%2520A2b%2520Receptor%2520Overexpression%2520in%2520Tumor%2520Progression%26jtitle%3DLife%2520Sci.%26date%3D2016%26volume%3D166%26spage%3D92%26epage%3D99%26doi%3D10.1016%2Fj.lfs.2016.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauregard, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguile Makao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacombe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fradet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fradet, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouliot, F.</span></span> <span> </span><span class="NLM_article-title">Metabolic Imaging of Prostate Cancer Reveals Intrapatient Intermetastasis Response Heterogeneity to Systemic Therapy</span>. <i>Eur. Urol. Focus</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">639</span>– <span class="NLM_lpage">642</span>, <span class="refDoi"> DOI: 10.1016/j.euf.2017.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.euf.2017.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=28753860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A280%3ADC%252BC1cfitFGktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=639-642&author=F.+Morinauthor=J.-M.+Beauregardauthor=M.+Bergeronauthor=M.+Nguile+Makaoauthor=L.+Lacombeauthor=V.+Fradetauthor=Y.+Fradetauthor=F.+Pouliot&title=Metabolic+Imaging+of+Prostate+Cancer+Reveals+Intrapatient+Intermetastasis+Response+Heterogeneity+to+Systemic+Therapy&doi=10.1016%2Fj.euf.2017.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic Imaging of Prostate Cancer Reveals Intrapatient Intermetastasis Response Heterogeneity to Systemic Therapy</span></div><div class="casAuthors">Morin Fannie; Bergeron Michelle; Nguile Makao Moliere; Lacombe Louis; Fradet Vincent; Fradet Yves; Beauregard Jean-Mathieu; Pouliot Frederic</div><div class="citationInfo"><span class="NLM_cas:title">European urology focus</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">639-642</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Although intrapatient heterogeneity of prostate cancer (PCa) has recently been characterized via genomic and transcriptomic studies, the heterogeneity of systemic treatment responses has yet to be reported or imaged.  Our objective was to evaluate the intrapatient intermetastasis response to systemic treatment among patients with metastatic PCa.  We evaluated the metabolic response for each individual metastatic lesion (n=165) in 15 patients with metastatic PCa who underwent (18)F-fluorodeoxyglucose positron emission tomography/computed tomography before and at least 3 mo after initiation of a systemic therapy that did not change in that period.  Intermetastasis heterogeneity was defined as opposite metabolic responses for at least two metastases from the same compartment (bone or soft tissue) between the two time points.  We found intrapatient intermetastasis response heterogeneity in 40% of the cases in our retrospective series.  Our results suggest that systemic therapies can induce heterogeneous responses among individual metastases in patients with PCa, supporting the polyclonal evolution of PCa in advanced disease.  Molecular imaging may thus be useful in identifying clinical resistance early after therapy initiation and could also allow targeted biopsy of resistant clones for molecular analysis.  PATIENT SUMMARY:  Systemic therapies can lead to heterogeneous responses in individual metastases of prostate cancer in a patient.  Molecular imaging may be useful for identifying heterogeneity and could allow targeted biopsy for molecular analysis or therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQB49LRiDThK-3MPKNEWB5RfW6udTcc2eZGzuIr2eG3FLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfitFGktQ%253D%253D&md5=27e1d24e55e958cfdf973c919b5bf7cd</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.euf.2017.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euf.2017.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DMorin%26aufirst%3DF.%26aulast%3DBeauregard%26aufirst%3DJ.-M.%26aulast%3DBergeron%26aufirst%3DM.%26aulast%3DNguile%2BMakao%26aufirst%3DM.%26aulast%3DLacombe%26aufirst%3DL.%26aulast%3DFradet%26aufirst%3DV.%26aulast%3DFradet%26aufirst%3DY.%26aulast%3DPouliot%26aufirst%3DF.%26atitle%3DMetabolic%2520Imaging%2520of%2520Prostate%2520Cancer%2520Reveals%2520Intrapatient%2520Intermetastasis%2520Response%2520Heterogeneity%2520to%2520Systemic%2520Therapy%26jtitle%3DEur.%2520Urol.%2520Focus%26date%3D2017%26volume%3D3%26spage%3D639%26epage%3D642%26doi%3D10.1016%2Fj.euf.2017.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costanzi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span> <span> </span><span class="NLM_article-title">A2B Adenosine Receptor Blockade Inhibits Growth of Prostate Cancer Cells</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1007/s11302-012-9350-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1007%2Fs11302-012-9350-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=23315335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVGjsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=271-280&author=Q.+Weiauthor=S.+Costanziauthor=R.+Balasubramanianauthor=Z.-G.+Gaoauthor=K.+A.+Jacobson&title=A2B+Adenosine+Receptor+Blockade+Inhibits+Growth+of+Prostate+Cancer+Cells&doi=10.1007%2Fs11302-012-9350-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A2B adenosine receptor blockade inhibits growth of prostate cancer cells</span></div><div class="casAuthors">Wei, Qiang; Costanzi, Stefano; Balasubramanian, Ramachandran; Gao, Zhan-Guo; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">271-280</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The role of the A2B adenosine receptor (AR) in prostate cell death and growth was studied.  The A2B AR gene expression quantified by real-time quant. RT-PCR and Western blot anal. was the highest among 4 AR subtypes (A1, A2A, A2B, and A3) in all 3 commonly used prostate cancer cell lines, PC-3, DU145, and LNCaP.  We explored the function of the A2B AR using PC-3 cells as a model.  The A2B AR was visualized in PC-3 cells by laser confocal microscopy.  The nonselective A2B AR agonist NECA and the selective A2B AR agonist BAY60-6583, but not the A2A AR agonist CGS21680, concn.-dependently induced adenosine 3',5'-cyclic monophosphate (cAMP) accumulation.  NECA diminished lactate dehydrogenase (LDH) release, TNF-α-induced increase of caspase-3 activity, and cycloheximide (CHX)-induced morphol. changes typical of apoptosis in PC-3 cells, which were blocked by a selective A2B AR antagonist PSB603.  NECA-induced proliferation of PC-3 cells was diminished by siRNA specific for the A2B AR.  The selective A2B AR antagonist PSB603 was shown to inhibit cell growth in all 3 cell lines.  Thus, A2B AR blockade inhibits growth of prostate cancer cells, suggesting selective A2B AR antagonists as potential novel therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovLTcPmvn2MLVg90H21EOLACvtfcHk0lgdienw3r61qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVGjsr4%253D&md5=204e30e689ba4767a5101f280d014be2</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2Fs11302-012-9350-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-012-9350-3%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DQ.%26aulast%3DCostanzi%26aufirst%3DS.%26aulast%3DBalasubramanian%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DZ.-G.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DA2B%2520Adenosine%2520Receptor%2520Blockade%2520Inhibits%2520Growth%2520of%2520Prostate%2520Cancer%2520Cells%26jtitle%3DPurinergic%2520Signalling%26date%3D2013%26volume%3D9%26spage%3D271%26epage%3D280%26doi%3D10.1007%2Fs11302-012-9350-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaji, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukimoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, S.</span></span> <span> </span><span class="NLM_article-title">Adenosine A2B Receptor Antagonist PSB603 Suppresses Tumor Growth and Metastasis by Inhibiting Induction of Regulatory T Cells</span>. <i>J. Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">198</span>, <span class="refDoi"> DOI: 10.2131/jts.39.191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.2131%2Fjts.39.191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=24646699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVSnt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=191-198&author=W.+Kajiauthor=S.+Tanakaauthor=M.+Tsukimotoauthor=S.+Kojima&title=Adenosine+A2B+Receptor+Antagonist+PSB603+Suppresses+Tumor+Growth+and+Metastasis+by+Inhibiting+Induction+of+Regulatory+T+Cells&doi=10.2131%2Fjts.39.191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2B receptor antagonist PSB603 suppresses tumor growth and metastasis by inhibiting induction of regulatory T cells</span></div><div class="casAuthors">Kaji, Wakako; Tanaka, Satomi; Tsukimoto, Mitsutoshi; Kojima, Shuji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Toxicological Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">191-198</span>CODEN:
                <span class="NLM_cas:coden">JTSCDR</span>;
        ISSN:<span class="NLM_cas:issn">0388-1350</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society of Toxicology</span>)
        </div><div class="casAbstract">Regulatory T cells (Treg) play a role in suppression of immune response, including anti-tumor immunity.  We have recently reported that treatment of naive CD4 T cells with adenosine A2B receptor antagonist PSB603 under Treg-skewing conditions inhibits expression of Foxp3, a marker of differentiation to Treg, without blocking IL-2 prodn. or CD25 expression, which are activation markers, in CD4 T cells.  We hypothesized that PSB603 suppresses cancer growth and metastasis by inhibiting induction of Treg, thereby facilitating anti-tumor immunity.  In this study, we first examd. the effect of PSB603 on tumor growth in B16 melanoma-bearing C57BL/6 mice.  Administration of PSB603 significantly suppressed the increase of tumor vol. as well as the increase of Treg population in these mice.  The populations of CD4 and CD8 T cells were higher and splenic lymphocyte-mediated cytotoxicity towards B16 melanoma was significantly increased in PSB603-treated mice.  We confirmed that PSB603 did not reduce the viability of B16 melanoma cells in vitro.  Moreover, we also examd. the effect of PSB603 on tumor metastasis in pulmonary metastasis model mice i.v. injected with B16 melanoma cells.  The metastasis was also suppressed in PSB603-treated mice, in which the population of Treg was significantly lower.  Overall, our results suggest that A2B receptor antagonist PSB603 enhances anti-tumor immunity by inhibiting differentiation to Treg, resulting in a delay of tumor growth and a suppression of metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxaYtuhdGYu7Vg90H21EOLACvtfcHk0lgdienw3r61qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVSnt7Y%253D&md5=16ceeaa074e25584f643702b800c0586</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2131%2Fjts.39.191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2131%252Fjts.39.191%26sid%3Dliteratum%253Aachs%26aulast%3DKaji%26aufirst%3DW.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DTsukimoto%26aufirst%3DM.%26aulast%3DKojima%26aufirst%3DS.%26atitle%3DAdenosine%2520A2B%2520Receptor%2520Antagonist%2520PSB603%2520Suppresses%2520Tumor%2520Growth%2520and%2520Metastasis%2520by%2520Inhibiting%2520Induction%2520of%2520Regulatory%2520T%2520Cells%26jtitle%3DJ.%2520Toxicol.%2520Sci.%26date%3D2014%26volume%3D39%26spage%3D191%26epage%3D198%26doi%3D10.2131%2Fjts.39.191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borrmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertarelli, D. C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florin, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheiff, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">1-Alkyl-8-(Piperazine-1-Sulfonyl)Phenylxanthines: Development and Characterization of Adenosine A2B Receptor Antagonists and a New Radioligand with Subnanomolar Affinity and Subtype Specificity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3994</span>– <span class="NLM_lpage">4006</span>, <span class="refDoi"> DOI: 10.1021/jm900413e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900413e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsVOmtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3994-4006&author=T.+Borrmannauthor=S.+Hinzauthor=D.+C.+G.+Bertarelliauthor=W.+Liauthor=N.+C.+Florinauthor=A.+B.+Scheiffauthor=C.+E.+M%C3%BCller&title=1-Alkyl-8-%28Piperazine-1-Sulfonyl%29Phenylxanthines%3A+Development+and+Characterization+of+Adenosine+A2B+Receptor+Antagonists+and+a+New+Radioligand+with+Subnanomolar+Affinity+and+Subtype+Specificity&doi=10.1021%2Fjm900413e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">1-Alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: Development and Characterization of Adenosine A2B Receptor Antagonists and a New Radioligand with Subnanomolar Affinity and Subtype Specificity</span></div><div class="casAuthors">Borrmann, Thomas; Hinz, Sonja; Bertarelli, Daniela C. G.; Li, Wenjin; Florin, Nicole C.; Scheiff, Anja B.; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3994-4006</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of 1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines was designed, synthesized, and characterized in radioligand binding and functional assays at A2B adenosine receptors.  A2B antagonists with subnanomolar affinity and high selectivity were discovered.  The most potent compds. were 1-ethyl-8-(4-(4-(4-trifluoromethylbenzyl)piperazine-1-sulfonyl)phenyl)xanthine (PSB-09120, Ki (human A2B) = 0.157 nM) and 8-(4-(4-(4-chlorobenzyl)piperazine-1-sulfonyl)phenyl)-1-propylxanthine (PSB-0788, Ki (human A2B) = 0.393 nM).  Moreover, 8-(4-(4-(4-chlorophenyl)piperazine-1-sulfonyl)phenyl)-1-propylxanthine ( PSB-603) was developed as an A2B-specific antagonist exhibiting a Ki value of 0.553 nM at the human A2B receptor and virtually no affinity for the human and rat A1 and A2A and the human A3 receptors up to a concn. of 10 μM.  A tritiated form of the compd. was prepd. as a new radioligand and characterized in kinetic, satn., and competition studies.  It was shown to be a useful pharmacol. tool for the selective labeling of human as well as rodent A2B receptors (KD human A2B 0.403 nM, mouse A2B 0.351 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWuka8J5BT1LVg90H21EOLACvtfcHk0ljXD3mn3T_e2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsVOmtLg%253D&md5=c32619fcbde66b6f4237b0467d9d2950</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm900413e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900413e%26sid%3Dliteratum%253Aachs%26aulast%3DBorrmann%26aufirst%3DT.%26aulast%3DHinz%26aufirst%3DS.%26aulast%3DBertarelli%26aufirst%3DD.%2BC.%2BG.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DFlorin%26aufirst%3DN.%2BC.%26aulast%3DScheiff%26aufirst%3DA.%2BB.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3D1-Alkyl-8-%2528Piperazine-1-Sulfonyl%2529Phenylxanthines%253A%2520Development%2520and%2520Characterization%2520of%2520Adenosine%2520A2B%2520Receptor%2520Antagonists%2520and%2520a%2520New%2520Radioligand%2520with%2520Subnanomolar%2520Affinity%2520and%2520Subtype%2520Specificity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3994%26epage%3D4006%26doi%3D10.1021%2Fjm900413e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seel, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temirak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namasivayam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arridu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schabikowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baqi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hockemeyer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">A2B Adenosine Receptor Antagonists with Picomolar Potency</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">4032</span>– <span class="NLM_lpage">4055</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00071</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00071" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkt1WgsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=4032-4055&author=J.+Jiangauthor=C.+J.+Seelauthor=A.+Temirakauthor=V.+Namasivayamauthor=A.+Arriduauthor=J.+Schabikowskiauthor=Y.+Baqiauthor=S.+Hinzauthor=J.+Hockemeyerauthor=C.+E.+M%C3%BCller&title=A2B+Adenosine+Receptor+Antagonists+with+Picomolar+Potency&doi=10.1021%2Facs.jmedchem.9b00071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A2B Adenosine Receptor Antagonists with Picomolar Potency</span></div><div class="casAuthors">Jiang, Jie; Seel, Catharina Julia; Temirak, Ahmed; Namasivayam, Vigneshwaran; Arridu, Antonella; Schabikowski, Jakub; Baqi, Younis; Hinz, Sonja; Hockemeyer, Joerg; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4032-4055</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The A2B adenosine receptor (A2BAR) was proposed as a novel target for the (immuno)therapy of cancer since A2BAR blockade results in antiproliferative, anti-angiogenic, anti-metastatic, and immuno-stimulatory effects.  In this study, we explored the structure-activity relationships of xanthin-8-yl-benzenesulfonamides mainly by introducing a variety of linkers and substituents attached to the sulfonamide residue.  A new, convergent strategy was established which facilitated the synthesis of the target compds.  Many of the new compds. exhibited subnanomolar affinity for the A2BAR combined with high selectivity.  Functional groups were introduced which will allow the attachment of dyes and other reporter groups.  8-(4-((4-(4-Bromophenyl)piperazin-1-yl)sulfonyl)phenyl)-1-propylxanthine (34, PSB-1901) was the most potent A2B-antagonist (Ki 0.0835 nM, KB 0.0598 nM, human A2BAR) with >10,000-fold selectivity vs. all other AR subtypes.  It was similarly potent and selective at the mouse A2BAR, making it a promising tool for preclin. studies.  Computational studies predicted halogen bonding to contribute to the outstanding potency of 34.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4rrMRRHJNf7Vg90H21EOLACvtfcHk0ljXD3mn3T_e2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkt1WgsbY%253D&md5=c15d1364f801ac72231a5955b7e724ab</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00071%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DSeel%26aufirst%3DC.%2BJ.%26aulast%3DTemirak%26aufirst%3DA.%26aulast%3DNamasivayam%26aufirst%3DV.%26aulast%3DArridu%26aufirst%3DA.%26aulast%3DSchabikowski%26aufirst%3DJ.%26aulast%3DBaqi%26aufirst%3DY.%26aulast%3DHinz%26aufirst%3DS.%26aulast%3DHockemeyer%26aufirst%3DJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DA2B%2520Adenosine%2520Receptor%2520Antagonists%2520with%2520Picomolar%2520Potency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D4032%26epage%3D4055%26doi%3D10.1021%2Facs.jmedchem.9b00071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayallah, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandoval-Ramírez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reith, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schobert, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preiss, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">1,8-Disubstituted Xanthine Derivatives: Synthesis of Potent A2B-Selective Adenosine Receptor Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1500</span>– <span class="NLM_lpage">1510</span>, <span class="refDoi"> DOI: 10.1021/jm011049y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm011049y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtFKlu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1500-1510&author=A.+M.+Hayallahauthor=J.+Sandoval-Ram%C3%ADrezauthor=U.+Reithauthor=U.+Schobertauthor=B.+Preissauthor=B.+Schumacherauthor=J.+W.+Dalyauthor=C.+E.+M%C3%BCller&title=1%2C8-Disubstituted+Xanthine+Derivatives%3A+Synthesis+of+Potent+A2B-Selective+Adenosine+Receptor+Antagonists&doi=10.1021%2Fjm011049y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">1,8-Disubstituted Xanthine Derivatives: Synthesis of Potent A2B-Selective Adenosine Receptor Antagonists</span></div><div class="casAuthors">Hayallah, Alaa M.; Sandoval-Ramirez, Jesus; Reith, Ulrike; Schobert, Ulrike; Preiss, Birgit; Schumacher, Britta; Daly, John W.; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1500-1510</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-Unsubstituted xanthine derivs. bearing a cyclopentyl or a Ph residue in the 8-position were synthesized and developed as A2B adenosine receptor antagonists.  Compds. bearing polar substituents were prepd. to obtain water-sol. derivs.  1-Alkyl-8-phenylxanthine derivs. were found to exhibit high affinity for A2B adenosine receptors (ARs).  1,8-Disubstituted xanthine derivs. were equipotent to or more potent than 1,3,8-trisubstituted xanthines at A2B ARs, but generally less potent at A1 and A2A, and much less potent at A3 ARs.  Thus, the new compds. exhibited increased A2B selectivity vs. all other AR subtypes.  9-Deazaxanthines (pyrrolo[2,3-d]pyrimidindiones) appeared to be less potent at A2B ARs than the corresponding xanthine derivs.  1-Propyl-8-p-sulfophenylxanthine (I) was the most selective compd. of the present series, exhibiting a Ki value of 53 nM at human A2B ARs and showing greater than 180-fold selectivity vs. human A1 ARs.  Compd. I was also highly selective vs. rat A1 ARs (41-fold) and vs. the other human AR subtypes (A2A > 400-fold and A3 > 180-fold).  The compd. is highly water-sol. due to its sulfonate function.  1-Butyl-8-p-carboxyphenylxanthine, another polar analog bearing a carboxylate function, exhibited a Ki value of 24 nM for A2B ARs, 49-fold selectivity vs. human and 20-fold selectivity vs. rat A1 ARs, and greater than 150-fold selectivity vs. human A2A and A3 ARs.  8-[4-[(2-Hydroxyethylamino)-2-oxoethoxy]phenyl]-1-propylxanthine (II) and 1-butyl-8-[4-[(4-benzylpiperazino)-2-oxoethoxy]phenyl]xanthine (III) were among the most potent A2B antagonists showing Ki values at A2B ARs of 1 nM, 57-fold for II and 94-fold for III selectivity vs. human A1, ca. 30-fold selectivity vs. rat A1, and greater than 400-fold selectivity vs. human A2A and A3 ARs.  The new potent, selective, water-sol. A2B antagonists may be useful research tools for investigating A2B receptor function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh8eeBzBfHfLVg90H21EOLACvtfcHk0ljXD3mn3T_e2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtFKlu7k%253D&md5=759d610ad10c658403730fc7f00f6054</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm011049y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm011049y%26sid%3Dliteratum%253Aachs%26aulast%3DHayallah%26aufirst%3DA.%2BM.%26aulast%3DSandoval-Ram%25C3%25ADrez%26aufirst%3DJ.%26aulast%3DReith%26aufirst%3DU.%26aulast%3DSchobert%26aufirst%3DU.%26aulast%3DPreiss%26aufirst%3DB.%26aulast%3DSchumacher%26aufirst%3DB.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3D1%252C8-Disubstituted%2520Xanthine%2520Derivatives%253A%2520Synthesis%2520of%2520Potent%2520A2B-Selective%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1500%26epage%3D1510%26doi%3D10.1021%2Fjm011049y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, X.-d.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span> <span> </span><span class="NLM_article-title">Anilide Derivatives of an 8-Phenylxanthine Carboxylic Congener Are Highly Potent and Selective Antagonists at Human A(2B) Adenosine Receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1165</span>– <span class="NLM_lpage">1172</span>, <span class="refDoi"> DOI: 10.1021/jm990421v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990421v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtlGqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1165-1172&author=Y.-C.+Kimauthor=X.-d.+Jiauthor=N.+Melmanauthor=J.+Lindenauthor=K.+A.+Jacobson&title=Anilide+Derivatives+of+an+8-Phenylxanthine+Carboxylic+Congener+Are+Highly+Potent+and+Selective+Antagonists+at+Human+A%282B%29+Adenosine+Receptors&doi=10.1021%2Fjm990421v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A2B adenosine receptors</span></div><div class="casAuthors">Kim, Yong-Chul; Ji, Xiao-duo; Melman, Neli; Linden, Joel; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1165-1172</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">No highly selective antagonists of the A2B adenosine receptor (AR) have been reported; however such antagonists have therapeutic potential as antiasthmatic agents.  Here the synthesis of potent and selective A2B receptor Antagonists is reported.  The structure-activity relationships (SAR) of 8-phenyl-1,3-di-(n-propyl)xanthine derivs. in binding to recombinant human A2B ARs in HEK-293 cells (HEK-A2B) and at other AR subtypes were explored.  Various amide derivs. of 8-[4-[[carboxymethyl]oxy]phenyl]-1,3-di(n-propyl)xanthine, I (R1 = n-Pr, X = OCH2, R2 = OH) (II), were synthesized.  A comparison of aryl, alkyl, and aralkyl amides demonstrated that simple anilides, particularly those substituted in the para-position with electron-withdrawing groups, such as nitro, cyano, and acetyl, bind selectively to human A2B receptors in the range of 1-3 nM.  The unsubstituted anilide I (R1 = n-Pr, X = OCH2, R2 = NHPh) had a Ki value at A2B receptors of 1.48 nM but was only moderately selective vs. human A1/A2A receptors and nonselective vs. rat A1 receptors.  Highly potent and selective A2B antagonists were a p-aminoacetophenone deriv. I (R1 = n-Pr, X = OCH2, R2 = 4-MeOC6H4NH) (Ki value 1.39 nM) and a p-cyanoanilide I (R1 = n-Pr, X = OCH2, R2 = NHC6H4CN-4) (III) (Ki value 1.97 nM).  Compd. III was 400-, 245-, and 123-fold selective for human A2B receptors vs. human A1/A2A/A3 receptors, resp., and 8.5- and 310-fold selective vs. rat A1/A2A receptors, resp.  Substitution of the 1,3-di-Pr groups with 1,3-di-Et offered no disadvantage for selectivity, and high affinities at A2B receptors were maintained.  Substitution of the p-carboxymethyloxy group of II and its amides with acrylic acid decreased affinity at A2B receptors while increasing affinity at A1 receptors. 1,3-Di(cyclohexylmethyl) groups greatly reduced affinity at ARs, although the p-carboxymethyloxy deriv. I (R1 = cyclohexylmethyl, X = CH:CH, R2 = OH) was moderately selective for A2B receptors.  Several selective A2B antagonists inhibited NECA-stimulated calcium mobilization in HEK-A2B cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1SbbnjfBwjbVg90H21EOLACvtfcHk0lh-2DiMpbAfdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtlGqu7s%253D&md5=af987bb9429d31d6b9aa660744185832</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm990421v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990421v%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.-C.%26aulast%3DJi%26aufirst%3DX.-d.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DAnilide%2520Derivatives%2520of%2520an%25208-Phenylxanthine%2520Carboxylic%2520Congener%2520Are%2520Highly%2520Potent%2520and%2520Selective%2520Antagonists%2520at%2520Human%2520A%25282B%2529%2520Adenosine%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D1165%26epage%3D1172%26doi%3D10.1021%2Fjm990421v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinig, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKibben, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castelhano, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLennan, S. J.</span></span> <span> </span><span class="NLM_article-title">[3H]OSIP339391, a Selective, Novel, and High Affinity Antagonist Radioligand for Adenosine A2B Receptors</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">312</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2004.03.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.bcp.2004.03.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=15194002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvV2hs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2004&pages=305-312&author=M.+Stewartauthor=A.+G.+Steinigauthor=C.+Maauthor=J.-P.+Songauthor=B.+McKibbenauthor=A.+L.+Castelhanoauthor=S.+J.+MacLennan&title=%5B3H%5DOSIP339391%2C+a+Selective%2C+Novel%2C+and+High+Affinity+Antagonist+Radioligand+for+Adenosine+A2B+Receptors&doi=10.1016%2Fj.bcp.2004.03.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]OSIP339391, a selective, novel, and high affinity antagonist radioligand for adenosine A2B receptors</span></div><div class="casAuthors">Stewart, Mike; Steinig, Arno G.; Ma, Chienling; Song, Jian-Ping; McKibben, Bryan; Castelhano, Arlindo L.; MacLennan, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">305-312</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Until recently, the characterization of adenosine A2B receptors has been hampered by the lack of high affinity radioligands.  This study describes the synthesis and in vitro characterization of the radiolabeled deriv. of OSIP339391, a novel, potent, and selective pyrrolopyrimidine A2B antagonist.  OSIP339391 had a selectivity of greater than 70-fold for A2B receptors over other human adenosine receptor subtypes.  The radiolabel was introduced by hydrogenation of the acetylenic precursor with tritium gas resulting in the incorporation (on av.) of three tritium atoms in the mol., yielding a ligand with specific activity of 87 Ci/mmol (3.2 TBq/mmol).  Using membranes from HEK-293 cells expressing the human recombinant A2B receptor, [3H]OSIP339391 was characterized in kinetic, satn., and competition binding expts.  From the assocn. and dissocn. rate studies, the affinity was 0.41 nM and in close agreement with that found in satn. binding expts. (0.17 nM).  In competition, binding studies using 0.5 nM [3H]OSIP339391, the affinity of a range of agonists and antagonists was consistent with previously reported data.  Thus, [3H]OSIP339391 is a novel, selective, and high affinity radioligand that can be a useful tool in the further exploration and characterization of recombinant and endogenous adenosine A2B receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWckJRLeNAK7Vg90H21EOLACvtfcHk0lh-2DiMpbAfdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvV2hs7g%253D&md5=a1725fd35398acd076bc3779e31aed00</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2004.03.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2004.03.026%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DM.%26aulast%3DSteinig%26aufirst%3DA.%2BG.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DSong%26aufirst%3DJ.-P.%26aulast%3DMcKibben%26aufirst%3DB.%26aulast%3DCastelhano%26aufirst%3DA.%2BL.%26aulast%3DMacLennan%26aufirst%3DS.%2BJ.%26atitle%3D%255B3H%255DOSIP339391%252C%2520a%2520Selective%252C%2520Novel%252C%2520and%2520High%2520Affinity%2520Antagonist%2520Radioligand%2520for%2520Adenosine%2520A2B%2520Receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2004%26volume%3D68%26spage%3D305%26epage%3D312%26doi%3D10.1016%2Fj.bcp.2004.03.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taliani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugliesi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barresi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simorini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salerno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Motta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marini, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosimelli, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosconati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Maro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniele, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trincavelli, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greco, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Settimo, F.</span></span> <span> </span><span class="NLM_article-title">3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A2BAdenosine Receptor Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1490</span>– <span class="NLM_lpage">1499</span>, <span class="refDoi"> DOI: 10.1021/jm201177b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201177b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsVyhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1490-1499&author=S.+Talianiauthor=I.+Pugliesiauthor=E.+Barresiauthor=F.+Simoriniauthor=S.+Salernoauthor=C.+La+Mottaauthor=A.+M.+Mariniauthor=B.+Cosimelliauthor=S.+Cosconatiauthor=S.+Di+Maroauthor=L.+Marinelliauthor=S.+Danieleauthor=M.+L.+Trincavelliauthor=G.+Grecoauthor=E.+Novellinoauthor=C.+Martiniauthor=F.+Da+Settimo&title=3-Aryl-%5B1%2C2%2C4%5Dtriazino%5B4%2C3-a%5Dbenzimidazol-4%2810H%29-one%3A+A+Novel+Template+for+the+Design+of+Highly+Selective+A2BAdenosine+Receptor+Antagonists&doi=10.1021%2Fjm201177b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A2B Adenosine Receptor Antagonists</span></div><div class="casAuthors">Taliani, Sabrina; Pugliesi, Isabella; Barresi, Elisabetta; Simorini, Francesca; Salerno, Silvia; La Motta, Concettina; Marini, Anna Maria; Cosimelli, Barbara; Cosconati, Sandro; Di Maro, Salvatore; Marinelli, Luciana; Daniele, Simona; Trincavelli, Maria Letizia; Greco, Giovanni; Novellino, Ettore; Martini, Claudia; Da Settimo, Federico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1490-1499</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In an effort to identify novel ligands possessing high affinity and selectivity for the A2B AR subtype, we further investigated the class of 3-aryl[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones, previously disclosed by us as selective A1 AR antagonists.  Preliminary assays on a no. of triazinobenzimidazoles derived from our "inhouse" collection revealed that all the derivs. selected showed significant affinity at A2B AR, no affinity at A3 AR, and various degrees of selectivity toward A1 and A2A ARs.  Investigation of a new series featuring modified substituents at the 10-position (4'-chlorophenyl or phenylethyl groups), and a chlorine atom at the 7-position (X) of the triazinobenzimidazole nucleus, yielded highly potent and selective A2B AR antagonists.  The presence of a pendant 3-Ph ring appears to hamper the interaction with A2A AR, conferring high A2B/A2A AR selectivity.  Compd. (I) is the most potent and selective compd., with an IC50 of 3.10 nM at A2B AR and no affinity at A1, A2A, and A3 ARs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqFYkkUBZbOrVg90H21EOLACvtfcHk0lh-2DiMpbAfdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsVyhsQ%253D%253D&md5=702fe023ad22921949ebb71d108656f1</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm201177b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201177b%26sid%3Dliteratum%253Aachs%26aulast%3DTaliani%26aufirst%3DS.%26aulast%3DPugliesi%26aufirst%3DI.%26aulast%3DBarresi%26aufirst%3DE.%26aulast%3DSimorini%26aufirst%3DF.%26aulast%3DSalerno%26aufirst%3DS.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DMarini%26aufirst%3DA.%2BM.%26aulast%3DCosimelli%26aufirst%3DB.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DDi%2BMaro%26aufirst%3DS.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DDaniele%26aufirst%3DS.%26aulast%3DTrincavelli%26aufirst%3DM.%2BL.%26aulast%3DGreco%26aufirst%3DG.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DMartini%26aufirst%3DC.%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26atitle%3D3-Aryl-%255B1%252C2%252C4%255Dtriazino%255B4%252C3-a%255Dbenzimidazol-4%252810H%2529-one%253A%2520A%2520Novel%2520Template%2520for%2520the%2520Design%2520of%2520Highly%2520Selective%2520A2BAdenosine%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1490%26epage%3D1499%26doi%3D10.1021%2Fjm201177b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nueda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esteve, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domenech, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinoso, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pont, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calbet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadavid, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cárdenas, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godessart, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beleta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warrellow, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, H.</span></span> <span> </span><span class="NLM_article-title">Discovery and Characterization of 4′-(2-Furyl)-N-Pyridin-3-yl-4, 5′-Bipyrimidin-2′-Amine (LAS38096), a Potent, Selective, and Efficacious A2B Adenosine Receptor Antagonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2732</span>– <span class="NLM_lpage">2736</span>, <span class="refDoi"> DOI: 10.1021/jm061333v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061333v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslarur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2732-2736&author=B.+Vidalauthor=A.+Nuedaauthor=C.+Esteveauthor=T.+Domenechauthor=S.+Benitoauthor=R.+F.+Reinosoauthor=M.+Pontauthor=M.+Calbetauthor=R.+L%C3%B3pezauthor=M.+I.+Cadavidauthor=M.+I.+Lozaauthor=%C3%81.+C%C3%A1rdenasauthor=N.+Godessartauthor=J.+Beletaauthor=G.+Warrellowauthor=H.+Ryder&title=Discovery+and+Characterization+of+4%E2%80%B2-%282-Furyl%29-N-Pyridin-3-yl-4%2C+5%E2%80%B2-Bipyrimidin-2%E2%80%B2-Amine+%28LAS38096%29%2C+a+Potent%2C+Selective%2C+and+Efficacious+A2B+Adenosine+Receptor+Antagonist&doi=10.1021%2Fjm061333v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of 4'-(2-Furyl)-N-pyridin-3-yl-4,5'-bipyrimidin-2'-amine (LAS38096), a Potent, Selective, and Efficacious A2B Adenosine Receptor Antagonist</span></div><div class="casAuthors">Vidal, Bernat; Nueda, Arsenio; Esteve, Cristina; Domenech, Teresa; Benito, Sonia; Reinoso, Raquel F.; Pont, Merce; Calbet, Marta; Lopez, Rosa; Cadavid, Maria Isabel; Loza, Maria Isabel; Cardenas, Alvaro; Godessart, Nuria; Beleta, Jorge; Warrellow, Graham; Ryder, Hamish</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2732-2736</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of N-heteroaryl 4'-(2-furyl)-4,5'-bipyrimidin-2'-amines has been identified as potent and selective A2B adenosine receptor antagonists.  In particular, compd. 5 showed high affinity for the A2B receptor (Ki = 17 nM), good selectivity (IC50: A1 > 1000 nM, A2A > 2500 nM, A3 > 1000 nM), displayed a favorable pharmacokinetic profile in preclin. species, and showed efficacy in functional in vitro models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpijtnGUoID7bVg90H21EOLACvtfcHk0lg9EVbLhoRuRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslarur0%253D&md5=017172644da88d13b26cddeb2ae96b84</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm061333v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061333v%26sid%3Dliteratum%253Aachs%26aulast%3DVidal%26aufirst%3DB.%26aulast%3DNueda%26aufirst%3DA.%26aulast%3DEsteve%26aufirst%3DC.%26aulast%3DDomenech%26aufirst%3DT.%26aulast%3DBenito%26aufirst%3DS.%26aulast%3DReinoso%26aufirst%3DR.%2BF.%26aulast%3DPont%26aufirst%3DM.%26aulast%3DCalbet%26aufirst%3DM.%26aulast%3DL%25C3%25B3pez%26aufirst%3DR.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DC%25C3%25A1rdenas%26aufirst%3D%25C3%2581.%26aulast%3DGodessart%26aufirst%3DN.%26aulast%3DBeleta%26aufirst%3DJ.%26aulast%3DWarrellow%26aufirst%3DG.%26aulast%3DRyder%26aufirst%3DH.%26atitle%3DDiscovery%2520and%2520Characterization%2520of%25204%25E2%2580%25B2-%25282-Furyl%2529-N-Pyridin-3-yl-4%252C%25205%25E2%2580%25B2-Bipyrimidin-2%25E2%2580%25B2-Amine%2520%2528LAS38096%2529%252C%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Efficacious%2520A2B%2520Adenosine%2520Receptor%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2732%26epage%3D2736%26doi%3D10.1021%2Fjm061333v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El
Maatougui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azuaje, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Gómez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miguez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crespo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carbajales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escalante, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Mera, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez-de-Terán, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotelo, E.</span></span> <span> </span><span class="NLM_article-title">Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1967</span>– <span class="NLM_lpage">1983</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01586</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01586" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslKnu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1967-1983&author=A.+El%0AMaatouguiauthor=J.+Azuajeauthor=M.+Gonz%C3%A1lez-G%C3%B3mezauthor=G.+Miguezauthor=A.+Crespoauthor=C.+Carbajalesauthor=L.+Escalanteauthor=X.+Garc%C3%ADa-Meraauthor=H.+Guti%C3%A9rrez-de-Ter%C3%A1nauthor=E.+Sotelo&title=Discovery+of+Potent+and+Highly+Selective+A2B+Adenosine+Receptor+Antagonist+Chemotypes&doi=10.1021%2Facs.jmedchem.5b01586"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes</span></div><div class="casAuthors">El Maatougui, Abdelaziz; Azuaje, Jhonny; Gonzalez-Gomez, Manuel; Miguez, Gabriel; Crespo, Abel; Carbajales, Carlos; Escalante, Luz; Garcia-Mera, Xerardo; Gutierrez-de-Teran, Hugo; Sotelo, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1967-1983</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Three novel families of A2B adenosine receptor antagonists were identified in the context of the structural exploration of the 3,4-dihydropyrimidin-2(1H)-one chemotype.  The most appealing series contain imidazole, 1,2,4-triazole, or benzimidazole rings fused to the 2,3-positions of the parent diazinone core.  The optimization process enabled identification of a highly potent (3.49 nM) A2B ligand that exhibits complete selectivity toward A1, A2A, and A3 receptors.  The results of functional cAMP expts. confirmed the antagonistic behavior of representative ligands.  The main SAR trends identified within the series were substantiated by a mol. modeling study based on a receptor-driven docking model constructed on the basis of the crystal structure of the human A2A receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRWpBQuLXYG7Vg90H21EOLACvtfcHk0lg9EVbLhoRuRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslKnu7g%253D&md5=4df99ab9a9e7dea11b5592ba9d64b334</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01586%26sid%3Dliteratum%253Aachs%26aulast%3DEl%2BMaatougui%26aufirst%3DA.%26aulast%3DAzuaje%26aufirst%3DJ.%26aulast%3DGonz%25C3%25A1lez-G%25C3%25B3mez%26aufirst%3DM.%26aulast%3DMiguez%26aufirst%3DG.%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DCarbajales%26aufirst%3DC.%26aulast%3DEscalante%26aufirst%3DL.%26aulast%3DGarc%25C3%25ADa-Mera%26aufirst%3DX.%26aulast%3DGuti%25C3%25A9rrez-de-Ter%25C3%25A1n%26aufirst%3DH.%26aulast%3DSotelo%26aufirst%3DE.%26atitle%3DDiscovery%2520of%2520Potent%2520and%2520Highly%2520Selective%2520A2B%2520Adenosine%2520Receptor%2520Antagonist%2520Chemotypes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1967%26epage%3D1983%26doi%3D10.1021%2Facs.jmedchem.5b01586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carbajales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azuaje, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadavid, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masaguer, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Mera, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez-de-Terán, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotelo, E.</span></span> <span> </span><span class="NLM_article-title">Enantiospecific Recognition at the A2B Adenosine Receptor by Alkyl 2-Cyanoimino-4-Substituted-6-Methyl-1,2,3,4-Tetrahydropyrimidine-5-Carboxylates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3372</span>– <span class="NLM_lpage">3382</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00138</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00138" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsVygsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3372-3382&author=C.+Carbajalesauthor=J.+Azuajeauthor=A.+Oliveiraauthor=M.+I.+Lozaauthor=J.+Breaauthor=M.+I.+Cadavidauthor=C.+F.+Masaguerauthor=X.+Garc%C3%ADa-Meraauthor=H.+Guti%C3%A9rrez-de-Ter%C3%A1nauthor=E.+Sotelo&title=Enantiospecific+Recognition+at+the+A2B+Adenosine+Receptor+by+Alkyl+2-Cyanoimino-4-Substituted-6-Methyl-1%2C2%2C3%2C4-Tetrahydropyrimidine-5-Carboxylates&doi=10.1021%2Facs.jmedchem.7b00138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Enantiospecific Recognition at the A2B Adenosine Receptor by Alkyl 2-Cyanoimino-4-substituted-6-methyl-1,2,3,4-tetrahydropyrimidine-5-carboxylates</span></div><div class="casAuthors">Carbajales, Carlos; Azuaje, Jhonny; Oliveira, Ana; Loza, Maria I.; Brea, Jose; Cadavid, Maria I.; Masaguer, Christian F.; Garcia-Mera, Xerardo; Gutierrez-de-Teran, Hugo; Sotelo, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3372-3382</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel family of structurally simple, potent, and selective nonxanthine A2BAR ligands was identified, and its antagonistic behavior confirmed through functional expts.  The reported alkyl 2-cyanoimino-4-substituted-6-methyl-1,2,3,4-tetrahy-dropyrimidine-5-carboxylates (16) were designed by bioisosteric replacement of the carbonyl group at position 2 in a series of 3,4-dihydropyrimidin-2-ones.  The scaffold (16) documented herein contains a chiral center at the heterocycle.  Accordingly, the most attractive ligand of the series [(±)16b, Ki= 24.3 nM] was resolved into its two enantiomers by chiral HPLC, and the abs. configuration was established by CD.  The biol. evaluation of both enantiomers demonstrated enantiospecific recognition at A2BAR, with the (S)-16b enantiomer retaining all the affinity (Ki= 15.1 nM), as predicted earlier by mol. modeling.  This constitutes the first example of enantiospecific recognition at the A2B adenosine receptor and opens new possibilities in ligand design for this receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovaUyWm1ZvpLVg90H21EOLACvtfcHk0lhf8FSAqGRRzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsVygsbc%253D&md5=478fd085f77fcd308514ba46b4bb8f7d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00138%26sid%3Dliteratum%253Aachs%26aulast%3DCarbajales%26aufirst%3DC.%26aulast%3DAzuaje%26aufirst%3DJ.%26aulast%3DOliveira%26aufirst%3DA.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DMasaguer%26aufirst%3DC.%2BF.%26aulast%3DGarc%25C3%25ADa-Mera%26aufirst%3DX.%26aulast%3DGuti%25C3%25A9rrez-de-Ter%25C3%25A1n%26aufirst%3DH.%26aulast%3DSotelo%26aufirst%3DE.%26atitle%3DEnantiospecific%2520Recognition%2520at%2520the%2520A2B%2520Adenosine%2520Receptor%2520by%2520Alkyl%25202-Cyanoimino-4-Substituted-6-Methyl-1%252C2%252C3%252C4-Tetrahydropyrimidine-5-Carboxylates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3372%26epage%3D3382%26doi%3D10.1021%2Facs.jmedchem.7b00138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crespo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Maatougui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biagini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azuaje, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadavid, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Mera, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez-de-Terán, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotelo, E.</span></span> <span> </span><span class="NLM_article-title">Discovery of 3,4-Dihydropyrimidin-2(1H)-ones As a Novel Class of Potent and Selective A2B Adenosine Receptor Antagonists</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1031</span>– <span class="NLM_lpage">1036</span>, <span class="refDoi"> DOI: 10.1021/ml400185v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400185v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKks77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1031-1036&author=A.+Crespoauthor=A.+El+Maatouguiauthor=P.+Biaginiauthor=J.+Azuajeauthor=A.+Coelhoauthor=J.+Breaauthor=M.+I.+Lozaauthor=M.+I.+Cadavidauthor=X.+Garc%C3%ADa-Meraauthor=H.+Guti%C3%A9rrez-de-Ter%C3%A1nauthor=E.+Sotelo&title=Discovery+of+3%2C4-Dihydropyrimidin-2%281H%29-ones+As+a+Novel+Class+of+Potent+and+Selective+A2B+Adenosine+Receptor+Antagonists&doi=10.1021%2Fml400185v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 3,4-Dihydropyrimidin-2(1H)-ones As a Novel Class of Potent and Selective A2B Adenosine Receptor Antagonists</span></div><div class="casAuthors">Crespo, Abel; El Maatougui, Abdelaziz; Biagini, Pierfrancesco; Azuaje, Jhonny; Coelho, Alberto; Brea, Jose; Loza, Maria Isabel; Cadavid, Maria Isabel; Garcia-Mera, Xerardo; Gutierrez-de-Teran, Hugo; Sotelo, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1031-1036</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe the discovery and optimization of 3,4-dihydropyrimidin-2-(1H)-ones as a novel family of (nonxanthine) A2B receptor antagonists that exhibit an unusually high selectivity profile.  The Biginelli-based hit optimization process enabled a thoughtful exploration of the structure-activity and structure-selectivity relationships for this chemotype, enabling the identification of ligands that combine structural simplicity with excellent hA2B AdoR affinity and remarkable selectivity profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcmq93mYNjxrVg90H21EOLACvtfcHk0lhf8FSAqGRRzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKks77J&md5=41f5ce37315529b35115ef6ec3cccba5</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fml400185v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400185v%26sid%3Dliteratum%253Aachs%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DEl%2BMaatougui%26aufirst%3DA.%26aulast%3DBiagini%26aufirst%3DP.%26aulast%3DAzuaje%26aufirst%3DJ.%26aulast%3DCoelho%26aufirst%3DA.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DGarc%25C3%25ADa-Mera%26aufirst%3DX.%26aulast%3DGuti%25C3%25A9rrez-de-Ter%25C3%25A1n%26aufirst%3DH.%26aulast%3DSotelo%26aufirst%3DE.%26atitle%3DDiscovery%2520of%25203%252C4-Dihydropyrimidin-2%25281H%2529-ones%2520As%2520a%2520Novel%2520Class%2520of%2520Potent%2520and%2520Selective%2520A2B%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1031%26epage%3D1036%26doi%3D10.1021%2Fml400185v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C. N.</span>; <span class="NLM_string-name">Jamal, M. S.</span></span> <i>Handbook of Experimental Pharmacology: Adenosine Receptors in Health and Disease</i>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1007%2F978-3-540-89615-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=C.+N.+Wilson&author=M.+S.+Jamal&title=Handbook+of+Experimental+Pharmacology%3A+Adenosine+Receptors+in+Health+and+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1007%2F978-3-540-89615-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-540-89615-9%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DC.%2BN.%26btitle%3DHandbook%2520of%2520Experimental%2520Pharmacology%253A%2520Adenosine%2520Receptors%2520in%2520Health%2520and%2520Disease%26pub%3DSpringer%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabrizi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gessi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span> <span> </span><span class="NLM_article-title">Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1021/cr0682195</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr0682195" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD1cXis1OisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=238-263&author=P.+G.+Baraldiauthor=M.+A.+Tabriziauthor=S.+Gessiauthor=P.+A.+Borea&title=Adenosine+Receptor+Antagonists%3A+Translating+Medicinal+Chemistry+and+Pharmacology+into+Clinical+Utility&doi=10.1021%2Fcr0682195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility</span></div><div class="casAuthors">Baraldi, Pier Giovanni; Tabrizi, Mojgan Aghazadeh; Gessi, Stefania; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">238-263</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review discusses the chem. and pharmacol. of adenosine A1, A2A, A2B and A3 receptor antagonists and their therapeutic potential in clin. developments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOXhQGKqAVLbVg90H21EOLACvtfcHk0lhf8FSAqGRRzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXis1OisQ%253D%253D&md5=1ae9e978507a1bbe7ab7aea0bdb33bb8</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fcr0682195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0682195%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DAdenosine%2520Receptor%2520Antagonists%253A%2520Translating%2520Medicinal%2520Chemistry%2520and%2520Pharmacology%2520into%2520Clinical%2520Utility%26jtitle%3DChem.%2520Rev.%26date%3D2008%26volume%3D108%26spage%3D238%26epage%3D263%26doi%3D10.1021%2Fcr0682195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tosh, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.-G.</span></span> <span> </span><span class="NLM_article-title">Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development</span>. <i>Front. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">124</span>, <span class="refDoi"> DOI: 10.3389/fncel.2019.00124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.3389%2Ffncel.2019.00124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=30983976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlKmurjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2019&pages=124&author=K.+A.+Jacobsonauthor=D.+K.+Toshauthor=S.+Jainauthor=Z.-G.+Gao&title=Historical+and+Current+Adenosine+Receptor+Agonists+in+Preclinical+and+Clinical+Development&doi=10.3389%2Ffncel.2019.00124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Historical and current adenosine receptor agonists in preclinical and clinical development</span></div><div class="casAuthors">Jacobson, Kenneth A.; Tosh, Dilip K.; Jain, Shanu; Gao, Zhan-Guo</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">124</span>CODEN:
                <span class="NLM_cas:coden">FCNRAH</span>;
        ISSN:<span class="NLM_cas:issn">1662-5102</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Adenosine receptors (ARs) function in the body's response to conditions of pathol. and stress assocd. with a functional imbalance, such as in the supply and demand of energy/oxygen/nutrients.  Extracellular adenosine concns. vary widely to raise or lower the basal activation of four subtypes of ARs.  Endogenous adenosine can correct an energy imbalance during hypoxia and other stress, for example, by slowing the heart rate by A1AR activation or increasing the blood supply to heart muscle by the A2AAR.  Moreover, exogenous AR agonists, antagonists, or allosteric modulators can be applied for therapeutic benefit, and medicinal chemists working toward that goal have reported thousands of such agents.  Thus, numerous clin. trials have ensued, using promising agents to modulate adenosinergic signaling, most of which have not succeeded.  Currently, short-acting, parenteral agonists, adenosine and Regadenoson, are the only AR agonists approved for human use.  However, new concepts and compds. are currently being developed and applied toward preclin. and clin. evaluation, and initial results are encouraging.  This review focuses on key compds. as AR agonists and pos. allosteric modulators (PAMs) for disease treatment or diagnosis.  AR agonists for treating inflammation, pain, cancer, non-alc. steatohepatitis, angina, sickle cell disease, ischemic conditions and diabetes have been under development.  Multiple clin. trials with two A3AR agonists are ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnH2YyZ_7M17Vg90H21EOLACvtfcHk0ljMX7wd7S7q6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlKmurjM&md5=5d4c03988f6137d909a2356a010eea0c</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2019.00124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncel.2019.00124%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DZ.-G.%26atitle%3DHistorical%2520and%2520Current%2520Adenosine%2520Receptor%2520Agonists%2520in%2520Preclinical%2520and%2520Clinical%2520Development%26jtitle%3DFront.%2520Cell.%2520Neurosci.%26date%3D2019%26volume%3D13%26spage%3D124%26doi%3D10.3389%2Ffncel.2019.00124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baqi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namasivayam, V.</span></span> <span> </span><span class="NLM_article-title">Medicinal Chemistry of A2B Adenosine Receptors</span>. <i>Receptors</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">168</span>, <span class="refDoi"> DOI: 10.1007/978-3-319-90808-3_6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1007%2F978-3-319-90808-3_6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2018&pages=137-168&author=C.+E.+M%C3%BCllerauthor=Y.+Baqiauthor=S.+Hinzauthor=V.+Namasivayam&title=Medicinal+Chemistry+of+A2B+Adenosine+Receptors&doi=10.1007%2F978-3-319-90808-3_6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-90808-3_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-319-90808-3_6%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DBaqi%26aufirst%3DY.%26aulast%3DHinz%26aufirst%3DS.%26aulast%3DNamasivayam%26aufirst%3DV.%26atitle%3DMedicinal%2520Chemistry%2520of%2520A2B%2520Adenosine%2520Receptors%26jtitle%3DReceptors%26date%3D2018%26volume%3D34%26spage%3D137%26epage%3D168%26doi%3D10.1007%2F978-3-319-90808-3_6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalla, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zablocki, J.</span></span> <span> </span><span class="NLM_article-title">Progress in the Discovery of Selective, High Affinity A2B Adenosine Receptor Antagonists as Clinical Candidates</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1007/s11302-008-9119-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1007%2Fs11302-008-9119-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=18568423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVCqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=21-29&author=R.+V.+Kallaauthor=J.+Zablocki&title=Progress+in+the+Discovery+of+Selective%2C+High+Affinity+A2B+Adenosine+Receptor+Antagonists+as+Clinical+Candidates&doi=10.1007%2Fs11302-008-9119-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the discovery of selective, high affinity A2B adenosine receptor antagonists as clinical candidates</span></div><div class="casAuthors">Kalla, Rao V.; Zablocki, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-29</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The selective, high affinity A2B adenosine receptor (AdoR) antagonists that were synthesized by several research groups should aid in detg. the role of the A2B AdoR in inflammatory diseases like asthma or rheumatoid arthritis (RA) and angiogenic diseases like diabetic retinopathy or cancer.  CV Therapeutics scientists discovered the selective, high affinity A2B AdoR antagonist 10, a 8-(4-pyrazolyl)-xanthine deriv. [CVT-6883, Ki(hA2B) = 22 nM; Ki(hA1) = 1,940 nM; Ki(hA2A) = 3,280; and Ki(hA3) = 1,070 nM] that has favorable pharmacokinetic (PK) properties (t 1/2 = 4 h and F > 35% rat).  Compd. 10 demonstrated functional antagonism at the A2B AdoR (KB = 6 nM) and efficacy in a mouse model of asthma.  In 2 phase 1 clin. trials, CVT-6883 was found to be safe, well tolerated, and suitable for once daily dosing.  A second compd. 20, 8-(5-pyrazolyl)-xanthine, was nominated for development from Baraldi's group in conjunction with King Pharmaceuticals that has favorable A2B AdoR affinity and selectivity [Ki(hA2B) = 5.5 nM; Ki(hA1) > 1,000 nM; Ki(hA2A) > 1,000; and Ki(hA3) > 1,000 nM], and it was demonstrated to be a functional antagonist.  A third compd. 32, a 2-aminopyrimidine, from the Almirall group has high A2B AdoR affinity and selectivity [Ki(hA2B) = 17 nM; Ki(hA1) > 1,000 nM; Ki(hA2A) > 2,500; and Ki(hA3) > 1,000 nM], and 32 was moved into preclin. safety testing.  Since 3 highly selective, high affinity A2B AdoR antagonists were nominated for development with 10 (CVT-6883) being the furthest along in the development process, the role of the A2B AdoR in various disease states will soon be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGfZeO3oRUfrVg90H21EOLACvtfcHk0ljMX7wd7S7q6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVCqsr0%253D&md5=c8a49309fda894766f9bb087689ff74c</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1007%2Fs11302-008-9119-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-008-9119-x%26sid%3Dliteratum%253Aachs%26aulast%3DKalla%26aufirst%3DR.%2BV.%26aulast%3DZablocki%26aufirst%3DJ.%26atitle%3DProgress%2520in%2520the%2520Discovery%2520of%2520Selective%252C%2520High%2520Affinity%2520A2B%2520Adenosine%2520Receptor%2520Antagonists%2520as%2520Clinical%2520Candidates%26jtitle%3DPurinergic%2520Signalling%26date%3D2009%26volume%3D5%26spage%3D21%26epage%3D29%26doi%3D10.1007%2Fs11302-008-9119-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mallo-Abreu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majellaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jespers, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azuaje, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caamaño, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Mera, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez-de-Terán, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotelo, E.</span></span> <span> </span><span class="NLM_article-title">Trifluorinated Pyrimidine-Based A2B Antagonists: Optimization and Evidence of Stereospecific Recognition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">9315</span>– <span class="NLM_lpage">9330</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01340</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01340" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVGgtLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=9315-9330&author=A.+Mallo-Abreuauthor=M.+Majellaroauthor=W.+Jespersauthor=J.+Azuajeauthor=O.+Caama%C3%B1oauthor=X.+Garc%C3%ADa-Meraauthor=J.+M.+Breaauthor=M.+I.+Lozaauthor=H.+Guti%C3%A9rrez-de-Ter%C3%A1nauthor=E.+Sotelo&title=Trifluorinated+Pyrimidine-Based+A2B+Antagonists%3A+Optimization+and+Evidence+of+Stereospecific+Recognition&doi=10.1021%2Facs.jmedchem.9b01340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Trifluorinated Pyrimidine-Based A2B Antagonists: Optimization and Evidence of Stereospecific Recognition</span></div><div class="casAuthors">Mallo-Abreu, Ana; Majellaro, Maria; Jespers, Willem; Azuaje, Jhonny; Caamano, Olga; Garcia-Mera, Xerardo; Brea, Jose M.; Loza, Maria I.; Gutierrez-de-Teran, Hugo; Sotelo, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9315-9330</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the identification of two subsets of fluorinated nonxanthine A2B adenosine receptor antagonists.  The novel derivs. explore the effect of fluorination at different positions of two pyrimidine-based scaffolds.  The most interesting ligands combine excellent hA2B affinity (Ki < 15 nM) and remarkable subtype selectivity.  The results of functional cAMP expts. confirmed the antagonistic behavior of representative ligands.  The compds. were designed on the basis of previous mol. models of the stereoselective binding of the parent scaffolds to the hA2B receptor, and we herein provide refinement of such models with the fluorinated compds., which allows the explanation of the spurious effects of the fluorination at the different positions explored.  These models are importantly confirmed by a synergistic study combining chiral HPLC, CD, diastereoselective synthesis, mol. modeling, and X-ray crystallog., providing exptl. evidence toward the stereospecific interaction between optimized trifluorinated stereoisomers and the hA2B receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9gue2m74iSLVg90H21EOLACvtfcHk0ljMX7wd7S7q6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVGgtLfE&md5=05cdd26c378514888ae09631f4f47c11</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01340%26sid%3Dliteratum%253Aachs%26aulast%3DMallo-Abreu%26aufirst%3DA.%26aulast%3DMajellaro%26aufirst%3DM.%26aulast%3DJespers%26aufirst%3DW.%26aulast%3DAzuaje%26aufirst%3DJ.%26aulast%3DCaama%25C3%25B1o%26aufirst%3DO.%26aulast%3DGarc%25C3%25ADa-Mera%26aufirst%3DX.%26aulast%3DBrea%26aufirst%3DJ.%2BM.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DGuti%25C3%25A9rrez-de-Ter%25C3%25A1n%26aufirst%3DH.%26aulast%3DSotelo%26aufirst%3DE.%26atitle%3DTrifluorinated%2520Pyrimidine-Based%2520A2B%2520Antagonists%253A%2520Optimization%2520and%2520Evidence%2520of%2520Stereospecific%2520Recognition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D9315%26epage%3D9330%26doi%3D10.1021%2Facs.jmedchem.9b01340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crespo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Maatougui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azuaje, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escalante, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majellaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadavid, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez-de-Terán, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotelo, E.</span></span> <span> </span><span class="NLM_article-title">Exploring the Influence of the Substituent at Position 4 in a Series of 3,4-Dihydropyrimidin-2(1H)-One A2B Adenosine Receptor Antagonists</span>. <i>Chem. Heterocycl. Compd.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">316</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1007/s10593-017-2054-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1007%2Fs10593-017-2054-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmslSgtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2017&pages=316-321&author=A.+Crespoauthor=A.+El+Maatouguiauthor=J.+Azuajeauthor=L.+Escalanteauthor=M.+Majellaroauthor=M.+I.+Lozaauthor=J.+Breaauthor=M.+I.+Cadavidauthor=H.+Guti%C3%A9rrez-de-Ter%C3%A1nauthor=E.+Sotelo&title=Exploring+the+Influence+of+the+Substituent+at+Position+4+in+a+Series+of+3%2C4-Dihydropyrimidin-2%281H%29-One+A2B+Adenosine+Receptor+Antagonists&doi=10.1007%2Fs10593-017-2054-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the influence of the substituent at position 4 in a series of 3,4-dihydropyrimidin-2(1H)-one A2B adenosine receptor antagonists</span></div><div class="casAuthors">Crespo, Abel; El Maatougui, Abdelaziz; Azuaje, Jhonny; Escalante, Luz; Majellaro, Maria; Loza, Maria Isabel; Brea, Jose; Cadavid, Maria Isabel; Gutierrez-de-Teran, Hugo; Sotelo, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry of Heterocyclic Compounds (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">316-321</span>CODEN:
                <span class="NLM_cas:coden">CHCCAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-3122</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In the context of a program to identify selective adenosine A2B receptor antagonists, a focused library of 4-substituted 3,4-dihydropyrimidin-2(1H)-ones was obtained and its affinity for the four human adenosine receptor subtypes was detd.  The synthesis was accomplished by using an exptl. simple and efficient Biginelli approach.  The biol. evaluation of the library revealed that all the documented derivs. exhibit low or negligible affinity for the A2B receptor, thus highlighting the crit. importance of the substituent at position 4 of the 3,4-dihydropyrimidin-2(1H)-one chemotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLOsDwm-I-PrVg90H21EOLACvtfcHk0ljMBq0rBwyg_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmslSgtrw%253D&md5=948787c55c8244ca3a646b39b12a4a21</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2Fs10593-017-2054-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10593-017-2054-4%26sid%3Dliteratum%253Aachs%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DEl%2BMaatougui%26aufirst%3DA.%26aulast%3DAzuaje%26aufirst%3DJ.%26aulast%3DEscalante%26aufirst%3DL.%26aulast%3DMajellaro%26aufirst%3DM.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DGuti%25C3%25A9rrez-de-Ter%25C3%25A1n%26aufirst%3DH.%26aulast%3DSotelo%26aufirst%3DE.%26atitle%3DExploring%2520the%2520Influence%2520of%2520the%2520Substituent%2520at%2520Position%25204%2520in%2520a%2520Series%2520of%25203%252C4-Dihydropyrimidin-2%25281H%2529-One%2520A2B%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DChem.%2520Heterocycl.%2520Compd.%26date%3D2017%26volume%3D53%26spage%3D316%26epage%3D321%26doi%3D10.1007%2Fs10593-017-2054-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kappe, C. O.</span></span> <span> </span><span class="NLM_article-title">Biologically Active Dihydropyrimidones of the Biginelli-Type - A Literature Survey</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1043</span>– <span class="NLM_lpage">1052</span>, <span class="refDoi"> DOI: 10.1016/S0223-5234(00)01189-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2FS0223-5234%2800%2901189-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=11248403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD3MXoslWkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2000&pages=1043-1052&author=C.+O.+Kappe&title=Biologically+Active+Dihydropyrimidones+of+the+Biginelli-Type+-+A+Literature+Survey&doi=10.1016%2FS0223-5234%2800%2901189-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Biologically active dihydropyrimidones of the Biginelli-type - a literature survey</span></div><div class="casAuthors">Kappe, C. Oliver</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1043-1052</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">A review with 87 refs.  In 1893, the synthesis of functionalized 3,4-dihydropyrimidin-2(1H)-ones (DHPMs) via three-component condensation reaction of an arom. aldehyde, urea and Et acetoacetate was reported for the first time by P. Biginelli.  In the past decades, such Biginelli-type dihydropyrimidones have received a considerable amt. of attention due to the interesting pharmacol. properties assocd. with this heterocyclic scaffold.  In this review, the authors highlight recent developments in this area, with a focus on the DHPMs recently developed as calcium channel modulators, α1a adrenoceptor-selective antagonists and compds. that target the mitotic machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocADVMvZ6u9rVg90H21EOLACvtfcHk0ljMBq0rBwyg_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXoslWkuw%253D%253D&md5=38e006618f4645627b38b5e83ed524c0</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2800%2901189-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252800%252901189-2%26sid%3Dliteratum%253Aachs%26aulast%3DKappe%26aufirst%3DC.%2BO.%26atitle%3DBiologically%2520Active%2520Dihydropyrimidones%2520of%2520the%2520Biginelli-Type%2520-%2520A%2520Literature%2520Survey%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2000%26volume%3D35%26spage%3D1043%26epage%3D1052%26doi%3D10.1016%2FS0223-5234%2800%2901189-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kappe, C. O.</span></span> <span> </span><span class="NLM_article-title">Recent Advances in the Biginelli Dihydropyrimidine Synthesis. New Tricks from an Old Dog</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">879</span>– <span class="NLM_lpage">888</span>, <span class="refDoi"> DOI: 10.1021/ar000048h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar000048h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsl2js7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2000&pages=879-888&author=C.+O.+Kappe&title=Recent+Advances+in+the+Biginelli+Dihydropyrimidine+Synthesis.+New+Tricks+from+an+Old+Dog&doi=10.1021%2Far000048h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in the Biginelli Dihydropyrimidine Synthesis. New Tricks from an Old Dog</span></div><div class="casAuthors">Kappe, C. Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">879-888</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with over 69 refs.  In 1893, P. Biginelli reported the synthesis of functionalized 3,4-dihydropyrimidin-2(1H)-ones (DHPMs) via three-component condensation reaction of an arom. aldehyde, urea, and Et acetoacetate.  In the past decade, this long-neglected multicomponent reaction has experienced a remarkable revival, mainly due to the interesting pharmacol. properties assocd. with this dihydropyrimidine scaffold.  In this Account, the authors highlight recent developments in the Biginelli reaction in areas such as solid-phase synthesis, combinatorial chem., and natural product synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMb9JwrXTB3LVg90H21EOLACvtfcHk0lgJSEffHLO0Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsl2js7k%253D&md5=8a73a965ef7dba741a05ddb978d9c1f1</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Far000048h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far000048h%26sid%3Dliteratum%253Aachs%26aulast%3DKappe%26aufirst%3DC.%2BO.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Biginelli%2520Dihydropyrimidine%2520Synthesis.%2520New%2520Tricks%2520from%2520an%2520Old%2520Dog%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2000%26volume%3D33%26spage%3D879%26epage%3D888%26doi%3D10.1021%2Far000048h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bose, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatima, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mereyala, H. B.</span></span> <span> </span><span class="NLM_article-title">Green Chemistry Approaches to the Synthesis of 5-Alkoxycarbonyl-4-aryl-3,4- dihydropyrimidin-2(1H)-ones by a Three-Component Coupling of One-Pot Condensation Reaction: Comparison of Ethanol, Water, and Solvent-free Conditions</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">587</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.1021/jo0205199</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0205199" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD38Xps1aitbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=587-590&author=D.+S.+Boseauthor=L.+Fatimaauthor=H.+B.+Mereyala&title=Green+Chemistry+Approaches+to+the+Synthesis+of+5-Alkoxycarbonyl-4-aryl-3%2C4-+dihydropyrimidin-2%281H%29-ones+by+a+Three-Component+Coupling+of+One-Pot+Condensation+Reaction%3A+Comparison+of+Ethanol%2C+Water%2C+and+Solvent-free+Conditions&doi=10.1021%2Fjo0205199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Green Chemistry Approaches to the Synthesis of 5-Alkoxycarbonyl-4-aryl-3,4- dihydropyrimidin-2(1H)-ones by a Three-Component Coupling of One-Pot Condensation Reaction: Comparison of Ethanol, Water, and Solvent-free Conditions</span></div><div class="casAuthors">Bose, D. Subhas; Fatima, Liyakat; Mereyala, Hari Babu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">587-590</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A general and practical green chem. route to the Biginelli cyclocondensation reaction using cerium(III) chloride as the catalyst (25% mol) is described under three different sets of reaction conditions.  This method provides an efficient and much improved modification of original Biginelli reaction reported in 1893, in terms of high yields, short reaction times, and simple work-up procedure, and it has the ability to tolerate a wide variety of substitutions in all three components, which is lacking in existing procedures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu-JnE1yuEvrVg90H21EOLACvtfcHk0lgJSEffHLO0Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xps1aitbw%253D&md5=2dc1162363d5e2bee3384ab6a42331f1</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjo0205199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0205199%26sid%3Dliteratum%253Aachs%26aulast%3DBose%26aufirst%3DD.%2BS.%26aulast%3DFatima%26aufirst%3DL.%26aulast%3DMereyala%26aufirst%3DH.%2BB.%26atitle%3DGreen%2520Chemistry%2520Approaches%2520to%2520the%2520Synthesis%2520of%25205-Alkoxycarbonyl-4-aryl-3%252C4-%2520dihydropyrimidin-2%25281H%2529-ones%2520by%2520a%2520Three-Component%2520Coupling%2520of%2520One-Pot%2520Condensation%2520Reaction%253A%2520Comparison%2520of%2520Ethanol%252C%2520Water%252C%2520and%2520Solvent-free%2520Conditions%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D587%26epage%3D590%26doi%3D10.1021%2Fjo0205199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mobaraki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Movassagh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karimi, B.</span></span> <span> </span><span class="NLM_article-title">Hydrophobicity-Enhanced Magnetic Solid Sulfonic Acid: A Simple Approach to Improve the Mass Transfer of Reaction Partners on the Surface of the Heterogeneous Catalyst in Water-Generating Reactions</span>. <i>Appl. Catal., A</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>472</i></span>,  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1016/j.apcata.2013.12.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.apcata.2013.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVWntb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=472&publication_year=2014&pages=123-133&author=A.+Mobarakiauthor=B.+Movassaghauthor=B.+Karimi&title=Hydrophobicity-Enhanced+Magnetic+Solid+Sulfonic+Acid%3A+A+Simple+Approach+to+Improve+the+Mass+Transfer+of+Reaction+Partners+on+the+Surface+of+the+Heterogeneous+Catalyst+in+Water-Generating+Reactions&doi=10.1016%2Fj.apcata.2013.12.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrophobicity-enhanced magnetic solid sulfonic acid: A simple approach to improve the mass transfer of reaction partners on the surface of the heterogeneous catalyst in water-generating reactions</span></div><div class="casAuthors">Mobaraki, Akbar; Movassagh, Barahman; Karimi, Babak</div><div class="citationInfo"><span class="NLM_cas:title">Applied Catalysis, A: General</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">472</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">123-133</span>CODEN:
                <span class="NLM_cas:coden">ACAGE4</span>;
        ISSN:<span class="NLM_cas:issn">0926-860X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Two novel and environmentally benign organosulfonic acid-functionalized silica-coated magnetic nanoparticle catalysts 1 (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="dd9bb8ee92e99d8eb492ef">[email protected]</a>@Et-PhSO3H) and 2 (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="387e5d0b770c786b51770a">[email protected]</a>@Me&Et-PhSO3H) were prepd. and their surface hydrophobicity was assessed by esterification reaction of fatty alcs.  Also, their water-toleration in two water-generating reactions was studied, namely: synthesis of bis(indolyl)methane and the Biginelli reaction of benzaldehyde, Me acetoacetate, and urea under solvent-free conditions.  In these reactions, the catalyst 2 that was more hydrophobic and water-resistant showed higher catalytic activity and was characterized extensively by various techniques.  This catalyst was successfully used in the Biginelli reaction of a series of aldehydes, β-keto esters, and urea/thiourea for the synthesis of a diverse range of pharmacol. active 3,4-dihydropyrimidin-2-one/thione (DHPM) derivs.  The catalyst 2 was easily sepd. by an external magnet and the recovered catalyst was reused in five cycles without any significant loss of activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOC0bnGeJsW7Vg90H21EOLACvtfcHk0lgJSEffHLO0Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVWntb4%253D&md5=3b5599eba6fad503d6cc1c66941a28b8</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.apcata.2013.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apcata.2013.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DMobaraki%26aufirst%3DA.%26aulast%3DMovassagh%26aufirst%3DB.%26aulast%3DKarimi%26aufirst%3DB.%26atitle%3DHydrophobicity-Enhanced%2520Magnetic%2520Solid%2520Sulfonic%2520Acid%253A%2520A%2520Simple%2520Approach%2520to%2520Improve%2520the%2520Mass%2520Transfer%2520of%2520Reaction%2520Partners%2520on%2520the%2520Surface%2520of%2520the%2520Heterogeneous%2520Catalyst%2520in%2520Water-Generating%2520Reactions%26jtitle%3DAppl.%2520Catal.%252C%2520A%26date%3D2014%26volume%3D472%26spage%3D123%26epage%3D133%26doi%3D10.1016%2Fj.apcata.2013.12.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghasemi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farshbaf Orafa, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirouzmand, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikzad Kojanag, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salehi, R.</span></span> <span> </span><span class="NLM_article-title">Zn<sup>2+</sup>/MCM-41 Catalyzed Biginelli Reaction of Heteroaryl Aldehydes and Evaluation of the Antimicrobial Activity and Cytotoxicity of the Pyrimidone Products</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6393</span>– <span class="NLM_lpage">6396</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2015.09.143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.tetlet.2015.09.143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1GktL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=6393-6396&author=Z.+Ghasemiauthor=F.+Farshbaf+Orafaauthor=M.+Pirouzmandauthor=G.+Zarriniauthor=B.+Nikzad+Kojanagauthor=R.+Salehi&title=Zn2%2B%2FMCM-41+Catalyzed+Biginelli+Reaction+of+Heteroaryl+Aldehydes+and+Evaluation+of+the+Antimicrobial+Activity+and+Cytotoxicity+of+the+Pyrimidone+Products&doi=10.1016%2Fj.tetlet.2015.09.143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Zn2+/MCM-41 catalyzed Biginelli reaction of heteroaryl aldehydes and evaluation of the antimicrobial activity and cytotoxicity of the pyrimidone products</span></div><div class="casAuthors">Ghasemi, Zarrin; Farshbaf Orafa, Farzaneh; Pirouzmand, Mahtab; Zarrini, Gholamreza; Nikzad Kojanag, Behnaz; Salehi, Roya</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">6393-6396</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The three component Biginelli condensation of various aryl aldehydes, 1,3-dicarbonyls and urea was investigated in the presence of free or MCM-41 supported ZnNO3.  The pyrimidone products, which were obtained under solvent-free conditions, were evaluated for antibacterial and antifungal activities as well as their cytotoxicities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFpr6tUyt4o7Vg90H21EOLACvtfcHk0lj_bKjmEPoRdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1GktL7O&md5=45e18ecb134d303ec3ebac2e317fdc10</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2015.09.143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2015.09.143%26sid%3Dliteratum%253Aachs%26aulast%3DGhasemi%26aufirst%3DZ.%26aulast%3DFarshbaf%2BOrafa%26aufirst%3DF.%26aulast%3DPirouzmand%26aufirst%3DM.%26aulast%3DZarrini%26aufirst%3DG.%26aulast%3DNikzad%2BKojanag%26aufirst%3DB.%26aulast%3DSalehi%26aufirst%3DR.%26atitle%3DZn2%252B%252FMCM-41%2520Catalyzed%2520Biginelli%2520Reaction%2520of%2520Heteroaryl%2520Aldehydes%2520and%2520Evaluation%2520of%2520the%2520Antimicrobial%2520Activity%2520and%2520Cytotoxicity%2520of%2520the%2520Pyrimidone%2520Products%26jtitle%3DTetrahedron%2520Lett.%26date%3D2015%26volume%3D56%26spage%3D6393%26epage%3D6396%26doi%3D10.1016%2Fj.tetlet.2015.09.143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, S.</span>; <span class="NLM_string-name">Desai, R.</span></span> <span> </span><span class="NLM_article-title">Novel compounds for treatment of diabetes, obesity or related disorders</span>. <span class="NLM_patent">WO 2013102929 A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=S.+Agarwal&author=R.+Desai&title=Novel+compounds+for+treatment+of+diabetes%2C+obesity+or+related+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DS.%26atitle%3DNovel%2520compounds%2520for%2520treatment%2520of%2520diabetes%252C%2520obesity%2520or%2520related%2520disorders%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ali, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismail, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perveen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wadood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghufran, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, B.</span></span> <span> </span><span class="NLM_article-title">Dihydropyrimidones: As novel class of β-glucuronidase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3624</span>– <span class="NLM_lpage">3635</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.bmc.2016.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=27325448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVWntrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=3624-3635&author=F.+Aliauthor=K.+M.+Khanauthor=U.+Salarauthor=S.+Iqbalauthor=M.+Tahaauthor=N.+H.+Ismailauthor=S.+Perveenauthor=A.+Wadoodauthor=M.+Ghufranauthor=B.+Ali&title=Dihydropyrimidones%3A+As+novel+class+of+%CE%B2-glucuronidase+inhibitors&doi=10.1016%2Fj.bmc.2016.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydropyrimidones: As novel class of β-glucuronidase inhibitors</span></div><div class="casAuthors">Ali, Farman; Khan, Khalid Mohammed; Salar, Uzma; Iqbal, Sarosh; Taha, Muhammad; Ismail, Nor Hadiani; Perveen, Shahnaz; Wadood, Abdul; Ghufran, Mehreen; Ali, Basharat</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3624-3635</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dihydropyrimidones (I) (R1 = Et, n-Bu, iso-Bu, Ph; 2,5-, 2,3-, 3,4-MeC6H4; 2-FC6H5; 2,6-ClC6H4; 3-OHC6H4; 4-OH, -NO2, -iso-Pr, -Cl, -Br, -CF3, -OEt, -OMe -NMe2, -OMeC6H5; 2-Me,4-OBnC6H4; 3-Me,4-OBnC6H4; 2-furanylC6H5; 2-, 3-thiophenyl; 1-, 2-naphthylC6H5; etc.) were synthesized via a "one-pot" three component reaction according to well-known Biginelli reaction by utilizing Cu(NO3)2·3H2O as catalyst, and screened for their in vitro β-glucuronidase inhibitory activity.  Mol. docking study was conducted to establish the structure-activity relationship (SAR) which demonstrated that a no. of structural features of dihydropyrimidone derivs. were involved to exhibit the inhibitory potential.  All compds. were characterized by spectroscopic techniques such as 1H, 13C NMR, EIMS and HREI-MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKnZ3otU-MNLVg90H21EOLACvtfcHk0lgE6eYTJKQ07g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVWntrfK&md5=8c7f5cca34fe44f4d0f80443ac41174a</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DF.%26aulast%3DKhan%26aufirst%3DK.%2BM.%26aulast%3DSalar%26aufirst%3DU.%26aulast%3DIqbal%26aufirst%3DS.%26aulast%3DTaha%26aufirst%3DM.%26aulast%3DIsmail%26aufirst%3DN.%2BH.%26aulast%3DPerveen%26aufirst%3DS.%26aulast%3DWadood%26aufirst%3DA.%26aulast%3DGhufran%26aufirst%3DM.%26aulast%3DAli%26aufirst%3DB.%26atitle%3DDihydropyrimidones%253A%2520As%2520novel%2520class%2520of%2520%25CE%25B2-glucuronidase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D3624%26epage%3D3635%26doi%3D10.1016%2Fj.bmc.2016.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zabihollahi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fassihi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aghasadeghi, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Memarian, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soleimani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majidzadeh-A, K.</span></span> <span> </span><span class="NLM_article-title">Inhibitory Effect and Structure-Activity Relationship of Some Biginelli-Type Pyrimidines against HSV-1</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1270</span>– <span class="NLM_lpage">1276</span>, <span class="refDoi"> DOI: 10.1007/s00044-012-0123-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1007%2Fs00044-012-0123-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC38Xot12itLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=1270-1276&author=R.+Zabihollahiauthor=A.+Fassihiauthor=M.+R.+Aghasadeghiauthor=H.+R.+Memarianauthor=M.+Soleimaniauthor=K.+Majidzadeh-A&title=Inhibitory+Effect+and+Structure-Activity+Relationship+of+Some+Biginelli-Type+Pyrimidines+against+HSV-1&doi=10.1007%2Fs00044-012-0123-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effect and structure-activity relationship of some Biginelli-type pyrimidines against HSV-1</span></div><div class="casAuthors">Zabihollahi, Rezvan; Fassihi, Afshin; Aghasadeghi, Mohamad Reza; Memarian, Hamid Reza; Soleimani, Mohammad; Majidzadeh-A, Keivan</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1270-1276</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Boston</span>)
        </div><div class="casAbstract">Inevitable emergence of multi-drug resistant strains to current available drugs makes an impetus for finding new therapeutic agents against herpes simplex virus (HSV).  In this study, a series of novel derivs. of Biginelli-type pyrimidines were evaluated as potential anti-HSV-1 compds. by plaque redn. method.  The cellular toxicity was assessed by XTT proliferation assay.  The time course of anti-HSV activity of the most active compd. was studied to show the anti-viral effect in various intervals of replication cycle.  Compds. 2, 6, 8, 11, 12, 17, 18, 20, and 40 had the highest activity for inhibition of HSV.  Compd. 40 inhibited HSV replication with IC50 of 0.9 μmol/l and had CC50 of up to 100 μmol/l.  This compd. was a noteworthy inhibitor against HSV with TI value of 111.  Compd. 20 also showed considerable inhibitory activity with IC50 of 1.8 μmol/l.  Result of time-of-addn. study showed that compd. 40 inhibits HSV replication at a stage after entry of virions to the target cells.  Anal. of structure of the studied compds. demonstrated clear relationships with their anti-HSV effects.  Some of the compds. seem to be promising candidates for future anti-HSV drug discovery researches.  Structural manipulation based on the obtained structure-activity relationships would propose some new leads for anti-HSV drug discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmioKCovOGprVg90H21EOLACvtfcHk0lgE6eYTJKQ07g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xot12itLs%253D&md5=0e955d44b947fa37029df2bf8a8396bd</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1007%2Fs00044-012-0123-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-012-0123-x%26sid%3Dliteratum%253Aachs%26aulast%3DZabihollahi%26aufirst%3DR.%26aulast%3DFassihi%26aufirst%3DA.%26aulast%3DAghasadeghi%26aufirst%3DM.%2BR.%26aulast%3DMemarian%26aufirst%3DH.%2BR.%26aulast%3DSoleimani%26aufirst%3DM.%26aulast%3DMajidzadeh-A%26aufirst%3DK.%26atitle%3DInhibitory%2520Effect%2520and%2520Structure-Activity%2520Relationship%2520of%2520Some%2520Biginelli-Type%2520Pyrimidines%2520against%2520HSV-1%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2013%26volume%3D22%26spage%3D1270%26epage%3D1276%26doi%3D10.1007%2Fs00044-012-0123-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Fattah, A. A.</span></span> <span> </span><span class="NLM_article-title">Expedient Synthesis of Biginelli-Type Dihydropyrimidinones Using α-(Benzotriazolyl)alkyl Urea Derivatives</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_fpage">2358</span>– <span class="NLM_lpage">2362</span>, <span class="refDoi"> DOI: 10.1055/s-2003-42398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1055%2Fs-2003-42398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptFGgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=2358-2362&author=A.+A.+Abdel-Fattah&title=Expedient+Synthesis+of+Biginelli-Type+Dihydropyrimidinones+Using+%CE%B1-%28Benzotriazolyl%29alkyl+Urea+Derivatives&doi=10.1055%2Fs-2003-42398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Expedient synthesis of Biginelli-type dihydropyrimidinones using α-(benzotriazolyl)alkyl urea derivatives</span></div><div class="casAuthors">Abdel-fattah, Ashraf A. A.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2358-2362</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Reaction of readily available α-(benzotriazolyl)alkyl urea derivs. (derived from arom., heteroarom., and aliph. aldehydes) with β-keto esters resulted in 3,4-dihydropyrimidin-2(1H)-ones in good to excellent yields.  The intermediate α-(benzotriazolyl)alkyl urea derivs. act as masked acyliminium ions in the reaction with β-keto esters.  The Lewis acid used in these reactions was zinc bromide (ZnBr2).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre4dvLADYe0bVg90H21EOLACvtfcHk0lgE6eYTJKQ07g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptFGgsrk%253D&md5=a556829c0a6c78678fb190762c1a7f53</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1055%2Fs-2003-42398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2003-42398%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Fattah%26aufirst%3DA.%2BA.%26atitle%3DExpedient%2520Synthesis%2520of%2520Biginelli-Type%2520Dihydropyrimidinones%2520Using%2520%25CE%25B1-%2528Benzotriazolyl%2529alkyl%2520Urea%2520Derivatives%26jtitle%3DSynthesis%26date%3D2003%26spage%3D2358%26epage%3D2362%26doi%3D10.1055%2Fs-2003-42398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shamim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodhi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashraf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ul-Haq, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perveen, S.</span></span> <span> </span><span class="NLM_article-title">5-Acetyl-6-Methyl-4-Aryl-3,4-Dihydropyrimidin-2(1H)-Ones: As Potent Urease Inhibitors; Synthesis, in Vitro Screening, and Molecular Modeling Study</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2017.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.bioorg.2017.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=29125971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslygt7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2018&pages=37-52&author=S.+Shamimauthor=K.+M.+Khanauthor=U.+Salarauthor=F.+Aliauthor=M.+A.+Lodhiauthor=M.+Tahaauthor=F.+A.+Khanauthor=S.+Ashrafauthor=Z.+Ul-Haqauthor=M.+Aliauthor=S.+Perveen&title=5-Acetyl-6-Methyl-4-Aryl-3%2C4-Dihydropyrimidin-2%281H%29-Ones%3A+As+Potent+Urease+Inhibitors%3B+Synthesis%2C+in+Vitro+Screening%2C+and+Molecular+Modeling+Study&doi=10.1016%2Fj.bioorg.2017.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">5-Acetyl-6-methyl-4-aryl-3,4-dihydropyrimidin-2(1H)-ones: As potent urease inhibitors; synthesis, in vitro screening, and molecular modeling study</span></div><div class="casAuthors">Shamim, Shahbaz; Khan, Khalid Mohammed; Salar, Uzma; Ali, Farman; Lodhi, Muhammad Arif; Taha, Muhammad; Ali Khan, Farman; Ashraf, Sajda; Ul-Haq, Zaheer; Ali, Muhammad; Perveen, Shahnaz</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37-52</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">5-Acetyl-6-methyl-4-aryl-3,4-dihydropyrimidin-2(1H)-ones I [R = Ph, 2-HOC6H4, 2-MeOC6H4, etc.] were synthesized in a "one-pot" three component reaction and structurally characterized by various spectroscopic techniques such as 1H, 13C NMR, EI-MS, HREI-MS, and IR.  All compds. were evaluated for their in-vitro urease inhibitory activity.  It was worth mentioning that except derivs. I [R = Ph, 2,3-di-MeOC6H3, 2,5-di-MeOC6H3, 2,3,4-tri-MeOC6H2] all were found to be more potent than the std. thiourea (IC50 = 21.25 ± 0.15 μM) and showed their urease inhibitory potential in the range of IC50 = 3.70 ± 0.5-20.14 ± 0.1 μM.  Structure-activity relationship (SAR) was rationalized by looking at the varying structural features of the mols.  However, mol. modeling study was performed to confirm the binding interactions of the mols. (ligand) with the active site of enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraSjRExvB1xbVg90H21EOLACvtfcHk0lgE6eYTJKQ07g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslygt7fI&md5=e21c0698b2ea669739c5621a9a08be7e</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2017.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2017.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DShamim%26aufirst%3DS.%26aulast%3DKhan%26aufirst%3DK.%2BM.%26aulast%3DSalar%26aufirst%3DU.%26aulast%3DAli%26aufirst%3DF.%26aulast%3DLodhi%26aufirst%3DM.%2BA.%26aulast%3DTaha%26aufirst%3DM.%26aulast%3DKhan%26aufirst%3DF.%2BA.%26aulast%3DAshraf%26aufirst%3DS.%26aulast%3DUl-Haq%26aufirst%3DZ.%26aulast%3DAli%26aufirst%3DM.%26aulast%3DPerveen%26aufirst%3DS.%26atitle%3D5-Acetyl-6-Methyl-4-Aryl-3%252C4-Dihydropyrimidin-2%25281H%2529-Ones%253A%2520As%2520Potent%2520Urease%2520Inhibitors%253B%2520Synthesis%252C%2520in%2520Vitro%2520Screening%252C%2520and%2520Molecular%2520Modeling%2520Study%26jtitle%3DBioorg.%2520Chem.%26date%3D2018%26volume%3D76%26spage%3D37%26epage%3D52%26doi%3D10.1016%2Fj.bioorg.2017.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lacotte, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buisson, D.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambroise, Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis, Evaluation and Absolute Configuration Assignment of Novel Dihydropyrimidin-2-Ones as Picomolar Sodium Iodide Symporter Inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">722</span>– <span class="NLM_lpage">727</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.01.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.ejmech.2013.01.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=23454514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlslSrt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=722-727&author=P.+Lacotteauthor=D.-A.+Buissonauthor=Y.+Ambroise&title=Synthesis%2C+Evaluation+and+Absolute+Configuration+Assignment+of+Novel+Dihydropyrimidin-2-Ones+as+Picomolar+Sodium+Iodide+Symporter+Inhibitors&doi=10.1016%2Fj.ejmech.2013.01.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, evaluation and absolute configuration assignment of novel dihydropyrimidin-2-ones as picomolar sodium iodide symporter inhibitors</span></div><div class="casAuthors">Lacotte, Pierre; Buisson, David-Alexandre; Ambroise, Yves</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">722-727</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A small library of dihydropyrimidin-2-ones (DHPMs) was synthesized and evaluated for their potency to block iodide entrapment in rat thyroid cells.  Synthesis was achieved using the multicomponent Biginelli reaction.  Twelve compds. were tested for the inhibition of sodium iodide symporter (NIS) in a cell-based assay.  One newly synthesized deriv. (I) exhibited a remarkably strong activity, with a half-max. inhibitory concn. value (IC50) of 65 pM.  Three DHPMs were further resolved from racemates using chiral HPLC and abs. configurations were assigned using CD spectroscopy.  Biol. evaluation showed that most of the activity against NIS resides in one enantiomer.  This study provides new insights for the development of anti-thyroid drugs, as well as for the synthesis of novel pharmacol. tools designed to investigate iodide transport mechanisms at cellular and mol. levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGEVLyOhgcmrVg90H21EOLACvtfcHk0lgKeELbmlwENA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlslSrt7k%253D&md5=9bf64392760b5262e515be8d2438227f</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.01.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.01.043%26sid%3Dliteratum%253Aachs%26aulast%3DLacotte%26aufirst%3DP.%26aulast%3DBuisson%26aufirst%3DD.-A.%26aulast%3DAmbroise%26aufirst%3DY.%26atitle%3DSynthesis%252C%2520Evaluation%2520and%2520Absolute%2520Configuration%2520Assignment%2520of%2520Novel%2520Dihydropyrimidin-2-Ones%2520as%2520Picomolar%2520Sodium%2520Iodide%2520Symporter%2520Inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D62%26spage%3D722%26epage%3D727%26doi%3D10.1016%2Fj.ejmech.2013.01.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uray, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdino, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belaj, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappe, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabian, W. M. F.</span></span> <span> </span><span class="NLM_article-title">Absolute Configuration in 4-Alkyl- and 4-Aryl-3,4-Dihydro-2(1H)-Pyrimidones: A Combined Theoretical and Experimental Investigation</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">6685</span>– <span class="NLM_lpage">6694</span>, <span class="refDoi"> DOI: 10.1021/jo010491l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo010491l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtlWgt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=6685-6694&author=G.+Urayauthor=P.+Verdinoauthor=F.+Belajauthor=C.+O.+Kappeauthor=W.+M.+F.+Fabian&title=Absolute+Configuration+in+4-Alkyl-+and+4-Aryl-3%2C4-Dihydro-2%281H%29-Pyrimidones%3A+A+Combined+Theoretical+and+Experimental+Investigation&doi=10.1021%2Fjo010491l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Absolute Configuration in 4-Alkyl- and 4-Aryl-3,4-dihydro-2(1H)-pyrimidones: A Combined Theoretical and Experimental Investigation</span></div><div class="casAuthors">Uray, Georg; Verdino, Petra; Belaj, Ferdinand; Kappe, C. Oliver; Fabian, Walter M. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6685-6694</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structural features (orientation of the carboxyl group, ring puckering), electronic absorption, and CD spectra of 4-alkyl- and 4-aryl-dihydropyrimidones are calcd. by semiempirical (AM1, INDO/S), ab initio (HF/6-31G*, CIS/6-31G*, RPA/6-31G*), and d. functional theory (B3LYP/6-31G*) methods.  These calcns. allow an assignment of the abs. configuration by comparison of simulated and exptl. CD spectra.  Although the ab initio methods greatly overestimate electronic transition energies, the general appearance of the exptl. CD spectra is quite nicely reproduced by these calcns. Thus, comparison of exptl. with calcd. CD spectra is a reliable tool for the assignment of the abs. configuration.  For 4-Me derivs. I (R=H,Me) , the first enantiopure DHPM examples with no addnl. arom. substituent, the stereochem. at C4 provided by the theor. results is confirmed by X-ray structure detn. of the diastereomeric salt II.  Addnl. support is the consistent HPLC elution order found for all investigated DHPMs on a cellulose-derived chiral stationary phase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwGwDyuvdNlbVg90H21EOLACvtfcHk0lgKeELbmlwENA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtlWgt78%253D&md5=31873cfc1d2eb8dcee41ac7ce9ed3997</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjo010491l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo010491l%26sid%3Dliteratum%253Aachs%26aulast%3DUray%26aufirst%3DG.%26aulast%3DVerdino%26aufirst%3DP.%26aulast%3DBelaj%26aufirst%3DF.%26aulast%3DKappe%26aufirst%3DC.%2BO.%26aulast%3DFabian%26aufirst%3DW.%2BM.%2BF.%26atitle%3DAbsolute%2520Configuration%2520in%25204-Alkyl-%2520and%25204-Aryl-3%252C4-Dihydro-2%25281H%2529-Pyrimidones%253A%2520A%2520Combined%2520Theoretical%2520and%2520Experimental%2520Investigation%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D6685%26epage%3D6694%26doi%3D10.1021%2Fjo010491l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krenn, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdino, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uray, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faber, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappe, C. O.</span></span> <span> </span><span class="NLM_article-title">Determination of Absolute Configuration in 4-aryl-3,4-dihydro-2(1H)-pyrimidones by High Performance Liquid Chromatography and CD Spectroscopy</span>. <i>Chirality</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">662</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1520-636X(1999)11:8<659::AID-CHIR8>3.0.CO;2-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1002%2F%28SICI%291520-636X%281999%2911%3A8%3C659%3A%3AAID-CHIR8%3E3.0.CO%3B2-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10467318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADyaK1MXmt1Gltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1999&pages=659-662&author=W.+Krennauthor=P.+Verdinoauthor=G.+Urayauthor=K.+Faberauthor=C.+O.+Kappe&title=Determination+of+Absolute+Configuration+in+4-aryl-3%2C4-dihydro-2%281H%29-pyrimidones+by+High+Performance+Liquid+Chromatography+and+CD+Spectroscopy&doi=10.1002%2F%28SICI%291520-636X%281999%2911%3A8%3C659%3A%3AAID-CHIR8%3E3.0.CO%3B2-V"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and reactions of Biginelli compounds. Part 15. Determination of absolute configuration in 4-aryl-3,4-dihydro-2(1H)-pyrimidones by high performance liquid chromatography and CD spectroscopy</span></div><div class="casAuthors">Krenn, Wolfram; Verdino, Petra; Uray, Georg; Faber, Kurt; Kappe, C. Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Chirality</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">659-662</span>CODEN:
                <span class="NLM_cas:coden">CHRLEP</span>;
        ISSN:<span class="NLM_cas:issn">0899-0042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The abs. configuration of three 4-aryl-3,4-dihydro-2(1H)-pyrimidones (Biginelli compds., DHPMs) was established by comparison of the typical CD spectra of individual enantiomers with ref. samples of known abs. configuration.  The enantiomers were obtained by semipreparative sepn. of racemic mixts. on a Chiralcel OD-H chiral stationary phase.  The method was used to establish the enantiopreference of various lipases in biocatalytic kinetic resoln. expts. employing activated DHPM esters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRexuWgQqobrVg90H21EOLACvtfcHk0lgKeELbmlwENA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmt1Gltrw%253D&md5=208693af983fa0f8cee2b018c79d78c5</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291520-636X%281999%2911%3A8%3C659%3A%3AAID-CHIR8%3E3.0.CO%3B2-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291520-636X%25281999%252911%253A8%253C659%253A%253AAID-CHIR8%253E3.0.CO%253B2-V%26sid%3Dliteratum%253Aachs%26aulast%3DKrenn%26aufirst%3DW.%26aulast%3DVerdino%26aufirst%3DP.%26aulast%3DUray%26aufirst%3DG.%26aulast%3DFaber%26aufirst%3DK.%26aulast%3DKappe%26aufirst%3DC.%2BO.%26atitle%3DDetermination%2520of%2520Absolute%2520Configuration%2520in%25204-aryl-3%252C4-dihydro-2%25281H%2529-pyrimidones%2520by%2520High%2520Performance%2520Liquid%2520Chromatography%2520and%2520CD%2520Spectroscopy%26jtitle%3DChirality%26date%3D1999%26volume%3D11%26spage%3D659%26epage%3D662%26doi%3D10.1002%2F%28SICI%291520-636X%281999%2911%3A8%3C659%3A%3AAID-CHIR8%3E3.0.CO%3B2-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crespo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Maatougui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biagini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azuaje, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadavid, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Mera, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez-de-Terán, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotelo, E.</span></span> <span> </span><span class="NLM_article-title">Discovery of 3,4-Dihydropyrimidin-2(1H)-ones As a Novel Class of Potent and Selective A2B Adenosine Receptor Antagonists</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1031</span>– <span class="NLM_lpage">1036</span>, <span class="refDoi"> DOI: 10.1021/ml400185v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400185v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKks77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1031-1036&author=A.+Crespoauthor=A.+El+Maatouguiauthor=P.+Biaginiauthor=J.+Azuajeauthor=A.+Coelhoauthor=J.+Breaauthor=M.+I.+Lozaauthor=M.+I.+Cadavidauthor=X.+Garc%C3%ADa-Meraauthor=H.+Guti%C3%A9rrez-de-Ter%C3%A1nauthor=E.+Sotelo&title=Discovery+of+3%2C4-Dihydropyrimidin-2%281H%29-ones+As+a+Novel+Class+of+Potent+and+Selective+A2B+Adenosine+Receptor+Antagonists&doi=10.1021%2Fml400185v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 3,4-Dihydropyrimidin-2(1H)-ones As a Novel Class of Potent and Selective A2B Adenosine Receptor Antagonists</span></div><div class="casAuthors">Crespo, Abel; El Maatougui, Abdelaziz; Biagini, Pierfrancesco; Azuaje, Jhonny; Coelho, Alberto; Brea, Jose; Loza, Maria Isabel; Cadavid, Maria Isabel; Garcia-Mera, Xerardo; Gutierrez-de-Teran, Hugo; Sotelo, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1031-1036</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe the discovery and optimization of 3,4-dihydropyrimidin-2-(1H)-ones as a novel family of (nonxanthine) A2B receptor antagonists that exhibit an unusually high selectivity profile.  The Biginelli-based hit optimization process enabled a thoughtful exploration of the structure-activity and structure-selectivity relationships for this chemotype, enabling the identification of ligands that combine structural simplicity with excellent hA2B AdoR affinity and remarkable selectivity profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcmq93mYNjxrVg90H21EOLACvtfcHk0lifK2f-OuBcMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKks77J&md5=41f5ce37315529b35115ef6ec3cccba5</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fml400185v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400185v%26sid%3Dliteratum%253Aachs%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DEl%2BMaatougui%26aufirst%3DA.%26aulast%3DBiagini%26aufirst%3DP.%26aulast%3DAzuaje%26aufirst%3DJ.%26aulast%3DCoelho%26aufirst%3DA.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DGarc%25C3%25ADa-Mera%26aufirst%3DX.%26aulast%3DGuti%25C3%25A9rrez-de-Ter%25C3%25A1n%26aufirst%3DH.%26aulast%3DSotelo%26aufirst%3DE.%26atitle%3DDiscovery%2520of%25203%252C4-Dihydropyrimidin-2%25281H%2529-ones%2520As%2520a%2520Novel%2520Class%2520of%2520Potent%2520and%2520Selective%2520A2B%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1031%26epage%3D1036%26doi%3D10.1021%2Fml400185v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chubukov, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitman, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structural Basis for Allosteric Regulation of GPCRS by Sodium Ions</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>337</i></span>,  <span class="NLM_fpage">232</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1126/science.1219218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1126%2Fscience.1219218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=22798613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVKqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=2012&pages=232-236&author=W.+Liuauthor=E.+Chunauthor=A.+A.+Thompsonauthor=P.+Chubukovauthor=F.+Xuauthor=V.+Katritchauthor=G.+W.+Hanauthor=C.+B.+Rothauthor=L.+H.+Heitmanauthor=A.+P.+Ijzermanauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structural+Basis+for+Allosteric+Regulation+of+GPCRS+by+Sodium+Ions&doi=10.1126%2Fscience.1219218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions</span></div><div class="casAuthors">Liu, Wei; Chun, Eugene; Thompson, Aaron A.; Chubukov, Pavel; Xu, Fei; Katritch, Vsevolod; Han, Gye Won; Roth, Christopher B.; Heitman, Laura H.; IJzerman, Adriaan P.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">337</span>
        (<span class="NLM_cas:issue">6091</span>),
    <span class="NLM_cas:pages">232-236</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Pharmacol. responses of G protein-coupled receptors (GPCRs) can be fine-tuned by allosteric modulators.  Structural studies of such effects have been limited due to the medium resoln. of GPCR structures.  We reengineered the human A2A adenosine receptor by replacing its third intracellular loop with apocytochrome b562RIL and solved the structure at 1.8 angstrom resoln.  The high-resoln. structure allowed us to identify 57 ordered water mols. inside the receptor comprising three major clusters.  The central cluster harbors a putative sodium ion bound to the highly conserved aspartate residue Asp2.50.  Addnl., two cholesterols stabilize the conformation of helix VI, and one of 23 ordered lipids intercalates inside the ligand-binding pocket.  These high-resoln. details shed light on the potential role of structured water mols., sodium ions, and lipids/cholesterol in GPCR stabilization and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvcjQimGnIMLVg90H21EOLACvtfcHk0lifK2f-OuBcMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVKqtbs%253D&md5=782b2235b76ef77b11b6456f8e4485e1</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1126%2Fscience.1219218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1219218%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DChun%26aufirst%3DE.%26aulast%3DThompson%26aufirst%3DA.%2BA.%26aulast%3DChubukov%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DF.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DRoth%26aufirst%3DC.%2BB.%26aulast%3DHeitman%26aufirst%3DL.%2BH.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructural%2520Basis%2520for%2520Allosteric%2520Regulation%2520of%2520GPCRS%2520by%2520Sodium%2520Ions%26jtitle%3DScience%26date%3D2012%26volume%3D337%26spage%3D232%26epage%3D236%26doi%3D10.1126%2Fscience.1219218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaakola, V.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, E. Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">The 2.6 Å Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>322</i></span>,  <span class="NLM_fpage">1211</span>– <span class="NLM_lpage">1217</span>, <span class="refDoi"> DOI: 10.1126/science.1164772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1126%2Fscience.1164772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=18832607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlyqtbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2008&pages=1211-1217&author=V.-P.+Jaakolaauthor=M.+T.+Griffithauthor=M.+A.+Hansonauthor=V.+Cherezovauthor=E.+Y.+T.+Chienauthor=J.+R.+Laneauthor=A.+P.+Ijzermanauthor=R.+C.+Stevens&title=The+2.6+%C3%85+Crystal+Structure+of+a+Human+A2A+Adenosine+Receptor+Bound+to+an+Antagonist&doi=10.1126%2Fscience.1164772"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist</span></div><div class="casAuthors">Jaakola, Veli-Pekka; Griffith, Mark T.; Hanson, Michael A.; Cherezov, Vadim; Chien, Ellen Y. T.; Lane, J. Robert; IJzerman, Adriaan P.; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">5905</span>),
    <span class="NLM_cas:pages">1211-1217</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The adenosine class of heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) mediates the important role of extracellular adenosine in many physiol. processes and is antagonized by caffeine.  The authors have detd. the crystal structure of the human A2A adenosine receptor, in complex with a high-affinity subtype-selective antagonist, ZM241385, to 2.6 angstrom resoln.  Four disulfide bridges in the extracellular domain, combined with a subtle repacking of the transmembrane helixes relative to the adrenergic and rhodopsin receptor structures, define a pocket distinct from that of other structurally detd. GPCRs.  The arrangement allows for the binding of the antagonist in an extended conformation, perpendicular to the membrane plane.  The binding site highlights an integral role for the extracellular loops, together with the helical core, in ligand recognition by this class of GPCRs and suggests a role for ZM241385 in restricting the movement of a tryptophan residue important in the activation mechanism of the class A receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7QL4wN4TdhrVg90H21EOLACvtfcHk0lifK2f-OuBcMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlyqtbfN&md5=5bdb862b41f345c244f3c162e058206b</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1126%2Fscience.1164772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1164772%26sid%3Dliteratum%253Aachs%26aulast%3DJaakola%26aufirst%3DV.-P.%26aulast%3DGriffith%26aufirst%3DM.%2BT.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DChien%26aufirst%3DE.%2BY.%2BT.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DThe%25202.6%2520%25C3%2585%2520Crystal%2520Structure%2520of%2520a%2520Human%2520A2A%2520Adenosine%2520Receptor%2520Bound%2520to%2520an%2520Antagonist%26jtitle%3DScience%26date%3D2008%26volume%3D322%26spage%3D1211%26epage%3D1217%26doi%3D10.1126%2Fscience.1164772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bortolato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tehan, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodnarchuk, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Essex, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, J. S.</span></span> <span> </span><span class="NLM_article-title">Water Network Perturbation in Ligand Binding: Adenosine A2A Antagonists as a Case Study</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">1700</span>– <span class="NLM_lpage">1713</span>, <span class="refDoi"> DOI: 10.1021/ci4001458</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci4001458" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosFymsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=1700-1713&author=A.+Bortolatoauthor=B.+G.+Tehanauthor=M.+S.+Bodnarchukauthor=J.+W.+Essexauthor=J.+S.+Mason&title=Water+Network+Perturbation+in+Ligand+Binding%3A+Adenosine+A2A+Antagonists+as+a+Case+Study&doi=10.1021%2Fci4001458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Water Network Perturbation in Ligand Binding: Adenosine A2A Antagonists as a Case Study</span></div><div class="casAuthors">Bortolato, Andrea; Tehan, Ben G.; Bodnarchuk, Michael S.; Essex, Jonathan W.; Mason, Jonathan S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1700-1713</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent efforts in the computational evaluation of the thermodn. properties of water mols. have resulted in the development of promising new in silico methods to evaluate the role of water in ligand binding.  These methods include WaterMap, SZMAP, GRID/CRY probe, and Grand Canonical Monte Carlo simulations.  They allow the prediction of the position and relative free energy of the water mol. in the protein active site and the anal. of the perturbation of an explicit water network (WNP) as a consequence of ligand binding.  We have for the first time extended these approaches toward the prediction of kinetics for small mols. and of relative free energy of binding with a focus on the perturbation of the water network and application to large diverse data sets.  Our results support a qual. correlation between the residence time of 12 related triazine adenosine A2A receptor antagonists and the no. and position of high energy trapped solvent mols.  From a quant. viewpoint, we successfully applied these computational techniques as an implicit solvent alternative, in linear combination with a mol. mechanics force field, to predict the relative ligand free energy of binding (WNP-MMSA).  The applicability of this linear method, based on the thermodn. additivity principle, did not extend to 375 diverse A2A receptor antagonists.  However, a fast but effective method could be enabled by replacing the linear approach with a machine learning technique using probabilistic classification trees, which classified the binding affinity correctly for 90% of the ligands in the training set and 67% in the test set.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8qdbPGtMIB7Vg90H21EOLACvtfcHk0lhAjyNiAvpJWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosFymsb4%253D&md5=e267cf2a427da3b0bb45e2f61510cdd5</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fci4001458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci4001458%26sid%3Dliteratum%253Aachs%26aulast%3DBortolato%26aufirst%3DA.%26aulast%3DTehan%26aufirst%3DB.%2BG.%26aulast%3DBodnarchuk%26aufirst%3DM.%2BS.%26aulast%3DEssex%26aufirst%3DJ.%2BW.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26atitle%3DWater%2520Network%2520Perturbation%2520in%2520Ligand%2520Binding%253A%2520Adenosine%2520A2A%2520Antagonists%2520as%2520a%2520Case%2520Study%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2013%26volume%3D53%26spage%3D1700%26epage%3D1713%26doi%3D10.1021%2Fci4001458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nayadu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behera, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudi, G.</span></span> <span> </span><span class="NLM_article-title">Fluorescent Probe Based CYP Inhibition Assay: A High Throughput Tool for Early Drug Discovery Screening</span>. <i>Int. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslagurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=303-307&author=S.+Nayaduauthor=D.+Beheraauthor=M.+Sharmaauthor=G.+Kaurauthor=G.+Gudi&title=Fluorescent+Probe+Based+CYP+Inhibition+Assay%3A+A+High+Throughput+Tool+for+Early+Drug+Discovery+Screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescent probe based CYP inhibition assay: a high throughput tool for early drug discovery screening</span></div><div class="casAuthors">Nayadu, Sneha; Behera, Dayanidhi; Sharma, Mansi; Kaur, Ginpreet; Gudi, Girish</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmacy and Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">303-307</span>CODEN:
                <span class="NLM_cas:coden">IJPPKB</span>;
        ISSN:<span class="NLM_cas:issn">0975-1491</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Pharmacy and Pharmaceutical Sciences</span>)
        </div><div class="casAbstract">Inhibition of cytochrome P 450 (CYP450) enzymes can result in potential clin. drug-drug interaction liabilities.  Because of the safety and economic concern leading to clin. failure or product withdrawal, screening of lead mols. for CYP450 inhibition potential is nowadays conducted much earlier in the drug development process.  At this early phase, a large no. of lead mols. are in need of evaluation.  Thus, safety, economic and throughput pressures have forced the development of assays that are rapid throughput but have high predictive value.  Fluorometric assays using recombinant human enzymes are ideally suited for this purpose.  Objective: This study was mainly designed with an objective to address the reliability of fluorogenic probes for CYP450 inhibition studies.  Methods: Individual cDNA-expressed CYP isoforms (1A2, 2D6, 3A4, 2C9 and 2C19) were applied to microtitre plate assays.  Std. inhibitors were co-incubated with fluorogenic substrates and their inhibitory potential (IC50) was detd.  Assay conditions in terms of CYP450 protein concn. and time of incubation were standardized, enzyme kinetics parameters of each fluorescent probe substrate were estd. and IC50 values of inhibitors were detd. and validated on different days to check reproducibility.  Results: The fluorescent probe based CYP Inhibition assay methods were found to be robust, efficient and highly reproducible.  Conclusion: These assays can be quite useful in preliminary high throughput screening of inhibitory potential of new drugs on individual P 450 enzymes and predicting clin. drug-drug interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4zlZRgoFis7Vg90H21EOLACvtfcHk0lhAjyNiAvpJWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslagurc%253D&md5=db0b6673e10320c6280f099c46e17072</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNayadu%26aufirst%3DS.%26aulast%3DBehera%26aufirst%3DD.%26aulast%3DSharma%26aufirst%3DM.%26aulast%3DKaur%26aufirst%3DG.%26aulast%3DGudi%26aufirst%3DG.%26atitle%3DFluorescent%2520Probe%2520Based%2520CYP%2520Inhibition%2520Assay%253A%2520A%2520High%2520Throughput%2520Tool%2520for%2520Early%2520Drug%2520Discovery%2520Screening%26jtitle%3DInt.%2520J.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D5%26spage%3D303%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDonnell, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, C. H.</span></span> <span> </span><span class="NLM_article-title">Basic Review of the Cytochrome P450 System</span>. <i>J. Adv. Pract. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.6004/jadpro.2013.4.4.7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.6004%2Fjadpro.2013.4.4.7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=25032007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A280%3ADC%252BC2cbjt1Wqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=263-268&author=A.+M.+McDonnellauthor=C.+H.+Dang&title=Basic+Review+of+the+Cytochrome+P450+System&doi=10.6004%2Fjadpro.2013.4.4.7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Basic review of the cytochrome p450 system</span></div><div class="casAuthors">McDonnell Anne M; Dang Cathyyen H</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the advanced practitioner in oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">263-8</span>
        ISSN:<span class="NLM_cas:issn">2150-0878</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTPX9EKZsk_ONyzdcP07UmufW6udTcc2eaeIVNn5Xoe5bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbjt1Wqsg%253D%253D&md5=92d64b3dfd3ec33f8492c1087cb85efd</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.6004%2Fjadpro.2013.4.4.7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.6004%252Fjadpro.2013.4.4.7%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonnell%26aufirst%3DA.%2BM.%26aulast%3DDang%26aufirst%3DC.%2BH.%26atitle%3DBasic%2520Review%2520of%2520the%2520Cytochrome%2520P450%2520System%26jtitle%3DJ.%2520Adv.%2520Pract.%2520Oncol.%26date%3D2013%26volume%3D4%26spage%3D263%26epage%3D268%26doi%3D10.6004%2Fjadpro.2013.4.4.7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egli, M.</span></span> <span> </span><span class="NLM_article-title">Recent Structural Insights into Cytochrome P450 Function</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">625</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2016.05.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.tips.2016.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=27267697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC28XosFSru7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2016&pages=625-640&author=F.+P.+Guengerichauthor=M.+R.+Watermanauthor=M.+Egli&title=Recent+Structural+Insights+into+Cytochrome+P450+Function&doi=10.1016%2Fj.tips.2016.05.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Structural Insights into Cytochrome P450 Function</span></div><div class="casAuthors">Guengerich, F. Peter; Waterman, Michael R.; Egli, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">625-640</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Cytochrome P 450 (P 450) enzymes are important in the metab. of drugs, steroids, fat-sol. vitamins, carcinogens, pesticides, and many other types of chems.  Their catalytic activities are important issues in areas such as drug-drug interactions and endocrine function.  During the past 30 years, structures of P450s have been very helpful in understanding function, particularly the mammalian P 450 structures available in the past 15 years.  We review recent activity in this area, focusing on the past 2 years (2014-2015).  Structural work with microbial P450s includes studies related to the biosynthesis of natural products and the use of parasitic and fungal P 450 structures as targets for drug discovery.  Studies on mammalian P450s include the utilization of information about 'drug-metabolizing' P450s to improve drug development and also to understand the mol. bases of endocrine dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAxcKiFmaVzrVg90H21EOLACvtfcHk0liXeyHAyMVi5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosFSru7Y%253D&md5=313a43149c12b6fb2e7c0a0ea6f2919e</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2016.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2016.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26aulast%3DWaterman%26aufirst%3DM.%2BR.%26aulast%3DEgli%26aufirst%3DM.%26atitle%3DRecent%2520Structural%2520Insights%2520into%2520Cytochrome%2520P450%2520Function%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2016%26volume%3D37%26spage%3D625%26epage%3D640%26doi%3D10.1016%2Fj.tips.2016.05.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P450 and Chemical Toxicology</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1021/tx700079z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx700079z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlynurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=70-83&author=F.+P.+Guengerich&title=Cytochrome+P450+and+Chemical+Toxicology&doi=10.1021%2Ftx700079z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450 and Chemical Toxicology</span></div><div class="casAuthors">Guengerich, F. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-83</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The field of cytochrome P 450 (P 450) research has developed considerably over the past 20 years, and many important papers on the roles of P450s in chem. toxicol. have appeared in Chem. Research in Toxicol.  Today, our basic understanding of many of the human P450s is relatively well-established, in terms of the details of the individual genes, sequences, and basic catalytic mechanisms.  Crystal structures of several of the major human P450s are now in hand.  The animal P450s are still important in the context of metab. and safety testing.  Many well-defined examples exist for roles of P450s in decreasing the adverse effects of drugs through biotransformation, and an equally interesting field of investigation is the bioactivation of chems., including drugs.  Unresolved problems include the characterization of the minor "orphan" P450s, ligand cooperativity and kinetic complexity of several P450s, the prediction of metab., the overall contribution of bioactivation to drug idiosyncratic problems, the extrapolation of animal test results to humans in drug development, and the contribution of genetic variation in human P450s to cancer incidence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQnvzpBM_I4LVg90H21EOLACvtfcHk0liXeyHAyMVi5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlynurbF&md5=444b8d63bf07dc2449af6413fa7fff00</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Ftx700079z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx700079z%26sid%3Dliteratum%253Aachs%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DCytochrome%2520P450%2520and%2520Chemical%2520Toxicology%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D70%26epage%3D83%26doi%3D10.1021%2Ftx700079z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Virtanen, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukkonen-Macchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vainio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Härkönen, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalkanen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yegutkin, G. G.</span></span> <span> </span><span class="NLM_article-title">Adenosine Inhibits Tumor Cell Invasion via Receptor-Independent Mechanisms</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1863</span>– <span class="NLM_lpage">1874</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-14-0302-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1158%2F1541-7786.MCR-14-0302-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=25080434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFSitLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=1863-1874&author=S.+S.+Virtanenauthor=A.+Kukkonen-Macchiauthor=M.+Vainioauthor=K.+Elimaauthor=P.+L.+H%C3%A4rk%C3%B6nenauthor=S.+Jalkanenauthor=G.+G.+Yegutkin&title=Adenosine+Inhibits+Tumor+Cell+Invasion+via+Receptor-Independent+Mechanisms&doi=10.1158%2F1541-7786.MCR-14-0302-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine Inhibits Tumor Cell Invasion via Receptor-Independent Mechanisms</span></div><div class="casAuthors">Virtanen, Sanna S.; Kukkonen-Macchi, Anu; Vainio, Minna; Elima, Kati; Haerkoenen, Pirkko L.; Jalkanen, Sirpa; Yegutkin, Gennady G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1863-1874</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Extracellular adenosine mediates diverse anti-inflammatory, angiogenic, and other signaling effects via binding to adenosine receptors, and it also regulates cell proliferation and death via activation of the intrinsic signaling pathways.  Given the emerging role of adenosine and other purines in tumor growth and metastasis, this study evaluated the effects of adenosine on the invasion of metastatic prostate and breast cancer cells.  Treatment with low micromolar concns. of adenosine, but not other nucleosides or adenosine receptor agonists, inhibited subsequent cell invasion and migration through Matrigel- and laminin-coated inserts.  These inhibitory effects occurred via intrinsic receptor-independent mechanisms, despite the abundant expression of A2B adenosine receptors (ADORA2B).  Extracellular nucleotides and adenosine were shown to be rapidly metabolized on tumor cell surfaces via sequential ecto-5'-nucleotidase (CD73/NT5E) and adenosine deaminase reactions with subsequent cellular uptake of nucleoside metabolites and their intracellular interconversion into ADP/ATP.  This was accompanied by concurrent inhibition of AMP-activated protein kinase and other signaling pathways.  No differences in the proliferation rates, cytoskeleton assembly, expression of major adhesion mols. [integrin-1β (ITGB1), CD44, focal adhesion kinase], and secretion of matrix metalloproteinases were detected between the control and treated cells, thus excluding the contribution of these components of invasion cascade to the inhibitory effects of adenosine.  These data provide a novel insight into the ability of adenosine to dampen immune responses and prevent tumor invasion via two different, adenosine receptor-dependent and -independent mechanisms.  Implications: This study suggests that the combined targeting of adenosine receptors and modulation of intracellular purine levels can affect tumor growth and metastasis phenotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5R7siQLWZJ7Vg90H21EOLACvtfcHk0liXeyHAyMVi5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFSitLfI&md5=807b7cab8b9d00e5bb3486cb61583565</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-14-0302-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-14-0302-T%26sid%3Dliteratum%253Aachs%26aulast%3DVirtanen%26aufirst%3DS.%2BS.%26aulast%3DKukkonen-Macchi%26aufirst%3DA.%26aulast%3DVainio%26aufirst%3DM.%26aulast%3DElima%26aufirst%3DK.%26aulast%3DH%25C3%25A4rk%25C3%25B6nen%26aufirst%3DP.%2BL.%26aulast%3DJalkanen%26aufirst%3DS.%26aulast%3DYegutkin%26aufirst%3DG.%2BG.%26atitle%3DAdenosine%2520Inhibits%2520Tumor%2520Cell%2520Invasion%2520via%2520Receptor-Independent%2520Mechanisms%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2014%26volume%3D12%26spage%3D1863%26epage%3D1874%26doi%3D10.1158%2F1541-7786.MCR-14-0302-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vijayan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, M. W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, M. J.</span></span> <span> </span><span class="NLM_article-title">Targeting Immunosuppressive Adenosine in Cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">709</span>– <span class="NLM_lpage">724</span>, <span class="refDoi"> DOI: 10.1038/nrc.2017.86</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1038%2Fnrc.2017.86" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=29059149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslehs7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=709-724&author=D.+Vijayanauthor=A.+Youngauthor=M.+W.+L.+Tengauthor=M.+J.+Smyth&title=Targeting+Immunosuppressive+Adenosine+in+Cancer&doi=10.1038%2Fnrc.2017.86"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting immunosuppressive adenosine in cancer</span></div><div class="casAuthors">Vijayan, Dipti; Young, Arabella; Teng, Michele W. L.; Smyth, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">709-724</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Despite the success of anti-programmed cell death protein 1 (PD1), anti-PD1 ligand 1 (PDL1) and anti-cytotoxic T lymphocyte antigen 4 (CTLA4) therapies in advanced cancer, a considerable proportion of patients remain unresponsive to these treatments (known as innate resistance).  In addn., one-third of patients relapse after initial response (known as adaptive resistance), which suggests that multiple non-redundant immunosuppressive mechanisms coexist within the tumor microenvironment.  A major immunosuppressive mechanism is the adenosinergic pathway, which now represents an attractive new therapeutic target for cancer therapy.  Activation of this pathway occurs within hypoxic tumors, where extracellular adenosine exerts local suppression through tumor-intrinsic and host-mediated mechanisms.  Preclin. studies in mice with adenosine receptor antagonists and antibodies have reported favorable antitumor immune responses with some definition of the mechanism of action.  Currently, agents targeting the adenosinergic pathway are undergoing first-in-human clin. trials as single agents and in combination with anti-PD1 or anti-PDL1 therapies.  In this Review, we describe the complex interplay of adenosine and adenosine receptors in the development of primary tumors and metastases and discuss the merits of targeting one or more components that compose the adenosinergic pathway.  We also review the early clin. data relating to therapeutic agents inhibiting the adenosinergic pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3aiRNPyIwHrVg90H21EOLACvtfcHk0liXeyHAyMVi5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslehs7rO&md5=24d252d351e30154a8f79bc37c2e4b2b</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2Fnrc.2017.86&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc.2017.86%26sid%3Dliteratum%253Aachs%26aulast%3DVijayan%26aufirst%3DD.%26aulast%3DYoung%26aufirst%3DA.%26aulast%3DTeng%26aufirst%3DM.%2BW.%2BL.%26aulast%3DSmyth%26aufirst%3DM.%2BJ.%26atitle%3DTargeting%2520Immunosuppressive%2520Adenosine%2520in%2520Cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2017%26volume%3D17%26spage%3D709%26epage%3D724%26doi%3D10.1038%2Fnrc.2017.86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akdemir, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cekic, C.</span></span> <span> </span><span class="NLM_article-title">The Expression of Adenosine A2B Receptor on Antigen-Presenting Cells Suppresses CD8+ T-cell Responses and Promotes Tumor Growth</span>. <i>Cancer Immunol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1064</span>– <span class="NLM_lpage">1074</span>, <span class="refDoi"> DOI: 10.1158/2326-6066.cir-19-0833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1158%2F2326-6066.cir-19-0833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=32381524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit12qu7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2020&pages=1064-1074&author=S.+Chenauthor=I.+Akdemirauthor=J.+Fanauthor=J.+Lindenauthor=B.+Zhangauthor=C.+Cekic&title=The+Expression+of+Adenosine+A2B+Receptor+on+Antigen-Presenting+Cells+Suppresses+CD8%2B+T-cell+Responses+and+Promotes+Tumor+Growth&doi=10.1158%2F2326-6066.cir-19-0833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">The expression of adenosine A2B receptor onantigen-presenting cells suppresses CD8+ T-cellresponses and promotes tumor growth</span></div><div class="casAuthors">Chen, Siqi; Akdemir, Imran; Fan, Jie; Linden, Joel; Zhang, Bin; Cekic, Caglar</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1064-1074</span>CODEN:
                <span class="NLM_cas:coden">CIRACV</span>;
        ISSN:<span class="NLM_cas:issn">2326-6066</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Accumulating evidence suggests that inhibiting adenosine-generating ecto-enzymes (CD39 and CD73) and/or adenosine A2A or A2B receptors (R) stimulates antitumor immunity and limits tumor progression.  Although activating A2ARs or A2BRs causes similar immunosuppressive and protumoral functions, few studies have investigated the distinct role of A2BR in cancer.  Here, we showed that A2BR expression by hematopoietic cells was primarily responsible for promoting tumor growth.  Deletion of A2BR profoundly enhanced anticancer T-cell immunity.  Although T-cell A2BR plays an insignificant role for A2BR-mediated immunosuppression and tumor promotion, A2BR deficiency in tumor-bearing mice caused increased infiltration of myeloid and CD103+ dendritic cells, which was assocd. with more effective cross-priming of adoptively transferred tumor antigen-specific CD8+ T cells.  A2BR deletion also intrinsically favored accumulation of myeloid and CD11bdim antigen-presenting cells (ARC) in the tumor microenvironment.  Both myeloid-specific or CD11c-specific conditional deletion of A2BR delayed primary tumor growth.  Myeloid, but not CD11c-specific conditional, depletion delayed lung metastasis.  Pharmacol. blockade of A2BR improved the antitumor effect of adoptive T-cell therapy.  Overall, these results suggested that A2BR expression on myeloid cells and APCs indirectly suppressed CD8+ T-cell responses and promoted metastasis.  These data provide a strong rationale to combine A2BR inhibition with T-cell-based immunotherapy for the treatment of tumor growth and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7p5YgU2oAJrVg90H21EOLACvtfcHk0lgO41NDTa7YIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit12qu7nF&md5=4b354530561fa259582e2b442e94ce9b</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1158%2F2326-6066.cir-19-0833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2326-6066.cir-19-0833%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DAkdemir%26aufirst%3DI.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DCekic%26aufirst%3DC.%26atitle%3DThe%2520Expression%2520of%2520Adenosine%2520A2B%2520Receptor%2520on%2520Antigen-Presenting%2520Cells%2520Suppresses%2520CD8%252B%2520T-cell%2520Responses%2520and%2520Promotes%2520Tumor%2520Growth%26jtitle%3DCancer%2520Immunol.%2520Res.%26date%3D2020%26volume%3D8%26spage%3D1064%26epage%3D1074%26doi%3D10.1158%2F2326-6066.cir-19-0833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bahreyni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samani, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahmani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behnam-Rassouli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khazaei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryzhikov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parizadeh, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassanian, S. M.</span></span> <span> </span><span class="NLM_article-title">Role of Adenosine Signaling in the Pathogenesis of Breast Cancer</span>. <i>J. Cell. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>233</i></span>,  <span class="NLM_fpage">1836</span>– <span class="NLM_lpage">1843</span>, <span class="refDoi"> DOI: 10.1002/jcp.25944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1002%2Fjcp.25944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=28383816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotF2kt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=2018&pages=1836-1843&author=A.+Bahreyniauthor=S.+S.+Samaniauthor=F.+Rahmaniauthor=R.+Behnam-Rassouliauthor=M.+Khazaeiauthor=M.+Ryzhikovauthor=M.+R.+Parizadehauthor=A.+Avanauthor=S.+M.+Hassanian&title=Role+of+Adenosine+Signaling+in+the+Pathogenesis+of+Breast+Cancer&doi=10.1002%2Fjcp.25944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Role of adenosine signaling in the pathogenesis of breast cancer</span></div><div class="casAuthors">Bahreyni, Amirhossein; Samani, Seyed Sattar; Rahmani, Farzad; Behnam-Rassouli, Reihane; Khazaei, Majid; Ryzhikov, Mikhail; Parizadeh, Mohammad Reza; Avan, Amir; Hassanian, Seyed Mahdi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">233</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1836-1843</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The plasma level of adenosine increases under ischemic and inflamed conditions in tumor microenvironment.  Adenosine elicits a range of signaling pathways in tumors, resulting in either inhibition or enhancement of tumor growth depending upon different subtypes of adenosine receptors activation and type of cancer.  Metab. of adenosine-5'-triphosphate (ATP) and its derivs. including adenosine is dysregulated in the breast tumor microenvironment, supporting the role of this metabolite in the pathogenesis of breast cancer.  Adenosine regulates inflammation, apoptosis, cell proliferation, and metastasis in breast cancer cells.  This review summarizes the role of adenosine in the pathogenesis of breast cancer for a better understanding and hence a better management of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCxZmEHlTUA7Vg90H21EOLACvtfcHk0lgO41NDTa7YIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotF2kt7c%253D&md5=7b21bc4ee4ed7ee88acdb2d068217bc6</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1002%2Fjcp.25944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.25944%26sid%3Dliteratum%253Aachs%26aulast%3DBahreyni%26aufirst%3DA.%26aulast%3DSamani%26aufirst%3DS.%2BS.%26aulast%3DRahmani%26aufirst%3DF.%26aulast%3DBehnam-Rassouli%26aufirst%3DR.%26aulast%3DKhazaei%26aufirst%3DM.%26aulast%3DRyzhikov%26aufirst%3DM.%26aulast%3DParizadeh%26aufirst%3DM.%2BR.%26aulast%3DAvan%26aufirst%3DA.%26aulast%3DHassanian%26aufirst%3DS.%2BM.%26atitle%3DRole%2520of%2520Adenosine%2520Signaling%2520in%2520the%2520Pathogenesis%2520of%2520Breast%2520Cancer%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2018%26volume%3D233%26spage%3D1836%26epage%3D1843%26doi%3D10.1002%2Fjcp.25944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farokhzad, O. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippard, S. J.</span></span> <span> </span><span class="NLM_article-title">Targeted Delivery of Cisplatin to Prostate Cancer Cells by Aptamer Functionalized Pt(IV) Prodrug-PLGA–PEG Nanoparticles</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">17356</span>– <span class="NLM_lpage">17361</span>, <span class="refDoi"> DOI: 10.1073/pnas.0809154105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1073%2Fpnas.0809154105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=18978032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWgu7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=17356-17361&author=S.+Dharauthor=F.+X.+Guauthor=R.+Langerauthor=O.+C.+Farokhzadauthor=S.+J.+Lippard&title=Targeted+Delivery+of+Cisplatin+to+Prostate+Cancer+Cells+by+Aptamer+Functionalized+Pt%28IV%29+Prodrug-PLGA%E2%80%93PEG+Nanoparticles&doi=10.1073%2Fpnas.0809154105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles</span></div><div class="casAuthors">Dhar, Shanta; Gu, Frank X.; Langer, Robert; Farokhzad, Omid C.; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">17356-17361</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Cisplatin is used to treat a variety of tumors, but dose limiting toxicities or intrinsic and acquired resistance limit its application in many types of cancer including prostate.  We report a unique strategy to deliver cisplatin to prostate cancer cells by constructing Pt(IV)-encapsulated prostate-specific membrane antigen (PSMA) targeted nanoparticles (NPs) of poly(D,L-lactic-co-glycolic acid) (PLGA)-poly(ethylene glycol) (PEG)-functionalized controlled release polymers.  By using PLGA-b-PEG nanoparticles with PSMA targeting aptamers (Apt) on the surface as a vehicle for the platinum(IV) compd. c,t,c-[Pt(NH3)2(O2CCH2CH2CH2CH2CH3)2Cl2] (I), a LD of cisplatin was delivered specifically to prostate cancer cells.  PSMA aptamer targeted delivery of Pt(IV) cargos to PSMA+ LNCaP prostate cancer cells by endocytosis of the nanoparticle vehicles was demonstrated using fluorescence microscopy by colocalization of green fluorescent labeled cholesterol-encapsulated NPs and early endosome marker EEA-1.  The choice of linear hexyl chains in I was the result of a systematic study to optimize encapsulation and controlled release from the polymer without compromising either feature.  Release of cisplatin from the polymeric nanoparticles after redn. of I and formation of cisplatin 1,2-intrastrand d(GpG) crosslinks on nuclear DNA was confirmed by using a monoclonal antibody for the adduct.  A comparison between the cytotoxic activities of Pt(IV)-encapsulated PLGA-b- PEG NPs with the PSMA aptamer on the surface (Pt-NP-Apt), cisplatin, and the nontargeted Pt(IV)-encapsulated NPs (Pt-NP) against human prostate PSMA-overexpressing LNCaP and PSMA-PC3 cancer cells revealed significant differences.  The effectiveness of PSMA targeted Pt-NP-Apt nanoparticles against the PSMA+ LNCaP cells is approx. an order of magnitude greater than that of free cisplatin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmradB-ZYWQbVg90H21EOLACvtfcHk0lgO41NDTa7YIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWgu7fL&md5=ee3bd248db95e9c2e9f56383289a4da9</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0809154105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0809154105%26sid%3Dliteratum%253Aachs%26aulast%3DDhar%26aufirst%3DS.%26aulast%3DGu%26aufirst%3DF.%2BX.%26aulast%3DLanger%26aufirst%3DR.%26aulast%3DFarokhzad%26aufirst%3DO.%2BC.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DTargeted%2520Delivery%2520of%2520Cisplatin%2520to%2520Prostate%2520Cancer%2520Cells%2520by%2520Aptamer%2520Functionalized%2520Pt%2528IV%2529%2520Prodrug-PLGA%25E2%2580%2593PEG%2520Nanoparticles%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D17356%26epage%3D17361%26doi%3D10.1073%2Fpnas.0809154105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Núñez-Iglesias, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Santiago, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartea, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soengas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasco, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freire-Garabal, M.</span></span> <span> </span><span class="NLM_article-title">Effects of 3-Butenyl Isothiocyanate on Phenotypically Different Prostate Cancer Cells</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2213</span>– <span class="NLM_lpage">2223</span>, <span class="refDoi"> DOI: 10.3892/ijo.2018.4545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.3892%2Fijo.2018.4545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=30226593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjsFWltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2018&pages=2213-2223&author=M.+J.+N%C3%BA%C3%B1ez-Iglesiasauthor=S.+Novioauthor=C.+Garc%C3%ADa-Santiagoauthor=M.+E.+Carteaauthor=P.+Soengasauthor=P.+Velascoauthor=M.+Freire-Garabal&title=Effects+of+3-Butenyl+Isothiocyanate+on+Phenotypically+Different+Prostate+Cancer+Cells&doi=10.3892%2Fijo.2018.4545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of 3-butenyl isothiocyanate on phenotypically different prostate cancer cells</span></div><div class="casAuthors">Nunez-Iglesias, M. J.; Novio, S.; Garcia-Santiago, C.; Cartea, M. E.; Soengas, P.; Velasco, P.; Freire-Garabal, M.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2213-2223</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1791-2423</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Isothiocyanates (ITCs) have gained increasing attention since they have been attributed the merits for the potential beneficial effects of cruciferous vegetable dietary consumption on cancer.  The aim of the present study was to det. the cytotoxic effects of 3-butenyl ITC (3-BI) on prostate cancer (PC) cells under in vitro conditions.  Two androgen-insensitive human PC cell lines, PC-3 and DU145, were assayed.  Cells were cultured in the presence of increasing concns. of 3-BI (5, 10, 30 and 50 μM) in the absence or presence of the chemotherapeutic drug docetaxel (DOCE) (1 and 2 nM).  The cytotoxic effects of these compds. were analyzed using the trypan blue exclusion assay at 24, 48 and 72 h.  Apoptosis and migration assays were also performed.  The results showed that 3-BI induced a dose-dependent cytotoxic effect on PC-3 cells at 24, 48 and 72 h.  These effects were significantly higher than those found with DOCE at 72 h of culture.  Moreover, 3-BI also potentiated the effects of DOCE in a dose-dependent manner.  Addnl., 3-BI showed inhibition of the migration of PC-3 cells.  Nevertheless, 3-BI was not effective in the DU145 PC cell line.  These results show a promising role for the 3-BI compd. as a co-adjuvant agent in DOCE-based therapy in certain types of PC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAXS5FOlVfK7Vg90H21EOLACvtfcHk0limiS4EVIkCNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjsFWltL8%253D&md5=d642aa510d0c68952c7f82ef93eb8d69</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.3892%2Fijo.2018.4545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.2018.4545%26sid%3Dliteratum%253Aachs%26aulast%3DN%25C3%25BA%25C3%25B1ez-Iglesias%26aufirst%3DM.%2BJ.%26aulast%3DNovio%26aufirst%3DS.%26aulast%3DGarc%25C3%25ADa-Santiago%26aufirst%3DC.%26aulast%3DCartea%26aufirst%3DM.%2BE.%26aulast%3DSoengas%26aufirst%3DP.%26aulast%3DVelasco%26aufirst%3DP.%26aulast%3DFreire-Garabal%26aufirst%3DM.%26atitle%3DEffects%2520of%25203-Butenyl%2520Isothiocyanate%2520on%2520Phenotypically%2520Different%2520Prostate%2520Cancer%2520Cells%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2018%26volume%3D53%26spage%3D2213%26epage%3D2223%26doi%3D10.3892%2Fijo.2018.4545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span> <span> </span><span class="NLM_article-title">SATB1 Is Overexpressed in Metastatic Prostate Cancer and Promotes Prostate Cancer Cell Growth and Invasion</span>. <i>J. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">111</span>, <span class="refDoi"> DOI: 10.1186/1479-5876-11-111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1186%2F1479-5876-11-111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=23642278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVSgsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=111&author=L.+Maoauthor=C.+Yangauthor=J.+Wangauthor=W.+Liauthor=R.+Wenauthor=J.+Chenauthor=J.+Zheng&title=SATB1+Is+Overexpressed+in+Metastatic+Prostate+Cancer+and+Promotes+Prostate+Cancer+Cell+Growth+and+Invasion&doi=10.1186%2F1479-5876-11-111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion</span></div><div class="casAuthors">Mao, Lijun; Yang, Chunhua; Wang, Junqi; Li, Wang; Wen, Rumin; Chen, Jiacun; Zheng, Junnian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Translational Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111</span>CODEN:
                <span class="NLM_cas:coden">JTMOBV</span>;
        ISSN:<span class="NLM_cas:issn">1479-5876</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Special AT-rich sequence binding protein 1 (SATB1) is a nuclear factor that functions as the global chromatin organizer to regulate chromatin structure and gene expression.  SATB1 has been shown to be abnormally expressed in various types of cancer.  However, the expression and role of SATB1 in prostate cancer remain unclear.  Methods: 120 cases of prostatic carcinoma and 60 cases of benign prostate hyperplasia were analyzed for SATB1 expression by immunohistochem.  LNCaP, DU-145, and PC3 prostate cancer cells were examd. for SATB1 expression by Western blot anal.  Cell proliferation and invasion was evaluated by CCK8 and transwell invasion assay, resp.  Results: SATB1 staining was stronger in prostatic carcinomas with metastasis than in those without metastasis, but was absent in benign prostate hyperplasia.  Furthermore, SATB1 expression was pos. correlated with bone metastasis and the Gleason score.  SATB1 overexpression promoted the proliferation and invasion of LNCaP cells while SATB1 knockdown inhibited the proliferation and invasion of DU-145 cells.  Conclusions: These findings provide novel insight into oncogenic role of SATB1 in prostate cancer, suggesting that SATB1 is a promising biomarker and therapeutic target for prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCHs8rj-fUDLVg90H21EOLACvtfcHk0limiS4EVIkCNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVSgsrc%253D&md5=8ff9872b9daf50d9b27684e030583762</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1186%2F1479-5876-11-111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1479-5876-11-111%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DWen%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DJ.%26atitle%3DSATB1%2520Is%2520Overexpressed%2520in%2520Metastatic%2520Prostate%2520Cancer%2520and%2520Promotes%2520Prostate%2520Cancer%2520Cell%2520Growth%2520and%2520Invasion%26jtitle%3DJ.%2520Transl.%2520Med.%26date%3D2013%26volume%3D11%26spage%3D111%26doi%3D10.1186%2F1479-5876-11-111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hejchman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taciak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowalski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maciejewska, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czajkowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borowska, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Śladowski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Młynarczuk-Biały, I.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Anticancer Activity of 7-Hydroxycoumarinyl Gallates</span>. <i>Pharmacol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">236</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1016/j.pharep.2014.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.pharep.2014.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=25712645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmt1SgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=236-244&author=E.+Hejchmanauthor=P.+Taciakauthor=S.+Kowalskiauthor=D.+Maciejewskaauthor=A.+Czajkowskaauthor=J.+Borowskaauthor=D.+%C5%9Aladowskiauthor=I.+M%C5%82ynarczuk-Bia%C5%82y&title=Synthesis+and+Anticancer+Activity+of+7-Hydroxycoumarinyl+Gallates&doi=10.1016%2Fj.pharep.2014.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and anticancer activity of 7-hydroxycoumarinyl gallates</span></div><div class="casAuthors">Hejchman, Elzbieta; Taciak, Przemyslaw; Kowalski, Sebastian; Maciejewska, Dorota; Czajkowska, Agnieszka; Borowska, Julia; Sladowski, Dariusz; Mlynarczuk-Bialy, Izabela</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">236-244</span>CODEN:
                <span class="NLM_cas:coden">PRHEDU</span>;
        ISSN:<span class="NLM_cas:issn">2299-5684</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The search for anti-cancer agents includes naturally occurring substances and theirs modifications.  Therefore we invented and designed compds. that represent fused derivs. of gallic acid with coumarins.  As a result, a series of 8 novel esters of gallic acid and 7-hydroxycoumarins were synthesized and evaluated for anticancer activity.  The structures of the compds. were established by IR, 1H, 13C NMR and HR MS spectra.  The esters were assayed for antiproliferative activity against human leukemia HL-60 and prostate cancer DU145 cell lines.  The activity of novel esters was evaluated by cell viability assays as well as by anal. of cell cycle and cell death mechanism.  The esters were found to be of similar or higher activity than gallic acid.  No pronounced harmful effect was obsd. in non-cancer cells.  The novel compds. represent an excellent starting point for the further optimization and the design of therapeutically effective anti-cancerous drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzVribZvviu7Vg90H21EOLACvtfcHk0limiS4EVIkCNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmt1SgsL0%253D&md5=2fcb78094a3979764719ff1f869a855c</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.pharep.2014.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharep.2014.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DHejchman%26aufirst%3DE.%26aulast%3DTaciak%26aufirst%3DP.%26aulast%3DKowalski%26aufirst%3DS.%26aulast%3DMaciejewska%26aufirst%3DD.%26aulast%3DCzajkowska%26aufirst%3DA.%26aulast%3DBorowska%26aufirst%3DJ.%26aulast%3D%25C5%259Aladowski%26aufirst%3DD.%26aulast%3DM%25C5%2582ynarczuk-Bia%25C5%2582y%26aufirst%3DI.%26atitle%3DSynthesis%2520and%2520Anticancer%2520Activity%2520of%25207-Hydroxycoumarinyl%2520Gallates%26jtitle%3DPharmacol.%2520Rep.%26date%3D2015%26volume%3D67%26spage%3D236%26epage%3D244%26doi%3D10.1016%2Fj.pharep.2014.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Härmä, V.</span>; <span class="NLM_string-name">Haavikko, R.</span>; <span class="NLM_string-name">Virtanen, J.</span>; <span class="NLM_string-name">Ahonen, I.</span>; <span class="NLM_string-name">Schukov, H.-P.</span>; <span class="NLM_string-name">Alakurtti, S.</span>; <span class="NLM_string-name">Purev, E.</span>; <span class="NLM_string-name">Rischer, H.</span>; <span class="NLM_string-name">Yli-Kauhaluoma, J.</span>; <span class="NLM_string-name">Moreira, V. M.</span>; <span class="NLM_string-name">Nees, M.</span>; <span class="NLM_string-name">Oksman-Caldentey, K.-M.</span></span> <span> </span><span class="NLM_article-title">Optimization of Invasion-Specific Effects of Betulin Derivatives on Prostate Cancer Cells through Lead Development</span>.  <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume">10</span> (). <span class="refDoi"> DOI: 10.1371/journal.pone.0126111</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1371%2Fjournal.pone.0126111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=25965345" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&author=V.+H%C3%A4rm%C3%A4&author=R.+Haavikko&author=J.+Virtanen&author=I.+Ahonen&author=H.-P.+Schukov&author=S.+Alakurtti&author=E.+Purev&author=H.+Rischer&author=J.+Yli-Kauhaluoma&author=V.+M.+Moreira&author=M.+Nees&author=K.-M.+Oksman-Caldentey&title=Optimization+of+Invasion-Specific+Effects+of+Betulin+Derivatives+on+Prostate+Cancer+Cells+through+Lead+Development&doi=10.1371%2Fjournal.pone.0126111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0126111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0126111%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25A4rm%25C3%25A4%26aufirst%3DV.%26atitle%3DOptimization%2520of%2520Invasion-Specific%2520Effects%2520of%2520Betulin%2520Derivatives%2520on%2520Prostate%2520Cancer%2520Cells%2520through%2520Lead%2520Development%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26doi%3D10.1371%2Fjournal.pone.0126111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrera-Abreu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohn, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Racine, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tajadura, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suryavanshi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bechtel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiemann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baum, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridley, A. J.</span></span> <span> </span><span class="NLM_article-title">Identification and Characterization of a Set of Conserved and New Regulators of Cytoskeletal Organization, Cell Morphology and Migration</span>. <i>BMC Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">54</span>, <span class="refDoi"> DOI: 10.1186/1741-7007-9-54</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1186%2F1741-7007-9-54" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=21834987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2gu7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=54&author=S.+Baiauthor=M.+Herrera-Abreuauthor=J.+L.+Rohnauthor=V.+Racineauthor=V.+Tajaduraauthor=N.+Suryavanshiauthor=S.+Bechtelauthor=S.+Wiemannauthor=B.+Baumauthor=A.+J.+Ridley&title=Identification+and+Characterization+of+a+Set+of+Conserved+and+New+Regulators+of+Cytoskeletal+Organization%2C+Cell+Morphology+and+Migration&doi=10.1186%2F1741-7007-9-54"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of a set of conserved and new regulators of cytoskeletal organisation, cell morphology and migration</span></div><div class="casAuthors">Bai, Siau Wei; Herrera-Abreu, Maria Teresa; Rohn, Jennifer L.; Racine, Victor; Tajadura, Virginia; Suryavanshi, Narendra; Bechtel, Stephanie; Wiemann, Stefan; Baum, Buzz; Ridley, Anne J.</div><div class="citationInfo"><span class="NLM_cas:title">BMC Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">54</span>CODEN:
                <span class="NLM_cas:coden">BBMIF7</span>;
        ISSN:<span class="NLM_cas:issn">1741-7007</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Cell migration is essential during development and in human disease progression including cancer.  Most cell migration studies conc. on known or predicted components of migration pathways.  Results: Here we use data from a genome-wide RNAi morphol. screen in Drosophila melanogaster cells together with bioinformatics to identify 26 new regulators of morphol. and cytoskeletal organization in human cells.  These include genes previously implicated in a wide range of functions, from mental retardation, Down syndrome and Huntington's disease to RNA and DNA-binding genes.  We classify these genes into 7 groups according to phenotype and identify those that affect cell migration.  We further characterize a subset of 7 genes, FAM40A, FAM40B, ARC, FMNL3, FNBP3/FBP11, LIMD1 and ZRANB1, each of which has a different effect on cell shape, actin filament distribution and cell migration.  Interestingly, in several instances closely related isoforms with a single Drosophila homolog have distinct phenotypes.  For example, FAM40B depletion induces cell elongation and tail retraction defects, whereas FAM40A depletion reduces cell spreading.  Conclusions: Our results identify multiple regulators of cell migration and cytoskeletal signaling that are highly conserved between Drosophila and humans, and show that closely related paralogs can have very different functions in these processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEUQp3NQF_0LVg90H21EOLACvtfcHk0lhyER86uqkFig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2gu7nF&md5=5a8e955c18176b5b1c0c9abf5c211672</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1186%2F1741-7007-9-54&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1741-7007-9-54%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DS.%26aulast%3DHerrera-Abreu%26aufirst%3DM.%26aulast%3DRohn%26aufirst%3DJ.%2BL.%26aulast%3DRacine%26aufirst%3DV.%26aulast%3DTajadura%26aufirst%3DV.%26aulast%3DSuryavanshi%26aufirst%3DN.%26aulast%3DBechtel%26aufirst%3DS.%26aulast%3DWiemann%26aufirst%3DS.%26aulast%3DBaum%26aufirst%3DB.%26aulast%3DRidley%26aufirst%3DA.%2BJ.%26atitle%3DIdentification%2520and%2520Characterization%2520of%2520a%2520Set%2520of%2520Conserved%2520and%2520New%2520Regulators%2520of%2520Cytoskeletal%2520Organization%252C%2520Cell%2520Morphology%2520and%2520Migration%26jtitle%3DBMC%2520Biol.%26date%3D2011%26volume%3D9%26spage%3D54%26doi%3D10.1186%2F1741-7007-9-54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, S. J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singletary, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venema, R. C.</span></span> <span> </span><span class="NLM_article-title">Sulforaphane Suppresses Angiogenesis and Disrupts Endothelial Mitotic Progression and Microtubule Polymerization</span>. <i>Vasc. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1016/j.vph.2006.06.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.vph.2006.06.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=16938492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFCitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=77-84&author=S.+J.+T.+Jacksonauthor=K.+W.+Singletaryauthor=R.+C.+Venema&title=Sulforaphane+Suppresses+Angiogenesis+and+Disrupts+Endothelial+Mitotic+Progression+and+Microtubule+Polymerization&doi=10.1016%2Fj.vph.2006.06.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Sulforaphane suppresses angiogenesis and disrupts endothelial mitotic progression and microtubule polymerization</span></div><div class="casAuthors">Jackson, Steven J. T.; Singletary, Keith W.; Venema, Richard C.</div><div class="citationInfo"><span class="NLM_cas:title">Vascular Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">77-84</span>CODEN:
                <span class="NLM_cas:coden">VPAHAJ</span>;
        ISSN:<span class="NLM_cas:issn">1537-1891</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sulforaphane (SUL), an isothiocyanate derived from broccoli and other cruciferous vegetables, is known to induce phase II detoxification enzymes, disrupt cancer cell microtubule polymn., and trigger cell cycle arrest in breast and colon cancer cells.  Here, we provide the first evidence that SUL also acts to inhibit angiogenesis via suppression of endothelial cell proliferation.  Bovine aortic endothelial (BAE) cells were exposed to concns. of up to 15 μM SUL prior to cell cycle anal. and mitotic index quantification.  Within 24 h, 15 μM SUL clearly induced G2/M accumulation and pre-metaphase arrest in BAE cells.  Moreover, immunofluorescence tubulin staining indicated that this same SUL concn. was efficacious in not only disrupting mitotic progression, but also in perturbing normal polymn. of mitotic (and cytoplasmic) microtubules.  Furthermore, daily administration of SUL (100 nmol/day, i.v. for 7 days) to female Balb/c mice bearing VEGF-impregnated Matrigel plugs strongly and significantly (P < 0.05) suppressed angiogenesis progression as measured by Hb concn.  Taken together, these findings suggest that the endothelial cell population is a novel target of SUL action both in vitro and in vivo.  This mechanism of SUL-induced endothelial microtubule disruption and early mitotic arrest may further discern a potential role of SUL as a chemopreventive agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeJtZdwJBhK7Vg90H21EOLACvtfcHk0lhyER86uqkFig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFCitw%253D%253D&md5=c8471b4b89ddb6698449854f4c1bb489</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.vph.2006.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vph.2006.06.015%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DS.%2BJ.%2BT.%26aulast%3DSingletary%26aufirst%3DK.%2BW.%26aulast%3DVenema%26aufirst%3DR.%2BC.%26atitle%3DSulforaphane%2520Suppresses%2520Angiogenesis%2520and%2520Disrupts%2520Endothelial%2520Mitotic%2520Progression%2520and%2520Microtubule%2520Polymerization%26jtitle%3DVasc.%2520Pharmacol.%26date%3D2007%26volume%3D46%26spage%3D77%26epage%3D84%26doi%3D10.1016%2Fj.vph.2006.06.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span> <i>Schrödinger</i>; <span class="NLM_publisher-name">Schrödinger
LLC</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schr%C3%B6dinger%3B+Schr%C3%B6dinger%0ALLC%3A+New+York%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchr%25C3%25B6dinger%26pub%3DSchr%25C3%25B6dinger%250ALLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piñeiro, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez-De-Terán, H.</span></span> <span> </span><span class="NLM_article-title">Molecular Dynamics Simulations Reveal Insights into Key Structural Elements of Adenosine Receptors</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">4194</span>– <span class="NLM_lpage">4208</span>, <span class="refDoi"> DOI: 10.1021/bi200100t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi200100t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVCksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=4194-4208&author=D.+Rodr%C3%ADguezauthor=%C3%81.+Pi%C3%B1eiroauthor=H.+Guti%C3%A9rrez-De-Ter%C3%A1n&title=Molecular+Dynamics+Simulations+Reveal+Insights+into+Key+Structural+Elements+of+Adenosine+Receptors&doi=10.1021%2Fbi200100t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Dynamics Simulations Reveal Insights into Key Structural Elements of Adenosine Receptors</span></div><div class="casAuthors">Rodriguez, David; Pineiro, Angel; Gutierrez-de-Teran, Hugo</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4194-4208</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The crystal structure of the human A2A adenosine receptor, a member of the G protein-coupled receptor (GPCR) family, is used as a starting point for the structural characterization of the conformational equil. around the inactive conformation of the human A2 (A2A and A2B) adenosine receptors (ARs).  A homol. model of the closely related A2BAR is reported, and the two receptors were simulated in their apo form through all-atom mol. dynamics (MD) simulations.  Different conditions were addnl. explored in the A2AAR, including the protonation state of crucial histidines or the presence of the cocrystd. ligand.  Our simulations reveal the role of several conserved residues in the ARs in the conformational equil. of the receptors.  The "ionic lock" absent in the crystal structure of the inactive A2AAR is rapidly formed in the two simulated receptors, and a complex network of interacting residues is presented that further stabilizes this structural element.  Notably, the obsd. rotameric transition of Trp6.48 ("toggle switch"), which is thought to initiate the activation process in GPCRs, is accompanied by a concerted rotation of the conserved residue of the A2ARs, His6.52.  This new conformation is further stabilized in the two receptors under study by a novel interaction network involving residues in transmembrane (TM) helixes TM5 (Asn5.42) and TM3 (Gln3.37), which resemble the conformational changes recently obsd. in the agonist-bound structure of β-adrenoreceptors.  Finally, the interaction between Glu1.39 and His7.43, a pair of conserved residues in the family of ARs, is found to be weaker than previously thought, and the role of this interaction in the structure and dynamics of the receptor is thoroughly examd.  All these findings suggest that, despite the commonalities with other GPCRs, the conformational equil. of ARs is also modulated by specific residues of the family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh0ijAwR8whbVg90H21EOLACvtfcHk0lgGf_eWpfPHOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVCksrk%253D&md5=c095b25f0e1a5b190620e77a78364b26</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fbi200100t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi200100t%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DD.%26aulast%3DPi%25C3%25B1eiro%26aufirst%3D%25C3%2581.%26aulast%3DGuti%25C3%25A9rrez-De-Ter%25C3%25A1n%26aufirst%3DH.%26atitle%3DMolecular%2520Dynamics%2520Simulations%2520Reveal%2520Insights%2520into%2520Key%2520Structural%2520Elements%2520of%2520Adenosine%2520Receptors%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D4194%26epage%3D4208%26doi%3D10.1021%2Fbi200100t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Šali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, T. L.</span></span> <span> </span><span class="NLM_article-title">Comparative Protein Modelling by Satisfaction of Spatial Restraints</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>234</i></span>,  <span class="NLM_fpage">779</span>– <span class="NLM_lpage">815</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1993.1626</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1006%2Fjmbi.1993.1626" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=8254673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADyaK2cXnt1ylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=234&publication_year=1993&pages=779-815&author=A.+%C5%A0aliauthor=T.+L.+Blundell&title=Comparative+Protein+Modelling+by+Satisfaction+of+Spatial+Restraints&doi=10.1006%2Fjmbi.1993.1626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative protein modeling by satisfaction of spatial restraints</span></div><div class="casAuthors">Sali, Andrej; Blundell, Tom L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">234</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">779-815</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    </div><div class="casAbstract">The authors describe a comparative protein modeling method designed to find the most probable structure for a sequence given its alignment with related structures.  The three-dimensional (3D) model is obtained by optimally satisfying spatial restraints derived from the alignment and expressed as probability d. functions (pdfs) for the features restrained.  For example, the probabilities for main-chain conformations of a modelled residue may be restrained by its residue type, main-chain conformation of an equiv. residue in a related protein, and the local similarity between the two sequences.  Several such pdfs are obtained from the correlations between structural features in 17 families of homologous proteins which have been aligned on the basis of their 3D structures.  The pdfs restrain Cα-Cα distances, main-chain N-O distances, main-chain and side-chain dihedral angles.  A smoothing procedure is used in the derivation of these relationships to minimize the problem of a sparse database.  The 3D model of a protein is obtained by optimization of the mol. pdf such that the model violates the input restraints as little as possible.  The mol. pdf is derived as a combination of pdfs restraining individual spatial features of the whole mol.  The optimization procedure is a variable target function method that applies the conjugate gradients algorithm to positions of all non-hydrogen atoms.  The method is automated and is illustrated by the modeling of trypsin from two other serine proteinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC4wGhwZvib7Vg90H21EOLACvtfcHk0lgGf_eWpfPHOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXnt1ylug%253D%253D&md5=d4a3c39b2205e36221dc187a3d1a478b</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1993.1626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1993.1626%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25A0ali%26aufirst%3DA.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26atitle%3DComparative%2520Protein%2520Modelling%2520by%2520Satisfaction%2520of%2520Spatial%2520Restraints%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1993%26volume%3D234%26spage%3D779%26epage%3D815%26doi%3D10.1006%2Fjmbi.1993.1626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez-de-Terán, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bello, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez, D.</span></span> <span> </span><span class="NLM_article-title">Characterization of the Dynamic Events of GPCRs by Automated Computational Simulations</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1042/BST20120287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1042%2FBST20120287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=23356284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1eitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=205-212&author=H.+Guti%C3%A9rrez-de-Ter%C3%A1nauthor=X.+Belloauthor=D.+Rodr%C3%ADguez&title=Characterization+of+the+Dynamic+Events+of+GPCRs+by+Automated+Computational+Simulations&doi=10.1042%2FBST20120287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the dynamic events of GPCRs by automated computational simulations</span></div><div class="casAuthors">Gutierrez-de-Teran, Hugo; Bello, Xabier; Rodriguez, David</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">205-212</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The recent advances in membrane protein crystallog. have provided extremely valuable structural information of the superfamily of GPCRs (G-protein-coupled receptors).  This has been particularly true for a few receptors whose structure was solved several times under different biochem. conditions.  It follows that the mechanisms of receptor conformational equil. and related dynamic events can be explored by computational simulations.  In the present article, we summarize our recent understanding of several dynamic features of GPCRs, accomplished through the use of MD (mol. dynamics) simulations.  Our pipeline for the MD simulations of GPCRs, implemented in the web service http://gpcr.usc.es, is updated in the present paper and illustrated by recent applications.  Special emphasis is put on the A2A adenosine receptor, one of the selected cases where crystal structures in several conformations and conditions exist, and on the dimerization process of the CXCR4 (CXC chemokine receptor 4).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSBHtH7UcGbLVg90H21EOLACvtfcHk0lgGf_eWpfPHOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1eitbc%253D&md5=f3f75b95ae7cd34c91b9d39a72a567f7</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1042%2FBST20120287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20120287%26sid%3Dliteratum%253Aachs%26aulast%3DGuti%25C3%25A9rrez-de-Ter%25C3%25A1n%26aufirst%3DH.%26aulast%3DBello%26aufirst%3DX.%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520the%2520Dynamic%2520Events%2520of%2520GPCRs%2520by%2520Automated%2520Computational%2520Simulations%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2013%26volume%3D41%26spage%3D205%26epage%3D212%26doi%3D10.1042%2FBST20120287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hess, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutzner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Der
Spoel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindahl, E.</span></span> <span> </span><span class="NLM_article-title">GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">435</span>– <span class="NLM_lpage">447</span>, <span class="refDoi"> DOI: 10.1021/ct700301q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct700301q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVSqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=435-447&author=B.+Hessauthor=C.+Kutznerauthor=D.+Van+Der%0ASpoelauthor=E.+Lindahl&title=GROMACS+4%3A+Algorithms+for+Highly+Efficient%2C+Load-Balanced%2C+and+Scalable+Molecular+Simulation&doi=10.1021%2Fct700301q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation</span></div><div class="casAuthors">Hess, Berk; Kutzner, Carsten; van der Spoel, David; Lindahl, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">435-447</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. simulation is an extremely useful, but computationally very expensive tool for studies of chem. and biomol. systems.  Here, we present a new implementation of our mol. simulation toolkit GROMACS which now both achieves extremely high performance on single processors from algorithmic optimizations and hand-coded routines and simultaneously scales very well on parallel machines.  The code encompasses a minimal-communication domain decompn. algorithm, full dynamic load balancing, a state-of-the-art parallel constraint solver, and efficient virtual site algorithms that allow removal of hydrogen atom degrees of freedom to enable integration time steps up to 5 fs for atomistic simulations also in parallel.  To improve the scaling properties of the common particle mesh Ewald electrostatics algorithms, we have in addn. used a Multiple-Program, Multiple-Data approach, with sep. node domains responsible for direct and reciprocal space interactions.  Not only does this combination of algorithms enable extremely long simulations of large systems but also it provides that simulation performance on quite modest nos. of std. cluster nodes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrajjWdk6mUFrVg90H21EOLACvtfcHk0lh8ls92HA0vTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVSqurc%253D&md5=d53c94901386260221792ea30f151c5f</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fct700301q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct700301q%26sid%3Dliteratum%253Aachs%26aulast%3DHess%26aufirst%3DB.%26aulast%3DKutzner%26aufirst%3DC.%26aulast%3DVan%2BDer%2BSpoel%26aufirst%3DD.%26aulast%3DLindahl%26aufirst%3DE.%26atitle%3DGROMACS%25204%253A%2520Algorithms%2520for%2520Highly%2520Efficient%252C%2520Load-Balanced%252C%2520and%2520Scalable%2520Molecular%2520Simulation%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2008%26volume%3D4%26spage%3D435%26epage%3D447%26doi%3D10.1021%2Fct700301q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaminski, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirado-Rives, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span> <span> </span><span class="NLM_article-title">Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides</span>. <i>J. Phys. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">6474</span>– <span class="NLM_lpage">6487</span>, <span class="refDoi"> DOI: 10.1021/jp003919d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp003919d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD3MXislKhsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2001&pages=6474-6487&author=G.+A.+Kaminskiauthor=R.+A.+Friesnerauthor=J.+Tirado-Rivesauthor=W.+L.+Jorgensen&title=Evaluation+and+Reparametrization+of+the+OPLS-AA+Force+Field+for+Proteins+via+Comparison+with+Accurate+Quantum+Chemical+Calculations+on+Peptides&doi=10.1021%2Fjp003919d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides</span></div><div class="casAuthors">Kaminski, George A.; Friesner, Richard A.; Tirado-Rives, Julian; Jorgensen, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">6474-6487</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1089-5647</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present results of improving the OPLS-AA force field for peptides by means of refitting the key Fourier torsional coeffs.  The fitting technique combines using accurate ab initio data as the target, choosing an efficient fitting subspace of the whole potential-energy surface, and detg. wts. for each of the fitting points based on magnitudes of the potential-energy gradient.  The av. energy RMS deviation from the LMP2/cc-pVTZ(-f)//HF/6-31G** data is reduced by ∼40% from 0.81 to 0.47 kcal/mol as a result of the fitting for the electrostatically uncharged dipeptides.  Transferability of the parameters is demonstrated by using the same alanine dipeptide-fitted backbone torsional parameters for all of the other dipeptides (with the appropriate side-chain refitting) and the alanine tetrapeptide.  Parameters of nonbonded interactions have also been refitted for the sulfur-contg. dipeptides (cysteine and methionine), and the validity of the new Coulombic charges and the van der Waals σ's and ε's is proved through reproducing gas-phase energies of complex formation heats of vaporization and densities of pure model liqs.  Moreover, a novel approach to fitting torsional parameters for electrostatically charged mol. systems has been presented and successfully tested on five dipeptides with charged side chains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSHwmffIQePbVg90H21EOLACvtfcHk0lh8ls92HA0vTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXislKhsLk%253D&md5=3ff059626977ee7f6342466f5820f5b7</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Fjp003919d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp003919d%26sid%3Dliteratum%253Aachs%26aulast%3DKaminski%26aufirst%3DG.%2BA.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26atitle%3DEvaluation%2520and%2520Reparametrization%2520of%2520the%2520OPLS-AA%2520Force%2520Field%2520for%2520Proteins%2520via%2520Comparison%2520with%2520Accurate%2520Quantum%2520Chemical%2520Calculations%2520on%2520Peptides%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2001%26volume%3D105%26spage%3D6474%26epage%3D6487%26doi%3D10.1021%2Fjp003919d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berger, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edholm, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jähnig, F.</span></span> <span> </span><span class="NLM_article-title">Molecular Dynamics Simulations of a Fluid Bilayer of Dipalmitoylphosphatidylcholine at Full Hydration, Constant Pressure, and Constant Temperature</span>. <i>Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">2002</span>– <span class="NLM_lpage">2013</span>, <span class="refDoi"> DOI: 10.1016/S0006-3495(97)78845-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2FS0006-3495%2897%2978845-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=9129804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADyaK2sXivVOjsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1997&pages=2002-2013&author=O.+Bergerauthor=O.+Edholmauthor=F.+J%C3%A4hnig&title=Molecular+Dynamics+Simulations+of+a+Fluid+Bilayer+of+Dipalmitoylphosphatidylcholine+at+Full+Hydration%2C+Constant+Pressure%2C+and+Constant+Temperature&doi=10.1016%2FS0006-3495%2897%2978845-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular dynamics simulations of a fluid bilayer of dipalmitoylphosphatidylcholine at full hydration, constant pressure, and constant temperature</span></div><div class="casAuthors">Berger, Oliver; Edholm, Olle; Jahnig, Fritz</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Journal</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2002-2013</span>CODEN:
                <span class="NLM_cas:coden">BIOJAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3495</span>.
    
            (<span class="NLM_cas:orgname">Biophysical Society</span>)
        </div><div class="casAbstract">Mol. dynamics simulations of 500 ps were performed on a system consisting of a bilayer of 64 mols. of the lipid dipalmitoylphosphatidylcholine and 23 water mols. per lipid at an isotropic pressure of 1 atm and 50°.  Special attention was devoted to reproduce the correct d. of the lipid, because this quantity is known exptl. with a precision better than 1%.  For this purpose, the Lennard-Jones parameters of the hydrocarbon chains were adjusted by simulating a system consisting of 128 pentadecane mols. and varying the Lennard-Jones parameters until the exptl. d. and heat of vaporization were obtained.  With these parameters the lipid d. resulted in perfect agreement with the exptl. d.  The orientational order parameter of the hydrocarbon chains agreed perfectly well with the exptl. values, which, because of its correlation with the area per lipid, makes it possible to give a proper est. of the area per lipid of 0.61±0.1 nm2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYuDXgD7e9r7Vg90H21EOLACvtfcHk0lh8ls92HA0vTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivVOjsL4%253D&md5=984ea49ced9d0e2ce912bf99220fd228</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2FS0006-3495%2897%2978845-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3495%252897%252978845-3%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DO.%26aulast%3DEdholm%26aufirst%3DO.%26aulast%3DJ%25C3%25A4hnig%26aufirst%3DF.%26atitle%3DMolecular%2520Dynamics%2520Simulations%2520of%2520a%2520Fluid%2520Bilayer%2520of%2520Dipalmitoylphosphatidylcholine%2520at%2520Full%2520Hydration%252C%2520Constant%2520Pressure%252C%2520and%2520Constant%2520Temperature%26jtitle%3DBiophys.%2520J.%26date%3D1997%26volume%3D72%26spage%3D2002%26epage%3D2013%26doi%3D10.1016%2FS0006-3495%2897%2978845-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marelius, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolmodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feierberg, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Åqvist, J.</span></span> <span> </span><span class="NLM_article-title">Q: A Molecular Dynamics Program for Free Energy Calculations and Empirical Valence Bond Simulations in Biomolecular Systems</span>. <i>J. Mol. Graphics Modell.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">225</span>, <span class="refDoi"> DOI: 10.1016/s1093-3263(98)80006-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fs1093-3263%2898%2980006-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10522241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADyaK1MXmsVWmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1998&pages=213-225&author=J.+Mareliusauthor=K.+Kolmodinauthor=I.+Feierbergauthor=J.+%C3%85qvist&title=Q%3A+A+Molecular+Dynamics+Program+for+Free+Energy+Calculations+and+Empirical+Valence+Bond+Simulations+in+Biomolecular+Systems&doi=10.1016%2Fs1093-3263%2898%2980006-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Q: a molecular dynamics program for free energy calculations and empirical valence bond simulations in biomolecular systems</span></div><div class="casAuthors">Marelius, J.; Kolmodin, K.; Feierberg, I.; Aqvist, J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4/5/6</span>),
    <span class="NLM_cas:pages">213-225</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A new mol. dynamics program for free energy calcns. in biomol. systems is presented.  It is principally designed for free energy perturbation simulations, empirical valence bond calcns., and binding affinity estn. by linear interaction energy methods.  Evaluation of ligand-binding selectivity and free energy profiles for nucleophile activation in two protein tyrosine phosphatases as well as abs. binding affinity estn. for a lysine-binding protein are given as examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK9PQiYqiBIrVg90H21EOLACvtfcHk0lh8ls92HA0vTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsVWmtL0%253D&md5=e89a1cff3b31988baec5cd9759326b72</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fs1093-3263%2898%2980006-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs1093-3263%252898%252980006-5%26sid%3Dliteratum%253Aachs%26aulast%3DMarelius%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DFeierberg%26aufirst%3DI.%26aulast%3D%25C3%2585qvist%26aufirst%3DJ.%26atitle%3DQ%253A%2520A%2520Molecular%2520Dynamics%2520Program%2520for%2520Free%2520Energy%2520Calculations%2520and%2520Empirical%2520Valence%2520Bond%2520Simulations%2520in%2520Biomolecular%2520Systems%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D1998%26volume%3D16%26spage%3D213%26epage%3D225%26doi%3D10.1016%2Fs1093-3263%2898%2980006-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jespers, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esguerra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Åqvist, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez-de-Terán, H.</span></span> <span> </span><span class="NLM_article-title">Qligfep: An Automated Workflow for Small Molecule Free Energy Calculations in Q</span>. <i>J. Cheminf.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1186/s13321-019-0348-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1186%2Fs13321-019-0348-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpslagsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=1-16&author=W.+Jespersauthor=M.+Esguerraauthor=J.+%C3%85qvistauthor=H.+Guti%C3%A9rrez-de-Ter%C3%A1n&title=Qligfep%3A+An+Automated+Workflow+for+Small+Molecule+Free+Energy+Calculations+in+Q&doi=10.1186%2Fs13321-019-0348-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">QligFEP: an automated workflow for small molecule free energy calculations in Q</span></div><div class="casAuthors">Jespers, Willem; Esguerra, Mauricio; Aaqvist, Johan; Gutierrez-de-Teran, Hugo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cheminformatics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>CODEN:
                <span class="NLM_cas:coden">JCOHB3</span>;
        ISSN:<span class="NLM_cas:issn">1758-2946</span>.
    
            (<span class="NLM_cas:orgname">SpringerOpen</span>)
        </div><div class="casAbstract">The process of ligand binding to a biol. target can be represented as the equil. between the relevant solvated and bound states of the ligand.  This which is the basis of structure-based, rigorous methods such as the estn. of relative binding affinities by free energy perturbation (FEP).  Despite the growing capacity of computing power and the development of more accurate force fields, a high throughput application of FEP is currently hampered due to the need, in the current schemes, of an expert user definition of the "alchem." transformations between mols. in the series explored.  Here, we present QligFEP, a soln. to this problem using an automated workflow for FEP calcns. based on a dual topol. approach.  In this scheme, the starting poses of each of the two ligands, for which the relative affinity is to be calcd., are explicitly present in the MD simulations assocd. with the (dual topol.) FEP transformation, making the perturbation pathway between the two ligands univocal.  We show that this generalized method can be applied to accurately est. solvation free energies for amino acid sidechain mimics, as well as the binding affinity shifts due to the chem. changes typical of lead optimization processes.  This is illustrated in a no. of protein systems extd. from other FEP studies in the literature: inhibitors of CDK2 kinase and a series of A2A adenosine G protein-coupled receptor antagonists, where the results obtained with QligFEP are in excellent agreement with exptl. data.  In addn., our protocol allows for scaffold hopping perturbations to identify the binding affinities between different core scaffolds, which we illustrate with a series of Chk1 kinase inhibitors.  QligFEP is implemented in the open-source MD package Q, and works with the most common family of force fields: OPLS, CHARMM and AMBER.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkmg7__Ub7KbVg90H21EOLACvtfcHk0ljzM8VyIq6LqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpslagsrw%253D&md5=a476389264078fd32cd0d040596e165c</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1186%2Fs13321-019-0348-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13321-019-0348-5%26sid%3Dliteratum%253Aachs%26aulast%3DJespers%26aufirst%3DW.%26aulast%3DEsguerra%26aufirst%3DM.%26aulast%3D%25C3%2585qvist%26aufirst%3DJ.%26aulast%3DGuti%25C3%25A9rrez-de-Ter%25C3%25A1n%26aufirst%3DH.%26atitle%3DQligfep%253A%2520An%2520Automated%2520Workflow%2520for%2520Small%2520Molecule%2520Free%2520Energy%2520Calculations%2520in%2520Q%26jtitle%3DJ.%2520Cheminf.%26date%3D2019%26volume%3D11%26spage%3D1%26epage%3D16%26doi%3D10.1186%2Fs13321-019-0348-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">King, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warshel, A.</span></span> <span> </span><span class="NLM_article-title">A Surface Constrained All-Atom Solvent Model for Effective Simulations of Polar Solutions</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">3647</span>– <span class="NLM_lpage">3661</span>, <span class="refDoi"> DOI: 10.1063/1.456845</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1063%2F1.456845" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADyaL1MXmsVWntrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1989&pages=3647-3661&author=G.+Kingauthor=A.+Warshel&title=A+Surface+Constrained+All-Atom+Solvent+Model+for+Effective+Simulations+of+Polar+Solutions&doi=10.1063%2F1.456845"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">A surface constrained all-atom solvent model for effective simulations of polar solutions</span></div><div class="casAuthors">King, Gregory; Warshel, Arieh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3647-61</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">A surface constrained all-atom solvent (SCAAS) model was developed in order to consistently treat the surface polarization effects in all-atom mol. dynamics simulations.  The SCAAS model introduces surface constraints as boundary conditions in order to make the necessarily finite system behave as if it was part of an infinite system.  The performance of the model with regard to various properties of bulk water is examd. by comparing its results to those obtained by PBC simulations.  The results obtained from SCAAS models of different sizes are found to be similar to each other and to the corresponding PBC results.  The performance of the model in simulations of solvated ions is emphasized and a comparison of the results obtained with spheres of different sizes demonstrates that the model does not possess significant size dependence.  This indicates that the model can be used with a relatively small no. of solvent mols. for convergent simulation of structure, energetics, and dynamics of polar solns.  The much simpler fixed center Langevin dipoles model was also examd. and found to provide a powerful tool for estg. solvation free energies.  Finally, a preliminary study of the dielec. properties of the SCAAS model is reported and the potential of this model for exploring the correct implementation of the solvent reaction field is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa1aigs5xWZrVg90H21EOLACvtfcHk0ljzM8VyIq6LqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXmsVWntrw%253D&md5=ae548b312d7b9b3c57a1b0fba27ec702</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1063%2F1.456845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.456845%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DG.%26aulast%3DWarshel%26aufirst%3DA.%26atitle%3DA%2520Surface%2520Constrained%2520All-Atom%2520Solvent%2520Model%2520for%2520Effective%2520Simulations%2520of%2520Polar%2520Solutions%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1989%26volume%3D91%26spage%3D3647%26epage%3D3661%26doi%3D10.1063%2F1.456845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warshel, A.</span></span> <span> </span><span class="NLM_article-title">A Local Reaction Field Method for Fast Evaluation of Long-Range Electrostatic Interactions in Molecular Simulations</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">3100</span>– <span class="NLM_lpage">3107</span>, <span class="refDoi"> DOI: 10.1063/1.462997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1063%2F1.462997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADyaK38Xlslykt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1992&pages=3100-3107&author=F.+S.+Leeauthor=A.+Warshel&title=A+Local+Reaction+Field+Method+for+Fast+Evaluation+of+Long-Range+Electrostatic+Interactions+in+Molecular+Simulations&doi=10.1063%2F1.462997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">A local-reaction-field method for fast evaluation of long-range electrostatic interactions in molecular simulations</span></div><div class="casAuthors">Lee, Frederick S.; Warshel, Arieh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">3100-7</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">This work introduces a simple and very effective approach for treating the long-range electrostatic forces.  The present method, which is referred to as the local reaction field method, follows some of the ideas of the previously developed generalized Ewald method but then develops into a much simpler method.  This is done by dividing the system into M groups of atoms and evaluating sep. the short- and long-range contributions to the potential of each group.  The short-range potential is evaluated explicitly as in any std. truncation method, while the long-range potential is approximated by the first four terms in a multipole expansion.  In addn., the long-range potential is updated only once in every L time steps leading to a method of the order of N × M × q/L + N × P where q is related to the no. of expansion terms and P is the av. no. of atoms inside the cutoff range.  The speed, accuracy, and precision of the present method is assessed by evaluating the self-energy of a sodium ion in water and the self-energies of the acidic residues of bovine pancreatic trypsin inhibitor using an adiabatic charging free-energy perturbation approach.  The present method reproduces accurately the corresponding results obtained without any cutoff but an order of magnitude faster.  Furthermore, at the limit of very large systems, the speed of this method can be 2 orders of magnitude faster than that of the no-cutoff method even when each group contains only a small no. of atoms.  The method gives much better results for electrostatic energies in proteins than those obtained by truncation methods.  The stability and speed of the local reaction field method provides a powerful tool for the microscopic evaluation of electrostatic energies in macromols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouTs-m9qDIu7Vg90H21EOLACvtfcHk0ljzM8VyIq6LqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xlslykt7c%253D&md5=f5ac55192f5da7dc896470ec208bf79c</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1063%2F1.462997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.462997%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DF.%2BS.%26aulast%3DWarshel%26aufirst%3DA.%26atitle%3DA%2520Local%2520Reaction%2520Field%2520Method%2520for%2520Fast%2520Evaluation%2520of%2520Long-Range%2520Electrostatic%2520Interactions%2520in%2520Molecular%2520Simulations%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1992%26volume%3D97%26spage%3D3100%26epage%3D3107%26doi%3D10.1063%2F1.462997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryckaert, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciccotti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berendsen, H. J. C.</span></span> <span> </span><span class="NLM_article-title">Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes</span>. <i>J. Comput. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1016/0021-9991(77)90098-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2F0021-9991%2877%2990098-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADyaE2sXktVGhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1977&pages=327-341&author=J.-P.+Ryckaertauthor=G.+Ciccottiauthor=H.+J.+C.+Berendsen&title=Numerical+Integration+of+the+Cartesian+Equations+of+Motion+of+a+System+with+Constraints%3A+Molecular+Dynamics+of+n-Alkanes&doi=10.1016%2F0021-9991%2877%2990098-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Numerical integration of the Cartesian equations of motion of a system with constraints:  molecular dynamics of n-alkanes</span></div><div class="casAuthors">Ryckaert, Jean Paul; Ciccotti, Giovanni; Berendsen, Herman J. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Physics</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">327-41</span>CODEN:
                <span class="NLM_cas:coden">JCTPAH</span>;
        ISSN:<span class="NLM_cas:issn">0021-9991</span>.
    </div><div class="casAbstract">A numerical algorithm integrating the 3N Cartesian equation of motion of a system of N points subject to holonomic constraints is applied to mol. dynamics simulation of a liq. of 64 butane mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYPlhG1U3Uw7Vg90H21EOLACvtfcHk0liiWOfRPsdBXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXktVGhsL4%253D&md5=b4aecddfde149117813a5ea4f5353ce2</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2F0021-9991%2877%2990098-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0021-9991%252877%252990098-5%26sid%3Dliteratum%253Aachs%26aulast%3DRyckaert%26aufirst%3DJ.-P.%26aulast%3DCiccotti%26aufirst%3DG.%26aulast%3DBerendsen%26aufirst%3DH.%2BJ.%2BC.%26atitle%3DNumerical%2520Integration%2520of%2520the%2520Cartesian%2520Equations%2520of%2520Motion%2520of%2520a%2520System%2520with%2520Constraints%253A%2520Molecular%2520Dynamics%2520of%2520n-Alkanes%26jtitle%3DJ.%2520Comput.%2520Phys.%26date%3D1977%26volume%3D23%26spage%3D327%26epage%3D341%26doi%3D10.1016%2F0021-9991%2877%2990098-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirado-Rives, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span> <span> </span><span class="NLM_article-title">Improved Peptide and Protein Torsional Energetics with the OPLS-AA Force Field</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3499</span>– <span class="NLM_lpage">3509</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.5b00356</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00356" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsFOlsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=3499-3509&author=M.+J.+Robertsonauthor=J.+Tirado-Rivesauthor=W.+L.+Jorgensen&title=Improved+Peptide+and+Protein+Torsional+Energetics+with+the+OPLS-AA+Force+Field&doi=10.1021%2Facs.jctc.5b00356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Improved Peptide and Protein Torsional Energetics with the OPLS-AA Force Field</span></div><div class="casAuthors">Robertson, Michael J.; Tirado-Rives, Julian; Jorgensen, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3499-3509</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development and validation of new peptide dihedral parameters are reported for the OPLS-AA force field.  High accuracy quantum chem. methods were used to scan φ, ψ, χ1, and χ2 potential energy surfaces for blocked dipeptides.  New Fourier coeffs. for the dihedral angle terms of the OPLS-AA force field were fit to these surfaces, utilizing a Boltzmann-weighted error function and systematically examg. the effects of weighting temp.  To prevent overfitting to the available data, a minimal no. of new residue-specific and peptide-specific torsion terms were developed.  Extensive exptl. soln.-phase and quantum chem. gas-phase benchmarks were used to assess the quality of the new parameters, named OPLS-AA/M, demonstrating significant improvement over previous OPLS-AA force fields.  A Boltzmann weighting temp. of 2000 K was detd. to be optimal for fitting the new Fourier coeffs. for dihedral angle parameters.  Conclusions are drawn from the results for best practices for developing new torsion parameters for protein force fields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxE-hNg6xKqLVg90H21EOLACvtfcHk0liiWOfRPsdBXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsFOlsbc%253D&md5=b9836b19acadc1a86369bca744ca9b13</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00356%26sid%3Dliteratum%253Aachs%26aulast%3DRobertson%26aufirst%3DM.%2BJ.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26atitle%3DImproved%2520Peptide%2520and%2520Protein%2520Torsional%2520Energetics%2520with%2520the%2520OPLS-AA%2520Force%2520Field%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2015%26volume%3D11%26spage%3D3499%26epage%3D3509%26doi%3D10.1021%2Facs.jctc.5b00356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, C. H.</span></span> <span> </span><span class="NLM_article-title">Efficient Estimation of Free Energy Differences from Monte Carlo Data</span>. <i>J. Comput. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.1016/0021-9991(76)90078-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2F0021-9991%2876%2990078-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1976&pages=245-268&author=C.+H.+Bennett&title=Efficient+Estimation+of+Free+Energy+Differences+from+Monte+Carlo+Data&doi=10.1016%2F0021-9991%2876%2990078-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2F0021-9991%2876%2990078-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0021-9991%252876%252990078-4%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DC.%2BH.%26atitle%3DEfficient%2520Estimation%2520of%2520Free%2520Energy%2520Differences%2520from%2520Monte%2520Carlo%2520Data%26jtitle%3DJ.%2520Comput.%2520Phys.%26date%3D1976%26volume%3D22%26spage%3D245%26epage%3D268%26doi%3D10.1016%2F0021-9991%2876%2990078-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 1 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun‐An  Xiao</span>, <span class="hlFld-ContribAuthor ">Hai  Peng</span>, <span class="hlFld-ContribAuthor ">Jin‐Shao  Liang</span>, <span class="hlFld-ContribAuthor ">Xiao‐Yan  Luo</span>, <span class="hlFld-ContribAuthor ">Xiu‐Liang  Cheng</span>, <span class="hlFld-ContribAuthor ">Wei  Su</span>. </span><span class="cited-content_cbyCitation_article-title">Gold‐Catalyzed Tandem Cycloisomerization/Ring Expansion of Alkynyl Spiro‐epoxyoxindoles: Access to Furo[2,3‐c]quinolinone Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>10 </em>
                                    (6)
                                     , 1436-1439. <a href="https://doi.org/10.1002/ajoc.202100202" title="DOI URL">https://doi.org/10.1002/ajoc.202100202</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.202100202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.202100202%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DGold%2525E2%252580%252590Catalyzed%252BTandem%252BCycloisomerization%25252FRing%252BExpansion%252Bof%252BAlkynyl%252BSpiro%2525E2%252580%252590epoxyoxindoles%25253A%252BAccess%252Bto%252BFuro%25255B2%25252C3%2525E2%252580%252590c%25255Dquinolinone%252BDerivatives%26aulast%3DXiao%26aufirst%3DJun%25E2%2580%2590An%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D6%26spage%3D1436%26epage%3D1439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0025.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of representative A<sub>2B</sub>AR antagonists.<a onclick="showRef(event, 'ref34 ref35 ref36 ref37 ref38 ref39 ref40 ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36 ref37 ref38 ref39 ref40 ref41 ref42 ref43">(34−43)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. General structure of previously explored chemotypes (panel A) and novel series herein documented (panel B, series <b>I–IX</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 3,4-Dihydropyrimidin-2-one/thione Series <b>I–III</b> (Cpds <b>16–99</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 3,4-Dihydropyrimidin-2-one Series <b>IV–VI</b> (Cpds <b>105–144</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 3,4-Dihydropyrimidin-2-one Series <b>VII–IX</b> (Cpds <b>145–180</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Radioligand binding and functional assays. (Left) Concentration–response curves of <b>47</b> (▲) and <b>38</b> (■) at hA<sub>2B</sub> ARs labeled with 22 nM [<sup>3</sup>H]DPCPX. (Right) Concentration–response curves of <b>47</b> (▲) and <b>38</b> (■) over 100 nM NECA-elicited cAMP formation. Points represent the mean ± SD (vertical bars) of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Chiral HPLC traces, CD spectra, and absolute configuration for (±)-<b>38</b> and (±)-<b>47</b> and its enantiomers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Proposed binding mode of the 3,4-dihydropyrimidin-2(1<i>H</i>)-one/thione scaffold (left) and graphical analysis of the SAR from tables <b>I–III</b> (right). The bars represent the p<i>K</i><sub>i</sub> value on the A<sub>2B</sub>AR for the highest affinity compound within each of the R<sub>4</sub> (top graph) or R<sub>5</sub> (bottom graph) substituents, as extracted from each of the three subsets (blue: subset <b>I</b>, compounds <b>16–43</b> in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>; orange, subset <b>II</b>, compounds <b>44–71</b> in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>; gray, subset <b>III</b>, compounds <b>72–99</b> in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of methylation on R<sub>1</sub>. The binding modes considered are depicted in panels (A,B) for the compound pair <b>19</b> (R<sub>1</sub> = NH) and <b>75</b> (R<sub>1</sub> = N–CH<sub>3</sub>). Panel (C) depicts the result of the FEP simulations, performed on each binding pose for 10 pairs of compounds. Color code corresponds to the binding pose, blue for pose A, and orange for pose B. * = no detectable binding.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Binding mode of compounds <b>19</b> (subset <b>I</b>, orange) and <b>47</b> (subset <b>II</b>, blue), before and after the corresponding FEP transformation in the A<sub>2B</sub>AR model (top). It can be appreciated by the shift in the binding orientation due to the heteroatom change. Experimental and calculated binding free energies between this and analogous compound pairs in subsets <b>I</b> and <b>II</b> are depicted in the bar graph (bottom). *No detectable binding.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Proposed binding mode of the 3,4-dihydropyrimidin-2-one scaffold (left) and graphical analysis of the SAR from tables <b>I</b> and <b>IX</b> (right). The bars represent the p<i>K</i><sub>i</sub> value for each of the R<sub>5</sub> substituents, for the three groups of R<sub>4</sub> with the highest affinity [2-furyl (blue), 3-furyl (orange), and 3-thienyl (gray)]. Binding mode of <b>19</b> (B, in pink) and <b>157</b> (C, in blue), binding site waters (from apo MD simulations) are depicted in spheres. Water 1 is replaced by both compounds; however, waters 2 and 3 are not displaced by <b>19</b> (<b>SYAF014</b>). These waters are buried deeply in the binding site and overlay with structural waters from the A<sub>2A</sub>AR crystal structure (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EIY">4EIY</a>). It is likely that these waters are favorably accommodated in the binding site and hence should not be displaced by any compound, in agreement with the decrease in affinity of <b>157</b> compared to <b>19</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Migration of PC-3, DU145 and LNCaP cells. (A) A<sub>2B</sub>AR antagonists (±)-<b>38</b> and (±)-<b>47</b> inhibited PC-3, LNCaP, and DU145 cell migration, in comparison to the controls (CTL) and <b>PSB603</b>. Results are expressed as mean ± SE, from at least three separate experiments, each conducted in triplicates. *A<sub>2B</sub>AR antagonists’ treatment was significantly different compared with control treatment (<i>p</i> < 0.05); ▲A<sub>2B</sub>AR antagonist (±)-<b>38</b> and A<sub>2B</sub>AR antagonist (±)-<b>47</b> were significantly different compared with A<sub>2B</sub>AR antagonist <b>PSB603</b> (<i>p</i> < 0.05). (B) Representative microphotographs of PC-3 cells (40×) which migrated through the chamber membranes: (B<sub>1</sub>) control, (B<sub>2</sub>), A<sub>2B</sub>AR antagonist <b>PSB603</b>, (B<sub>3</sub>) A<sub>2B</sub>AR antagonist (±)-<b>38</b>, (B<sub>4</sub>) A<sub>2B</sub>AR antagonist (±)-<b>47</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/medium/jm0c01431_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Cytopathic changes of PC-3 cells observed by confocal laser scanning microscopy. Blue (DAPI), green (CFDA-SE), and red (phalloidin–ATTO 647N) and merge of three channels. Cells treated with (±)-<b>47</b> (10.2 nM) or (±)-<b>38</b> (23.6 nM) showed predominantly rounded shape phenotype with DNA condensation. Untreated PC-3 cells showed an elongated phenotype with cytoplasmic projections when compared with A<sub>B2</sub>AR antagonist-treated PC-3 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01431/20210107/images/large/jm0c01431_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01431&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i51">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58536" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58536" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 96 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rivkees, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reppert, S. M.</span></span> <span> </span><span class="NLM_article-title">RFL9 Encodes an A2b-Adenosine Receptor</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1598</span>– <span class="NLM_lpage">1604</span>, <span class="refDoi"> DOI: 10.1210/mend.6.10.1333049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1210%2Fmend.6.10.1333049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1333049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADyaK3sXhvF2qug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1992&pages=1598-1604&author=S.+A.+Rivkeesauthor=S.+M.+Reppert&title=RFL9+Encodes+an+A2b-Adenosine+Receptor&doi=10.1210%2Fmend.6.10.1333049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">RFL9 encodes an A2b-adenosine receptor</span></div><div class="casAuthors">Rivkees, Scott A.; Reppert, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1598-604</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    </div><div class="casAbstract">The authors recently reported the cloning of a cDNA (designated RFL9) that encodes a novel A2-adenosine receptor subtype.  Here, the pharmacol. properties of RFL9 were characterized in stably transfected CHO cells by examg. cAMP responses to drug treatments.  The pharmacol. profile of cAMP responses in RFL9-transfected cells was similar to that expected for A2b-adenosine receptors and distinct from that of CHO cells transfected with the A2a-adenosine receptor.  When RFL9-transfected cells were compared with VA 13 fibroblasts, the human cell line in which endogenous A2b-adenosine receptors were originally characterized, the dose-response curves of cAMP responses to drug treatments were highly correlated.  Northern blot anal. of RNA prepd. from VA 13 fibroblasts revealed specific hybridizing transcripts when probed for RFL9, but no hybridizing signal for A2a-adenosine receptor mRNA.  Using degenerate oligonucleotide primers designed to detect adenosine receptors by PCR reaction, only 1 cDNA fragment homologous to the rat A2b-adenosine receptor was isolated from VA 13 cells.  These results strongly suggest that RFL9 encodes the proposed A2b-adenosine receptor subtype.  The identification of the cDNA for an A2b-adenosine receptor will allow more rigorous characterization of its anatomical distribution and functional properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGcZ6WQ3bIxbVg90H21EOLACvtfcHk0lj7uz3mrMDQmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhvF2qug%253D%253D&md5=1dbb93e3006dea720c62f570aec7b676</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1210%2Fmend.6.10.1333049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fmend.6.10.1333049%26sid%3Dliteratum%253Aachs%26aulast%3DRivkees%26aufirst%3DS.%2BA.%26aulast%3DReppert%26aufirst%3DS.%2BM.%26atitle%3DRFL9%2520Encodes%2520an%2520A2b-Adenosine%2520Receptor%26jtitle%3DMol.%2520Endocrinol.%26date%3D1992%26volume%3D6%26spage%3D1598%26epage%3D1604%26doi%3D10.1210%2Fmend.6.10.1333049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furlong, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selbie, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shine, J.</span></span> <span> </span><span class="NLM_article-title">Molecular Cloning and Expression of an Adenosine A2b Receptor from Human Brain</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>187</i></span>,  <span class="NLM_fpage">86</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(05)81462-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2FS0006-291X%2805%2981462-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1325798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADyaK3sXksVWitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=1992&pages=86-93&author=K.+D.+Pierceauthor=T.+J.+Furlongauthor=L.+A.+Selbieauthor=J.+Shine&title=Molecular+Cloning+and+Expression+of+an+Adenosine+A2b+Receptor+from+Human+Brain&doi=10.1016%2FS0006-291X%2805%2981462-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning and expression of an adenosine A2b receptor from human brain</span></div><div class="casAuthors">Pierce, Kerrie D.; Furlong, Timothy J.; Selbie, Lisa A.; Shine, John</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">86-93</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">A novel receptor cDNA was isolated from a human hippocampal cDNA library.  The encoded polypeptide contains structural features consistent with its classification as a G protein-coupled receptor and shares 45% homol. with the human A1 and A2a adenosine receptors.  Chinese hamster ovary K1 cells expressing this receptor showed marked stimulation of adenylate cyclase when treated with 1 mM adenosine.  There was no response to ligands selective for A1 and A2a receptors but the general adenosine agonist N-ethylcarboxyamidoadenosine (NECA) caused a 10-fold increase in cAMP accumulation with an EC50 of approx. 0.9 μM.  This effect was inhibited by the adenosine receptor antagonist theophylline.  Specific binding of A1 and A2a selective agonists and NECA was not detected.  It is proposed that the novel receptor is a human brain adenosine A2b receptor subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYMoxdq7h-XrVg90H21EOLACvtfcHk0lhTPt_HCDwUyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXksVWitrY%253D&md5=508a77e25ebb1a3513d044122228dd6b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2805%2981462-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252805%252981462-7%26sid%3Dliteratum%253Aachs%26aulast%3DPierce%26aufirst%3DK.%2BD.%26aulast%3DFurlong%26aufirst%3DT.%2BJ.%26aulast%3DSelbie%26aufirst%3DL.%2BA.%26aulast%3DShine%26aufirst%3DJ.%26atitle%3DMolecular%2520Cloning%2520and%2520Expression%2520of%2520an%2520Adenosine%2520A2b%2520Receptor%2520from%2520Human%2520Brain%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1992%26volume%3D187%26spage%3D86%26epage%3D93%26doi%3D10.1016%2FS0006-291X%2805%2981462-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beukers, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Den Dulk, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Tilburg, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span> <span> </span><span class="NLM_article-title">Why Are A2B Receptors Low-Affinity Adenosine Receptors? Mutation of Asn273 to Tyr Increases Affinity of Human A2B Receptor for 2-(1-Hexynyl)adenosine</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1349</span>– <span class="NLM_lpage">1356</span>, <span class="refDoi"> DOI: 10.1124/mol.58.6.1349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1124%2Fmol.58.6.1349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=11093773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovFeqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2000&pages=1349-1356&author=M.+W.+Beukersauthor=H.+Den+Dulkauthor=E.+W.+Van+Tilburgauthor=J.+Brouwerauthor=A.+P.+Ijzerman&title=Why+Are+A2B+Receptors+Low-Affinity+Adenosine+Receptors%3F+Mutation+of+Asn273+to+Tyr+Increases+Affinity+of+Human+A2B+Receptor+for+2-%281-Hexynyl%29adenosine&doi=10.1124%2Fmol.58.6.1349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Why are A2B receptors low-affinity adenosine receptors? Mutation of Asn273 to Tyr increases affinity of human A2B receptor for 2-(1-hexynyl)adenosine</span></div><div class="casAuthors">Beukers, Margot W.; den Dulk, Hans; Van Tilburg, Erica W.; Brouwer, Jaap; Ijerman, Adriaan P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1349-1356</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Adenosine A2B receptors are known as low-affinity receptors due to their modest-to-negligible affinity for adenosine and prototypic agonists.  Despite numerous synthetic efforts, 5'-N-ethylcarboxamidoadenosine (NECA) still is the ref. agonist, albeit nonselective for this receptor.  In the authors' search for higher affinity agonists, the authors developed decision schemes to select amino acids for mutation to the corresponding residues in the most homologous, higher affinity, human A2A receptor.  One scheme exploited knowledge on sequence alignments and modeling data and yielded three residues, V11, L58, and F59, mutation of which did not affect agonist affinity.  The second scheme combined knowledge on sequence alignments and mutation data and pointed to Ala 12 and Asn 273.  Mutation of Ala 12 to threonine did not affect the affinity for NECA, (R)-N6-(phenylisopropyl)adenosine (R-PIA), and 2Cl Ado.  The affinity of the N273Y mutant for NECA and R-PIA and for the antagonists xanthine amine congener (XAC), ZM241385, and SCH58261 was also unaltered.  However, this mutant had a slightly increased affinity for a 2-substituted adenosine deriv., CGS21680.  This prompted the authors to investigate other 2-substituted adenosines, with selectivity and high affinity for A2A receptors.  All four compds. tested had improved affinity for the N273Y receptor.  Of these, 2-(1-hexynyl)adenosine had submicromolar affinity for the N273Y receptor, 0.18±0.10 μM, with a 61-fold affinity gain over the wt receptor.  In addn., the non-NECA analog (S)-PHP adenosine had an affinity of 1.7±0.5 μM for the wt receptor.  The high affinity of (S)-PHP adenosine for the wt receptor suggests that further modifications at the 2-position may yield agonists with even higher affinity for A2B receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTiX-Z-7VU-LVg90H21EOLACvtfcHk0lhTPt_HCDwUyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovFeqs78%253D&md5=9325abaf777165625a71c5f5b0d6aa2c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1124%2Fmol.58.6.1349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.58.6.1349%26sid%3Dliteratum%253Aachs%26aulast%3DBeukers%26aufirst%3DM.%2BW.%26aulast%3DDen%2BDulk%26aufirst%3DH.%26aulast%3DVan%2BTilburg%26aufirst%3DE.%2BW.%26aulast%3DBrouwer%26aufirst%3DJ.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3DWhy%2520Are%2520A2B%2520Receptors%2520Low-Affinity%2520Adenosine%2520Receptors%253F%2520Mutation%2520of%2520Asn273%2520to%2520Tyr%2520Increases%2520Affinity%2520of%2520Human%2520A2B%2520Receptor%2520for%25202-%25281-Hexynyl%2529adenosine%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D58%26spage%3D1349%26epage%3D1356%26doi%3D10.1124%2Fmol.58.6.1349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fredholm, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irenius, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kull, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulte, G.</span></span> <span> </span><span class="NLM_article-title">Comparison of the Potency of Adenosine as an Agonist at Human Adenosine Receptors Expressed in Chinese Hamster Ovary Cells</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">448</span>, <span class="refDoi"> DOI: 10.1016/S0006-2952(00)00570-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2FS0006-2952%2800%2900570-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=11226378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsVOiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=443-448&author=B.+B.+Fredholmauthor=E.+Ireniusauthor=B.+Kullauthor=G.+Schulte&title=Comparison+of+the+Potency+of+Adenosine+as+an+Agonist+at+Human+Adenosine+Receptors+Expressed+in+Chinese+Hamster+Ovary+Cells&doi=10.1016%2FS0006-2952%2800%2900570-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells</span></div><div class="casAuthors">Fredholm, B. B.; Irenius, E.; Kull, B.; Schulte, G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">443-448</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The potency of adenosine and inosine as agonists at human adenosine receptors was examd. in a functional assay using changes in cAMP formation in intact Chinese hamster ovary (CHO) cells stably transfected with the human A1, A2A, A2B, and A3 receptors.  Adenosine increased cAMP formation in cells expressing the A2A (EC50: 0.7 μM) and A2B (EC50: 24 μM) receptors and inhibited forskolin (0.3-3 μM)-stimulated cAMP formation in cells expressing the A1 (EC50: 0.31 μM) and A3 receptors (EC50: 0.29 μM).  The potency of adenosine at the A2A and A2B receptors was not altered by the presence of the uptake inhibitor nitrobenzylthioinosine (NBMPR), whereas it was increased about 6-fold by NBMPR at the A1 and A3 receptors.  In the presence of NBMPR, inosine was a potent agonist (EC50: 7 and 0.08 μM at the A1 and A3 receptors, resp.), but with low efficacy esp. at the A3 receptors.  No effect of inosine was seen at the A2 receptors.  Caffeine, theophylline, and paraxanthine shifted the dose-response curve for adenosine at the A1, A2A, and A2B receptors.  These results indicate that adenosine is the endogenous agonist at all human adenosine receptors and that physiol. levels of this nucleoside can activate A1, A2A, and A3 receptors on cells where they are abundantly expressed, whereas pathophysiol. conditions are required to stimulate A2B receptors to produce cAMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8KNx0HlJjOrVg90H21EOLACvtfcHk0lhTPt_HCDwUyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsVOiu7c%253D&md5=dd9a7630a12458fcca188164c702cc13</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2800%2900570-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252800%252900570-0%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DIrenius%26aufirst%3DE.%26aulast%3DKull%26aufirst%3DB.%26aulast%3DSchulte%26aufirst%3DG.%26atitle%3DComparison%2520of%2520the%2520Potency%2520of%2520Adenosine%2520as%2520an%2520Agonist%2520at%2520Human%2520Adenosine%2520Receptors%2520Expressed%2520in%2520Chinese%2520Hamster%2520Ovary%2520Cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2001%26volume%3D61%26spage%3D443%26epage%3D448%26doi%3D10.1016%2FS0006-2952%2800%2900570-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fredholm, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors-An Update</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1124/pr.110.003285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1124%2Fpr.110.003285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=21303899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslGisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=1-34&author=B.+B.+Fredholmauthor=A.+P.+Ijzermanauthor=K.+A.+Jacobsonauthor=J.+Lindenauthor=C.+E.+M%C3%BCller&title=International+Union+of+Basic+and+Clinical+Pharmacology.+LXXXI.+Nomenclature+and+Classification+of+Adenosine+Receptors-An+Update&doi=10.1124%2Fpr.110.003285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors - an update</span></div><div class="casAuthors">Fredholm, Bertil B.; IJzerman, Adriaan P.; Jacobson, Kenneth A.; Linden, Joel; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-34</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  In the 10 years since our previous International Union of Basic and Clin. Pharmacol. report on the nomenclature and classification of adenosine receptors, no developments have led to major changes in the recommendations.  However, there have been so many other developments that an update is needed.  The fact that the structure of one of the adenosine receptors has recently been solved has already led to new ways of in silico screening of ligands.  The evidence that adenosine receptors can form homo- and hetero-multimers has accumulated, but the functional significance of such complexes remains unclear.  The availability of mice with genetic modification of all the adenosine receptors has led to a clarification of the functional roles of adenosine, and to excellent means to study the specificity of drugs.  There are also interesting assocns. between disease and structural variants in one or more of the adenosine receptors.  Several new selective agonists and antagonists have become available.  They provide improved possibilities for receptor classification.  There are also developments hinting at the usefulness of allosteric modulators.  Many drugs targeting adenosine receptors are in clin. trials, but the established therapeutic use is still very limited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNqbDC-UZ5sbVg90H21EOLACvtfcHk0lhUSL92XWgLRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslGisrY%253D&md5=e184c127e06b800bbcf15402ed27f02a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.003285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.003285%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DInternational%2520Union%2520of%2520Basic%2520and%2520Clinical%2520Pharmacology.%2520LXXXI.%2520Nomenclature%2520and%2520Classification%2520of%2520Adenosine%2520Receptors-An%2520Update%26jtitle%3DPharmacol.%2520Rev.%26date%3D2011%26volume%3D63%26spage%3D1%26epage%3D34%26doi%3D10.1124%2Fpr.110.003285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koupenova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliades, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toselli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravid, K.</span></span> <span> </span><span class="NLM_article-title">A New Role for the A2b Adenosine Receptor in Regulating Platelet Function</span>. <i>J. Thromb. Haemostasis</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">817</span>– <span class="NLM_lpage">827</span>, <span class="refDoi"> DOI: 10.1111/j.1538-7836.2010.03769.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1111%2Fj.1538-7836.2010.03769.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=20102488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVGksbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=817-827&author=D.+Yangauthor=H.+Chenauthor=M.+Koupenovaauthor=S.+H.+Carrollauthor=A.+Eliadesauthor=J.+E.+Freedmanauthor=P.+Toselliauthor=K.+Ravid&title=A+New+Role+for+the+A2b+Adenosine+Receptor+in+Regulating+Platelet+Function&doi=10.1111%2Fj.1538-7836.2010.03769.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A new role for the A2b adenosine receptor in regulating platelet function</span></div><div class="casAuthors">Yang, D.; Chen, H.; Koupenova, M.; Carroll, S. H.; Eliades, A.; Freedman, J. E.; Toselli, P.; Ravid, K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-827</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background: Activation of platelets is a crit. component of atherothrombosis and plays a central role in the progression of unstable cardiovascular syndromes.  Adenosine, acting through adenosine receptors, increases intracellular cAMP levels and inhibits platelet aggregation.  The A2a adenosine receptor has already been recognized as a mediator of adenosine-dependent effects on platelet aggregation, and here we present a new role for the A2b adenosine receptor (A2bAR) in this process.  Methods and Results: As compared with platelets from wild-type controls, platelets derived from A2bAR knockout mice have significantly greater ADP receptor activation-induced aggregation.  Although mouse megakaryocytes and platelets express low levels of the A2bAR transcript, this gene is highly upregulated following injury and systemic inflammation in vivo.  Under these conditions, A2bAR-mediated inhibition of platelet aggregation significantly increases.  Our studies also identify a novel mechanism by which the A2bAR could regulate platelet aggregation; namely, ablation of the A2bAR leads to upregulated expression of the P2Y1 ADP receptor, whereas A2bAR-mediated or direct elevation of cAMP has the opposite effect.  Thus, the A2bAR regulates platelet function beyond mediating the immediate effect of adenosine on aggregation.  Conclusions: Taken together, these investigations show for the first time that the platelet A2bAR is upregulated under stress in vivo, plays a significant role in regulating ADP receptor expression, and inhibits agonist-induced platelet aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN-oGDZCyD2LVg90H21EOLACvtfcHk0lhUSL92XWgLRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVGksbs%253D&md5=882c8143d7bb1fe14a7b8f4300d07b0c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2010.03769.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2010.03769.x%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DKoupenova%26aufirst%3DM.%26aulast%3DCarroll%26aufirst%3DS.%2BH.%26aulast%3DEliades%26aufirst%3DA.%26aulast%3DFreedman%26aufirst%3DJ.%2BE.%26aulast%3DToselli%26aufirst%3DP.%26aulast%3DRavid%26aufirst%3DK.%26atitle%3DA%2520New%2520Role%2520for%2520the%2520A2b%2520Adenosine%2520Receptor%2520in%2520Regulating%2520Platelet%2520Function%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2010%26volume%3D8%26spage%3D817%26epage%3D827%26doi%3D10.1111%2Fj.1538-7836.2010.03769.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koupenova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCrann, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopeikina, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravid, K.</span></span> <span> </span><span class="NLM_article-title">The A2b Adenosine Receptor Protects against Vascular Injury</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">792</span>– <span class="NLM_lpage">796</span>, <span class="refDoi"> DOI: 10.1073/PNAS.0705563105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1073%2FPNAS.0705563105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=18184815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVSjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=792-796&author=D.+Yangauthor=M.+Koupenovaauthor=D.+J.+McCrannauthor=K.+J.+Kopeikinaauthor=H.+M.+Kaganauthor=B.+M.+Schreiberauthor=K.+Ravid&title=The+A2b+Adenosine+Receptor+Protects+against+Vascular+Injury&doi=10.1073%2FPNAS.0705563105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The A2b adenosine receptor protects against vascular injury</span></div><div class="casAuthors">Yang, Dan; Koupenova, Milka; McCrann, Donald J.; Kopeikina, Katherine J.; Kagan, Herbert M.; Schreiber, Barbara M.; Ravid, Katya</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">792-796</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The A2b adenosine receptor (A2bAR) is highly abundant in bone marrow macrophages and vascular smooth muscle cells (VSMC).  To examine the functional significance of this receptor expression, we applied a femoral artery injury model to A2bAR knockout (KO) mice and showed that the A2bAR prevents vascular lesion formation in an injury model that resembles human restenosis after angioplasty.  While considering related mechanisms, we noted higher levels of TNF-α, an up-regulator of CXCR4, and of VSMC proliferation in the injured KO mice.  In accordance, CXCR4, which is known to attract progenitor cells during tissue regeneration, is up-regulated in lesions of the KO mice.  In addn., aortic smooth muscle cells derived from A2bAR KO mice display greater proliferation in comparison with controls.  Bone marrow transplantation expts. indicated that the majority of the signal for lesion formation in the null mice originates from bone marrow cells.  Thus, this study highlights the significance of the A2bAR in regulating CXCR4 expression in vivo and in protecting against vascular lesion formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJnXsJjGPbcLVg90H21EOLACvtfcHk0lhUSL92XWgLRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVSjs7Y%253D&md5=edc8e50d8d5160ba8f0c21691cf806d5</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2FPNAS.0705563105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252FPNAS.0705563105%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DD.%26aulast%3DKoupenova%26aufirst%3DM.%26aulast%3DMcCrann%26aufirst%3DD.%2BJ.%26aulast%3DKopeikina%26aufirst%3DK.%2BJ.%26aulast%3DKagan%26aufirst%3DH.%2BM.%26aulast%3DSchreiber%26aufirst%3DB.%2BM.%26aulast%3DRavid%26aufirst%3DK.%26atitle%3DThe%2520A2b%2520Adenosine%2520Receptor%2520Protects%2520against%2520Vascular%2520Injury%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D792%26epage%3D796%26doi%3D10.1073%2FPNAS.0705563105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koupenova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makitalo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. Hilaire, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toselli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamperti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavras, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravid, K.</span></span> <span> </span><span class="NLM_article-title">The A2B Adenosine Receptor Protects against Inflammation and Excessive Vascular Adhesion</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">1913</span>– <span class="NLM_lpage">1923</span>, <span class="refDoi"> DOI: 10.1172/JCI27933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1172%2FJCI27933" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=16823489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvV2lur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2006&pages=1913-1923&author=D.+Yangauthor=Y.+Zhangauthor=H.+G.+Nguyenauthor=M.+Koupenovaauthor=A.+K.+Chauhanauthor=M.+Makitaloauthor=M.+R.+Jonesauthor=C.+St.+Hilaireauthor=D.+C.+Seldinauthor=P.+Toselliauthor=E.+Lampertiauthor=B.+M.+Schreiberauthor=H.+Gavrasauthor=D.+D.+Wagnerauthor=K.+Ravid&title=The+A2B+Adenosine+Receptor+Protects+against+Inflammation+and+Excessive+Vascular+Adhesion&doi=10.1172%2FJCI27933"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The A2B adenosine receptor protects against inflammation and excessive vascular adhesion</span></div><div class="casAuthors">Yang, Dan; Zhang, Ying; Nguyen, Hao G.; Koupenova, Milka; Chauhan, Anil K.; Makitalo, Maria; Jones, Matthew R.; St. Hilaire, Cynthia; Seldin, David C.; Toselli, Paul; Lamperti, Edward; Schreiber, Barbara M.; Gavras, Haralambos; Wagner, Denisa D.; Ravid, Katya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1913-1923</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Adenosine has been described as playing a role in the control of inflammation, but it has not been certain which of its receptors mediate this effect.  Here, we generated an A2B adenosine receptor-knockout/reporter gene-knock-in (A2BAR-knockout/reporter gene-knock-in) mouse model and showed receptor gene expression in the vasculature and macrophages, the ablation of which causes low-grade inflammation compared with age-, sex-, and strain-matched control mice.  Augmentation of proinflammatory cytokines, such as TNF-α, and a consequent downregulation of IκB-α are the underlying mechanisms for an obsd. upregulation of adhesion mols. in the vasculature of these A2BAR-null mice.  Intriguingly, leukocyte adhesion to the vasculature is significantly increased in the A2BAR-knockout mice.  Exposure to an endotoxin results in augmented proinflammatory cytokine levels in A2BAR-null mice compared with control mice.  Bone marrow transplantations indicated that bone marrow (and to a lesser extent vascular) A2BARs regulate these processes.  Hence, we identify the A2BAR as a new crit. regulator of inflammation and vascular adhesion primarily via signals from hematopoietic cells to the vasculature, focusing attention on the receptor as a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwUPBsNqSZV7Vg90H21EOLACvtfcHk0ljyRa2IjDonKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvV2lur4%253D&md5=aa57093195cd8aac440709eb86067f7d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1172%2FJCI27933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI27933%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DNguyen%26aufirst%3DH.%2BG.%26aulast%3DKoupenova%26aufirst%3DM.%26aulast%3DChauhan%26aufirst%3DA.%2BK.%26aulast%3DMakitalo%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DM.%2BR.%26aulast%3DSt.%2BHilaire%26aufirst%3DC.%26aulast%3DSeldin%26aufirst%3DD.%2BC.%26aulast%3DToselli%26aufirst%3DP.%26aulast%3DLamperti%26aufirst%3DE.%26aulast%3DSchreiber%26aufirst%3DB.%2BM.%26aulast%3DGavras%26aufirst%3DH.%26aulast%3DWagner%26aufirst%3DD.%2BD.%26aulast%3DRavid%26aufirst%3DK.%26atitle%3DThe%2520A2B%2520Adenosine%2520Receptor%2520Protects%2520against%2520Inflammation%2520and%2520Excessive%2520Vascular%2520Adhesion%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2006%26volume%3D116%26spage%3D1913%26epage%3D1923%26doi%3D10.1172%2FJCI27933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morello, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miele, L.</span></span> <span> </span><span class="NLM_article-title">Targeting the Adenosine A2b Receptor in the Tumor Microenvironment Overcomes Local Immunosuppression by Myeloid-Derived Suppressor Cells</span>. <i>Oncoimmunology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">e27989</span> <span class="refDoi"> DOI: 10.4161/onci.27989</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.4161%2Fonci.27989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=25101221" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&author=S.+Morelloauthor=L.+Miele&title=Targeting+the+Adenosine+A2b+Receptor+in+the+Tumor+Microenvironment+Overcomes+Local+Immunosuppression+by+Myeloid-Derived+Suppressor+Cells&doi=10.4161%2Fonci.27989"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.4161%2Fonci.27989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fonci.27989%26sid%3Dliteratum%253Aachs%26aulast%3DMorello%26aufirst%3DS.%26aulast%3DMiele%26aufirst%3DL.%26atitle%3DTargeting%2520the%2520Adenosine%2520A2b%2520Receptor%2520in%2520the%2520Tumor%2520Microenvironment%2520Overcomes%2520Local%2520Immunosuppression%2520by%2520Myeloid-Derived%2520Suppressor%2520Cells%26jtitle%3DOncoimmunology%26date%3D2014%26volume%3D3%26doi%3D10.4161%2Fonci.27989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vecchio, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C. Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, L. T.</span></span> <span> </span><span class="NLM_article-title">Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>357</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1124/jpet.115.230003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1124%2Fjpet.115.230003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=26791603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvVeksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2016&pages=36-44&author=E.+A.+Vecchioauthor=C.+Y.+R.+Tanauthor=K.+J.+Gregoryauthor=A.+Christopoulosauthor=P.+J.+Whiteauthor=L.+T.+May&title=Ligand-Independent+Adenosine+A2B+Receptor+Constitutive+Activity+as+a+Promoter+of+Prostate+Cancer+Cell+Proliferation&doi=10.1124%2Fjpet.115.230003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand-independent adenosine A2B receptor constitutive activity as a promoter of prostate cancer cell proliferation</span></div><div class="casAuthors">Vecchio, Elizabeth A.; Tan, Christina Y. R.; Gregory, Karen J.; Christopoulos, Arthur; White, Paul J.; May, Lauren T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-44</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Aberrant ligand-independent G protein-coupled receptor constitutive activity has been implicated in the pathophysiol. of a no. of cancers.  The adenosine A2B receptor (A2BAR) is dynamically upregulated under pathol. conditions assocd. with a hypoxic microenvironment, including solid tumors.  This, in turn, may amplify ligand-independent A2BAR signal transduction.  The contribution of A2BAR constitutive activity to disease progression is currently unknown yet of fundamental importance, as the preferred therapeutic modality for drugs designed to reduce A2BAR constitutive activity would be inverse agonism as opposed to neutral antagonism.  The current study investigated A2BAR constitutive activity in a heterologous expression system and a native 22Rv1 human prostate cancer cell line exposed to hypoxic conditions (2% O2).  The A2BAR inverse agonists, ZM241385 [4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-ylamino]ethyl)phenol] or PSB-603 (8-(4-(4-(4-chlorophenyl)piperazide-1-sulfonyl)phenyl)-1-propylxanthine), mediated a concn.-dependent decrease in baseline cAMP levels in both cellular systems.  Proliferation of multiple prostate cancer cell lines was also attenuated in the presence of PSB-603.  Importantly, both the decrease in baseline cAMP accumulation and the redn. of proliferation were not influenced by the addn. of adenosine deaminase, demonstrating that these effects are not dependent on stimulation of A2BARs by the endogenous agonist adenosine.  Our study is the first to reveal that wild-type human A2BARs have high constitutive activity in both model and native cells.  Furthermore, our findings demonstrate that this ligand-independent A2BAR constitutive activity is sufficient to promote prostate cancer cell proliferation in vitro.  More broadly, A2BAR constitutive activity may have wider, currently unappreciated implications in pathol. conditions assocd. with a hypoxic microenvironment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXgR2SqHb3o7Vg90H21EOLACvtfcHk0ljyRa2IjDonKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvVeksbw%253D&md5=47cef2c343e8efedf7b9497f704e6a33</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.230003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.230003%26sid%3Dliteratum%253Aachs%26aulast%3DVecchio%26aufirst%3DE.%2BA.%26aulast%3DTan%26aufirst%3DC.%2BY.%2BR.%26aulast%3DGregory%26aufirst%3DK.%2BJ.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DWhite%26aufirst%3DP.%2BJ.%26aulast%3DMay%26aufirst%3DL.%2BT.%26atitle%3DLigand-Independent%2520Adenosine%2520A2B%2520Receptor%2520Constitutive%2520Activity%2520as%2520a%2520Promoter%2520of%2520Prostate%2520Cancer%2520Cell%2520Proliferation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D357%26spage%3D36%26epage%3D44%26doi%3D10.1124%2Fjpet.115.230003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnston-Cox, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenstein, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koupenova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravid, K.</span></span> <span> </span><span class="NLM_article-title">The Macrophage A2b Adenosine Receptor Regulates Tissue Insulin Sensitivity</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e98775</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0098775</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1371%2Fjournal.pone.0098775" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=24892847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGqsr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=H.+Johnston-Coxauthor=A.+S.+Eisensteinauthor=M.+Koupenovaauthor=S.+Carrollauthor=K.+Ravid&title=The+Macrophage+A2b+Adenosine+Receptor+Regulates+Tissue+Insulin+Sensitivity&doi=10.1371%2Fjournal.pone.0098775"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The macrophage A2b adenosine receptor regulates tissue insulin sensitivity</span></div><div class="casAuthors">Johnston-Cox, Hillary; Eisenstein, Anna S.; Koupenova, Milka; Carroll, Shannon; Ravid, Katya</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e98775/1-e98775/13, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">High fat diet (HFD)-induced type 2 diabetes continues to be an epidemic with significant risk for various pathologies.  Previously, we identified the A2b adenosine receptor (A2bAR), an established regulator of inflammation, as a regulator of HFD-induced insulin resistance.  In particular, HFD was assocd. with vast upregulation of liver A2bAR in control mice, and while mice lacking this receptor showed augmented liver inflammation and tissue insulin resistance.  As the A2bAR is expressed in different tissues, here, we provide the first lead to cellular mechanism by demonstrating that the receptor's influence on tissue insulin sensitivity is mediated via its expression in macrophages.  This was shown using a newly generated transgenic mouse model expressing the A2bAR gene in the macrophage lineage on an otherwise A2bAR null background.  Reinstatement of macrophage A2bAR expression in A2bAR null mice fed HFD restored insulin tolerance and tissue insulin signaling to the level of control mice.  The mol. mechanism for this effect involves A2bAR-mediated changes in cyclic adenosine monophosphate in macrophages, reducing the expression and release of inflammatory cytokines, which downregulate insulin receptor-2.  Thus, our results illustrate that macrophage A2bAR signaling is needed and sufficient for relaying the protective effect of the A2bAR against HFD-induced tissue inflammation and insulin resistance in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDs57NNj6wULVg90H21EOLACvtfcHk0li3uPZE6pK93w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGqsr%252FP&md5=c80ec59afda6fc6a4cdac9f590553726</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0098775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0098775%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston-Cox%26aufirst%3DH.%26aulast%3DEisenstein%26aufirst%3DA.%2BS.%26aulast%3DKoupenova%26aufirst%3DM.%26aulast%3DCarroll%26aufirst%3DS.%26aulast%3DRavid%26aufirst%3DK.%26atitle%3DThe%2520Macrophage%2520A2b%2520Adenosine%2520Receptor%2520Regulates%2520Tissue%2520Insulin%2520Sensitivity%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0098775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span> <span> </span><span class="NLM_article-title">Adenosine A2B Receptor: From Cell Biology to Human Diseases</span>. <i>Front. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">37</span>, <span class="refDoi"> DOI: 10.3389/fchem.2016.00037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.3389%2Ffchem.2016.00037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=27606311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVCmtrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&pages=37&author=Y.+Sunauthor=P.+Huang&title=Adenosine+A2B+Receptor%3A+From+Cell+Biology+to+Human+Diseases&doi=10.3389%2Ffchem.2016.00037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2B receptor: from cell biology to human diseases</span></div><div class="casAuthors">Sun, Ying; Huang, Pingbo</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Chemistry (Lausanne, Switzerland)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37/1-37/11</span>CODEN:
                <span class="NLM_cas:coden">FCLSAA</span>;
        ISSN:<span class="NLM_cas:issn">2296-2646</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Extracellular adenosine is a ubiquitous signaling mol. that modulates a wide array of biol. processes.  Recently, significant advances have been made in our understanding of A2B adenosine receptor (A2BAR).  In this review, we first summarize some of the general characteristics of A2BAR, and then we describe the multiple binding partners of the receptor, such as newly identified α-actinin-1 and p105, and discuss how these assocd. proteins could modulate A2BAR's functions, including certain seemingly paradoxical functions of the receptor.  Growing evidence indicates a crit. role of A2BAR in cancer, renal disease, and diabetes, in addn. to its importance in the regulation of vascular diseases, and lung disease.  Here, we also discuss the role of A2BAR in cancer, renal disease, and diabetes and the potential of the receptor as a target for treating these three diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhaEqMALVWUbVg90H21EOLACvtfcHk0li3uPZE6pK93w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVCmtrvL&md5=5216d780e9ceb31511d6810fef526d12</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3389%2Ffchem.2016.00037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffchem.2016.00037%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DP.%26atitle%3DAdenosine%2520A2B%2520Receptor%253A%2520From%2520Cell%2520Biology%2520to%2520Human%2520Diseases%26jtitle%3DFront.%2520Chem.%26date%3D2016%26volume%3D4%26spage%3D37%26doi%3D10.3389%2Ffchem.2016.00037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corset, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen-Ba-Charvet, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forcet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyse, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chédotal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehlen, P.</span></span> <span> </span><span class="NLM_article-title">Netrin-1-Mediated Axon Outgrowth and CAMP Production Requires Interaction with Adenosine A2b Receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>407</i></span>,  <span class="NLM_fpage">747</span>– <span class="NLM_lpage">750</span>, <span class="refDoi"> DOI: 10.1038/35037600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1038%2F35037600" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=11048721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsFWku74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2000&pages=747-750&author=V.+Corsetauthor=K.+T.+Nguyen-Ba-Charvetauthor=C.+Forcetauthor=E.+Moyseauthor=A.+Ch%C3%A9dotalauthor=P.+Mehlen&title=Netrin-1-Mediated+Axon+Outgrowth+and+CAMP+Production+Requires+Interaction+with+Adenosine+A2b+Receptor&doi=10.1038%2F35037600"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Netrin-1-mediated axon outgrowth and cAMP production requires interaction with adenosine A2b receptor</span></div><div class="casAuthors">Corset, Veronique; Nguyen-Ba-Charvet, Kim Tuyen; Forcet, Christelle; Moyse, Emmanuel; Chedotal, Alain; Mehlen, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">407</span>
        (<span class="NLM_cas:issue">6805</span>),
    <span class="NLM_cas:pages">747-750</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The netrins, a family of laminin-related secreted proteins, are crit. in controlling axon elongation and pathfinding.  The DCC (for deleted in colorectal cancer) protein was proposed as a receptor for netrin-1 in the light of many observations including the inhibition of netrin-1-mediated axon outgrowth and attraction in the presence of an anti-DCC antiserum, the similitude of nervous system defects in DCC and netrin-1 knockout mice and the results of receptor swapping expts.  Previous studies have failed to show a direct interaction of DCC with netrin-1 (ref.10), suggesting the possibility of an addnl. receptor or coreceptor.  Here we show that DCC interacts with the membrane-assocd. adenosine A2b receptor, a G-protein-coupled receptor that induces cAMP accumulation on binding adenosine.  We show that A2b is actually a netrin-1 receptor and induces cAMP accumulation on binding netrin-1.  Finally, we show that netrin-1-dependent outgrowth of dorsal spinal cord axons directly involves A2b.  Together our results indicate that the growth-promoting function of netrin-1 may require a receptor complex contg. DCC and A2b.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWTieJp7rtDLVg90H21EOLACvtfcHk0li3uPZE6pK93w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsFWku74%253D&md5=23b775be990bb35322e434e236ac8195</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2F35037600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35037600%26sid%3Dliteratum%253Aachs%26aulast%3DCorset%26aufirst%3DV.%26aulast%3DNguyen-Ba-Charvet%26aufirst%3DK.%2BT.%26aulast%3DForcet%26aufirst%3DC.%26aulast%3DMoyse%26aufirst%3DE.%26aulast%3DCh%25C3%25A9dotal%26aufirst%3DA.%26aulast%3DMehlen%26aufirst%3DP.%26atitle%3DNetrin-1-Mediated%2520Axon%2520Outgrowth%2520and%2520CAMP%2520Production%2520Requires%2520Interaction%2520with%2520Adenosine%2520A2b%2520Receptor%26jtitle%3DNature%26date%3D2000%26volume%3D407%26spage%3D747%26epage%3D750%26doi%3D10.1038%2F35037600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peakman, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, S. J.</span></span> <span> </span><span class="NLM_article-title">Adenosine A<sub>2B</sub>-receptor-mediated Cyclic AMP Accumulation in Primary Rat Astrocytes</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">198</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.1994.tb14043.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1111%2Fj.1476-5381.1994.tb14043.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=8012696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADyaK2cXht1GrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=1994&pages=191-198&author=M.-C.+Peakmanauthor=S.+J.+Hill&title=Adenosine+A2B-receptor-mediated+Cyclic+AMP+Accumulation+in+Primary+Rat+Astrocytes&doi=10.1111%2Fj.1476-5381.1994.tb14043.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2B-receptor-mediated cyclic AMP accumulation in primary rat astrocytes</span></div><div class="casAuthors">Peakman, Marie Claire; Hill, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">191-8</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">The effects of adenosine receptor agonists and antagonists on the accumulation of cAMP have been investigated in primary cultures of rat astrocytes.  Adenosine A2-receptor stimulation caused a concn.-dependent increase in the accumulation of [3H]-cAMP in cells prelabeled with [3H]-adenine.  The rank order of agonist potencies was 5'-N-ethylcarboxamidoadenosine (NECA; EC50 = 1 μM) > adenosine (EC50 = 5 μM) > 2-chloroadenosine (EC50 = 20 μM) >> CGS 21680 (EC50 > 10 μM).  The presence of 0.5 μM dipyridamole, an adenosine uptake blocker, had no effect on the potency of adenosine.  The response to 10 μM NECA was antagonized in a concn.-dependent manner by the non-selective adenosine receptor antagonists, xanthine amine congener (apparent KD = 12 nM), PD 115,199 (apparent KD = 134 nM) and 8-cyclopentyl-1,3-dipropylxanthine, had no significant effect on the responses to NECA or 2-chloroadenosine at concns. ≤1 μM.  Stimulation of A1-receptors with the selective agonist, N6-cyclopentyladenosine, did not alter the basal accumulation of [3H]-cAMP but inhibited a forskolin-mediated elevation of [3H]-cAMP accumulation by a maximal value of 42%.  This inhibition was fully reversed in the presence of 0.1 μM, 8-cyclopentyl-1,3-dipropylxanthine.  The time course for NECA-mediated [3H]-cAMP accumulation was investigated.  The results suggest that there is a substantial efflux of cAMP from the cells in addn. to the rapid and sustained elevation of intracellular cAMP (5 fold over basal) which was also obsd.  These data indicate that rat astrocytes in primary culture express an A2B-adenosine receptor coupled pos. to adenylyl cyclase.  Furthermore, the presence of A1-receptors neg. coupled to adenylyl cyclase appears to have no significant effect on the A2B-receptor-mediated cAMP responses to NECA and 2-chloroadenosine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-zban9p9AwbVg90H21EOLACvtfcHk0li3uPZE6pK93w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXht1GrsbY%253D&md5=40c90aa0d78e7cb0c27e2661ba6ca95e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1994.tb14043.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1994.tb14043.x%26sid%3Dliteratum%253Aachs%26aulast%3DPeakman%26aufirst%3DM.-C.%26aulast%3DHill%26aufirst%3DS.%2BJ.%26atitle%3DAdenosine%2520A2B-receptor-mediated%2520Cyclic%2520AMP%2520Accumulation%2520in%2520Primary%2520Rat%2520Astrocytes%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D111%26spage%3D191%26epage%3D198%26doi%3D10.1111%2Fj.1476-5381.1994.tb14043.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovarova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chason, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koller, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilley, S. L.</span></span> <span> </span><span class="NLM_article-title">Enhanced Mast Cell Activation in Mice Deficient in the A2b Adenosine Receptor</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>204</i></span>,  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1084/jem.20061372</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1084%2Fjem.20061372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=17200408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=204&publication_year=2007&pages=117-128&author=X.+Huaauthor=M.+Kovarovaauthor=K.+D.+Chasonauthor=M.+Nguyenauthor=B.+H.+Kollerauthor=S.+L.+Tilley&title=Enhanced+Mast+Cell+Activation+in+Mice+Deficient+in+the+A2b+Adenosine+Receptor&doi=10.1084%2Fjem.20061372"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced mast cell activation in mice deficient in the A2b adenosine receptor</span></div><div class="casAuthors">Hua, Xiaoyang; Kovarova, Martina; Chason, Kelly D.; Nguyen, MyTrang; Koller, Beverly H.; Tilley, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">204</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">117-128</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Antigen-mediated crosslinking of IgE bound to mast cells via the high affinity receptor for IgE triggers a signaling cascade that results in the release of intracellular calcium stores, followed by an influx of extracellular calcium.  The collective increase in intracellular calcium is crit. to the release of the granular contents of the mast cell, which include the mediators of acute anaphylaxis.  We show that the sensitivity of the mast cell to antigen-mediated degranulation through this pathway can be dramatically influenced by the A2b adenosine receptor.  Loss of this Gs-coupled receptor on mouse bone marrow-derived mast cells results in decreased basal levels of cAMP and an excessive influx of extracellular calcium through store-operated calcium channels following antigen activation.  Mice lacking the A2b receptor display increased sensitivity to IgE-mediated anaphylaxis.  Collectively, these findings show that the A2b adenosine receptor functions as a crit. regulator of signaling pathways within the mast cell, which act in concert to limit the magnitude of mast cell responsiveness when antigen is encountered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWkx7Pzlq4GLVg90H21EOLACvtfcHk0lgRw0gybLscMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGjtrs%253D&md5=2596326ac056edc83bc37fd48dcd9a46</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1084%2Fjem.20061372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20061372%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DX.%26aulast%3DKovarova%26aufirst%3DM.%26aulast%3DChason%26aufirst%3DK.%2BD.%26aulast%3DNguyen%26aufirst%3DM.%26aulast%3DKoller%26aufirst%3DB.%2BH.%26aulast%3DTilley%26aufirst%3DS.%2BL.%26atitle%3DEnhanced%2520Mast%2520Cell%2520Activation%2520in%2520Mice%2520Deficient%2520in%2520the%2520A2b%2520Adenosine%2520Receptor%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2007%26volume%3D204%26spage%3D117%26epage%3D128%26doi%3D10.1084%2Fjem.20061372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eckle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faigle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laucher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eltzschig, H. K.</span></span> <span> </span><span class="NLM_article-title">A2B Adenosine Receptor Dampens Hypoxia-Induced Vascular Leak</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">2024</span>– <span class="NLM_lpage">2035</span>, <span class="refDoi"> DOI: 10.1182/blood-2007-10-117044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1182%2Fblood-2007-10-117044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=18056839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVeisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=2024-2035&author=T.+Eckleauthor=M.+Faigleauthor=A.+Grenzauthor=S.+Laucherauthor=L.+F.+Thompsonauthor=H.+K.+Eltzschig&title=A2B+Adenosine+Receptor+Dampens+Hypoxia-Induced+Vascular+Leak&doi=10.1182%2Fblood-2007-10-117044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A2B adenosine receptor dampens hypoxia-induced vascular leak</span></div><div class="casAuthors">Eckle, Tobias; Faigle, Marion; Grenz, Almut; Laucher, Stefanie; Thompson, Linda F.; Eltzschig, Holger K.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2024-2035</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Extracellular adenosine has been implicated in adaptation to hypoxia and previous studies demonstrated a central role in vascular responses.  Here, we examd. the contribution of individual adenosine receptors (ARs: A1AR/A2AAR/A2BAR/A3AR) to vascular leak induced by hypoxia.  Initial profiling studies revealed that siRNA-mediated repression of the A2BAR selectively increased endothelial leak in response to hypoxia in vitro.  In parallel, vascular permeability was significantly increased in vascular organs of A2BAR-/--mice subjected to ambient hypoxia (8% oxygen, 4 h; eg, lung: 2.1 ± 0.12-fold increase).  By contrast, hypoxia-induced vascular leak was not accentuated in A1AR-/--, A2AAR-/--, or A3AR-/--deficient mice, suggesting a degree of specificity for the A2BAR.  Further studies in wild type mice revealed that the selective A2BAR antagonist PSB1115 resulted in profound increases in hypoxia-assocd. vascular leakage while A2BAR agonist (BAY60-6583 [2-[6-amino-3,5-dicyano-4-[4-(cyclopropylmethoxy)-phenyl]pyridin-2-ylsulfanyl]acetamide]) treatment was assocd. with almost complete reversal of hypoxia-induced vascular leakage (eg, lung: 2.0 ± 0.21-fold redn.).  Studies in bone marrow chimeric A2BAR mice suggested a predominant role of vascular A2BARs in this response, while hypoxia-assocd. increases in tissue neutrophils were, at least in part, mediated by A2BAR expressing hematopoietic cells.  Taken together, these studies provide pharmacol. and genetic evidence for vascular A2BAR signaling as central control point of hypoxia-assocd. vascular leak.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpha1gIw4tRgbVg90H21EOLACvtfcHk0lgRw0gybLscMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVeisLk%253D&md5=c909fd42970de5e4a9a82d6eccc3c392</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-10-117044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-10-117044%26sid%3Dliteratum%253Aachs%26aulast%3DEckle%26aufirst%3DT.%26aulast%3DFaigle%26aufirst%3DM.%26aulast%3DGrenz%26aufirst%3DA.%26aulast%3DLaucher%26aufirst%3DS.%26aulast%3DThompson%26aufirst%3DL.%2BF.%26aulast%3DEltzschig%26aufirst%3DH.%2BK.%26atitle%3DA2B%2520Adenosine%2520Receptor%2520Dampens%2520Hypoxia-Induced%2520Vascular%2520Leak%26jtitle%3DBlood%26date%3D2008%26volume%3D111%26spage%3D2024%26epage%3D2035%26doi%3D10.1182%2Fblood-2007-10-117044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Addi, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefort, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Communi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledent, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macours, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilley, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boeynaems, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robaye, B.</span></span> <span> </span><span class="NLM_article-title">Modulation of Murine Dendritic Cell Function by Adenine Nucleotides and Adenosine: Involvement of the A2B Receptor</span>. <i>Eur. J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1610</span>– <span class="NLM_lpage">1620</span>, <span class="refDoi"> DOI: 10.1002/eji.200737781</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1002%2Feji.200737781" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=18465770" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2008&pages=1610-1620&author=A.+B.+Addiauthor=A.+Lefortauthor=X.+Huaauthor=F.+Libertauthor=D.+Communiauthor=C.+Ledentauthor=P.+Macoursauthor=S.+L.+Tilleyauthor=J.-M.+Boeynaemsauthor=B.+Robaye&title=Modulation+of+Murine+Dendritic+Cell+Function+by+Adenine+Nucleotides+and+Adenosine%3A+Involvement+of+the+A2B+Receptor&doi=10.1002%2Feji.200737781"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Feji.200737781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Feji.200737781%26sid%3Dliteratum%253Aachs%26aulast%3DAddi%26aufirst%3DA.%2BB.%26aulast%3DLefort%26aufirst%3DA.%26aulast%3DHua%26aufirst%3DX.%26aulast%3DLibert%26aufirst%3DF.%26aulast%3DCommuni%26aufirst%3DD.%26aulast%3DLedent%26aufirst%3DC.%26aulast%3DMacours%26aufirst%3DP.%26aulast%3DTilley%26aufirst%3DS.%2BL.%26aulast%3DBoeynaems%26aufirst%3DJ.-M.%26aulast%3DRobaye%26aufirst%3DB.%26atitle%3DModulation%2520of%2520Murine%2520Dendritic%2520Cell%2520Function%2520by%2520Adenine%2520Nucleotides%2520and%2520Adenosine%253A%2520Involvement%2520of%2520the%2520A2B%2520Receptor%26jtitle%3DEur.%2520J.%2520Immunol.%26date%3D2008%26volume%3D38%26spage%3D1610%26epage%3D1620%26doi%3D10.1002%2Feji.200737781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xaus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirabet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloberas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lluis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celada, A.</span></span> <span> </span><span class="NLM_article-title">IFN-γ Up-Regulates the A2B Adenosine Receptor Expression in Macrophages: A Mechanism of Macrophage Deactivation</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">3607</span>– <span class="NLM_lpage">3614</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10092821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADyaK1MXhvFSjuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=1999&pages=3607-3614&author=J.+Xausauthor=M.+Mirabetauthor=J.+Lloberasauthor=C.+Solerauthor=C.+Lluisauthor=R.+Francoauthor=A.+Celada&title=IFN-%CE%B3+Up-Regulates+the+A2B+Adenosine+Receptor+Expression+in+Macrophages%3A+A+Mechanism+of+Macrophage+Deactivation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">IFN-γ up-regulates the A2B adenosine receptor expression in macrophages: a mechanism of macrophage deactivation</span></div><div class="casAuthors">Xaus, Jordi; Mirabet, Maribel; Lloberas, Jorge; Soler, Concepcio; Lluis, Carme; Franco, Rafael; Celada, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3607-3614</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Adenosine is a potent endogenous anti-inflammatory agent released by cells in metabolically unfavorable conditions, such as hypoxia or ischemia.  Adenosine modulates different functional activities in macrophages.  Some of these activities are believed to be induced through the uptake of adenosine into the macrophages, while others are due to the interaction with specific cell surface receptors.  In murine bone marrow-derived macrophages, the use of different radioligands for adenosine receptors suggests the presence of A2B and A3 adenosine receptor subtypes.  The presence of A2B receptors was confirmed by flow cytometry using specific Abs.  The A2B receptor is functional in murine macrophages, as indicated by the fact that agonists of A2B receptors, but not agonists for A1, A2A, or A3, lead to an increase in cAMP levels.  IFN-γ up-regulates the surface protein and gene expression of the A2B adenosine receptor by induction of de novo synthesis.  The up-regulation of A2B receptors correlates with an increase in cAMP prodn. in macrophages treated with adenosine receptor agonist.  The stimulation of A2B receptors by adenosine or its analogs inhibits the IFN-γ-induced expression of MHC class II genes and also the IFN-γ-induced expression of nitric oxide synthase and of proinflammatory cytokines.  Therefore, the up-regulation of the A2B adenosine receptor expression induced by IFN-γ could be a feedback mechanism for macrophage deactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMbFXIDoX68LVg90H21EOLACvtfcHk0lhAdzVkUwf8Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvFSjuro%253D&md5=b032792b6d7ef790c0d1fa137827bedc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXaus%26aufirst%3DJ.%26aulast%3DMirabet%26aufirst%3DM.%26aulast%3DLloberas%26aufirst%3DJ.%26aulast%3DSoler%26aufirst%3DC.%26aulast%3DLluis%26aufirst%3DC.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DCelada%26aufirst%3DA.%26atitle%3DIFN-%25CE%25B3%2520Up-Regulates%2520the%2520A2B%2520Adenosine%2520Receptor%2520Expression%2520in%2520Macrophages%253A%2520A%2520Mechanism%2520of%2520Macrophage%2520Deactivation%26jtitle%3DJ.%2520Immunol.%26date%3D1999%26volume%3D162%26spage%3D3607%26epage%3D3614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westerman, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faigle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eltzschig, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colgan, S. P.</span></span> <span> </span><span class="NLM_article-title">HIF-dependent Induction of Adenosine A2B Receptor in Hypoxia</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2242</span>– <span class="NLM_lpage">2250</span>, <span class="refDoi"> DOI: 10.1096/fj.06-6419com</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1096%2Ffj.06-6419com" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=17077301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFyktLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=2242-2250&author=T.+Kongauthor=K.+A.+Westermanauthor=M.+Faigleauthor=H.+K.+Eltzschigauthor=S.+P.+Colgan&title=HIF-dependent+Induction+of+Adenosine+A2B+Receptor+in+Hypoxia&doi=10.1096%2Ffj.06-6419com"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">HIF-dependent induction of adenosine A2B receptor in hypoxia</span></div><div class="casAuthors">Kong, Tianqing; Westerman, Karen A.; Faigle, Marion; Eltzschig, Holger K.; Colgan, Sean P.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2242-2250</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Adenosine has been widely assocd. with hypoxia of many origins, including those assocd. with inflammation and tumorogenesis.  A no. of recent studies have implicated metabolic control of adenosine generation at sites of tissue hypoxia.  Here, we examine adenosine receptor control and amplification of signaling through transcriptional regulation of endothelial and epithelial adenosine receptors.  Initial studies confirmed previous findings indicating selective induction of human adenosine A2B receptor (A2BR) by hypoxia.  Anal. of the cloned human A2BR promoter identified a functional hypoxia-responsive region, including a functional binding site for hypoxia-inducible factor (HIF) within the A2BR promoter.  Further studies examg. HIF-1α DNA binding and HIF-1α gain and loss of function confirmed strong dependence of A2BR induction by HIF-1α in vitro and in vivo mouse models.  Addnl. studies in endothelia overexpressing full-length A2BR revealed functional phenotypes of increased barrier function and enhanced angiogenesis.  Taken together, these results demonstrate transcriptional coordination of A2BR by HIF-1α and amplified adenosine signaling during hypoxia.  These findings may provide an important link between hypoxia and metabolic conditions assocd. with inflammation and angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrepOsJmxWH5LVg90H21EOLACvtfcHk0lhAdzVkUwf8Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFyktLfJ&md5=4c994b176904887886214a1f60f57512</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1096%2Ffj.06-6419com&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.06-6419com%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DT.%26aulast%3DWesterman%26aufirst%3DK.%2BA.%26aulast%3DFaigle%26aufirst%3DM.%26aulast%3DEltzschig%26aufirst%3DH.%2BK.%26aulast%3DColgan%26aufirst%3DS.%2BP.%26atitle%3DHIF-dependent%2520Induction%2520of%2520Adenosine%2520A2B%2520Receptor%2520in%2520Hypoxia%26jtitle%3DFASEB%2520J.%26date%3D2006%26volume%3D20%26spage%3D2242%26epage%3D2250%26doi%3D10.1096%2Ffj.06-6419com" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hart, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schittenhelm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eltzschig, H. K.</span></span> <span> </span><span class="NLM_article-title">Cutting Edge: A2B Adenosine Receptor Signaling Provides Potent Protection during Intestinal Ischemia/Reperfusion Injury</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>182</i></span>,  <span class="NLM_fpage">3965</span>– <span class="NLM_lpage">3968</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.0802193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.4049%2Fjimmunol.0802193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=19299692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVSjtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2009&pages=3965-3968&author=M.+L.+Hartauthor=B.+Jacobiauthor=J.+Schittenhelmauthor=M.+Hennauthor=H.+K.+Eltzschig&title=Cutting+Edge%3A+A2B+Adenosine+Receptor+Signaling+Provides+Potent+Protection+during+Intestinal+Ischemia%2FReperfusion+Injury&doi=10.4049%2Fjimmunol.0802193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Cutting Edge: A2B Adenosine Receptor Signaling Provides Potent Protection during Intestinal Ischemia/Reperfusion Injury</span></div><div class="casAuthors">Hart, Melanie L.; Jacobi, Barbara; Schittenhelm, Jens; Henn, Martina; Eltzschig, Holger K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3965-3968</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Gastrointestinal ischemia/reperfusion (IR) injury significantly contributes to the morbidity and mortality of crit. illness.  In this study, we hypothesized a protective role for extracellular adenosine signaling in intestinal IR injury.  Initial profiling studies of mucosal scrapings following murine IR demonstrated selective induction of the A2B adenosine receptor (A2BAR) transcript.  Moreover, gene-targeted mice for the A2BAR showed more profound intestinal IR injury compared with controls.  In contrast, A2AAR-/- mice exhibited no differences in intestinal injury compared with littermate controls.  In addn., selective inhibition of the A2BAR resulted in enhanced intestinal inflammation and injury during IR.  Furthermore, A2BAR agonist treatment (BAY 60-6583) protected from intestinal injury, inflammation, and permeability dysfunction in wild-type mice, whereas the therapeutic effects of BAY 60-6583 were abolished following targeted A2BAR gene deletion.  Taken together, these studies demonstrate the A2BAR as a novel therapeutic target for protection during gastrointestinal IR injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeBKjh09rg8LVg90H21EOLACvtfcHk0lhAdzVkUwf8Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVSjtrk%253D&md5=e8d66aaf5f902c4ee2e69efacf16ebf8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0802193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0802193%26sid%3Dliteratum%253Aachs%26aulast%3DHart%26aufirst%3DM.%2BL.%26aulast%3DJacobi%26aufirst%3DB.%26aulast%3DSchittenhelm%26aufirst%3DJ.%26aulast%3DHenn%26aufirst%3DM.%26aulast%3DEltzschig%26aufirst%3DH.%2BK.%26atitle%3DCutting%2520Edge%253A%2520A2B%2520Adenosine%2520Receptor%2520Signaling%2520Provides%2520Potent%2520Protection%2520during%2520Intestinal%2520Ischemia%252FReperfusion%2520Injury%26jtitle%3DJ.%2520Immunol.%26date%3D2009%26volume%3D182%26spage%3D3965%26epage%3D3968%26doi%3D10.4049%2Fjimmunol.0802193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haskó, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csóka, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Németh, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vizi, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacher, P.</span></span> <span> </span><span class="NLM_article-title">A2B Adenosine Receptors in Immunity and Inflammation</span>. <i>Trends Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1016/j.it.2009.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.it.2009.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=19427267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1ynt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=263-270&author=G.+Hask%C3%B3author=B.+Cs%C3%B3kaauthor=Z.+H.+N%C3%A9methauthor=E.+S.+Viziauthor=P.+Pacher&title=A2B+Adenosine+Receptors+in+Immunity+and+Inflammation&doi=10.1016%2Fj.it.2009.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A2B adenosine receptors in immunity and inflammation</span></div><div class="casAuthors">Hasko, Gyoergy; Csoka, Balazs; Nemeth, Zoltan H.; Vizi, E. Sylvester; Pacher, Pal</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">263-270</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A2B adenosine receptors are increasingly recognized as important orchestrators of inflammation.  A2B receptor activation promotes the inflammatory response of mast cells, epithelial cells, smooth muscle cells and fibroblasts, thereby contributing to the pathophysiol. of asthma and colitis.  A2B receptor stimulation limits endothelial cell inflammatory responses and permeability and suppresses macrophage activation thereby preventing tissue injury after episodes of hypoxia and ischemia.  A2B receptor stimulation also promotes the prodn. of angiogenic cytokines by endothelial cells, mast cells and dendritic cells, aiding granuloma tissue formation and inflammatory resoln., but can also contribute to tumor growth.  A2B receptors are, thus, potentially important pharmacol. targets in treating immune system dysfunction and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk5JA17dyrT7Vg90H21EOLACvtfcHk0lhAdzVkUwf8Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1ynt7s%253D&md5=4aebd9d9b7d823dcc0a89f94b539d127</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2009.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2009.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DHask%25C3%25B3%26aufirst%3DG.%26aulast%3DCs%25C3%25B3ka%26aufirst%3DB.%26aulast%3DN%25C3%25A9meth%26aufirst%3DZ.%2BH.%26aulast%3DVizi%26aufirst%3DE.%2BS.%26aulast%3DPacher%26aufirst%3DP.%26atitle%3DA2B%2520Adenosine%2520Receptors%2520in%2520Immunity%2520and%2520Inflammation%26jtitle%3DTrends%2520Immunol.%26date%3D2009%26volume%3D30%26spage%3D263%26epage%3D270%26doi%3D10.1016%2Fj.it.2009.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aherne, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kewley, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eltzschig, H. K.</span></span> <span> </span><span class="NLM_article-title">The Resurgence of A2B Adenosine Receptor Signaling</span>. <i>Biochim. Biophys. Acta, Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1808</i></span>,  <span class="NLM_fpage">1329</span>– <span class="NLM_lpage">1339</span>, <span class="refDoi"> DOI: 10.1016/j.bbamem.2010.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.bbamem.2010.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=20546702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFSrsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1808&publication_year=2011&pages=1329-1339&author=C.+M.+Aherneauthor=E.+M.+Kewleyauthor=H.+K.+Eltzschig&title=The+Resurgence+of+A2B+Adenosine+Receptor+Signaling&doi=10.1016%2Fj.bbamem.2010.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The resurgence of A2B adenosine receptor signaling</span></div><div class="casAuthors">Aherne, Carol M.; Kewley, Emily M.; Eltzschig, Holger K.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1808</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1329-1339</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Since its discovery as a low-affinity adenosine receptor (AR), the A2B receptor (A2BAR), has proven enigmatic in its function.  The previous discovery of the A2AAR, which shares many similarities with the A2BAR but demonstrates significantly greater affinity for its endogenous ligand, led to the original perception that the A2BAR was not of substantial physiol. relevance.  In addn., lack of specific pharmacol. agents targeting the A2BAR made its initial characterization challenging.  However, the importance of this receptor was reconsidered when it was obsd. that the A2BAR is highly transcriptionally regulated by factors implicated in inflammatory hypoxia.  Moreover, the notion that during ischemia or inflammation extracellular adenosine is dramatically elevated to levels sufficient for A2BAR activation, indicated that A2BAR signaling may be important to dampen inflammation particularly during tissue hypoxia.  In addn., the recent advent of techniques for murine genetic manipulation along with development of pharmacol. agents with enhanced A2BAR specificity has provided invaluable tools for focused studies on the explicit role of A2BAR signaling in different disease models.  Currently, studies performed with combined genetic and pharmacol. approaches have demonstrated that A2BAR signaling plays a tissue protective role in many models of acute diseases e.g. myocardial ischemia, or acute lung injury.  These studies indicate that the A2BAR is expressed on a wide variety of cell types and exerts tissue/cell specific effects.  This is an important consideration for future studies where tissue or cell type specific targeting of the A2BAR may be used as therapeutic approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyVvyCnJhXUrVg90H21EOLACvtfcHk0liAk6GPamkt6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFSrsro%253D&md5=3dc9fe6ec9d65ab132d4b8425450657c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2010.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2010.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DAherne%26aufirst%3DC.%2BM.%26aulast%3DKewley%26aufirst%3DE.%2BM.%26aulast%3DEltzschig%26aufirst%3DH.%2BK.%26atitle%3DThe%2520Resurgence%2520of%2520A2B%2520Adenosine%2520Receptor%2520Signaling%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2011%26volume%3D1808%26spage%3D1329%26epage%3D1339%26doi%3D10.1016%2Fj.bbamem.2010.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mittal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barkauskas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalimutho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stannard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caramia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haibe-Kains, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, M. J.</span></span> <span> </span><span class="NLM_article-title">Adenosine 2B Receptor Expression on Cancer Cells Promotes Metastasis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">4372</span>– <span class="NLM_lpage">4382</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-16-0544</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1158%2F0008-5472.CAN-16-0544" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=27221704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gmt7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=4372-4382&author=D.+Mittalauthor=D.+Sinhaauthor=D.+Barkauskasauthor=A.+Youngauthor=M.+Kalimuthoauthor=K.+Stannardauthor=F.+Caramiaauthor=B.+Haibe-Kainsauthor=J.+Staggauthor=K.+K.+Khannaauthor=S.+Loiauthor=M.+J.+Smyth&title=Adenosine+2B+Receptor+Expression+on+Cancer+Cells+Promotes+Metastasis&doi=10.1158%2F0008-5472.CAN-16-0544"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine 2B Receptor Expression on Cancer Cells Promotes Metastasis</span></div><div class="casAuthors">Mittal, Deepak; Sinha, Debottam; Barkauskas, Deborah; Young, Arabella; Kalimutho, Murugan; Stannard, Kimberley; Caramia, Franco; Haibe-Kains, Benjamin; Stagg, John; Khanna, Kum Kum; Loi, Sherene; Smyth, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4372-4382</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Adenosine plays an important role in inflammation and tumor development, progression, and responses to therapy.  We show that an adenosine 2B receptor inhibitor (A2BRi) decreases both exptl. and spontaneous metastasis and combines with chemotherapy or immune checkpoint inhibitors in mouse models of melanoma and triple-neg. breast cancer (TNBC) metastasis.  Decreased metastasis upon A2BR inhibition is independent of host A2BR and lymphocytes and myeloid cells.  Knockdown of A2BR on mouse and human cancer cells reduces their metastasis in vivo and decreases their viability and colony-forming ability, while transiently delaying cell-cycle arrest in vitro.  The prometastatic activity of adenosine is partly tumor A2BR dependent and independent of host A2BR expression.  In humans, TNBC cell lines express higher A2BR than luminal and Her2+ breast cancer cell lines, and high expression of A2BR is assocd. with worse prognosis in TNBC.  Collectively, high A2BR on mouse and human tumors promotes cancer metastasis and is an ideal candidate for therapeutic intervention.  Cancer Res; 76(15); 4372-82. 2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxwJQYAF4O6LVg90H21EOLACvtfcHk0liAk6GPamkt6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gmt7jO&md5=cc697ab12211e6cfd4d6d20fdec04bf5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-16-0544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-16-0544%26sid%3Dliteratum%253Aachs%26aulast%3DMittal%26aufirst%3DD.%26aulast%3DSinha%26aufirst%3DD.%26aulast%3DBarkauskas%26aufirst%3DD.%26aulast%3DYoung%26aufirst%3DA.%26aulast%3DKalimutho%26aufirst%3DM.%26aulast%3DStannard%26aufirst%3DK.%26aulast%3DCaramia%26aufirst%3DF.%26aulast%3DHaibe-Kains%26aufirst%3DB.%26aulast%3DStagg%26aufirst%3DJ.%26aulast%3DKhanna%26aufirst%3DK.%2BK.%26aulast%3DLoi%26aufirst%3DS.%26aulast%3DSmyth%26aufirst%3DM.%2BJ.%26atitle%3DAdenosine%25202B%2520Receptor%2520Expression%2520on%2520Cancer%2520Cells%2520Promotes%2520Metastasis%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D4372%26epage%3D4382%26doi%3D10.1158%2F0008-5472.CAN-16-0544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iannone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miele, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiolino, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morello, S.</span></span> <span> </span><span class="NLM_article-title">Blockade of A2b Adenosine Receptor Reduces Tumor Growth and Immune Suppression Mediated by Myeloid-Derived Suppressor Cells in a Mouse Model of Melanoma</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1400</span>– <span class="NLM_lpage">1409</span>, <span class="refDoi"> DOI: 10.1593/neo.131748</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1593%2Fneo.131748" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=24403862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWls73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=1400-1409&author=R.+Iannoneauthor=L.+Mieleauthor=P.+Maiolinoauthor=A.+Pintoauthor=S.+Morello&title=Blockade+of+A2b+Adenosine+Receptor+Reduces+Tumor+Growth+and+Immune+Suppression+Mediated+by+Myeloid-Derived+Suppressor+Cells+in+a+Mouse+Model+of+Melanoma&doi=10.1593%2Fneo.131748"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of A2b adenosine receptor reduces tumor growth and immune suppression mediated by myeloid-derived suppressor cells in a mouse model of melanoma</span></div><div class="casAuthors">Iannone, Raffaella; Miele, Lucio; Maiolino, Piera; Pinto, Aldo; Morello, Silvana</div><div class="citationInfo"><span class="NLM_cas:title">Neoplasia (Ann Arbor, MI, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1400-1409, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEOPFL</span>;
        ISSN:<span class="NLM_cas:issn">1522-8002</span>.
    
            (<span class="NLM_cas:orgname">Neoplasia Press Inc.</span>)
        </div><div class="casAbstract">The A2b receptor (A2bR) belongs to the adenosine receptor family.  Emerging evidence suggest that A2bR is implicated in tumor progression in some murine tumor models, but the therapeutic potential of targeting A2bR in melanoma has not been examd.  This study first shows that melanoma-bearing mice treated with Bay 60-6583, a selective A2bR agonist, had increased melanoma growth.  This effect was assocd. with higher levels of immune regulatory mediators interleukin-10 (IL-10) and monocyte chemoattractant protein 1 (MCP-1) and accumulation of tumor-assocd. CD11b pos. Gr1 pos. cells (CD11b+Gr1+) myeloid-derived suppressor cells (MDSCs).  Depletion of CD11b+Gr1+ cells completely reversed the protumor activity of Bay 60-6583.  Conversely, pharmacol. blockade of A2bR with PSB1115 reversed immune suppression in the tumor microenvironment, leading to a significant melanoma growth delay.  PSB1115 treatment reduced both levels of IL-10 and MCP-1 and CD11b+Gr1+ cell no. in melanoma lesions.  These effects were assocd. with higher frequency of tumor-infiltrating CD8 pos. (CD8+) T cells and natural killer T (NKT) cells and increased levels of T helper 1 (Th1)-like cytokines.  Adoptive transfer of CD11b+Gr1+ cells abrogated the antitumor activity of PSB1115.  These data suggest that the antitumor activity of PSB1115 relies on its ability to lower accumulation of tumor-infiltrating MDSCs and restore an efficient antitumor T cell response.  The antitumor effect of PSB1115 was not obsd. in melanoma-bearing nude mice.  Furthermore, PSB1115 enhanced the antitumor efficacy of dacarbazine.These data indicate that A2bR antagonists such as PSB1115 should be investigated as adjuvants in the treatment of melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCc_1YKSaS8rVg90H21EOLACvtfcHk0liAk6GPamkt6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWls73K&md5=0b4cb56ad530f6cca9027d845a7577cc</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1593%2Fneo.131748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.131748%26sid%3Dliteratum%253Aachs%26aulast%3DIannone%26aufirst%3DR.%26aulast%3DMiele%26aufirst%3DL.%26aulast%3DMaiolino%26aufirst%3DP.%26aulast%3DPinto%26aufirst%3DA.%26aulast%3DMorello%26aufirst%3DS.%26atitle%3DBlockade%2520of%2520A2b%2520Adenosine%2520Receptor%2520Reduces%2520Tumor%2520Growth%2520and%2520Immune%2520Suppression%2520Mediated%2520by%2520Myeloid-Derived%2520Suppressor%2520Cells%2520in%2520a%2520Mouse%2520Model%2520of%2520Melanoma%26jtitle%3DNeoplasia%26date%3D2013%26volume%3D15%26spage%3D1400%26epage%3D1409%26doi%3D10.1593%2Fneo.131748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span> <span> </span><span class="NLM_article-title">A2B Adenosine Receptor and Cancer</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5139</span>, <span class="refDoi"> DOI: 10.3390/ijms20205139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.3390%2Fijms20205139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BB3cXovF2gtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=5139&author=Z.-G.+Gaoauthor=K.+A.+Jacobson&title=A2B+Adenosine+Receptor+and+Cancer&doi=10.3390%2Fijms20205139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A2B adenosine receptor and cancer</span></div><div class="casAuthors">Gao, Zhan-Guo; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5139</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  There are four subtypes of adenosine receptors (ARs), named A1, A2A, A2B and A3, all of which are G protein-coupled receptors (GPCRs).  Locally produced adenosine is a suppressant in anti-tumor immune surveillance.  The A2BAR, coupled to both Gαs and Gαi G proteins, is one of the several GPCRs that are expressed in a significantly higher level in certain cancer tissues, in comparison to adjacent normal tissues.  There is growing evidence that the A2BAR plays an important role in tumor cell proliferation, angiogenesis, metastasis, and immune suppression.  Thus, A2BAR antagonists are novel, potentially attractive anticancer agents.  Several antagonists targeting A2BAR are currently in clin. trials for various types of cancers.  In this review, we first describe the signaling, agonists, and antagonists of the A2BAR.  We further discuss the role of the A2BAR in the progression of various cancers, and the rationale of using A2BAR antagonists in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJLj5N04AxZrVg90H21EOLACvtfcHk0lhbYpNAb5eD_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXovF2gtLg%253D&md5=cd00c1fcfc81f12134a0753be8a61c8e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3390%2Fijms20205139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms20205139%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.-G.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DA2B%2520Adenosine%2520Receptor%2520and%2520Cancer%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2019%26volume%3D20%26spage%3D5139%26doi%3D10.3390%2Fijms20205139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mousavi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panjehpour, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izadpanahi, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aghaei, M.</span></span> <span> </span><span class="NLM_article-title">Expression of Adenosine Receptor Subclasses in Malignant and Adjacent Normal Human Prostate Tissues</span>. <i>Prostate</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">747</span>, <span class="refDoi"> DOI: 10.1002/pros.22955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1002%2Fpros.22955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=25704103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtlChs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=735-747&author=S.+Mousaviauthor=M.+Panjehpourauthor=M.+H.+Izadpanahiauthor=M.+Aghaei&title=Expression+of+Adenosine+Receptor+Subclasses+in+Malignant+and+Adjacent+Normal+Human+Prostate+Tissues&doi=10.1002%2Fpros.22955"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of adenosine receptor subclasses in malignant and adjacent normal human prostate tissues</span></div><div class="casAuthors">Mousavi, Samira; Panjehpour, Mojtaba; Izadpanahi, Mohammad Hossein; Aghaei, Mahmoud</div><div class="citationInfo"><span class="NLM_cas:title">Prostate (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">735-747</span>CODEN:
                <span class="NLM_cas:coden">PRSTDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-4137</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">BACKGROUND : Adenosine, a purine nucleoside plays important roles in the pathogenesis of cancer initiation and promotion via interaction with four adenosine receptors.  In the present study we examd. the differential expression pattern of adenosine receptors in the malignant and adjacent normal human prostate tissues.  METHODS : Prostate cancer tissue samples and adjacent normal tissues were obtained from 20 patients undergoing radical prostatectomy and histopathol. diagnosis was confirmed for each sample.  Total RNA was extd. and reverse transcribed into cDNA and the mRNA expression levels of adenosine receptors were investigated by Taq-man real-time RT-PCR expt.  Quant. protein anal. was done by Western blotting expt.  Moreover, the mRNA and protein expression levels of adenosine receptors were measured after androgen treatment.  RESULT : Taq-man real-time RT-PCR measurements show different expression levels of adenosine receptor transcripts.  A2B adenosine receptor was predominantly expressed in tumor tissues (2.4-fold) followed by significantly expression of A3 (1.6-fold) and A2A adenosine receptors (1.5-fold) compared to adjacent normal tissues.  The presence of adenosine receptors at protein levels in prostate cancer tissues compared with normal tissues was shown the following rank order: A2B > A3 > A2A > A1.  Androgen receptor regulates adenosine receptors mRNA and protein expression in AR-pos. LNCaP cells, which was not seen in AR-neg. PC-3 cells.  CONCLUSION : These results indicated for the first time, the differential mRNA expression profile and protein levels of adenosine receptors in the human prostate cancer.  Interestingly, the A2B adenosine receptor followed by A3 is highly expressed in prostate tumor samples in comparison with the adjacent normal tissues.  The findings support the possible key role of A2B adenosine receptor in promoting cancer cell growth and suggest that A2B may be a novel target for prostate cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc-kyXeidoIrVg90H21EOLACvtfcHk0lhbYpNAb5eD_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtlChs7c%253D&md5=888f50cad93ee10a1f6e7e65a7415f02</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fpros.22955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.22955%26sid%3Dliteratum%253Aachs%26aulast%3DMousavi%26aufirst%3DS.%26aulast%3DPanjehpour%26aufirst%3DM.%26aulast%3DIzadpanahi%26aufirst%3DM.%2BH.%26aulast%3DAghaei%26aufirst%3DM.%26atitle%3DExpression%2520of%2520Adenosine%2520Receptor%2520Subclasses%2520in%2520Malignant%2520and%2520Adjacent%2520Normal%2520Human%2520Prostate%2520Tissues%26jtitle%3DProstate%26date%3D2015%26volume%3D75%26spage%3D735%26epage%3D747%26doi%3D10.1002%2Fpros.22955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novio, S.</span>; <span class="NLM_string-name">Nuñez-Iglesias, M. J.</span>; <span class="NLM_string-name">Freire-Garabal, M.</span></span> <span> </span><span class="NLM_article-title">Adenosine Signaling Pathways as Potential Therapeutic Targets in Prostate Cancer Disease</span>.  <i>Molecular Oncology: Underlying Mechanisms and Translational Advancements</i>; <span class="NLM_publisher-name">Springer International Publishing</span>: <span class="NLM_publisher-loc">Madrid</span>, <span class="NLM_year">2017</span>; pp  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">107</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1007%2F978-3-319-53082-6_4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=93-107&author=S.+Novio&author=M.+J.+Nu%C3%B1ez-Iglesias&author=M.+Freire-Garabal&title=Molecular+Oncology%3A+Underlying+Mechanisms+and+Translational+Advancements"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-53082-6_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-319-53082-6_4%26sid%3Dliteratum%253Aachs%26aulast%3DNovio%26aufirst%3DS.%26atitle%3DAdenosine%2520Signaling%2520Pathways%2520as%2520Potential%2520Therapeutic%2520Targets%2520in%2520Prostate%2520Cancer%2520Disease%26btitle%3DMolecular%2520Oncology%253A%2520Underlying%2520Mechanisms%2520and%2520Translational%2520Advancements%26pub%3DSpringer%2520International%2520Publishing%26date%3D2017%26spage%3D93%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turcotte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stagg, J.</span></span> <span> </span><span class="NLM_article-title">Targeting A2 Adenosine Receptors in Cancer</span>. <i>Immunol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.1038/icb.2017.8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1038%2Ficb.2017.8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=28174424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVSgtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2017&pages=333-339&author=D.+Allardauthor=M.+Turcotteauthor=J.+Stagg&title=Targeting+A2+Adenosine+Receptors+in+Cancer&doi=10.1038%2Ficb.2017.8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting A2 adenosine receptors in cancer</span></div><div class="casAuthors">Allard, David; Turcotte, Martin; Stagg, John</div><div class="citationInfo"><span class="NLM_cas:title">Immunology & Cell Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">333-339</span>CODEN:
                <span class="NLM_cas:coden">ICBIEZ</span>;
        ISSN:<span class="NLM_cas:issn">0818-9641</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tumor cells use various ways to evade anti-tumor immune responses.  Adenosine, a potent immunosuppressive metabolite, is often found elevated in the extracellular tumor microenvironment.  Therefore, targeting adenosine-generating enzymes (CD39 and CD73) or adenosine receptors has emerged as a novel means to stimulate anti-tumor immunity.  In particular, the A2 (A2a and A2b) adenosine receptors exhibit similar immunosuppressive and pro-angiogenic functions, yet have distinct biol. roles in cancer.  In this review, we describe the common and distinct biol. consequences of A2a and A2b adenosine receptor signaling in cancer.  We discuss recent pre-clin. studies and summarize the different mechanisms-of-action of adenosine-targeting drugs.  We also review the rationale for combining inhibitors of the adenosine pathway with other anticancer therapies such immune checkpoint inhibitors, tumor vaccines, chemotherapy and adoptive T cell therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfxdUqQmLeObVg90H21EOLACvtfcHk0lhbYpNAb5eD_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVSgtL8%253D&md5=c017e871d31f34803f9bca71303570aa</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Ficb.2017.8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Ficb.2017.8%26sid%3Dliteratum%253Aachs%26aulast%3DAllard%26aufirst%3DD.%26aulast%3DTurcotte%26aufirst%3DM.%26aulast%3DStagg%26aufirst%3DJ.%26atitle%3DTargeting%2520A2%2520Adenosine%2520Receptors%2520in%2520Cancer%26jtitle%3DImmunol.%2520Cell%2520Biol.%26date%3D2017%26volume%3D95%26spage%3D333%26epage%3D339%26doi%3D10.1038%2Ficb.2017.8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sorrentino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morello, S.</span></span> <span> </span><span class="NLM_article-title">Role of Adenosine in Tumor Progression: Focus on A2B Receptor as Potential Therapeutic Target</span>. <i>J. Cancer Metastasis Treat.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">127</span>, <span class="refDoi"> DOI: 10.20517/2394-4722.2017.29</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.20517%2F2394-4722.2017.29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkslCisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=127&author=C.+Sorrentinoauthor=S.+Morello&title=Role+of+Adenosine+in+Tumor+Progression%3A+Focus+on+A2B+Receptor+as+Potential+Therapeutic+Target&doi=10.20517%2F2394-4722.2017.29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Role of adenosine in tumor progression: focus on A2B receptor as potential therapeutic target</span></div><div class="casAuthors">Sorrentino, Claudia; Morello, Silvana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cancer Metastasis and Treatment</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127-138</span>CODEN:
                <span class="NLM_cas:coden">JCMTCU</span>;
        ISSN:<span class="NLM_cas:issn">2454-2857</span>.
    
            (<span class="NLM_cas:orgname">OAE Publishing Inc.</span>)
        </div><div class="casAbstract">Adenosine receptors are a family of G-coupled receptors which mediate the anti-inflammatory and immune-suppressive effects of adenosine in a damaged tissue.  A large no. of evidence indicate that the accumulation of adenosine under hypoxic conditions favors tumor progression, helping cancer cells to evade immune responses.  Tumor cells and/or lymphoid and myeloid cells can express the adenosine-generating enzyme CD73 and/or A2A receptor, which in turn strongly suppresses an effective T-cell-mediated response, while promotes the activity of suppressive cells such as Treg and myeloid-derived suppressor cells.  CD73 inhibitors and A2A antagonists, either as single agents, or in combination with immune-checkpoints inhibitors such as anti PD-1 monoclonal antibodies, are currently in Phase I clin. trial in cancer patients.  Recent studies show that A2B receptor plays an important role in mediating the pro-tumor effects of adenosine, since its selective blockade can inhibit tumor growth in some murine tumor models.  Targeting A2B receptor reduces immunosuppression induced by myeloid cells and inhibits the stromal cells activity within the tumor microenvironment, limiting tumor angiogenesis and metastatic processes.  Here, the authors review the current data on involvement of A2B receptor in regulating tumor progression and discuss the development of A2B receptor inhibitors as potential therapeutic agents in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4x_7esAsf_LVg90H21EOLACvtfcHk0li2-9lf3yuw0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkslCisLs%253D&md5=fa3c6d881e962ae9f9f61eb99ecc0a54</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.20517%2F2394-4722.2017.29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.20517%252F2394-4722.2017.29%26sid%3Dliteratum%253Aachs%26aulast%3DSorrentino%26aufirst%3DC.%26aulast%3DMorello%26aufirst%3DS.%26atitle%3DRole%2520of%2520Adenosine%2520in%2520Tumor%2520Progression%253A%2520Focus%2520on%2520A2B%2520Receptor%2520as%2520Potential%2520Therapeutic%2520Target%26jtitle%3DJ.%2520Cancer%2520Metastasis%2520Treat.%26date%3D2017%26volume%3D3%26spage%3D127%26doi%3D10.20517%2F2394-4722.2017.29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sepúlveda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuentes, E.</span></span> <span> </span><span class="NLM_article-title">Role of Adenosine A2b Receptor Overexpression in Tumor Progression</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">92</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2016.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.lfs.2016.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=27729268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslCkurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2016&pages=92-99&author=C.+Sep%C3%BAlvedaauthor=I.+Palomoauthor=E.+Fuentes&title=Role+of+Adenosine+A2b+Receptor+Overexpression+in+Tumor+Progression&doi=10.1016%2Fj.lfs.2016.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Role of adenosine A2b receptor overexpression in tumor progression</span></div><div class="casAuthors">Sepulveda, Cesar; Palomo, Ivan; Fuentes, Eduardo</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">92-99</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The adenosine A2b receptor is a G-protein coupled receptor.  Its activation occurs with high extracellular adenosine concn., for example in inflammation or hypoxia.  These conditions are generated in the tumor environment.  Studies show that A2b receptor is overexpressed in various tumor lines and biopsies from patients with different cancers.  This suggests that A2b receptor can be used by tumor cells to promote progression.  Thus A2b participates in different events, such as angiogenesis and metastasis, besides exerting immunomodulatory effects that protect tumor cells.  Therefore, adenosine A2b receptor appears as an interesting therapeutic target for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4zsCypv39ubVg90H21EOLACvtfcHk0li2-9lf3yuw0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslCkurfJ&md5=23f5235b7c2f663665e5db2521e064b8</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2016.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2016.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DSep%25C3%25BAlveda%26aufirst%3DC.%26aulast%3DPalomo%26aufirst%3DI.%26aulast%3DFuentes%26aufirst%3DE.%26atitle%3DRole%2520of%2520Adenosine%2520A2b%2520Receptor%2520Overexpression%2520in%2520Tumor%2520Progression%26jtitle%3DLife%2520Sci.%26date%3D2016%26volume%3D166%26spage%3D92%26epage%3D99%26doi%3D10.1016%2Fj.lfs.2016.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauregard, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguile Makao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacombe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fradet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fradet, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouliot, F.</span></span> <span> </span><span class="NLM_article-title">Metabolic Imaging of Prostate Cancer Reveals Intrapatient Intermetastasis Response Heterogeneity to Systemic Therapy</span>. <i>Eur. Urol. Focus</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">639</span>– <span class="NLM_lpage">642</span>, <span class="refDoi"> DOI: 10.1016/j.euf.2017.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.euf.2017.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=28753860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A280%3ADC%252BC1cfitFGktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=639-642&author=F.+Morinauthor=J.-M.+Beauregardauthor=M.+Bergeronauthor=M.+Nguile+Makaoauthor=L.+Lacombeauthor=V.+Fradetauthor=Y.+Fradetauthor=F.+Pouliot&title=Metabolic+Imaging+of+Prostate+Cancer+Reveals+Intrapatient+Intermetastasis+Response+Heterogeneity+to+Systemic+Therapy&doi=10.1016%2Fj.euf.2017.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic Imaging of Prostate Cancer Reveals Intrapatient Intermetastasis Response Heterogeneity to Systemic Therapy</span></div><div class="casAuthors">Morin Fannie; Bergeron Michelle; Nguile Makao Moliere; Lacombe Louis; Fradet Vincent; Fradet Yves; Beauregard Jean-Mathieu; Pouliot Frederic</div><div class="citationInfo"><span class="NLM_cas:title">European urology focus</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">639-642</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Although intrapatient heterogeneity of prostate cancer (PCa) has recently been characterized via genomic and transcriptomic studies, the heterogeneity of systemic treatment responses has yet to be reported or imaged.  Our objective was to evaluate the intrapatient intermetastasis response to systemic treatment among patients with metastatic PCa.  We evaluated the metabolic response for each individual metastatic lesion (n=165) in 15 patients with metastatic PCa who underwent (18)F-fluorodeoxyglucose positron emission tomography/computed tomography before and at least 3 mo after initiation of a systemic therapy that did not change in that period.  Intermetastasis heterogeneity was defined as opposite metabolic responses for at least two metastases from the same compartment (bone or soft tissue) between the two time points.  We found intrapatient intermetastasis response heterogeneity in 40% of the cases in our retrospective series.  Our results suggest that systemic therapies can induce heterogeneous responses among individual metastases in patients with PCa, supporting the polyclonal evolution of PCa in advanced disease.  Molecular imaging may thus be useful in identifying clinical resistance early after therapy initiation and could also allow targeted biopsy of resistant clones for molecular analysis.  PATIENT SUMMARY:  Systemic therapies can lead to heterogeneous responses in individual metastases of prostate cancer in a patient.  Molecular imaging may be useful for identifying heterogeneity and could allow targeted biopsy for molecular analysis or therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQB49LRiDThK-3MPKNEWB5RfW6udTcc2eY2Hx2Wz_6TErntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfitFGktQ%253D%253D&md5=27e1d24e55e958cfdf973c919b5bf7cd</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.euf.2017.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euf.2017.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DMorin%26aufirst%3DF.%26aulast%3DBeauregard%26aufirst%3DJ.-M.%26aulast%3DBergeron%26aufirst%3DM.%26aulast%3DNguile%2BMakao%26aufirst%3DM.%26aulast%3DLacombe%26aufirst%3DL.%26aulast%3DFradet%26aufirst%3DV.%26aulast%3DFradet%26aufirst%3DY.%26aulast%3DPouliot%26aufirst%3DF.%26atitle%3DMetabolic%2520Imaging%2520of%2520Prostate%2520Cancer%2520Reveals%2520Intrapatient%2520Intermetastasis%2520Response%2520Heterogeneity%2520to%2520Systemic%2520Therapy%26jtitle%3DEur.%2520Urol.%2520Focus%26date%3D2017%26volume%3D3%26spage%3D639%26epage%3D642%26doi%3D10.1016%2Fj.euf.2017.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costanzi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span> <span> </span><span class="NLM_article-title">A2B Adenosine Receptor Blockade Inhibits Growth of Prostate Cancer Cells</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1007/s11302-012-9350-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1007%2Fs11302-012-9350-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=23315335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVGjsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=271-280&author=Q.+Weiauthor=S.+Costanziauthor=R.+Balasubramanianauthor=Z.-G.+Gaoauthor=K.+A.+Jacobson&title=A2B+Adenosine+Receptor+Blockade+Inhibits+Growth+of+Prostate+Cancer+Cells&doi=10.1007%2Fs11302-012-9350-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A2B adenosine receptor blockade inhibits growth of prostate cancer cells</span></div><div class="casAuthors">Wei, Qiang; Costanzi, Stefano; Balasubramanian, Ramachandran; Gao, Zhan-Guo; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">271-280</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The role of the A2B adenosine receptor (AR) in prostate cell death and growth was studied.  The A2B AR gene expression quantified by real-time quant. RT-PCR and Western blot anal. was the highest among 4 AR subtypes (A1, A2A, A2B, and A3) in all 3 commonly used prostate cancer cell lines, PC-3, DU145, and LNCaP.  We explored the function of the A2B AR using PC-3 cells as a model.  The A2B AR was visualized in PC-3 cells by laser confocal microscopy.  The nonselective A2B AR agonist NECA and the selective A2B AR agonist BAY60-6583, but not the A2A AR agonist CGS21680, concn.-dependently induced adenosine 3',5'-cyclic monophosphate (cAMP) accumulation.  NECA diminished lactate dehydrogenase (LDH) release, TNF-α-induced increase of caspase-3 activity, and cycloheximide (CHX)-induced morphol. changes typical of apoptosis in PC-3 cells, which were blocked by a selective A2B AR antagonist PSB603.  NECA-induced proliferation of PC-3 cells was diminished by siRNA specific for the A2B AR.  The selective A2B AR antagonist PSB603 was shown to inhibit cell growth in all 3 cell lines.  Thus, A2B AR blockade inhibits growth of prostate cancer cells, suggesting selective A2B AR antagonists as potential novel therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovLTcPmvn2MLVg90H21EOLACvtfcHk0lhZ-c0e3M6HmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVGjsr4%253D&md5=204e30e689ba4767a5101f280d014be2</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2Fs11302-012-9350-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-012-9350-3%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DQ.%26aulast%3DCostanzi%26aufirst%3DS.%26aulast%3DBalasubramanian%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DZ.-G.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DA2B%2520Adenosine%2520Receptor%2520Blockade%2520Inhibits%2520Growth%2520of%2520Prostate%2520Cancer%2520Cells%26jtitle%3DPurinergic%2520Signalling%26date%3D2013%26volume%3D9%26spage%3D271%26epage%3D280%26doi%3D10.1007%2Fs11302-012-9350-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaji, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukimoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, S.</span></span> <span> </span><span class="NLM_article-title">Adenosine A2B Receptor Antagonist PSB603 Suppresses Tumor Growth and Metastasis by Inhibiting Induction of Regulatory T Cells</span>. <i>J. Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">198</span>, <span class="refDoi"> DOI: 10.2131/jts.39.191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.2131%2Fjts.39.191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=24646699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVSnt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=191-198&author=W.+Kajiauthor=S.+Tanakaauthor=M.+Tsukimotoauthor=S.+Kojima&title=Adenosine+A2B+Receptor+Antagonist+PSB603+Suppresses+Tumor+Growth+and+Metastasis+by+Inhibiting+Induction+of+Regulatory+T+Cells&doi=10.2131%2Fjts.39.191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2B receptor antagonist PSB603 suppresses tumor growth and metastasis by inhibiting induction of regulatory T cells</span></div><div class="casAuthors">Kaji, Wakako; Tanaka, Satomi; Tsukimoto, Mitsutoshi; Kojima, Shuji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Toxicological Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">191-198</span>CODEN:
                <span class="NLM_cas:coden">JTSCDR</span>;
        ISSN:<span class="NLM_cas:issn">0388-1350</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society of Toxicology</span>)
        </div><div class="casAbstract">Regulatory T cells (Treg) play a role in suppression of immune response, including anti-tumor immunity.  We have recently reported that treatment of naive CD4 T cells with adenosine A2B receptor antagonist PSB603 under Treg-skewing conditions inhibits expression of Foxp3, a marker of differentiation to Treg, without blocking IL-2 prodn. or CD25 expression, which are activation markers, in CD4 T cells.  We hypothesized that PSB603 suppresses cancer growth and metastasis by inhibiting induction of Treg, thereby facilitating anti-tumor immunity.  In this study, we first examd. the effect of PSB603 on tumor growth in B16 melanoma-bearing C57BL/6 mice.  Administration of PSB603 significantly suppressed the increase of tumor vol. as well as the increase of Treg population in these mice.  The populations of CD4 and CD8 T cells were higher and splenic lymphocyte-mediated cytotoxicity towards B16 melanoma was significantly increased in PSB603-treated mice.  We confirmed that PSB603 did not reduce the viability of B16 melanoma cells in vitro.  Moreover, we also examd. the effect of PSB603 on tumor metastasis in pulmonary metastasis model mice i.v. injected with B16 melanoma cells.  The metastasis was also suppressed in PSB603-treated mice, in which the population of Treg was significantly lower.  Overall, our results suggest that A2B receptor antagonist PSB603 enhances anti-tumor immunity by inhibiting differentiation to Treg, resulting in a delay of tumor growth and a suppression of metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxaYtuhdGYu7Vg90H21EOLACvtfcHk0lhZ-c0e3M6HmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVSnt7Y%253D&md5=16ceeaa074e25584f643702b800c0586</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2131%2Fjts.39.191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2131%252Fjts.39.191%26sid%3Dliteratum%253Aachs%26aulast%3DKaji%26aufirst%3DW.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DTsukimoto%26aufirst%3DM.%26aulast%3DKojima%26aufirst%3DS.%26atitle%3DAdenosine%2520A2B%2520Receptor%2520Antagonist%2520PSB603%2520Suppresses%2520Tumor%2520Growth%2520and%2520Metastasis%2520by%2520Inhibiting%2520Induction%2520of%2520Regulatory%2520T%2520Cells%26jtitle%3DJ.%2520Toxicol.%2520Sci.%26date%3D2014%26volume%3D39%26spage%3D191%26epage%3D198%26doi%3D10.2131%2Fjts.39.191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borrmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertarelli, D. C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florin, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheiff, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">1-Alkyl-8-(Piperazine-1-Sulfonyl)Phenylxanthines: Development and Characterization of Adenosine A2B Receptor Antagonists and a New Radioligand with Subnanomolar Affinity and Subtype Specificity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3994</span>– <span class="NLM_lpage">4006</span>, <span class="refDoi"> DOI: 10.1021/jm900413e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900413e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsVOmtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3994-4006&author=T.+Borrmannauthor=S.+Hinzauthor=D.+C.+G.+Bertarelliauthor=W.+Liauthor=N.+C.+Florinauthor=A.+B.+Scheiffauthor=C.+E.+M%C3%BCller&title=1-Alkyl-8-%28Piperazine-1-Sulfonyl%29Phenylxanthines%3A+Development+and+Characterization+of+Adenosine+A2B+Receptor+Antagonists+and+a+New+Radioligand+with+Subnanomolar+Affinity+and+Subtype+Specificity&doi=10.1021%2Fjm900413e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">1-Alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: Development and Characterization of Adenosine A2B Receptor Antagonists and a New Radioligand with Subnanomolar Affinity and Subtype Specificity</span></div><div class="casAuthors">Borrmann, Thomas; Hinz, Sonja; Bertarelli, Daniela C. G.; Li, Wenjin; Florin, Nicole C.; Scheiff, Anja B.; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3994-4006</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of 1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines was designed, synthesized, and characterized in radioligand binding and functional assays at A2B adenosine receptors.  A2B antagonists with subnanomolar affinity and high selectivity were discovered.  The most potent compds. were 1-ethyl-8-(4-(4-(4-trifluoromethylbenzyl)piperazine-1-sulfonyl)phenyl)xanthine (PSB-09120, Ki (human A2B) = 0.157 nM) and 8-(4-(4-(4-chlorobenzyl)piperazine-1-sulfonyl)phenyl)-1-propylxanthine (PSB-0788, Ki (human A2B) = 0.393 nM).  Moreover, 8-(4-(4-(4-chlorophenyl)piperazine-1-sulfonyl)phenyl)-1-propylxanthine ( PSB-603) was developed as an A2B-specific antagonist exhibiting a Ki value of 0.553 nM at the human A2B receptor and virtually no affinity for the human and rat A1 and A2A and the human A3 receptors up to a concn. of 10 μM.  A tritiated form of the compd. was prepd. as a new radioligand and characterized in kinetic, satn., and competition studies.  It was shown to be a useful pharmacol. tool for the selective labeling of human as well as rodent A2B receptors (KD human A2B 0.403 nM, mouse A2B 0.351 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWuka8J5BT1LVg90H21EOLACvtfcHk0lhZ-c0e3M6HmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsVOmtLg%253D&md5=c32619fcbde66b6f4237b0467d9d2950</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm900413e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900413e%26sid%3Dliteratum%253Aachs%26aulast%3DBorrmann%26aufirst%3DT.%26aulast%3DHinz%26aufirst%3DS.%26aulast%3DBertarelli%26aufirst%3DD.%2BC.%2BG.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DFlorin%26aufirst%3DN.%2BC.%26aulast%3DScheiff%26aufirst%3DA.%2BB.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3D1-Alkyl-8-%2528Piperazine-1-Sulfonyl%2529Phenylxanthines%253A%2520Development%2520and%2520Characterization%2520of%2520Adenosine%2520A2B%2520Receptor%2520Antagonists%2520and%2520a%2520New%2520Radioligand%2520with%2520Subnanomolar%2520Affinity%2520and%2520Subtype%2520Specificity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3994%26epage%3D4006%26doi%3D10.1021%2Fjm900413e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seel, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temirak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namasivayam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arridu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schabikowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baqi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hockemeyer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">A2B Adenosine Receptor Antagonists with Picomolar Potency</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">4032</span>– <span class="NLM_lpage">4055</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00071</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00071" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkt1WgsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=4032-4055&author=J.+Jiangauthor=C.+J.+Seelauthor=A.+Temirakauthor=V.+Namasivayamauthor=A.+Arriduauthor=J.+Schabikowskiauthor=Y.+Baqiauthor=S.+Hinzauthor=J.+Hockemeyerauthor=C.+E.+M%C3%BCller&title=A2B+Adenosine+Receptor+Antagonists+with+Picomolar+Potency&doi=10.1021%2Facs.jmedchem.9b00071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A2B Adenosine Receptor Antagonists with Picomolar Potency</span></div><div class="casAuthors">Jiang, Jie; Seel, Catharina Julia; Temirak, Ahmed; Namasivayam, Vigneshwaran; Arridu, Antonella; Schabikowski, Jakub; Baqi, Younis; Hinz, Sonja; Hockemeyer, Joerg; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4032-4055</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The A2B adenosine receptor (A2BAR) was proposed as a novel target for the (immuno)therapy of cancer since A2BAR blockade results in antiproliferative, anti-angiogenic, anti-metastatic, and immuno-stimulatory effects.  In this study, we explored the structure-activity relationships of xanthin-8-yl-benzenesulfonamides mainly by introducing a variety of linkers and substituents attached to the sulfonamide residue.  A new, convergent strategy was established which facilitated the synthesis of the target compds.  Many of the new compds. exhibited subnanomolar affinity for the A2BAR combined with high selectivity.  Functional groups were introduced which will allow the attachment of dyes and other reporter groups.  8-(4-((4-(4-Bromophenyl)piperazin-1-yl)sulfonyl)phenyl)-1-propylxanthine (34, PSB-1901) was the most potent A2B-antagonist (Ki 0.0835 nM, KB 0.0598 nM, human A2BAR) with >10,000-fold selectivity vs. all other AR subtypes.  It was similarly potent and selective at the mouse A2BAR, making it a promising tool for preclin. studies.  Computational studies predicted halogen bonding to contribute to the outstanding potency of 34.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4rrMRRHJNf7Vg90H21EOLACvtfcHk0ljp6X9QnrHQRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkt1WgsbY%253D&md5=c15d1364f801ac72231a5955b7e724ab</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00071%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DSeel%26aufirst%3DC.%2BJ.%26aulast%3DTemirak%26aufirst%3DA.%26aulast%3DNamasivayam%26aufirst%3DV.%26aulast%3DArridu%26aufirst%3DA.%26aulast%3DSchabikowski%26aufirst%3DJ.%26aulast%3DBaqi%26aufirst%3DY.%26aulast%3DHinz%26aufirst%3DS.%26aulast%3DHockemeyer%26aufirst%3DJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DA2B%2520Adenosine%2520Receptor%2520Antagonists%2520with%2520Picomolar%2520Potency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D4032%26epage%3D4055%26doi%3D10.1021%2Facs.jmedchem.9b00071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayallah, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandoval-Ramírez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reith, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schobert, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preiss, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">1,8-Disubstituted Xanthine Derivatives: Synthesis of Potent A2B-Selective Adenosine Receptor Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1500</span>– <span class="NLM_lpage">1510</span>, <span class="refDoi"> DOI: 10.1021/jm011049y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm011049y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtFKlu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1500-1510&author=A.+M.+Hayallahauthor=J.+Sandoval-Ram%C3%ADrezauthor=U.+Reithauthor=U.+Schobertauthor=B.+Preissauthor=B.+Schumacherauthor=J.+W.+Dalyauthor=C.+E.+M%C3%BCller&title=1%2C8-Disubstituted+Xanthine+Derivatives%3A+Synthesis+of+Potent+A2B-Selective+Adenosine+Receptor+Antagonists&doi=10.1021%2Fjm011049y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">1,8-Disubstituted Xanthine Derivatives: Synthesis of Potent A2B-Selective Adenosine Receptor Antagonists</span></div><div class="casAuthors">Hayallah, Alaa M.; Sandoval-Ramirez, Jesus; Reith, Ulrike; Schobert, Ulrike; Preiss, Birgit; Schumacher, Britta; Daly, John W.; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1500-1510</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-Unsubstituted xanthine derivs. bearing a cyclopentyl or a Ph residue in the 8-position were synthesized and developed as A2B adenosine receptor antagonists.  Compds. bearing polar substituents were prepd. to obtain water-sol. derivs.  1-Alkyl-8-phenylxanthine derivs. were found to exhibit high affinity for A2B adenosine receptors (ARs).  1,8-Disubstituted xanthine derivs. were equipotent to or more potent than 1,3,8-trisubstituted xanthines at A2B ARs, but generally less potent at A1 and A2A, and much less potent at A3 ARs.  Thus, the new compds. exhibited increased A2B selectivity vs. all other AR subtypes.  9-Deazaxanthines (pyrrolo[2,3-d]pyrimidindiones) appeared to be less potent at A2B ARs than the corresponding xanthine derivs.  1-Propyl-8-p-sulfophenylxanthine (I) was the most selective compd. of the present series, exhibiting a Ki value of 53 nM at human A2B ARs and showing greater than 180-fold selectivity vs. human A1 ARs.  Compd. I was also highly selective vs. rat A1 ARs (41-fold) and vs. the other human AR subtypes (A2A > 400-fold and A3 > 180-fold).  The compd. is highly water-sol. due to its sulfonate function.  1-Butyl-8-p-carboxyphenylxanthine, another polar analog bearing a carboxylate function, exhibited a Ki value of 24 nM for A2B ARs, 49-fold selectivity vs. human and 20-fold selectivity vs. rat A1 ARs, and greater than 150-fold selectivity vs. human A2A and A3 ARs.  8-[4-[(2-Hydroxyethylamino)-2-oxoethoxy]phenyl]-1-propylxanthine (II) and 1-butyl-8-[4-[(4-benzylpiperazino)-2-oxoethoxy]phenyl]xanthine (III) were among the most potent A2B antagonists showing Ki values at A2B ARs of 1 nM, 57-fold for II and 94-fold for III selectivity vs. human A1, ca. 30-fold selectivity vs. rat A1, and greater than 400-fold selectivity vs. human A2A and A3 ARs.  The new potent, selective, water-sol. A2B antagonists may be useful research tools for investigating A2B receptor function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh8eeBzBfHfLVg90H21EOLACvtfcHk0ljp6X9QnrHQRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtFKlu7k%253D&md5=759d610ad10c658403730fc7f00f6054</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm011049y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm011049y%26sid%3Dliteratum%253Aachs%26aulast%3DHayallah%26aufirst%3DA.%2BM.%26aulast%3DSandoval-Ram%25C3%25ADrez%26aufirst%3DJ.%26aulast%3DReith%26aufirst%3DU.%26aulast%3DSchobert%26aufirst%3DU.%26aulast%3DPreiss%26aufirst%3DB.%26aulast%3DSchumacher%26aufirst%3DB.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3D1%252C8-Disubstituted%2520Xanthine%2520Derivatives%253A%2520Synthesis%2520of%2520Potent%2520A2B-Selective%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1500%26epage%3D1510%26doi%3D10.1021%2Fjm011049y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, X.-d.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span> <span> </span><span class="NLM_article-title">Anilide Derivatives of an 8-Phenylxanthine Carboxylic Congener Are Highly Potent and Selective Antagonists at Human A(2B) Adenosine Receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1165</span>– <span class="NLM_lpage">1172</span>, <span class="refDoi"> DOI: 10.1021/jm990421v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990421v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtlGqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1165-1172&author=Y.-C.+Kimauthor=X.-d.+Jiauthor=N.+Melmanauthor=J.+Lindenauthor=K.+A.+Jacobson&title=Anilide+Derivatives+of+an+8-Phenylxanthine+Carboxylic+Congener+Are+Highly+Potent+and+Selective+Antagonists+at+Human+A%282B%29+Adenosine+Receptors&doi=10.1021%2Fjm990421v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A2B adenosine receptors</span></div><div class="casAuthors">Kim, Yong-Chul; Ji, Xiao-duo; Melman, Neli; Linden, Joel; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1165-1172</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">No highly selective antagonists of the A2B adenosine receptor (AR) have been reported; however such antagonists have therapeutic potential as antiasthmatic agents.  Here the synthesis of potent and selective A2B receptor Antagonists is reported.  The structure-activity relationships (SAR) of 8-phenyl-1,3-di-(n-propyl)xanthine derivs. in binding to recombinant human A2B ARs in HEK-293 cells (HEK-A2B) and at other AR subtypes were explored.  Various amide derivs. of 8-[4-[[carboxymethyl]oxy]phenyl]-1,3-di(n-propyl)xanthine, I (R1 = n-Pr, X = OCH2, R2 = OH) (II), were synthesized.  A comparison of aryl, alkyl, and aralkyl amides demonstrated that simple anilides, particularly those substituted in the para-position with electron-withdrawing groups, such as nitro, cyano, and acetyl, bind selectively to human A2B receptors in the range of 1-3 nM.  The unsubstituted anilide I (R1 = n-Pr, X = OCH2, R2 = NHPh) had a Ki value at A2B receptors of 1.48 nM but was only moderately selective vs. human A1/A2A receptors and nonselective vs. rat A1 receptors.  Highly potent and selective A2B antagonists were a p-aminoacetophenone deriv. I (R1 = n-Pr, X = OCH2, R2 = 4-MeOC6H4NH) (Ki value 1.39 nM) and a p-cyanoanilide I (R1 = n-Pr, X = OCH2, R2 = NHC6H4CN-4) (III) (Ki value 1.97 nM).  Compd. III was 400-, 245-, and 123-fold selective for human A2B receptors vs. human A1/A2A/A3 receptors, resp., and 8.5- and 310-fold selective vs. rat A1/A2A receptors, resp.  Substitution of the 1,3-di-Pr groups with 1,3-di-Et offered no disadvantage for selectivity, and high affinities at A2B receptors were maintained.  Substitution of the p-carboxymethyloxy group of II and its amides with acrylic acid decreased affinity at A2B receptors while increasing affinity at A1 receptors. 1,3-Di(cyclohexylmethyl) groups greatly reduced affinity at ARs, although the p-carboxymethyloxy deriv. I (R1 = cyclohexylmethyl, X = CH:CH, R2 = OH) was moderately selective for A2B receptors.  Several selective A2B antagonists inhibited NECA-stimulated calcium mobilization in HEK-A2B cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1SbbnjfBwjbVg90H21EOLACvtfcHk0ljp6X9QnrHQRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtlGqu7s%253D&md5=af987bb9429d31d6b9aa660744185832</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm990421v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990421v%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.-C.%26aulast%3DJi%26aufirst%3DX.-d.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DAnilide%2520Derivatives%2520of%2520an%25208-Phenylxanthine%2520Carboxylic%2520Congener%2520Are%2520Highly%2520Potent%2520and%2520Selective%2520Antagonists%2520at%2520Human%2520A%25282B%2529%2520Adenosine%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D1165%26epage%3D1172%26doi%3D10.1021%2Fjm990421v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinig, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKibben, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castelhano, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLennan, S. J.</span></span> <span> </span><span class="NLM_article-title">[3H]OSIP339391, a Selective, Novel, and High Affinity Antagonist Radioligand for Adenosine A2B Receptors</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">312</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2004.03.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.bcp.2004.03.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=15194002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvV2hs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2004&pages=305-312&author=M.+Stewartauthor=A.+G.+Steinigauthor=C.+Maauthor=J.-P.+Songauthor=B.+McKibbenauthor=A.+L.+Castelhanoauthor=S.+J.+MacLennan&title=%5B3H%5DOSIP339391%2C+a+Selective%2C+Novel%2C+and+High+Affinity+Antagonist+Radioligand+for+Adenosine+A2B+Receptors&doi=10.1016%2Fj.bcp.2004.03.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]OSIP339391, a selective, novel, and high affinity antagonist radioligand for adenosine A2B receptors</span></div><div class="casAuthors">Stewart, Mike; Steinig, Arno G.; Ma, Chienling; Song, Jian-Ping; McKibben, Bryan; Castelhano, Arlindo L.; MacLennan, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">305-312</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Until recently, the characterization of adenosine A2B receptors has been hampered by the lack of high affinity radioligands.  This study describes the synthesis and in vitro characterization of the radiolabeled deriv. of OSIP339391, a novel, potent, and selective pyrrolopyrimidine A2B antagonist.  OSIP339391 had a selectivity of greater than 70-fold for A2B receptors over other human adenosine receptor subtypes.  The radiolabel was introduced by hydrogenation of the acetylenic precursor with tritium gas resulting in the incorporation (on av.) of three tritium atoms in the mol., yielding a ligand with specific activity of 87 Ci/mmol (3.2 TBq/mmol).  Using membranes from HEK-293 cells expressing the human recombinant A2B receptor, [3H]OSIP339391 was characterized in kinetic, satn., and competition binding expts.  From the assocn. and dissocn. rate studies, the affinity was 0.41 nM and in close agreement with that found in satn. binding expts. (0.17 nM).  In competition, binding studies using 0.5 nM [3H]OSIP339391, the affinity of a range of agonists and antagonists was consistent with previously reported data.  Thus, [3H]OSIP339391 is a novel, selective, and high affinity radioligand that can be a useful tool in the further exploration and characterization of recombinant and endogenous adenosine A2B receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWckJRLeNAK7Vg90H21EOLACvtfcHk0ljxTCci0-pYtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvV2hs7g%253D&md5=a1725fd35398acd076bc3779e31aed00</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2004.03.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2004.03.026%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DM.%26aulast%3DSteinig%26aufirst%3DA.%2BG.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DSong%26aufirst%3DJ.-P.%26aulast%3DMcKibben%26aufirst%3DB.%26aulast%3DCastelhano%26aufirst%3DA.%2BL.%26aulast%3DMacLennan%26aufirst%3DS.%2BJ.%26atitle%3D%255B3H%255DOSIP339391%252C%2520a%2520Selective%252C%2520Novel%252C%2520and%2520High%2520Affinity%2520Antagonist%2520Radioligand%2520for%2520Adenosine%2520A2B%2520Receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2004%26volume%3D68%26spage%3D305%26epage%3D312%26doi%3D10.1016%2Fj.bcp.2004.03.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taliani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugliesi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barresi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simorini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salerno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Motta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marini, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosimelli, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosconati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Maro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniele, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trincavelli, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greco, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Settimo, F.</span></span> <span> </span><span class="NLM_article-title">3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A2BAdenosine Receptor Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1490</span>– <span class="NLM_lpage">1499</span>, <span class="refDoi"> DOI: 10.1021/jm201177b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201177b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsVyhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1490-1499&author=S.+Talianiauthor=I.+Pugliesiauthor=E.+Barresiauthor=F.+Simoriniauthor=S.+Salernoauthor=C.+La+Mottaauthor=A.+M.+Mariniauthor=B.+Cosimelliauthor=S.+Cosconatiauthor=S.+Di+Maroauthor=L.+Marinelliauthor=S.+Danieleauthor=M.+L.+Trincavelliauthor=G.+Grecoauthor=E.+Novellinoauthor=C.+Martiniauthor=F.+Da+Settimo&title=3-Aryl-%5B1%2C2%2C4%5Dtriazino%5B4%2C3-a%5Dbenzimidazol-4%2810H%29-one%3A+A+Novel+Template+for+the+Design+of+Highly+Selective+A2BAdenosine+Receptor+Antagonists&doi=10.1021%2Fjm201177b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A2B Adenosine Receptor Antagonists</span></div><div class="casAuthors">Taliani, Sabrina; Pugliesi, Isabella; Barresi, Elisabetta; Simorini, Francesca; Salerno, Silvia; La Motta, Concettina; Marini, Anna Maria; Cosimelli, Barbara; Cosconati, Sandro; Di Maro, Salvatore; Marinelli, Luciana; Daniele, Simona; Trincavelli, Maria Letizia; Greco, Giovanni; Novellino, Ettore; Martini, Claudia; Da Settimo, Federico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1490-1499</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In an effort to identify novel ligands possessing high affinity and selectivity for the A2B AR subtype, we further investigated the class of 3-aryl[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones, previously disclosed by us as selective A1 AR antagonists.  Preliminary assays on a no. of triazinobenzimidazoles derived from our "inhouse" collection revealed that all the derivs. selected showed significant affinity at A2B AR, no affinity at A3 AR, and various degrees of selectivity toward A1 and A2A ARs.  Investigation of a new series featuring modified substituents at the 10-position (4'-chlorophenyl or phenylethyl groups), and a chlorine atom at the 7-position (X) of the triazinobenzimidazole nucleus, yielded highly potent and selective A2B AR antagonists.  The presence of a pendant 3-Ph ring appears to hamper the interaction with A2A AR, conferring high A2B/A2A AR selectivity.  Compd. (I) is the most potent and selective compd., with an IC50 of 3.10 nM at A2B AR and no affinity at A1, A2A, and A3 ARs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqFYkkUBZbOrVg90H21EOLACvtfcHk0ljxTCci0-pYtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsVyhsQ%253D%253D&md5=702fe023ad22921949ebb71d108656f1</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm201177b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201177b%26sid%3Dliteratum%253Aachs%26aulast%3DTaliani%26aufirst%3DS.%26aulast%3DPugliesi%26aufirst%3DI.%26aulast%3DBarresi%26aufirst%3DE.%26aulast%3DSimorini%26aufirst%3DF.%26aulast%3DSalerno%26aufirst%3DS.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DMarini%26aufirst%3DA.%2BM.%26aulast%3DCosimelli%26aufirst%3DB.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DDi%2BMaro%26aufirst%3DS.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DDaniele%26aufirst%3DS.%26aulast%3DTrincavelli%26aufirst%3DM.%2BL.%26aulast%3DGreco%26aufirst%3DG.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DMartini%26aufirst%3DC.%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26atitle%3D3-Aryl-%255B1%252C2%252C4%255Dtriazino%255B4%252C3-a%255Dbenzimidazol-4%252810H%2529-one%253A%2520A%2520Novel%2520Template%2520for%2520the%2520Design%2520of%2520Highly%2520Selective%2520A2BAdenosine%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1490%26epage%3D1499%26doi%3D10.1021%2Fjm201177b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nueda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esteve, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domenech, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinoso, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pont, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calbet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadavid, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cárdenas, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godessart, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beleta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warrellow, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, H.</span></span> <span> </span><span class="NLM_article-title">Discovery and Characterization of 4′-(2-Furyl)-N-Pyridin-3-yl-4, 5′-Bipyrimidin-2′-Amine (LAS38096), a Potent, Selective, and Efficacious A2B Adenosine Receptor Antagonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2732</span>– <span class="NLM_lpage">2736</span>, <span class="refDoi"> DOI: 10.1021/jm061333v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061333v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslarur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2732-2736&author=B.+Vidalauthor=A.+Nuedaauthor=C.+Esteveauthor=T.+Domenechauthor=S.+Benitoauthor=R.+F.+Reinosoauthor=M.+Pontauthor=M.+Calbetauthor=R.+L%C3%B3pezauthor=M.+I.+Cadavidauthor=M.+I.+Lozaauthor=%C3%81.+C%C3%A1rdenasauthor=N.+Godessartauthor=J.+Beletaauthor=G.+Warrellowauthor=H.+Ryder&title=Discovery+and+Characterization+of+4%E2%80%B2-%282-Furyl%29-N-Pyridin-3-yl-4%2C+5%E2%80%B2-Bipyrimidin-2%E2%80%B2-Amine+%28LAS38096%29%2C+a+Potent%2C+Selective%2C+and+Efficacious+A2B+Adenosine+Receptor+Antagonist&doi=10.1021%2Fjm061333v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of 4'-(2-Furyl)-N-pyridin-3-yl-4,5'-bipyrimidin-2'-amine (LAS38096), a Potent, Selective, and Efficacious A2B Adenosine Receptor Antagonist</span></div><div class="casAuthors">Vidal, Bernat; Nueda, Arsenio; Esteve, Cristina; Domenech, Teresa; Benito, Sonia; Reinoso, Raquel F.; Pont, Merce; Calbet, Marta; Lopez, Rosa; Cadavid, Maria Isabel; Loza, Maria Isabel; Cardenas, Alvaro; Godessart, Nuria; Beleta, Jorge; Warrellow, Graham; Ryder, Hamish</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2732-2736</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of N-heteroaryl 4'-(2-furyl)-4,5'-bipyrimidin-2'-amines has been identified as potent and selective A2B adenosine receptor antagonists.  In particular, compd. 5 showed high affinity for the A2B receptor (Ki = 17 nM), good selectivity (IC50: A1 > 1000 nM, A2A > 2500 nM, A3 > 1000 nM), displayed a favorable pharmacokinetic profile in preclin. species, and showed efficacy in functional in vitro models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpijtnGUoID7bVg90H21EOLACvtfcHk0ljxTCci0-pYtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslarur0%253D&md5=017172644da88d13b26cddeb2ae96b84</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm061333v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061333v%26sid%3Dliteratum%253Aachs%26aulast%3DVidal%26aufirst%3DB.%26aulast%3DNueda%26aufirst%3DA.%26aulast%3DEsteve%26aufirst%3DC.%26aulast%3DDomenech%26aufirst%3DT.%26aulast%3DBenito%26aufirst%3DS.%26aulast%3DReinoso%26aufirst%3DR.%2BF.%26aulast%3DPont%26aufirst%3DM.%26aulast%3DCalbet%26aufirst%3DM.%26aulast%3DL%25C3%25B3pez%26aufirst%3DR.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DC%25C3%25A1rdenas%26aufirst%3D%25C3%2581.%26aulast%3DGodessart%26aufirst%3DN.%26aulast%3DBeleta%26aufirst%3DJ.%26aulast%3DWarrellow%26aufirst%3DG.%26aulast%3DRyder%26aufirst%3DH.%26atitle%3DDiscovery%2520and%2520Characterization%2520of%25204%25E2%2580%25B2-%25282-Furyl%2529-N-Pyridin-3-yl-4%252C%25205%25E2%2580%25B2-Bipyrimidin-2%25E2%2580%25B2-Amine%2520%2528LAS38096%2529%252C%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Efficacious%2520A2B%2520Adenosine%2520Receptor%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2732%26epage%3D2736%26doi%3D10.1021%2Fjm061333v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El
Maatougui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azuaje, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Gómez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miguez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crespo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carbajales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escalante, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Mera, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez-de-Terán, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotelo, E.</span></span> <span> </span><span class="NLM_article-title">Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1967</span>– <span class="NLM_lpage">1983</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01586</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01586" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslKnu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1967-1983&author=A.+El%0AMaatouguiauthor=J.+Azuajeauthor=M.+Gonz%C3%A1lez-G%C3%B3mezauthor=G.+Miguezauthor=A.+Crespoauthor=C.+Carbajalesauthor=L.+Escalanteauthor=X.+Garc%C3%ADa-Meraauthor=H.+Guti%C3%A9rrez-de-Ter%C3%A1nauthor=E.+Sotelo&title=Discovery+of+Potent+and+Highly+Selective+A2B+Adenosine+Receptor+Antagonist+Chemotypes&doi=10.1021%2Facs.jmedchem.5b01586"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes</span></div><div class="casAuthors">El Maatougui, Abdelaziz; Azuaje, Jhonny; Gonzalez-Gomez, Manuel; Miguez, Gabriel; Crespo, Abel; Carbajales, Carlos; Escalante, Luz; Garcia-Mera, Xerardo; Gutierrez-de-Teran, Hugo; Sotelo, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1967-1983</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Three novel families of A2B adenosine receptor antagonists were identified in the context of the structural exploration of the 3,4-dihydropyrimidin-2(1H)-one chemotype.  The most appealing series contain imidazole, 1,2,4-triazole, or benzimidazole rings fused to the 2,3-positions of the parent diazinone core.  The optimization process enabled identification of a highly potent (3.49 nM) A2B ligand that exhibits complete selectivity toward A1, A2A, and A3 receptors.  The results of functional cAMP expts. confirmed the antagonistic behavior of representative ligands.  The main SAR trends identified within the series were substantiated by a mol. modeling study based on a receptor-driven docking model constructed on the basis of the crystal structure of the human A2A receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRWpBQuLXYG7Vg90H21EOLACvtfcHk0lhkZvymaKFHzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslKnu7g%253D&md5=4df99ab9a9e7dea11b5592ba9d64b334</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01586%26sid%3Dliteratum%253Aachs%26aulast%3DEl%2BMaatougui%26aufirst%3DA.%26aulast%3DAzuaje%26aufirst%3DJ.%26aulast%3DGonz%25C3%25A1lez-G%25C3%25B3mez%26aufirst%3DM.%26aulast%3DMiguez%26aufirst%3DG.%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DCarbajales%26aufirst%3DC.%26aulast%3DEscalante%26aufirst%3DL.%26aulast%3DGarc%25C3%25ADa-Mera%26aufirst%3DX.%26aulast%3DGuti%25C3%25A9rrez-de-Ter%25C3%25A1n%26aufirst%3DH.%26aulast%3DSotelo%26aufirst%3DE.%26atitle%3DDiscovery%2520of%2520Potent%2520and%2520Highly%2520Selective%2520A2B%2520Adenosine%2520Receptor%2520Antagonist%2520Chemotypes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1967%26epage%3D1983%26doi%3D10.1021%2Facs.jmedchem.5b01586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carbajales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azuaje, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadavid, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masaguer, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Mera, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez-de-Terán, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotelo, E.</span></span> <span> </span><span class="NLM_article-title">Enantiospecific Recognition at the A2B Adenosine Receptor by Alkyl 2-Cyanoimino-4-Substituted-6-Methyl-1,2,3,4-Tetrahydropyrimidine-5-Carboxylates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3372</span>– <span class="NLM_lpage">3382</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00138</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00138" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsVygsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3372-3382&author=C.+Carbajalesauthor=J.+Azuajeauthor=A.+Oliveiraauthor=M.+I.+Lozaauthor=J.+Breaauthor=M.+I.+Cadavidauthor=C.+F.+Masaguerauthor=X.+Garc%C3%ADa-Meraauthor=H.+Guti%C3%A9rrez-de-Ter%C3%A1nauthor=E.+Sotelo&title=Enantiospecific+Recognition+at+the+A2B+Adenosine+Receptor+by+Alkyl+2-Cyanoimino-4-Substituted-6-Methyl-1%2C2%2C3%2C4-Tetrahydropyrimidine-5-Carboxylates&doi=10.1021%2Facs.jmedchem.7b00138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Enantiospecific Recognition at the A2B Adenosine Receptor by Alkyl 2-Cyanoimino-4-substituted-6-methyl-1,2,3,4-tetrahydropyrimidine-5-carboxylates</span></div><div class="casAuthors">Carbajales, Carlos; Azuaje, Jhonny; Oliveira, Ana; Loza, Maria I.; Brea, Jose; Cadavid, Maria I.; Masaguer, Christian F.; Garcia-Mera, Xerardo; Gutierrez-de-Teran, Hugo; Sotelo, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3372-3382</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel family of structurally simple, potent, and selective nonxanthine A2BAR ligands was identified, and its antagonistic behavior confirmed through functional expts.  The reported alkyl 2-cyanoimino-4-substituted-6-methyl-1,2,3,4-tetrahy-dropyrimidine-5-carboxylates (16) were designed by bioisosteric replacement of the carbonyl group at position 2 in a series of 3,4-dihydropyrimidin-2-ones.  The scaffold (16) documented herein contains a chiral center at the heterocycle.  Accordingly, the most attractive ligand of the series [(±)16b, Ki= 24.3 nM] was resolved into its two enantiomers by chiral HPLC, and the abs. configuration was established by CD.  The biol. evaluation of both enantiomers demonstrated enantiospecific recognition at A2BAR, with the (S)-16b enantiomer retaining all the affinity (Ki= 15.1 nM), as predicted earlier by mol. modeling.  This constitutes the first example of enantiospecific recognition at the A2B adenosine receptor and opens new possibilities in ligand design for this receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovaUyWm1ZvpLVg90H21EOLACvtfcHk0lhkZvymaKFHzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsVygsbc%253D&md5=478fd085f77fcd308514ba46b4bb8f7d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00138%26sid%3Dliteratum%253Aachs%26aulast%3DCarbajales%26aufirst%3DC.%26aulast%3DAzuaje%26aufirst%3DJ.%26aulast%3DOliveira%26aufirst%3DA.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DMasaguer%26aufirst%3DC.%2BF.%26aulast%3DGarc%25C3%25ADa-Mera%26aufirst%3DX.%26aulast%3DGuti%25C3%25A9rrez-de-Ter%25C3%25A1n%26aufirst%3DH.%26aulast%3DSotelo%26aufirst%3DE.%26atitle%3DEnantiospecific%2520Recognition%2520at%2520the%2520A2B%2520Adenosine%2520Receptor%2520by%2520Alkyl%25202-Cyanoimino-4-Substituted-6-Methyl-1%252C2%252C3%252C4-Tetrahydropyrimidine-5-Carboxylates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3372%26epage%3D3382%26doi%3D10.1021%2Facs.jmedchem.7b00138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crespo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Maatougui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biagini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azuaje, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadavid, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Mera, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez-de-Terán, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotelo, E.</span></span> <span> </span><span class="NLM_article-title">Discovery of 3,4-Dihydropyrimidin-2(1H)-ones As a Novel Class of Potent and Selective A2B Adenosine Receptor Antagonists</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1031</span>– <span class="NLM_lpage">1036</span>, <span class="refDoi"> DOI: 10.1021/ml400185v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400185v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKks77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1031-1036&author=A.+Crespoauthor=A.+El+Maatouguiauthor=P.+Biaginiauthor=J.+Azuajeauthor=A.+Coelhoauthor=J.+Breaauthor=M.+I.+Lozaauthor=M.+I.+Cadavidauthor=X.+Garc%C3%ADa-Meraauthor=H.+Guti%C3%A9rrez-de-Ter%C3%A1nauthor=E.+Sotelo&title=Discovery+of+3%2C4-Dihydropyrimidin-2%281H%29-ones+As+a+Novel+Class+of+Potent+and+Selective+A2B+Adenosine+Receptor+Antagonists&doi=10.1021%2Fml400185v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 3,4-Dihydropyrimidin-2(1H)-ones As a Novel Class of Potent and Selective A2B Adenosine Receptor Antagonists</span></div><div class="casAuthors">Crespo, Abel; El Maatougui, Abdelaziz; Biagini, Pierfrancesco; Azuaje, Jhonny; Coelho, Alberto; Brea, Jose; Loza, Maria Isabel; Cadavid, Maria Isabel; Garcia-Mera, Xerardo; Gutierrez-de-Teran, Hugo; Sotelo, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1031-1036</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe the discovery and optimization of 3,4-dihydropyrimidin-2-(1H)-ones as a novel family of (nonxanthine) A2B receptor antagonists that exhibit an unusually high selectivity profile.  The Biginelli-based hit optimization process enabled a thoughtful exploration of the structure-activity and structure-selectivity relationships for this chemotype, enabling the identification of ligands that combine structural simplicity with excellent hA2B AdoR affinity and remarkable selectivity profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcmq93mYNjxrVg90H21EOLACvtfcHk0lgtouXGMo0tZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKks77J&md5=41f5ce37315529b35115ef6ec3cccba5</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fml400185v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400185v%26sid%3Dliteratum%253Aachs%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DEl%2BMaatougui%26aufirst%3DA.%26aulast%3DBiagini%26aufirst%3DP.%26aulast%3DAzuaje%26aufirst%3DJ.%26aulast%3DCoelho%26aufirst%3DA.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DGarc%25C3%25ADa-Mera%26aufirst%3DX.%26aulast%3DGuti%25C3%25A9rrez-de-Ter%25C3%25A1n%26aufirst%3DH.%26aulast%3DSotelo%26aufirst%3DE.%26atitle%3DDiscovery%2520of%25203%252C4-Dihydropyrimidin-2%25281H%2529-ones%2520As%2520a%2520Novel%2520Class%2520of%2520Potent%2520and%2520Selective%2520A2B%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1031%26epage%3D1036%26doi%3D10.1021%2Fml400185v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C. N.</span>; <span class="NLM_string-name">Jamal, M. S.</span></span> <i>Handbook of Experimental Pharmacology: Adenosine Receptors in Health and Disease</i>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1007%2F978-3-540-89615-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=C.+N.+Wilson&author=M.+S.+Jamal&title=Handbook+of+Experimental+Pharmacology%3A+Adenosine+Receptors+in+Health+and+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1007%2F978-3-540-89615-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-540-89615-9%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DC.%2BN.%26btitle%3DHandbook%2520of%2520Experimental%2520Pharmacology%253A%2520Adenosine%2520Receptors%2520in%2520Health%2520and%2520Disease%26pub%3DSpringer%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabrizi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gessi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span> <span> </span><span class="NLM_article-title">Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1021/cr0682195</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr0682195" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD1cXis1OisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=238-263&author=P.+G.+Baraldiauthor=M.+A.+Tabriziauthor=S.+Gessiauthor=P.+A.+Borea&title=Adenosine+Receptor+Antagonists%3A+Translating+Medicinal+Chemistry+and+Pharmacology+into+Clinical+Utility&doi=10.1021%2Fcr0682195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility</span></div><div class="casAuthors">Baraldi, Pier Giovanni; Tabrizi, Mojgan Aghazadeh; Gessi, Stefania; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">238-263</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review discusses the chem. and pharmacol. of adenosine A1, A2A, A2B and A3 receptor antagonists and their therapeutic potential in clin. developments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOXhQGKqAVLbVg90H21EOLACvtfcHk0lgtouXGMo0tZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXis1OisQ%253D%253D&md5=1ae9e978507a1bbe7ab7aea0bdb33bb8</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fcr0682195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0682195%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DAdenosine%2520Receptor%2520Antagonists%253A%2520Translating%2520Medicinal%2520Chemistry%2520and%2520Pharmacology%2520into%2520Clinical%2520Utility%26jtitle%3DChem.%2520Rev.%26date%3D2008%26volume%3D108%26spage%3D238%26epage%3D263%26doi%3D10.1021%2Fcr0682195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tosh, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.-G.</span></span> <span> </span><span class="NLM_article-title">Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development</span>. <i>Front. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">124</span>, <span class="refDoi"> DOI: 10.3389/fncel.2019.00124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.3389%2Ffncel.2019.00124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=30983976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlKmurjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2019&pages=124&author=K.+A.+Jacobsonauthor=D.+K.+Toshauthor=S.+Jainauthor=Z.-G.+Gao&title=Historical+and+Current+Adenosine+Receptor+Agonists+in+Preclinical+and+Clinical+Development&doi=10.3389%2Ffncel.2019.00124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Historical and current adenosine receptor agonists in preclinical and clinical development</span></div><div class="casAuthors">Jacobson, Kenneth A.; Tosh, Dilip K.; Jain, Shanu; Gao, Zhan-Guo</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">124</span>CODEN:
                <span class="NLM_cas:coden">FCNRAH</span>;
        ISSN:<span class="NLM_cas:issn">1662-5102</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Adenosine receptors (ARs) function in the body's response to conditions of pathol. and stress assocd. with a functional imbalance, such as in the supply and demand of energy/oxygen/nutrients.  Extracellular adenosine concns. vary widely to raise or lower the basal activation of four subtypes of ARs.  Endogenous adenosine can correct an energy imbalance during hypoxia and other stress, for example, by slowing the heart rate by A1AR activation or increasing the blood supply to heart muscle by the A2AAR.  Moreover, exogenous AR agonists, antagonists, or allosteric modulators can be applied for therapeutic benefit, and medicinal chemists working toward that goal have reported thousands of such agents.  Thus, numerous clin. trials have ensued, using promising agents to modulate adenosinergic signaling, most of which have not succeeded.  Currently, short-acting, parenteral agonists, adenosine and Regadenoson, are the only AR agonists approved for human use.  However, new concepts and compds. are currently being developed and applied toward preclin. and clin. evaluation, and initial results are encouraging.  This review focuses on key compds. as AR agonists and pos. allosteric modulators (PAMs) for disease treatment or diagnosis.  AR agonists for treating inflammation, pain, cancer, non-alc. steatohepatitis, angina, sickle cell disease, ischemic conditions and diabetes have been under development.  Multiple clin. trials with two A3AR agonists are ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnH2YyZ_7M17Vg90H21EOLACvtfcHk0lgtouXGMo0tZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlKmurjM&md5=5d4c03988f6137d909a2356a010eea0c</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2019.00124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncel.2019.00124%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DZ.-G.%26atitle%3DHistorical%2520and%2520Current%2520Adenosine%2520Receptor%2520Agonists%2520in%2520Preclinical%2520and%2520Clinical%2520Development%26jtitle%3DFront.%2520Cell.%2520Neurosci.%26date%3D2019%26volume%3D13%26spage%3D124%26doi%3D10.3389%2Ffncel.2019.00124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baqi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namasivayam, V.</span></span> <span> </span><span class="NLM_article-title">Medicinal Chemistry of A2B Adenosine Receptors</span>. <i>Receptors</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">168</span>, <span class="refDoi"> DOI: 10.1007/978-3-319-90808-3_6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1007%2F978-3-319-90808-3_6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2018&pages=137-168&author=C.+E.+M%C3%BCllerauthor=Y.+Baqiauthor=S.+Hinzauthor=V.+Namasivayam&title=Medicinal+Chemistry+of+A2B+Adenosine+Receptors&doi=10.1007%2F978-3-319-90808-3_6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-90808-3_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-319-90808-3_6%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DBaqi%26aufirst%3DY.%26aulast%3DHinz%26aufirst%3DS.%26aulast%3DNamasivayam%26aufirst%3DV.%26atitle%3DMedicinal%2520Chemistry%2520of%2520A2B%2520Adenosine%2520Receptors%26jtitle%3DReceptors%26date%3D2018%26volume%3D34%26spage%3D137%26epage%3D168%26doi%3D10.1007%2F978-3-319-90808-3_6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalla, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zablocki, J.</span></span> <span> </span><span class="NLM_article-title">Progress in the Discovery of Selective, High Affinity A2B Adenosine Receptor Antagonists as Clinical Candidates</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1007/s11302-008-9119-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1007%2Fs11302-008-9119-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=18568423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVCqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=21-29&author=R.+V.+Kallaauthor=J.+Zablocki&title=Progress+in+the+Discovery+of+Selective%2C+High+Affinity+A2B+Adenosine+Receptor+Antagonists+as+Clinical+Candidates&doi=10.1007%2Fs11302-008-9119-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the discovery of selective, high affinity A2B adenosine receptor antagonists as clinical candidates</span></div><div class="casAuthors">Kalla, Rao V.; Zablocki, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-29</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The selective, high affinity A2B adenosine receptor (AdoR) antagonists that were synthesized by several research groups should aid in detg. the role of the A2B AdoR in inflammatory diseases like asthma or rheumatoid arthritis (RA) and angiogenic diseases like diabetic retinopathy or cancer.  CV Therapeutics scientists discovered the selective, high affinity A2B AdoR antagonist 10, a 8-(4-pyrazolyl)-xanthine deriv. [CVT-6883, Ki(hA2B) = 22 nM; Ki(hA1) = 1,940 nM; Ki(hA2A) = 3,280; and Ki(hA3) = 1,070 nM] that has favorable pharmacokinetic (PK) properties (t 1/2 = 4 h and F > 35% rat).  Compd. 10 demonstrated functional antagonism at the A2B AdoR (KB = 6 nM) and efficacy in a mouse model of asthma.  In 2 phase 1 clin. trials, CVT-6883 was found to be safe, well tolerated, and suitable for once daily dosing.  A second compd. 20, 8-(5-pyrazolyl)-xanthine, was nominated for development from Baraldi's group in conjunction with King Pharmaceuticals that has favorable A2B AdoR affinity and selectivity [Ki(hA2B) = 5.5 nM; Ki(hA1) > 1,000 nM; Ki(hA2A) > 1,000; and Ki(hA3) > 1,000 nM], and it was demonstrated to be a functional antagonist.  A third compd. 32, a 2-aminopyrimidine, from the Almirall group has high A2B AdoR affinity and selectivity [Ki(hA2B) = 17 nM; Ki(hA1) > 1,000 nM; Ki(hA2A) > 2,500; and Ki(hA3) > 1,000 nM], and 32 was moved into preclin. safety testing.  Since 3 highly selective, high affinity A2B AdoR antagonists were nominated for development with 10 (CVT-6883) being the furthest along in the development process, the role of the A2B AdoR in various disease states will soon be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGfZeO3oRUfrVg90H21EOLACvtfcHk0ljCNOzJzqjFtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVCqsr0%253D&md5=c8a49309fda894766f9bb087689ff74c</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1007%2Fs11302-008-9119-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-008-9119-x%26sid%3Dliteratum%253Aachs%26aulast%3DKalla%26aufirst%3DR.%2BV.%26aulast%3DZablocki%26aufirst%3DJ.%26atitle%3DProgress%2520in%2520the%2520Discovery%2520of%2520Selective%252C%2520High%2520Affinity%2520A2B%2520Adenosine%2520Receptor%2520Antagonists%2520as%2520Clinical%2520Candidates%26jtitle%3DPurinergic%2520Signalling%26date%3D2009%26volume%3D5%26spage%3D21%26epage%3D29%26doi%3D10.1007%2Fs11302-008-9119-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mallo-Abreu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majellaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jespers, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azuaje, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caamaño, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Mera, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez-de-Terán, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotelo, E.</span></span> <span> </span><span class="NLM_article-title">Trifluorinated Pyrimidine-Based A2B Antagonists: Optimization and Evidence of Stereospecific Recognition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">9315</span>– <span class="NLM_lpage">9330</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01340</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01340" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVGgtLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=9315-9330&author=A.+Mallo-Abreuauthor=M.+Majellaroauthor=W.+Jespersauthor=J.+Azuajeauthor=O.+Caama%C3%B1oauthor=X.+Garc%C3%ADa-Meraauthor=J.+M.+Breaauthor=M.+I.+Lozaauthor=H.+Guti%C3%A9rrez-de-Ter%C3%A1nauthor=E.+Sotelo&title=Trifluorinated+Pyrimidine-Based+A2B+Antagonists%3A+Optimization+and+Evidence+of+Stereospecific+Recognition&doi=10.1021%2Facs.jmedchem.9b01340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Trifluorinated Pyrimidine-Based A2B Antagonists: Optimization and Evidence of Stereospecific Recognition</span></div><div class="casAuthors">Mallo-Abreu, Ana; Majellaro, Maria; Jespers, Willem; Azuaje, Jhonny; Caamano, Olga; Garcia-Mera, Xerardo; Brea, Jose M.; Loza, Maria I.; Gutierrez-de-Teran, Hugo; Sotelo, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9315-9330</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the identification of two subsets of fluorinated nonxanthine A2B adenosine receptor antagonists.  The novel derivs. explore the effect of fluorination at different positions of two pyrimidine-based scaffolds.  The most interesting ligands combine excellent hA2B affinity (Ki < 15 nM) and remarkable subtype selectivity.  The results of functional cAMP expts. confirmed the antagonistic behavior of representative ligands.  The compds. were designed on the basis of previous mol. models of the stereoselective binding of the parent scaffolds to the hA2B receptor, and we herein provide refinement of such models with the fluorinated compds., which allows the explanation of the spurious effects of the fluorination at the different positions explored.  These models are importantly confirmed by a synergistic study combining chiral HPLC, CD, diastereoselective synthesis, mol. modeling, and X-ray crystallog., providing exptl. evidence toward the stereospecific interaction between optimized trifluorinated stereoisomers and the hA2B receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9gue2m74iSLVg90H21EOLACvtfcHk0ljCNOzJzqjFtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVGgtLfE&md5=05cdd26c378514888ae09631f4f47c11</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01340%26sid%3Dliteratum%253Aachs%26aulast%3DMallo-Abreu%26aufirst%3DA.%26aulast%3DMajellaro%26aufirst%3DM.%26aulast%3DJespers%26aufirst%3DW.%26aulast%3DAzuaje%26aufirst%3DJ.%26aulast%3DCaama%25C3%25B1o%26aufirst%3DO.%26aulast%3DGarc%25C3%25ADa-Mera%26aufirst%3DX.%26aulast%3DBrea%26aufirst%3DJ.%2BM.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DGuti%25C3%25A9rrez-de-Ter%25C3%25A1n%26aufirst%3DH.%26aulast%3DSotelo%26aufirst%3DE.%26atitle%3DTrifluorinated%2520Pyrimidine-Based%2520A2B%2520Antagonists%253A%2520Optimization%2520and%2520Evidence%2520of%2520Stereospecific%2520Recognition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D9315%26epage%3D9330%26doi%3D10.1021%2Facs.jmedchem.9b01340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crespo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Maatougui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azuaje, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escalante, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majellaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadavid, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez-de-Terán, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotelo, E.</span></span> <span> </span><span class="NLM_article-title">Exploring the Influence of the Substituent at Position 4 in a Series of 3,4-Dihydropyrimidin-2(1H)-One A2B Adenosine Receptor Antagonists</span>. <i>Chem. Heterocycl. Compd.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">316</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1007/s10593-017-2054-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1007%2Fs10593-017-2054-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmslSgtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2017&pages=316-321&author=A.+Crespoauthor=A.+El+Maatouguiauthor=J.+Azuajeauthor=L.+Escalanteauthor=M.+Majellaroauthor=M.+I.+Lozaauthor=J.+Breaauthor=M.+I.+Cadavidauthor=H.+Guti%C3%A9rrez-de-Ter%C3%A1nauthor=E.+Sotelo&title=Exploring+the+Influence+of+the+Substituent+at+Position+4+in+a+Series+of+3%2C4-Dihydropyrimidin-2%281H%29-One+A2B+Adenosine+Receptor+Antagonists&doi=10.1007%2Fs10593-017-2054-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the influence of the substituent at position 4 in a series of 3,4-dihydropyrimidin-2(1H)-one A2B adenosine receptor antagonists</span></div><div class="casAuthors">Crespo, Abel; El Maatougui, Abdelaziz; Azuaje, Jhonny; Escalante, Luz; Majellaro, Maria; Loza, Maria Isabel; Brea, Jose; Cadavid, Maria Isabel; Gutierrez-de-Teran, Hugo; Sotelo, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry of Heterocyclic Compounds (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">316-321</span>CODEN:
                <span class="NLM_cas:coden">CHCCAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-3122</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In the context of a program to identify selective adenosine A2B receptor antagonists, a focused library of 4-substituted 3,4-dihydropyrimidin-2(1H)-ones was obtained and its affinity for the four human adenosine receptor subtypes was detd.  The synthesis was accomplished by using an exptl. simple and efficient Biginelli approach.  The biol. evaluation of the library revealed that all the documented derivs. exhibit low or negligible affinity for the A2B receptor, thus highlighting the crit. importance of the substituent at position 4 of the 3,4-dihydropyrimidin-2(1H)-one chemotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLOsDwm-I-PrVg90H21EOLACvtfcHk0ljCNOzJzqjFtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmslSgtrw%253D&md5=948787c55c8244ca3a646b39b12a4a21</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2Fs10593-017-2054-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10593-017-2054-4%26sid%3Dliteratum%253Aachs%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DEl%2BMaatougui%26aufirst%3DA.%26aulast%3DAzuaje%26aufirst%3DJ.%26aulast%3DEscalante%26aufirst%3DL.%26aulast%3DMajellaro%26aufirst%3DM.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DGuti%25C3%25A9rrez-de-Ter%25C3%25A1n%26aufirst%3DH.%26aulast%3DSotelo%26aufirst%3DE.%26atitle%3DExploring%2520the%2520Influence%2520of%2520the%2520Substituent%2520at%2520Position%25204%2520in%2520a%2520Series%2520of%25203%252C4-Dihydropyrimidin-2%25281H%2529-One%2520A2B%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DChem.%2520Heterocycl.%2520Compd.%26date%3D2017%26volume%3D53%26spage%3D316%26epage%3D321%26doi%3D10.1007%2Fs10593-017-2054-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kappe, C. O.</span></span> <span> </span><span class="NLM_article-title">Biologically Active Dihydropyrimidones of the Biginelli-Type - A Literature Survey</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1043</span>– <span class="NLM_lpage">1052</span>, <span class="refDoi"> DOI: 10.1016/S0223-5234(00)01189-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2FS0223-5234%2800%2901189-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=11248403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD3MXoslWkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2000&pages=1043-1052&author=C.+O.+Kappe&title=Biologically+Active+Dihydropyrimidones+of+the+Biginelli-Type+-+A+Literature+Survey&doi=10.1016%2FS0223-5234%2800%2901189-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Biologically active dihydropyrimidones of the Biginelli-type - a literature survey</span></div><div class="casAuthors">Kappe, C. Oliver</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1043-1052</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">A review with 87 refs.  In 1893, the synthesis of functionalized 3,4-dihydropyrimidin-2(1H)-ones (DHPMs) via three-component condensation reaction of an arom. aldehyde, urea and Et acetoacetate was reported for the first time by P. Biginelli.  In the past decades, such Biginelli-type dihydropyrimidones have received a considerable amt. of attention due to the interesting pharmacol. properties assocd. with this heterocyclic scaffold.  In this review, the authors highlight recent developments in this area, with a focus on the DHPMs recently developed as calcium channel modulators, α1a adrenoceptor-selective antagonists and compds. that target the mitotic machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocADVMvZ6u9rVg90H21EOLACvtfcHk0lh1YCZ6yDO_dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXoslWkuw%253D%253D&md5=38e006618f4645627b38b5e83ed524c0</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2800%2901189-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252800%252901189-2%26sid%3Dliteratum%253Aachs%26aulast%3DKappe%26aufirst%3DC.%2BO.%26atitle%3DBiologically%2520Active%2520Dihydropyrimidones%2520of%2520the%2520Biginelli-Type%2520-%2520A%2520Literature%2520Survey%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2000%26volume%3D35%26spage%3D1043%26epage%3D1052%26doi%3D10.1016%2FS0223-5234%2800%2901189-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kappe, C. O.</span></span> <span> </span><span class="NLM_article-title">Recent Advances in the Biginelli Dihydropyrimidine Synthesis. New Tricks from an Old Dog</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">879</span>– <span class="NLM_lpage">888</span>, <span class="refDoi"> DOI: 10.1021/ar000048h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar000048h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsl2js7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2000&pages=879-888&author=C.+O.+Kappe&title=Recent+Advances+in+the+Biginelli+Dihydropyrimidine+Synthesis.+New+Tricks+from+an+Old+Dog&doi=10.1021%2Far000048h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in the Biginelli Dihydropyrimidine Synthesis. New Tricks from an Old Dog</span></div><div class="casAuthors">Kappe, C. Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">879-888</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with over 69 refs.  In 1893, P. Biginelli reported the synthesis of functionalized 3,4-dihydropyrimidin-2(1H)-ones (DHPMs) via three-component condensation reaction of an arom. aldehyde, urea, and Et acetoacetate.  In the past decade, this long-neglected multicomponent reaction has experienced a remarkable revival, mainly due to the interesting pharmacol. properties assocd. with this dihydropyrimidine scaffold.  In this Account, the authors highlight recent developments in the Biginelli reaction in areas such as solid-phase synthesis, combinatorial chem., and natural product synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMb9JwrXTB3LVg90H21EOLACvtfcHk0lh1YCZ6yDO_dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsl2js7k%253D&md5=8a73a965ef7dba741a05ddb978d9c1f1</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Far000048h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far000048h%26sid%3Dliteratum%253Aachs%26aulast%3DKappe%26aufirst%3DC.%2BO.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Biginelli%2520Dihydropyrimidine%2520Synthesis.%2520New%2520Tricks%2520from%2520an%2520Old%2520Dog%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2000%26volume%3D33%26spage%3D879%26epage%3D888%26doi%3D10.1021%2Far000048h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bose, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatima, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mereyala, H. B.</span></span> <span> </span><span class="NLM_article-title">Green Chemistry Approaches to the Synthesis of 5-Alkoxycarbonyl-4-aryl-3,4- dihydropyrimidin-2(1H)-ones by a Three-Component Coupling of One-Pot Condensation Reaction: Comparison of Ethanol, Water, and Solvent-free Conditions</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">587</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.1021/jo0205199</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0205199" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD38Xps1aitbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=587-590&author=D.+S.+Boseauthor=L.+Fatimaauthor=H.+B.+Mereyala&title=Green+Chemistry+Approaches+to+the+Synthesis+of+5-Alkoxycarbonyl-4-aryl-3%2C4-+dihydropyrimidin-2%281H%29-ones+by+a+Three-Component+Coupling+of+One-Pot+Condensation+Reaction%3A+Comparison+of+Ethanol%2C+Water%2C+and+Solvent-free+Conditions&doi=10.1021%2Fjo0205199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Green Chemistry Approaches to the Synthesis of 5-Alkoxycarbonyl-4-aryl-3,4- dihydropyrimidin-2(1H)-ones by a Three-Component Coupling of One-Pot Condensation Reaction: Comparison of Ethanol, Water, and Solvent-free Conditions</span></div><div class="casAuthors">Bose, D. Subhas; Fatima, Liyakat; Mereyala, Hari Babu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">587-590</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A general and practical green chem. route to the Biginelli cyclocondensation reaction using cerium(III) chloride as the catalyst (25% mol) is described under three different sets of reaction conditions.  This method provides an efficient and much improved modification of original Biginelli reaction reported in 1893, in terms of high yields, short reaction times, and simple work-up procedure, and it has the ability to tolerate a wide variety of substitutions in all three components, which is lacking in existing procedures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu-JnE1yuEvrVg90H21EOLACvtfcHk0lh1YCZ6yDO_dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xps1aitbw%253D&md5=2dc1162363d5e2bee3384ab6a42331f1</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjo0205199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0205199%26sid%3Dliteratum%253Aachs%26aulast%3DBose%26aufirst%3DD.%2BS.%26aulast%3DFatima%26aufirst%3DL.%26aulast%3DMereyala%26aufirst%3DH.%2BB.%26atitle%3DGreen%2520Chemistry%2520Approaches%2520to%2520the%2520Synthesis%2520of%25205-Alkoxycarbonyl-4-aryl-3%252C4-%2520dihydropyrimidin-2%25281H%2529-ones%2520by%2520a%2520Three-Component%2520Coupling%2520of%2520One-Pot%2520Condensation%2520Reaction%253A%2520Comparison%2520of%2520Ethanol%252C%2520Water%252C%2520and%2520Solvent-free%2520Conditions%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D587%26epage%3D590%26doi%3D10.1021%2Fjo0205199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mobaraki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Movassagh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karimi, B.</span></span> <span> </span><span class="NLM_article-title">Hydrophobicity-Enhanced Magnetic Solid Sulfonic Acid: A Simple Approach to Improve the Mass Transfer of Reaction Partners on the Surface of the Heterogeneous Catalyst in Water-Generating Reactions</span>. <i>Appl. Catal., A</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>472</i></span>,  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1016/j.apcata.2013.12.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.apcata.2013.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVWntb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=472&publication_year=2014&pages=123-133&author=A.+Mobarakiauthor=B.+Movassaghauthor=B.+Karimi&title=Hydrophobicity-Enhanced+Magnetic+Solid+Sulfonic+Acid%3A+A+Simple+Approach+to+Improve+the+Mass+Transfer+of+Reaction+Partners+on+the+Surface+of+the+Heterogeneous+Catalyst+in+Water-Generating+Reactions&doi=10.1016%2Fj.apcata.2013.12.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrophobicity-enhanced magnetic solid sulfonic acid: A simple approach to improve the mass transfer of reaction partners on the surface of the heterogeneous catalyst in water-generating reactions</span></div><div class="casAuthors">Mobaraki, Akbar; Movassagh, Barahman; Karimi, Babak</div><div class="citationInfo"><span class="NLM_cas:title">Applied Catalysis, A: General</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">472</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">123-133</span>CODEN:
                <span class="NLM_cas:coden">ACAGE4</span>;
        ISSN:<span class="NLM_cas:issn">0926-860X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Two novel and environmentally benign organosulfonic acid-functionalized silica-coated magnetic nanoparticle catalysts 1 (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="6f290a5c205b2f3c06205d">[email protected]</a>@Et-PhSO3H) and 2 (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="95d3f0a6daa1d5c6fcdaa7">[email protected]</a>@Me&Et-PhSO3H) were prepd. and their surface hydrophobicity was assessed by esterification reaction of fatty alcs.  Also, their water-toleration in two water-generating reactions was studied, namely: synthesis of bis(indolyl)methane and the Biginelli reaction of benzaldehyde, Me acetoacetate, and urea under solvent-free conditions.  In these reactions, the catalyst 2 that was more hydrophobic and water-resistant showed higher catalytic activity and was characterized extensively by various techniques.  This catalyst was successfully used in the Biginelli reaction of a series of aldehydes, β-keto esters, and urea/thiourea for the synthesis of a diverse range of pharmacol. active 3,4-dihydropyrimidin-2-one/thione (DHPM) derivs.  The catalyst 2 was easily sepd. by an external magnet and the recovered catalyst was reused in five cycles without any significant loss of activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOC0bnGeJsW7Vg90H21EOLACvtfcHk0lgIpwvdJhDOCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVWntb4%253D&md5=3b5599eba6fad503d6cc1c66941a28b8</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.apcata.2013.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apcata.2013.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DMobaraki%26aufirst%3DA.%26aulast%3DMovassagh%26aufirst%3DB.%26aulast%3DKarimi%26aufirst%3DB.%26atitle%3DHydrophobicity-Enhanced%2520Magnetic%2520Solid%2520Sulfonic%2520Acid%253A%2520A%2520Simple%2520Approach%2520to%2520Improve%2520the%2520Mass%2520Transfer%2520of%2520Reaction%2520Partners%2520on%2520the%2520Surface%2520of%2520the%2520Heterogeneous%2520Catalyst%2520in%2520Water-Generating%2520Reactions%26jtitle%3DAppl.%2520Catal.%252C%2520A%26date%3D2014%26volume%3D472%26spage%3D123%26epage%3D133%26doi%3D10.1016%2Fj.apcata.2013.12.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghasemi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farshbaf Orafa, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirouzmand, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikzad Kojanag, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salehi, R.</span></span> <span> </span><span class="NLM_article-title">Zn<sup>2+</sup>/MCM-41 Catalyzed Biginelli Reaction of Heteroaryl Aldehydes and Evaluation of the Antimicrobial Activity and Cytotoxicity of the Pyrimidone Products</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6393</span>– <span class="NLM_lpage">6396</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2015.09.143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.tetlet.2015.09.143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1GktL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=6393-6396&author=Z.+Ghasemiauthor=F.+Farshbaf+Orafaauthor=M.+Pirouzmandauthor=G.+Zarriniauthor=B.+Nikzad+Kojanagauthor=R.+Salehi&title=Zn2%2B%2FMCM-41+Catalyzed+Biginelli+Reaction+of+Heteroaryl+Aldehydes+and+Evaluation+of+the+Antimicrobial+Activity+and+Cytotoxicity+of+the+Pyrimidone+Products&doi=10.1016%2Fj.tetlet.2015.09.143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Zn2+/MCM-41 catalyzed Biginelli reaction of heteroaryl aldehydes and evaluation of the antimicrobial activity and cytotoxicity of the pyrimidone products</span></div><div class="casAuthors">Ghasemi, Zarrin; Farshbaf Orafa, Farzaneh; Pirouzmand, Mahtab; Zarrini, Gholamreza; Nikzad Kojanag, Behnaz; Salehi, Roya</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">6393-6396</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The three component Biginelli condensation of various aryl aldehydes, 1,3-dicarbonyls and urea was investigated in the presence of free or MCM-41 supported ZnNO3.  The pyrimidone products, which were obtained under solvent-free conditions, were evaluated for antibacterial and antifungal activities as well as their cytotoxicities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFpr6tUyt4o7Vg90H21EOLACvtfcHk0lgIpwvdJhDOCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1GktL7O&md5=45e18ecb134d303ec3ebac2e317fdc10</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2015.09.143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2015.09.143%26sid%3Dliteratum%253Aachs%26aulast%3DGhasemi%26aufirst%3DZ.%26aulast%3DFarshbaf%2BOrafa%26aufirst%3DF.%26aulast%3DPirouzmand%26aufirst%3DM.%26aulast%3DZarrini%26aufirst%3DG.%26aulast%3DNikzad%2BKojanag%26aufirst%3DB.%26aulast%3DSalehi%26aufirst%3DR.%26atitle%3DZn2%252B%252FMCM-41%2520Catalyzed%2520Biginelli%2520Reaction%2520of%2520Heteroaryl%2520Aldehydes%2520and%2520Evaluation%2520of%2520the%2520Antimicrobial%2520Activity%2520and%2520Cytotoxicity%2520of%2520the%2520Pyrimidone%2520Products%26jtitle%3DTetrahedron%2520Lett.%26date%3D2015%26volume%3D56%26spage%3D6393%26epage%3D6396%26doi%3D10.1016%2Fj.tetlet.2015.09.143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, S.</span>; <span class="NLM_string-name">Desai, R.</span></span> <span> </span><span class="NLM_article-title">Novel compounds for treatment of diabetes, obesity or related disorders</span>. <span class="NLM_patent">WO 2013102929 A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=S.+Agarwal&author=R.+Desai&title=Novel+compounds+for+treatment+of+diabetes%2C+obesity+or+related+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DS.%26atitle%3DNovel%2520compounds%2520for%2520treatment%2520of%2520diabetes%252C%2520obesity%2520or%2520related%2520disorders%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ali, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismail, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perveen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wadood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghufran, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, B.</span></span> <span> </span><span class="NLM_article-title">Dihydropyrimidones: As novel class of β-glucuronidase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3624</span>– <span class="NLM_lpage">3635</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.bmc.2016.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=27325448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVWntrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=3624-3635&author=F.+Aliauthor=K.+M.+Khanauthor=U.+Salarauthor=S.+Iqbalauthor=M.+Tahaauthor=N.+H.+Ismailauthor=S.+Perveenauthor=A.+Wadoodauthor=M.+Ghufranauthor=B.+Ali&title=Dihydropyrimidones%3A+As+novel+class+of+%CE%B2-glucuronidase+inhibitors&doi=10.1016%2Fj.bmc.2016.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydropyrimidones: As novel class of β-glucuronidase inhibitors</span></div><div class="casAuthors">Ali, Farman; Khan, Khalid Mohammed; Salar, Uzma; Iqbal, Sarosh; Taha, Muhammad; Ismail, Nor Hadiani; Perveen, Shahnaz; Wadood, Abdul; Ghufran, Mehreen; Ali, Basharat</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3624-3635</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dihydropyrimidones (I) (R1 = Et, n-Bu, iso-Bu, Ph; 2,5-, 2,3-, 3,4-MeC6H4; 2-FC6H5; 2,6-ClC6H4; 3-OHC6H4; 4-OH, -NO2, -iso-Pr, -Cl, -Br, -CF3, -OEt, -OMe -NMe2, -OMeC6H5; 2-Me,4-OBnC6H4; 3-Me,4-OBnC6H4; 2-furanylC6H5; 2-, 3-thiophenyl; 1-, 2-naphthylC6H5; etc.) were synthesized via a "one-pot" three component reaction according to well-known Biginelli reaction by utilizing Cu(NO3)2·3H2O as catalyst, and screened for their in vitro β-glucuronidase inhibitory activity.  Mol. docking study was conducted to establish the structure-activity relationship (SAR) which demonstrated that a no. of structural features of dihydropyrimidone derivs. were involved to exhibit the inhibitory potential.  All compds. were characterized by spectroscopic techniques such as 1H, 13C NMR, EIMS and HREI-MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKnZ3otU-MNLVg90H21EOLACvtfcHk0lh18kSDPibySQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVWntrfK&md5=8c7f5cca34fe44f4d0f80443ac41174a</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DF.%26aulast%3DKhan%26aufirst%3DK.%2BM.%26aulast%3DSalar%26aufirst%3DU.%26aulast%3DIqbal%26aufirst%3DS.%26aulast%3DTaha%26aufirst%3DM.%26aulast%3DIsmail%26aufirst%3DN.%2BH.%26aulast%3DPerveen%26aufirst%3DS.%26aulast%3DWadood%26aufirst%3DA.%26aulast%3DGhufran%26aufirst%3DM.%26aulast%3DAli%26aufirst%3DB.%26atitle%3DDihydropyrimidones%253A%2520As%2520novel%2520class%2520of%2520%25CE%25B2-glucuronidase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D3624%26epage%3D3635%26doi%3D10.1016%2Fj.bmc.2016.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zabihollahi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fassihi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aghasadeghi, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Memarian, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soleimani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majidzadeh-A, K.</span></span> <span> </span><span class="NLM_article-title">Inhibitory Effect and Structure-Activity Relationship of Some Biginelli-Type Pyrimidines against HSV-1</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1270</span>– <span class="NLM_lpage">1276</span>, <span class="refDoi"> DOI: 10.1007/s00044-012-0123-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1007%2Fs00044-012-0123-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC38Xot12itLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=1270-1276&author=R.+Zabihollahiauthor=A.+Fassihiauthor=M.+R.+Aghasadeghiauthor=H.+R.+Memarianauthor=M.+Soleimaniauthor=K.+Majidzadeh-A&title=Inhibitory+Effect+and+Structure-Activity+Relationship+of+Some+Biginelli-Type+Pyrimidines+against+HSV-1&doi=10.1007%2Fs00044-012-0123-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effect and structure-activity relationship of some Biginelli-type pyrimidines against HSV-1</span></div><div class="casAuthors">Zabihollahi, Rezvan; Fassihi, Afshin; Aghasadeghi, Mohamad Reza; Memarian, Hamid Reza; Soleimani, Mohammad; Majidzadeh-A, Keivan</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1270-1276</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Boston</span>)
        </div><div class="casAbstract">Inevitable emergence of multi-drug resistant strains to current available drugs makes an impetus for finding new therapeutic agents against herpes simplex virus (HSV).  In this study, a series of novel derivs. of Biginelli-type pyrimidines were evaluated as potential anti-HSV-1 compds. by plaque redn. method.  The cellular toxicity was assessed by XTT proliferation assay.  The time course of anti-HSV activity of the most active compd. was studied to show the anti-viral effect in various intervals of replication cycle.  Compds. 2, 6, 8, 11, 12, 17, 18, 20, and 40 had the highest activity for inhibition of HSV.  Compd. 40 inhibited HSV replication with IC50 of 0.9 μmol/l and had CC50 of up to 100 μmol/l.  This compd. was a noteworthy inhibitor against HSV with TI value of 111.  Compd. 20 also showed considerable inhibitory activity with IC50 of 1.8 μmol/l.  Result of time-of-addn. study showed that compd. 40 inhibits HSV replication at a stage after entry of virions to the target cells.  Anal. of structure of the studied compds. demonstrated clear relationships with their anti-HSV effects.  Some of the compds. seem to be promising candidates for future anti-HSV drug discovery researches.  Structural manipulation based on the obtained structure-activity relationships would propose some new leads for anti-HSV drug discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmioKCovOGprVg90H21EOLACvtfcHk0lh18kSDPibySQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xot12itLs%253D&md5=0e955d44b947fa37029df2bf8a8396bd</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1007%2Fs00044-012-0123-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-012-0123-x%26sid%3Dliteratum%253Aachs%26aulast%3DZabihollahi%26aufirst%3DR.%26aulast%3DFassihi%26aufirst%3DA.%26aulast%3DAghasadeghi%26aufirst%3DM.%2BR.%26aulast%3DMemarian%26aufirst%3DH.%2BR.%26aulast%3DSoleimani%26aufirst%3DM.%26aulast%3DMajidzadeh-A%26aufirst%3DK.%26atitle%3DInhibitory%2520Effect%2520and%2520Structure-Activity%2520Relationship%2520of%2520Some%2520Biginelli-Type%2520Pyrimidines%2520against%2520HSV-1%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2013%26volume%3D22%26spage%3D1270%26epage%3D1276%26doi%3D10.1007%2Fs00044-012-0123-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Fattah, A. A.</span></span> <span> </span><span class="NLM_article-title">Expedient Synthesis of Biginelli-Type Dihydropyrimidinones Using α-(Benzotriazolyl)alkyl Urea Derivatives</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_fpage">2358</span>– <span class="NLM_lpage">2362</span>, <span class="refDoi"> DOI: 10.1055/s-2003-42398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1055%2Fs-2003-42398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptFGgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=2358-2362&author=A.+A.+Abdel-Fattah&title=Expedient+Synthesis+of+Biginelli-Type+Dihydropyrimidinones+Using+%CE%B1-%28Benzotriazolyl%29alkyl+Urea+Derivatives&doi=10.1055%2Fs-2003-42398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Expedient synthesis of Biginelli-type dihydropyrimidinones using α-(benzotriazolyl)alkyl urea derivatives</span></div><div class="casAuthors">Abdel-fattah, Ashraf A. A.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2358-2362</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Reaction of readily available α-(benzotriazolyl)alkyl urea derivs. (derived from arom., heteroarom., and aliph. aldehydes) with β-keto esters resulted in 3,4-dihydropyrimidin-2(1H)-ones in good to excellent yields.  The intermediate α-(benzotriazolyl)alkyl urea derivs. act as masked acyliminium ions in the reaction with β-keto esters.  The Lewis acid used in these reactions was zinc bromide (ZnBr2).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre4dvLADYe0bVg90H21EOLACvtfcHk0lh18kSDPibySQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptFGgsrk%253D&md5=a556829c0a6c78678fb190762c1a7f53</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1055%2Fs-2003-42398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2003-42398%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Fattah%26aufirst%3DA.%2BA.%26atitle%3DExpedient%2520Synthesis%2520of%2520Biginelli-Type%2520Dihydropyrimidinones%2520Using%2520%25CE%25B1-%2528Benzotriazolyl%2529alkyl%2520Urea%2520Derivatives%26jtitle%3DSynthesis%26date%3D2003%26spage%3D2358%26epage%3D2362%26doi%3D10.1055%2Fs-2003-42398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shamim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodhi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashraf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ul-Haq, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perveen, S.</span></span> <span> </span><span class="NLM_article-title">5-Acetyl-6-Methyl-4-Aryl-3,4-Dihydropyrimidin-2(1H)-Ones: As Potent Urease Inhibitors; Synthesis, in Vitro Screening, and Molecular Modeling Study</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2017.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.bioorg.2017.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=29125971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslygt7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2018&pages=37-52&author=S.+Shamimauthor=K.+M.+Khanauthor=U.+Salarauthor=F.+Aliauthor=M.+A.+Lodhiauthor=M.+Tahaauthor=F.+A.+Khanauthor=S.+Ashrafauthor=Z.+Ul-Haqauthor=M.+Aliauthor=S.+Perveen&title=5-Acetyl-6-Methyl-4-Aryl-3%2C4-Dihydropyrimidin-2%281H%29-Ones%3A+As+Potent+Urease+Inhibitors%3B+Synthesis%2C+in+Vitro+Screening%2C+and+Molecular+Modeling+Study&doi=10.1016%2Fj.bioorg.2017.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">5-Acetyl-6-methyl-4-aryl-3,4-dihydropyrimidin-2(1H)-ones: As potent urease inhibitors; synthesis, in vitro screening, and molecular modeling study</span></div><div class="casAuthors">Shamim, Shahbaz; Khan, Khalid Mohammed; Salar, Uzma; Ali, Farman; Lodhi, Muhammad Arif; Taha, Muhammad; Ali Khan, Farman; Ashraf, Sajda; Ul-Haq, Zaheer; Ali, Muhammad; Perveen, Shahnaz</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37-52</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">5-Acetyl-6-methyl-4-aryl-3,4-dihydropyrimidin-2(1H)-ones I [R = Ph, 2-HOC6H4, 2-MeOC6H4, etc.] were synthesized in a "one-pot" three component reaction and structurally characterized by various spectroscopic techniques such as 1H, 13C NMR, EI-MS, HREI-MS, and IR.  All compds. were evaluated for their in-vitro urease inhibitory activity.  It was worth mentioning that except derivs. I [R = Ph, 2,3-di-MeOC6H3, 2,5-di-MeOC6H3, 2,3,4-tri-MeOC6H2] all were found to be more potent than the std. thiourea (IC50 = 21.25 ± 0.15 μM) and showed their urease inhibitory potential in the range of IC50 = 3.70 ± 0.5-20.14 ± 0.1 μM.  Structure-activity relationship (SAR) was rationalized by looking at the varying structural features of the mols.  However, mol. modeling study was performed to confirm the binding interactions of the mols. (ligand) with the active site of enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraSjRExvB1xbVg90H21EOLACvtfcHk0lh18kSDPibySQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslygt7fI&md5=e21c0698b2ea669739c5621a9a08be7e</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2017.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2017.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DShamim%26aufirst%3DS.%26aulast%3DKhan%26aufirst%3DK.%2BM.%26aulast%3DSalar%26aufirst%3DU.%26aulast%3DAli%26aufirst%3DF.%26aulast%3DLodhi%26aufirst%3DM.%2BA.%26aulast%3DTaha%26aufirst%3DM.%26aulast%3DKhan%26aufirst%3DF.%2BA.%26aulast%3DAshraf%26aufirst%3DS.%26aulast%3DUl-Haq%26aufirst%3DZ.%26aulast%3DAli%26aufirst%3DM.%26aulast%3DPerveen%26aufirst%3DS.%26atitle%3D5-Acetyl-6-Methyl-4-Aryl-3%252C4-Dihydropyrimidin-2%25281H%2529-Ones%253A%2520As%2520Potent%2520Urease%2520Inhibitors%253B%2520Synthesis%252C%2520in%2520Vitro%2520Screening%252C%2520and%2520Molecular%2520Modeling%2520Study%26jtitle%3DBioorg.%2520Chem.%26date%3D2018%26volume%3D76%26spage%3D37%26epage%3D52%26doi%3D10.1016%2Fj.bioorg.2017.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lacotte, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buisson, D.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambroise, Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis, Evaluation and Absolute Configuration Assignment of Novel Dihydropyrimidin-2-Ones as Picomolar Sodium Iodide Symporter Inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">722</span>– <span class="NLM_lpage">727</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.01.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.ejmech.2013.01.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=23454514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlslSrt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=722-727&author=P.+Lacotteauthor=D.-A.+Buissonauthor=Y.+Ambroise&title=Synthesis%2C+Evaluation+and+Absolute+Configuration+Assignment+of+Novel+Dihydropyrimidin-2-Ones+as+Picomolar+Sodium+Iodide+Symporter+Inhibitors&doi=10.1016%2Fj.ejmech.2013.01.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, evaluation and absolute configuration assignment of novel dihydropyrimidin-2-ones as picomolar sodium iodide symporter inhibitors</span></div><div class="casAuthors">Lacotte, Pierre; Buisson, David-Alexandre; Ambroise, Yves</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">722-727</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A small library of dihydropyrimidin-2-ones (DHPMs) was synthesized and evaluated for their potency to block iodide entrapment in rat thyroid cells.  Synthesis was achieved using the multicomponent Biginelli reaction.  Twelve compds. were tested for the inhibition of sodium iodide symporter (NIS) in a cell-based assay.  One newly synthesized deriv. (I) exhibited a remarkably strong activity, with a half-max. inhibitory concn. value (IC50) of 65 pM.  Three DHPMs were further resolved from racemates using chiral HPLC and abs. configurations were assigned using CD spectroscopy.  Biol. evaluation showed that most of the activity against NIS resides in one enantiomer.  This study provides new insights for the development of anti-thyroid drugs, as well as for the synthesis of novel pharmacol. tools designed to investigate iodide transport mechanisms at cellular and mol. levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGEVLyOhgcmrVg90H21EOLACvtfcHk0ljcL9GnSWnzgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlslSrt7k%253D&md5=9bf64392760b5262e515be8d2438227f</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.01.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.01.043%26sid%3Dliteratum%253Aachs%26aulast%3DLacotte%26aufirst%3DP.%26aulast%3DBuisson%26aufirst%3DD.-A.%26aulast%3DAmbroise%26aufirst%3DY.%26atitle%3DSynthesis%252C%2520Evaluation%2520and%2520Absolute%2520Configuration%2520Assignment%2520of%2520Novel%2520Dihydropyrimidin-2-Ones%2520as%2520Picomolar%2520Sodium%2520Iodide%2520Symporter%2520Inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D62%26spage%3D722%26epage%3D727%26doi%3D10.1016%2Fj.ejmech.2013.01.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uray, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdino, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belaj, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappe, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabian, W. M. F.</span></span> <span> </span><span class="NLM_article-title">Absolute Configuration in 4-Alkyl- and 4-Aryl-3,4-Dihydro-2(1H)-Pyrimidones: A Combined Theoretical and Experimental Investigation</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">6685</span>– <span class="NLM_lpage">6694</span>, <span class="refDoi"> DOI: 10.1021/jo010491l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo010491l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtlWgt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=6685-6694&author=G.+Urayauthor=P.+Verdinoauthor=F.+Belajauthor=C.+O.+Kappeauthor=W.+M.+F.+Fabian&title=Absolute+Configuration+in+4-Alkyl-+and+4-Aryl-3%2C4-Dihydro-2%281H%29-Pyrimidones%3A+A+Combined+Theoretical+and+Experimental+Investigation&doi=10.1021%2Fjo010491l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Absolute Configuration in 4-Alkyl- and 4-Aryl-3,4-dihydro-2(1H)-pyrimidones: A Combined Theoretical and Experimental Investigation</span></div><div class="casAuthors">Uray, Georg; Verdino, Petra; Belaj, Ferdinand; Kappe, C. Oliver; Fabian, Walter M. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6685-6694</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structural features (orientation of the carboxyl group, ring puckering), electronic absorption, and CD spectra of 4-alkyl- and 4-aryl-dihydropyrimidones are calcd. by semiempirical (AM1, INDO/S), ab initio (HF/6-31G*, CIS/6-31G*, RPA/6-31G*), and d. functional theory (B3LYP/6-31G*) methods.  These calcns. allow an assignment of the abs. configuration by comparison of simulated and exptl. CD spectra.  Although the ab initio methods greatly overestimate electronic transition energies, the general appearance of the exptl. CD spectra is quite nicely reproduced by these calcns. Thus, comparison of exptl. with calcd. CD spectra is a reliable tool for the assignment of the abs. configuration.  For 4-Me derivs. I (R=H,Me) , the first enantiopure DHPM examples with no addnl. arom. substituent, the stereochem. at C4 provided by the theor. results is confirmed by X-ray structure detn. of the diastereomeric salt II.  Addnl. support is the consistent HPLC elution order found for all investigated DHPMs on a cellulose-derived chiral stationary phase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwGwDyuvdNlbVg90H21EOLACvtfcHk0ljcL9GnSWnzgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtlWgt78%253D&md5=31873cfc1d2eb8dcee41ac7ce9ed3997</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjo010491l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo010491l%26sid%3Dliteratum%253Aachs%26aulast%3DUray%26aufirst%3DG.%26aulast%3DVerdino%26aufirst%3DP.%26aulast%3DBelaj%26aufirst%3DF.%26aulast%3DKappe%26aufirst%3DC.%2BO.%26aulast%3DFabian%26aufirst%3DW.%2BM.%2BF.%26atitle%3DAbsolute%2520Configuration%2520in%25204-Alkyl-%2520and%25204-Aryl-3%252C4-Dihydro-2%25281H%2529-Pyrimidones%253A%2520A%2520Combined%2520Theoretical%2520and%2520Experimental%2520Investigation%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D6685%26epage%3D6694%26doi%3D10.1021%2Fjo010491l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krenn, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdino, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uray, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faber, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappe, C. O.</span></span> <span> </span><span class="NLM_article-title">Determination of Absolute Configuration in 4-aryl-3,4-dihydro-2(1H)-pyrimidones by High Performance Liquid Chromatography and CD Spectroscopy</span>. <i>Chirality</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">662</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1520-636X(1999)11:8<659::AID-CHIR8>3.0.CO;2-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1002%2F%28SICI%291520-636X%281999%2911%3A8%3C659%3A%3AAID-CHIR8%3E3.0.CO%3B2-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10467318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADyaK1MXmt1Gltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1999&pages=659-662&author=W.+Krennauthor=P.+Verdinoauthor=G.+Urayauthor=K.+Faberauthor=C.+O.+Kappe&title=Determination+of+Absolute+Configuration+in+4-aryl-3%2C4-dihydro-2%281H%29-pyrimidones+by+High+Performance+Liquid+Chromatography+and+CD+Spectroscopy&doi=10.1002%2F%28SICI%291520-636X%281999%2911%3A8%3C659%3A%3AAID-CHIR8%3E3.0.CO%3B2-V"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and reactions of Biginelli compounds. Part 15. Determination of absolute configuration in 4-aryl-3,4-dihydro-2(1H)-pyrimidones by high performance liquid chromatography and CD spectroscopy</span></div><div class="casAuthors">Krenn, Wolfram; Verdino, Petra; Uray, Georg; Faber, Kurt; Kappe, C. Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Chirality</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">659-662</span>CODEN:
                <span class="NLM_cas:coden">CHRLEP</span>;
        ISSN:<span class="NLM_cas:issn">0899-0042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The abs. configuration of three 4-aryl-3,4-dihydro-2(1H)-pyrimidones (Biginelli compds., DHPMs) was established by comparison of the typical CD spectra of individual enantiomers with ref. samples of known abs. configuration.  The enantiomers were obtained by semipreparative sepn. of racemic mixts. on a Chiralcel OD-H chiral stationary phase.  The method was used to establish the enantiopreference of various lipases in biocatalytic kinetic resoln. expts. employing activated DHPM esters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRexuWgQqobrVg90H21EOLACvtfcHk0lgZf4w4Gc3-QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmt1Gltrw%253D&md5=208693af983fa0f8cee2b018c79d78c5</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291520-636X%281999%2911%3A8%3C659%3A%3AAID-CHIR8%3E3.0.CO%3B2-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291520-636X%25281999%252911%253A8%253C659%253A%253AAID-CHIR8%253E3.0.CO%253B2-V%26sid%3Dliteratum%253Aachs%26aulast%3DKrenn%26aufirst%3DW.%26aulast%3DVerdino%26aufirst%3DP.%26aulast%3DUray%26aufirst%3DG.%26aulast%3DFaber%26aufirst%3DK.%26aulast%3DKappe%26aufirst%3DC.%2BO.%26atitle%3DDetermination%2520of%2520Absolute%2520Configuration%2520in%25204-aryl-3%252C4-dihydro-2%25281H%2529-pyrimidones%2520by%2520High%2520Performance%2520Liquid%2520Chromatography%2520and%2520CD%2520Spectroscopy%26jtitle%3DChirality%26date%3D1999%26volume%3D11%26spage%3D659%26epage%3D662%26doi%3D10.1002%2F%28SICI%291520-636X%281999%2911%3A8%3C659%3A%3AAID-CHIR8%3E3.0.CO%3B2-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crespo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Maatougui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biagini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azuaje, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadavid, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Mera, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez-de-Terán, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotelo, E.</span></span> <span> </span><span class="NLM_article-title">Discovery of 3,4-Dihydropyrimidin-2(1H)-ones As a Novel Class of Potent and Selective A2B Adenosine Receptor Antagonists</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1031</span>– <span class="NLM_lpage">1036</span>, <span class="refDoi"> DOI: 10.1021/ml400185v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400185v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKks77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1031-1036&author=A.+Crespoauthor=A.+El+Maatouguiauthor=P.+Biaginiauthor=J.+Azuajeauthor=A.+Coelhoauthor=J.+Breaauthor=M.+I.+Lozaauthor=M.+I.+Cadavidauthor=X.+Garc%C3%ADa-Meraauthor=H.+Guti%C3%A9rrez-de-Ter%C3%A1nauthor=E.+Sotelo&title=Discovery+of+3%2C4-Dihydropyrimidin-2%281H%29-ones+As+a+Novel+Class+of+Potent+and+Selective+A2B+Adenosine+Receptor+Antagonists&doi=10.1021%2Fml400185v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 3,4-Dihydropyrimidin-2(1H)-ones As a Novel Class of Potent and Selective A2B Adenosine Receptor Antagonists</span></div><div class="casAuthors">Crespo, Abel; El Maatougui, Abdelaziz; Biagini, Pierfrancesco; Azuaje, Jhonny; Coelho, Alberto; Brea, Jose; Loza, Maria Isabel; Cadavid, Maria Isabel; Garcia-Mera, Xerardo; Gutierrez-de-Teran, Hugo; Sotelo, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1031-1036</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe the discovery and optimization of 3,4-dihydropyrimidin-2-(1H)-ones as a novel family of (nonxanthine) A2B receptor antagonists that exhibit an unusually high selectivity profile.  The Biginelli-based hit optimization process enabled a thoughtful exploration of the structure-activity and structure-selectivity relationships for this chemotype, enabling the identification of ligands that combine structural simplicity with excellent hA2B AdoR affinity and remarkable selectivity profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcmq93mYNjxrVg90H21EOLACvtfcHk0lgZf4w4Gc3-QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKks77J&md5=41f5ce37315529b35115ef6ec3cccba5</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fml400185v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400185v%26sid%3Dliteratum%253Aachs%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DEl%2BMaatougui%26aufirst%3DA.%26aulast%3DBiagini%26aufirst%3DP.%26aulast%3DAzuaje%26aufirst%3DJ.%26aulast%3DCoelho%26aufirst%3DA.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DGarc%25C3%25ADa-Mera%26aufirst%3DX.%26aulast%3DGuti%25C3%25A9rrez-de-Ter%25C3%25A1n%26aufirst%3DH.%26aulast%3DSotelo%26aufirst%3DE.%26atitle%3DDiscovery%2520of%25203%252C4-Dihydropyrimidin-2%25281H%2529-ones%2520As%2520a%2520Novel%2520Class%2520of%2520Potent%2520and%2520Selective%2520A2B%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1031%26epage%3D1036%26doi%3D10.1021%2Fml400185v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chubukov, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitman, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structural Basis for Allosteric Regulation of GPCRS by Sodium Ions</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>337</i></span>,  <span class="NLM_fpage">232</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1126/science.1219218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1126%2Fscience.1219218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=22798613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVKqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=2012&pages=232-236&author=W.+Liuauthor=E.+Chunauthor=A.+A.+Thompsonauthor=P.+Chubukovauthor=F.+Xuauthor=V.+Katritchauthor=G.+W.+Hanauthor=C.+B.+Rothauthor=L.+H.+Heitmanauthor=A.+P.+Ijzermanauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structural+Basis+for+Allosteric+Regulation+of+GPCRS+by+Sodium+Ions&doi=10.1126%2Fscience.1219218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions</span></div><div class="casAuthors">Liu, Wei; Chun, Eugene; Thompson, Aaron A.; Chubukov, Pavel; Xu, Fei; Katritch, Vsevolod; Han, Gye Won; Roth, Christopher B.; Heitman, Laura H.; IJzerman, Adriaan P.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">337</span>
        (<span class="NLM_cas:issue">6091</span>),
    <span class="NLM_cas:pages">232-236</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Pharmacol. responses of G protein-coupled receptors (GPCRs) can be fine-tuned by allosteric modulators.  Structural studies of such effects have been limited due to the medium resoln. of GPCR structures.  We reengineered the human A2A adenosine receptor by replacing its third intracellular loop with apocytochrome b562RIL and solved the structure at 1.8 angstrom resoln.  The high-resoln. structure allowed us to identify 57 ordered water mols. inside the receptor comprising three major clusters.  The central cluster harbors a putative sodium ion bound to the highly conserved aspartate residue Asp2.50.  Addnl., two cholesterols stabilize the conformation of helix VI, and one of 23 ordered lipids intercalates inside the ligand-binding pocket.  These high-resoln. details shed light on the potential role of structured water mols., sodium ions, and lipids/cholesterol in GPCR stabilization and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvcjQimGnIMLVg90H21EOLACvtfcHk0lgZf4w4Gc3-QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVKqtbs%253D&md5=782b2235b76ef77b11b6456f8e4485e1</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1126%2Fscience.1219218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1219218%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DChun%26aufirst%3DE.%26aulast%3DThompson%26aufirst%3DA.%2BA.%26aulast%3DChubukov%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DF.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DRoth%26aufirst%3DC.%2BB.%26aulast%3DHeitman%26aufirst%3DL.%2BH.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructural%2520Basis%2520for%2520Allosteric%2520Regulation%2520of%2520GPCRS%2520by%2520Sodium%2520Ions%26jtitle%3DScience%26date%3D2012%26volume%3D337%26spage%3D232%26epage%3D236%26doi%3D10.1126%2Fscience.1219218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaakola, V.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, E. Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">The 2.6 Å Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>322</i></span>,  <span class="NLM_fpage">1211</span>– <span class="NLM_lpage">1217</span>, <span class="refDoi"> DOI: 10.1126/science.1164772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1126%2Fscience.1164772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=18832607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlyqtbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2008&pages=1211-1217&author=V.-P.+Jaakolaauthor=M.+T.+Griffithauthor=M.+A.+Hansonauthor=V.+Cherezovauthor=E.+Y.+T.+Chienauthor=J.+R.+Laneauthor=A.+P.+Ijzermanauthor=R.+C.+Stevens&title=The+2.6+%C3%85+Crystal+Structure+of+a+Human+A2A+Adenosine+Receptor+Bound+to+an+Antagonist&doi=10.1126%2Fscience.1164772"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist</span></div><div class="casAuthors">Jaakola, Veli-Pekka; Griffith, Mark T.; Hanson, Michael A.; Cherezov, Vadim; Chien, Ellen Y. T.; Lane, J. Robert; IJzerman, Adriaan P.; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">5905</span>),
    <span class="NLM_cas:pages">1211-1217</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The adenosine class of heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) mediates the important role of extracellular adenosine in many physiol. processes and is antagonized by caffeine.  The authors have detd. the crystal structure of the human A2A adenosine receptor, in complex with a high-affinity subtype-selective antagonist, ZM241385, to 2.6 angstrom resoln.  Four disulfide bridges in the extracellular domain, combined with a subtle repacking of the transmembrane helixes relative to the adrenergic and rhodopsin receptor structures, define a pocket distinct from that of other structurally detd. GPCRs.  The arrangement allows for the binding of the antagonist in an extended conformation, perpendicular to the membrane plane.  The binding site highlights an integral role for the extracellular loops, together with the helical core, in ligand recognition by this class of GPCRs and suggests a role for ZM241385 in restricting the movement of a tryptophan residue important in the activation mechanism of the class A receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7QL4wN4TdhrVg90H21EOLACvtfcHk0liIWFe-X8XUig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlyqtbfN&md5=5bdb862b41f345c244f3c162e058206b</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1126%2Fscience.1164772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1164772%26sid%3Dliteratum%253Aachs%26aulast%3DJaakola%26aufirst%3DV.-P.%26aulast%3DGriffith%26aufirst%3DM.%2BT.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DChien%26aufirst%3DE.%2BY.%2BT.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DThe%25202.6%2520%25C3%2585%2520Crystal%2520Structure%2520of%2520a%2520Human%2520A2A%2520Adenosine%2520Receptor%2520Bound%2520to%2520an%2520Antagonist%26jtitle%3DScience%26date%3D2008%26volume%3D322%26spage%3D1211%26epage%3D1217%26doi%3D10.1126%2Fscience.1164772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bortolato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tehan, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodnarchuk, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Essex, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, J. S.</span></span> <span> </span><span class="NLM_article-title">Water Network Perturbation in Ligand Binding: Adenosine A2A Antagonists as a Case Study</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">1700</span>– <span class="NLM_lpage">1713</span>, <span class="refDoi"> DOI: 10.1021/ci4001458</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci4001458" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosFymsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=1700-1713&author=A.+Bortolatoauthor=B.+G.+Tehanauthor=M.+S.+Bodnarchukauthor=J.+W.+Essexauthor=J.+S.+Mason&title=Water+Network+Perturbation+in+Ligand+Binding%3A+Adenosine+A2A+Antagonists+as+a+Case+Study&doi=10.1021%2Fci4001458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Water Network Perturbation in Ligand Binding: Adenosine A2A Antagonists as a Case Study</span></div><div class="casAuthors">Bortolato, Andrea; Tehan, Ben G.; Bodnarchuk, Michael S.; Essex, Jonathan W.; Mason, Jonathan S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1700-1713</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent efforts in the computational evaluation of the thermodn. properties of water mols. have resulted in the development of promising new in silico methods to evaluate the role of water in ligand binding.  These methods include WaterMap, SZMAP, GRID/CRY probe, and Grand Canonical Monte Carlo simulations.  They allow the prediction of the position and relative free energy of the water mol. in the protein active site and the anal. of the perturbation of an explicit water network (WNP) as a consequence of ligand binding.  We have for the first time extended these approaches toward the prediction of kinetics for small mols. and of relative free energy of binding with a focus on the perturbation of the water network and application to large diverse data sets.  Our results support a qual. correlation between the residence time of 12 related triazine adenosine A2A receptor antagonists and the no. and position of high energy trapped solvent mols.  From a quant. viewpoint, we successfully applied these computational techniques as an implicit solvent alternative, in linear combination with a mol. mechanics force field, to predict the relative ligand free energy of binding (WNP-MMSA).  The applicability of this linear method, based on the thermodn. additivity principle, did not extend to 375 diverse A2A receptor antagonists.  However, a fast but effective method could be enabled by replacing the linear approach with a machine learning technique using probabilistic classification trees, which classified the binding affinity correctly for 90% of the ligands in the training set and 67% in the test set.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8qdbPGtMIB7Vg90H21EOLACvtfcHk0liIWFe-X8XUig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosFymsb4%253D&md5=e267cf2a427da3b0bb45e2f61510cdd5</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fci4001458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci4001458%26sid%3Dliteratum%253Aachs%26aulast%3DBortolato%26aufirst%3DA.%26aulast%3DTehan%26aufirst%3DB.%2BG.%26aulast%3DBodnarchuk%26aufirst%3DM.%2BS.%26aulast%3DEssex%26aufirst%3DJ.%2BW.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26atitle%3DWater%2520Network%2520Perturbation%2520in%2520Ligand%2520Binding%253A%2520Adenosine%2520A2A%2520Antagonists%2520as%2520a%2520Case%2520Study%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2013%26volume%3D53%26spage%3D1700%26epage%3D1713%26doi%3D10.1021%2Fci4001458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nayadu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behera, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudi, G.</span></span> <span> </span><span class="NLM_article-title">Fluorescent Probe Based CYP Inhibition Assay: A High Throughput Tool for Early Drug Discovery Screening</span>. <i>Int. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslagurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=303-307&author=S.+Nayaduauthor=D.+Beheraauthor=M.+Sharmaauthor=G.+Kaurauthor=G.+Gudi&title=Fluorescent+Probe+Based+CYP+Inhibition+Assay%3A+A+High+Throughput+Tool+for+Early+Drug+Discovery+Screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescent probe based CYP inhibition assay: a high throughput tool for early drug discovery screening</span></div><div class="casAuthors">Nayadu, Sneha; Behera, Dayanidhi; Sharma, Mansi; Kaur, Ginpreet; Gudi, Girish</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmacy and Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">303-307</span>CODEN:
                <span class="NLM_cas:coden">IJPPKB</span>;
        ISSN:<span class="NLM_cas:issn">0975-1491</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Pharmacy and Pharmaceutical Sciences</span>)
        </div><div class="casAbstract">Inhibition of cytochrome P 450 (CYP450) enzymes can result in potential clin. drug-drug interaction liabilities.  Because of the safety and economic concern leading to clin. failure or product withdrawal, screening of lead mols. for CYP450 inhibition potential is nowadays conducted much earlier in the drug development process.  At this early phase, a large no. of lead mols. are in need of evaluation.  Thus, safety, economic and throughput pressures have forced the development of assays that are rapid throughput but have high predictive value.  Fluorometric assays using recombinant human enzymes are ideally suited for this purpose.  Objective: This study was mainly designed with an objective to address the reliability of fluorogenic probes for CYP450 inhibition studies.  Methods: Individual cDNA-expressed CYP isoforms (1A2, 2D6, 3A4, 2C9 and 2C19) were applied to microtitre plate assays.  Std. inhibitors were co-incubated with fluorogenic substrates and their inhibitory potential (IC50) was detd.  Assay conditions in terms of CYP450 protein concn. and time of incubation were standardized, enzyme kinetics parameters of each fluorescent probe substrate were estd. and IC50 values of inhibitors were detd. and validated on different days to check reproducibility.  Results: The fluorescent probe based CYP Inhibition assay methods were found to be robust, efficient and highly reproducible.  Conclusion: These assays can be quite useful in preliminary high throughput screening of inhibitory potential of new drugs on individual P 450 enzymes and predicting clin. drug-drug interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4zlZRgoFis7Vg90H21EOLACvtfcHk0liIWFe-X8XUig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslagurc%253D&md5=db0b6673e10320c6280f099c46e17072</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNayadu%26aufirst%3DS.%26aulast%3DBehera%26aufirst%3DD.%26aulast%3DSharma%26aufirst%3DM.%26aulast%3DKaur%26aufirst%3DG.%26aulast%3DGudi%26aufirst%3DG.%26atitle%3DFluorescent%2520Probe%2520Based%2520CYP%2520Inhibition%2520Assay%253A%2520A%2520High%2520Throughput%2520Tool%2520for%2520Early%2520Drug%2520Discovery%2520Screening%26jtitle%3DInt.%2520J.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D5%26spage%3D303%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDonnell, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, C. H.</span></span> <span> </span><span class="NLM_article-title">Basic Review of the Cytochrome P450 System</span>. <i>J. Adv. Pract. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.6004/jadpro.2013.4.4.7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.6004%2Fjadpro.2013.4.4.7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=25032007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A280%3ADC%252BC2cbjt1Wqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=263-268&author=A.+M.+McDonnellauthor=C.+H.+Dang&title=Basic+Review+of+the+Cytochrome+P450+System&doi=10.6004%2Fjadpro.2013.4.4.7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Basic review of the cytochrome p450 system</span></div><div class="casAuthors">McDonnell Anne M; Dang Cathyyen H</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the advanced practitioner in oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">263-8</span>
        ISSN:<span class="NLM_cas:issn">2150-0878</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTPX9EKZsk_ONyzdcP07UmufW6udTcc2eYRaSKZZC2eMbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbjt1Wqsg%253D%253D&md5=92d64b3dfd3ec33f8492c1087cb85efd</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.6004%2Fjadpro.2013.4.4.7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.6004%252Fjadpro.2013.4.4.7%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonnell%26aufirst%3DA.%2BM.%26aulast%3DDang%26aufirst%3DC.%2BH.%26atitle%3DBasic%2520Review%2520of%2520the%2520Cytochrome%2520P450%2520System%26jtitle%3DJ.%2520Adv.%2520Pract.%2520Oncol.%26date%3D2013%26volume%3D4%26spage%3D263%26epage%3D268%26doi%3D10.6004%2Fjadpro.2013.4.4.7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egli, M.</span></span> <span> </span><span class="NLM_article-title">Recent Structural Insights into Cytochrome P450 Function</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">625</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2016.05.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.tips.2016.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=27267697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC28XosFSru7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2016&pages=625-640&author=F.+P.+Guengerichauthor=M.+R.+Watermanauthor=M.+Egli&title=Recent+Structural+Insights+into+Cytochrome+P450+Function&doi=10.1016%2Fj.tips.2016.05.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Structural Insights into Cytochrome P450 Function</span></div><div class="casAuthors">Guengerich, F. Peter; Waterman, Michael R.; Egli, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">625-640</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Cytochrome P 450 (P 450) enzymes are important in the metab. of drugs, steroids, fat-sol. vitamins, carcinogens, pesticides, and many other types of chems.  Their catalytic activities are important issues in areas such as drug-drug interactions and endocrine function.  During the past 30 years, structures of P450s have been very helpful in understanding function, particularly the mammalian P 450 structures available in the past 15 years.  We review recent activity in this area, focusing on the past 2 years (2014-2015).  Structural work with microbial P450s includes studies related to the biosynthesis of natural products and the use of parasitic and fungal P 450 structures as targets for drug discovery.  Studies on mammalian P450s include the utilization of information about 'drug-metabolizing' P450s to improve drug development and also to understand the mol. bases of endocrine dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAxcKiFmaVzrVg90H21EOLACvtfcHk0lhyuu_Ain_f2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosFSru7Y%253D&md5=313a43149c12b6fb2e7c0a0ea6f2919e</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2016.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2016.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26aulast%3DWaterman%26aufirst%3DM.%2BR.%26aulast%3DEgli%26aufirst%3DM.%26atitle%3DRecent%2520Structural%2520Insights%2520into%2520Cytochrome%2520P450%2520Function%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2016%26volume%3D37%26spage%3D625%26epage%3D640%26doi%3D10.1016%2Fj.tips.2016.05.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P450 and Chemical Toxicology</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1021/tx700079z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx700079z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlynurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=70-83&author=F.+P.+Guengerich&title=Cytochrome+P450+and+Chemical+Toxicology&doi=10.1021%2Ftx700079z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450 and Chemical Toxicology</span></div><div class="casAuthors">Guengerich, F. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-83</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The field of cytochrome P 450 (P 450) research has developed considerably over the past 20 years, and many important papers on the roles of P450s in chem. toxicol. have appeared in Chem. Research in Toxicol.  Today, our basic understanding of many of the human P450s is relatively well-established, in terms of the details of the individual genes, sequences, and basic catalytic mechanisms.  Crystal structures of several of the major human P450s are now in hand.  The animal P450s are still important in the context of metab. and safety testing.  Many well-defined examples exist for roles of P450s in decreasing the adverse effects of drugs through biotransformation, and an equally interesting field of investigation is the bioactivation of chems., including drugs.  Unresolved problems include the characterization of the minor "orphan" P450s, ligand cooperativity and kinetic complexity of several P450s, the prediction of metab., the overall contribution of bioactivation to drug idiosyncratic problems, the extrapolation of animal test results to humans in drug development, and the contribution of genetic variation in human P450s to cancer incidence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQnvzpBM_I4LVg90H21EOLACvtfcHk0lhyuu_Ain_f2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlynurbF&md5=444b8d63bf07dc2449af6413fa7fff00</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Ftx700079z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx700079z%26sid%3Dliteratum%253Aachs%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DCytochrome%2520P450%2520and%2520Chemical%2520Toxicology%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D70%26epage%3D83%26doi%3D10.1021%2Ftx700079z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Virtanen, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukkonen-Macchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vainio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Härkönen, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalkanen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yegutkin, G. G.</span></span> <span> </span><span class="NLM_article-title">Adenosine Inhibits Tumor Cell Invasion via Receptor-Independent Mechanisms</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1863</span>– <span class="NLM_lpage">1874</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-14-0302-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1158%2F1541-7786.MCR-14-0302-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=25080434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFSitLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=1863-1874&author=S.+S.+Virtanenauthor=A.+Kukkonen-Macchiauthor=M.+Vainioauthor=K.+Elimaauthor=P.+L.+H%C3%A4rk%C3%B6nenauthor=S.+Jalkanenauthor=G.+G.+Yegutkin&title=Adenosine+Inhibits+Tumor+Cell+Invasion+via+Receptor-Independent+Mechanisms&doi=10.1158%2F1541-7786.MCR-14-0302-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine Inhibits Tumor Cell Invasion via Receptor-Independent Mechanisms</span></div><div class="casAuthors">Virtanen, Sanna S.; Kukkonen-Macchi, Anu; Vainio, Minna; Elima, Kati; Haerkoenen, Pirkko L.; Jalkanen, Sirpa; Yegutkin, Gennady G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1863-1874</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Extracellular adenosine mediates diverse anti-inflammatory, angiogenic, and other signaling effects via binding to adenosine receptors, and it also regulates cell proliferation and death via activation of the intrinsic signaling pathways.  Given the emerging role of adenosine and other purines in tumor growth and metastasis, this study evaluated the effects of adenosine on the invasion of metastatic prostate and breast cancer cells.  Treatment with low micromolar concns. of adenosine, but not other nucleosides or adenosine receptor agonists, inhibited subsequent cell invasion and migration through Matrigel- and laminin-coated inserts.  These inhibitory effects occurred via intrinsic receptor-independent mechanisms, despite the abundant expression of A2B adenosine receptors (ADORA2B).  Extracellular nucleotides and adenosine were shown to be rapidly metabolized on tumor cell surfaces via sequential ecto-5'-nucleotidase (CD73/NT5E) and adenosine deaminase reactions with subsequent cellular uptake of nucleoside metabolites and their intracellular interconversion into ADP/ATP.  This was accompanied by concurrent inhibition of AMP-activated protein kinase and other signaling pathways.  No differences in the proliferation rates, cytoskeleton assembly, expression of major adhesion mols. [integrin-1β (ITGB1), CD44, focal adhesion kinase], and secretion of matrix metalloproteinases were detected between the control and treated cells, thus excluding the contribution of these components of invasion cascade to the inhibitory effects of adenosine.  These data provide a novel insight into the ability of adenosine to dampen immune responses and prevent tumor invasion via two different, adenosine receptor-dependent and -independent mechanisms.  Implications: This study suggests that the combined targeting of adenosine receptors and modulation of intracellular purine levels can affect tumor growth and metastasis phenotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5R7siQLWZJ7Vg90H21EOLACvtfcHk0lhyuu_Ain_f2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFSitLfI&md5=807b7cab8b9d00e5bb3486cb61583565</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-14-0302-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-14-0302-T%26sid%3Dliteratum%253Aachs%26aulast%3DVirtanen%26aufirst%3DS.%2BS.%26aulast%3DKukkonen-Macchi%26aufirst%3DA.%26aulast%3DVainio%26aufirst%3DM.%26aulast%3DElima%26aufirst%3DK.%26aulast%3DH%25C3%25A4rk%25C3%25B6nen%26aufirst%3DP.%2BL.%26aulast%3DJalkanen%26aufirst%3DS.%26aulast%3DYegutkin%26aufirst%3DG.%2BG.%26atitle%3DAdenosine%2520Inhibits%2520Tumor%2520Cell%2520Invasion%2520via%2520Receptor-Independent%2520Mechanisms%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2014%26volume%3D12%26spage%3D1863%26epage%3D1874%26doi%3D10.1158%2F1541-7786.MCR-14-0302-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vijayan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, M. W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, M. J.</span></span> <span> </span><span class="NLM_article-title">Targeting Immunosuppressive Adenosine in Cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">709</span>– <span class="NLM_lpage">724</span>, <span class="refDoi"> DOI: 10.1038/nrc.2017.86</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1038%2Fnrc.2017.86" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=29059149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslehs7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=709-724&author=D.+Vijayanauthor=A.+Youngauthor=M.+W.+L.+Tengauthor=M.+J.+Smyth&title=Targeting+Immunosuppressive+Adenosine+in+Cancer&doi=10.1038%2Fnrc.2017.86"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting immunosuppressive adenosine in cancer</span></div><div class="casAuthors">Vijayan, Dipti; Young, Arabella; Teng, Michele W. L.; Smyth, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">709-724</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Despite the success of anti-programmed cell death protein 1 (PD1), anti-PD1 ligand 1 (PDL1) and anti-cytotoxic T lymphocyte antigen 4 (CTLA4) therapies in advanced cancer, a considerable proportion of patients remain unresponsive to these treatments (known as innate resistance).  In addn., one-third of patients relapse after initial response (known as adaptive resistance), which suggests that multiple non-redundant immunosuppressive mechanisms coexist within the tumor microenvironment.  A major immunosuppressive mechanism is the adenosinergic pathway, which now represents an attractive new therapeutic target for cancer therapy.  Activation of this pathway occurs within hypoxic tumors, where extracellular adenosine exerts local suppression through tumor-intrinsic and host-mediated mechanisms.  Preclin. studies in mice with adenosine receptor antagonists and antibodies have reported favorable antitumor immune responses with some definition of the mechanism of action.  Currently, agents targeting the adenosinergic pathway are undergoing first-in-human clin. trials as single agents and in combination with anti-PD1 or anti-PDL1 therapies.  In this Review, we describe the complex interplay of adenosine and adenosine receptors in the development of primary tumors and metastases and discuss the merits of targeting one or more components that compose the adenosinergic pathway.  We also review the early clin. data relating to therapeutic agents inhibiting the adenosinergic pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3aiRNPyIwHrVg90H21EOLACvtfcHk0liPZHpLkMVxPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslehs7rO&md5=24d252d351e30154a8f79bc37c2e4b2b</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2Fnrc.2017.86&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc.2017.86%26sid%3Dliteratum%253Aachs%26aulast%3DVijayan%26aufirst%3DD.%26aulast%3DYoung%26aufirst%3DA.%26aulast%3DTeng%26aufirst%3DM.%2BW.%2BL.%26aulast%3DSmyth%26aufirst%3DM.%2BJ.%26atitle%3DTargeting%2520Immunosuppressive%2520Adenosine%2520in%2520Cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2017%26volume%3D17%26spage%3D709%26epage%3D724%26doi%3D10.1038%2Fnrc.2017.86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akdemir, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cekic, C.</span></span> <span> </span><span class="NLM_article-title">The Expression of Adenosine A2B Receptor on Antigen-Presenting Cells Suppresses CD8+ T-cell Responses and Promotes Tumor Growth</span>. <i>Cancer Immunol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1064</span>– <span class="NLM_lpage">1074</span>, <span class="refDoi"> DOI: 10.1158/2326-6066.cir-19-0833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1158%2F2326-6066.cir-19-0833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=32381524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit12qu7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2020&pages=1064-1074&author=S.+Chenauthor=I.+Akdemirauthor=J.+Fanauthor=J.+Lindenauthor=B.+Zhangauthor=C.+Cekic&title=The+Expression+of+Adenosine+A2B+Receptor+on+Antigen-Presenting+Cells+Suppresses+CD8%2B+T-cell+Responses+and+Promotes+Tumor+Growth&doi=10.1158%2F2326-6066.cir-19-0833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">The expression of adenosine A2B receptor onantigen-presenting cells suppresses CD8+ T-cellresponses and promotes tumor growth</span></div><div class="casAuthors">Chen, Siqi; Akdemir, Imran; Fan, Jie; Linden, Joel; Zhang, Bin; Cekic, Caglar</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1064-1074</span>CODEN:
                <span class="NLM_cas:coden">CIRACV</span>;
        ISSN:<span class="NLM_cas:issn">2326-6066</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Accumulating evidence suggests that inhibiting adenosine-generating ecto-enzymes (CD39 and CD73) and/or adenosine A2A or A2B receptors (R) stimulates antitumor immunity and limits tumor progression.  Although activating A2ARs or A2BRs causes similar immunosuppressive and protumoral functions, few studies have investigated the distinct role of A2BR in cancer.  Here, we showed that A2BR expression by hematopoietic cells was primarily responsible for promoting tumor growth.  Deletion of A2BR profoundly enhanced anticancer T-cell immunity.  Although T-cell A2BR plays an insignificant role for A2BR-mediated immunosuppression and tumor promotion, A2BR deficiency in tumor-bearing mice caused increased infiltration of myeloid and CD103+ dendritic cells, which was assocd. with more effective cross-priming of adoptively transferred tumor antigen-specific CD8+ T cells.  A2BR deletion also intrinsically favored accumulation of myeloid and CD11bdim antigen-presenting cells (ARC) in the tumor microenvironment.  Both myeloid-specific or CD11c-specific conditional deletion of A2BR delayed primary tumor growth.  Myeloid, but not CD11c-specific conditional, depletion delayed lung metastasis.  Pharmacol. blockade of A2BR improved the antitumor effect of adoptive T-cell therapy.  Overall, these results suggested that A2BR expression on myeloid cells and APCs indirectly suppressed CD8+ T-cell responses and promoted metastasis.  These data provide a strong rationale to combine A2BR inhibition with T-cell-based immunotherapy for the treatment of tumor growth and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7p5YgU2oAJrVg90H21EOLACvtfcHk0liPZHpLkMVxPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit12qu7nF&md5=4b354530561fa259582e2b442e94ce9b</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1158%2F2326-6066.cir-19-0833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2326-6066.cir-19-0833%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DAkdemir%26aufirst%3DI.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DCekic%26aufirst%3DC.%26atitle%3DThe%2520Expression%2520of%2520Adenosine%2520A2B%2520Receptor%2520on%2520Antigen-Presenting%2520Cells%2520Suppresses%2520CD8%252B%2520T-cell%2520Responses%2520and%2520Promotes%2520Tumor%2520Growth%26jtitle%3DCancer%2520Immunol.%2520Res.%26date%3D2020%26volume%3D8%26spage%3D1064%26epage%3D1074%26doi%3D10.1158%2F2326-6066.cir-19-0833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bahreyni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samani, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahmani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behnam-Rassouli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khazaei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryzhikov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parizadeh, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassanian, S. M.</span></span> <span> </span><span class="NLM_article-title">Role of Adenosine Signaling in the Pathogenesis of Breast Cancer</span>. <i>J. Cell. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>233</i></span>,  <span class="NLM_fpage">1836</span>– <span class="NLM_lpage">1843</span>, <span class="refDoi"> DOI: 10.1002/jcp.25944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1002%2Fjcp.25944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=28383816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotF2kt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=2018&pages=1836-1843&author=A.+Bahreyniauthor=S.+S.+Samaniauthor=F.+Rahmaniauthor=R.+Behnam-Rassouliauthor=M.+Khazaeiauthor=M.+Ryzhikovauthor=M.+R.+Parizadehauthor=A.+Avanauthor=S.+M.+Hassanian&title=Role+of+Adenosine+Signaling+in+the+Pathogenesis+of+Breast+Cancer&doi=10.1002%2Fjcp.25944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Role of adenosine signaling in the pathogenesis of breast cancer</span></div><div class="casAuthors">Bahreyni, Amirhossein; Samani, Seyed Sattar; Rahmani, Farzad; Behnam-Rassouli, Reihane; Khazaei, Majid; Ryzhikov, Mikhail; Parizadeh, Mohammad Reza; Avan, Amir; Hassanian, Seyed Mahdi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">233</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1836-1843</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The plasma level of adenosine increases under ischemic and inflamed conditions in tumor microenvironment.  Adenosine elicits a range of signaling pathways in tumors, resulting in either inhibition or enhancement of tumor growth depending upon different subtypes of adenosine receptors activation and type of cancer.  Metab. of adenosine-5'-triphosphate (ATP) and its derivs. including adenosine is dysregulated in the breast tumor microenvironment, supporting the role of this metabolite in the pathogenesis of breast cancer.  Adenosine regulates inflammation, apoptosis, cell proliferation, and metastasis in breast cancer cells.  This review summarizes the role of adenosine in the pathogenesis of breast cancer for a better understanding and hence a better management of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCxZmEHlTUA7Vg90H21EOLACvtfcHk0liPZHpLkMVxPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotF2kt7c%253D&md5=7b21bc4ee4ed7ee88acdb2d068217bc6</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1002%2Fjcp.25944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.25944%26sid%3Dliteratum%253Aachs%26aulast%3DBahreyni%26aufirst%3DA.%26aulast%3DSamani%26aufirst%3DS.%2BS.%26aulast%3DRahmani%26aufirst%3DF.%26aulast%3DBehnam-Rassouli%26aufirst%3DR.%26aulast%3DKhazaei%26aufirst%3DM.%26aulast%3DRyzhikov%26aufirst%3DM.%26aulast%3DParizadeh%26aufirst%3DM.%2BR.%26aulast%3DAvan%26aufirst%3DA.%26aulast%3DHassanian%26aufirst%3DS.%2BM.%26atitle%3DRole%2520of%2520Adenosine%2520Signaling%2520in%2520the%2520Pathogenesis%2520of%2520Breast%2520Cancer%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2018%26volume%3D233%26spage%3D1836%26epage%3D1843%26doi%3D10.1002%2Fjcp.25944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farokhzad, O. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippard, S. J.</span></span> <span> </span><span class="NLM_article-title">Targeted Delivery of Cisplatin to Prostate Cancer Cells by Aptamer Functionalized Pt(IV) Prodrug-PLGA–PEG Nanoparticles</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">17356</span>– <span class="NLM_lpage">17361</span>, <span class="refDoi"> DOI: 10.1073/pnas.0809154105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1073%2Fpnas.0809154105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=18978032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWgu7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=17356-17361&author=S.+Dharauthor=F.+X.+Guauthor=R.+Langerauthor=O.+C.+Farokhzadauthor=S.+J.+Lippard&title=Targeted+Delivery+of+Cisplatin+to+Prostate+Cancer+Cells+by+Aptamer+Functionalized+Pt%28IV%29+Prodrug-PLGA%E2%80%93PEG+Nanoparticles&doi=10.1073%2Fpnas.0809154105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles</span></div><div class="casAuthors">Dhar, Shanta; Gu, Frank X.; Langer, Robert; Farokhzad, Omid C.; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">17356-17361</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Cisplatin is used to treat a variety of tumors, but dose limiting toxicities or intrinsic and acquired resistance limit its application in many types of cancer including prostate.  We report a unique strategy to deliver cisplatin to prostate cancer cells by constructing Pt(IV)-encapsulated prostate-specific membrane antigen (PSMA) targeted nanoparticles (NPs) of poly(D,L-lactic-co-glycolic acid) (PLGA)-poly(ethylene glycol) (PEG)-functionalized controlled release polymers.  By using PLGA-b-PEG nanoparticles with PSMA targeting aptamers (Apt) on the surface as a vehicle for the platinum(IV) compd. c,t,c-[Pt(NH3)2(O2CCH2CH2CH2CH2CH3)2Cl2] (I), a LD of cisplatin was delivered specifically to prostate cancer cells.  PSMA aptamer targeted delivery of Pt(IV) cargos to PSMA+ LNCaP prostate cancer cells by endocytosis of the nanoparticle vehicles was demonstrated using fluorescence microscopy by colocalization of green fluorescent labeled cholesterol-encapsulated NPs and early endosome marker EEA-1.  The choice of linear hexyl chains in I was the result of a systematic study to optimize encapsulation and controlled release from the polymer without compromising either feature.  Release of cisplatin from the polymeric nanoparticles after redn. of I and formation of cisplatin 1,2-intrastrand d(GpG) crosslinks on nuclear DNA was confirmed by using a monoclonal antibody for the adduct.  A comparison between the cytotoxic activities of Pt(IV)-encapsulated PLGA-b- PEG NPs with the PSMA aptamer on the surface (Pt-NP-Apt), cisplatin, and the nontargeted Pt(IV)-encapsulated NPs (Pt-NP) against human prostate PSMA-overexpressing LNCaP and PSMA-PC3 cancer cells revealed significant differences.  The effectiveness of PSMA targeted Pt-NP-Apt nanoparticles against the PSMA+ LNCaP cells is approx. an order of magnitude greater than that of free cisplatin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmradB-ZYWQbVg90H21EOLACvtfcHk0lh-HhiRrzbw4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWgu7fL&md5=ee3bd248db95e9c2e9f56383289a4da9</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0809154105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0809154105%26sid%3Dliteratum%253Aachs%26aulast%3DDhar%26aufirst%3DS.%26aulast%3DGu%26aufirst%3DF.%2BX.%26aulast%3DLanger%26aufirst%3DR.%26aulast%3DFarokhzad%26aufirst%3DO.%2BC.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DTargeted%2520Delivery%2520of%2520Cisplatin%2520to%2520Prostate%2520Cancer%2520Cells%2520by%2520Aptamer%2520Functionalized%2520Pt%2528IV%2529%2520Prodrug-PLGA%25E2%2580%2593PEG%2520Nanoparticles%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D17356%26epage%3D17361%26doi%3D10.1073%2Fpnas.0809154105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Núñez-Iglesias, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Santiago, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartea, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soengas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasco, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freire-Garabal, M.</span></span> <span> </span><span class="NLM_article-title">Effects of 3-Butenyl Isothiocyanate on Phenotypically Different Prostate Cancer Cells</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2213</span>– <span class="NLM_lpage">2223</span>, <span class="refDoi"> DOI: 10.3892/ijo.2018.4545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.3892%2Fijo.2018.4545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=30226593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjsFWltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2018&pages=2213-2223&author=M.+J.+N%C3%BA%C3%B1ez-Iglesiasauthor=S.+Novioauthor=C.+Garc%C3%ADa-Santiagoauthor=M.+E.+Carteaauthor=P.+Soengasauthor=P.+Velascoauthor=M.+Freire-Garabal&title=Effects+of+3-Butenyl+Isothiocyanate+on+Phenotypically+Different+Prostate+Cancer+Cells&doi=10.3892%2Fijo.2018.4545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of 3-butenyl isothiocyanate on phenotypically different prostate cancer cells</span></div><div class="casAuthors">Nunez-Iglesias, M. J.; Novio, S.; Garcia-Santiago, C.; Cartea, M. E.; Soengas, P.; Velasco, P.; Freire-Garabal, M.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2213-2223</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1791-2423</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Isothiocyanates (ITCs) have gained increasing attention since they have been attributed the merits for the potential beneficial effects of cruciferous vegetable dietary consumption on cancer.  The aim of the present study was to det. the cytotoxic effects of 3-butenyl ITC (3-BI) on prostate cancer (PC) cells under in vitro conditions.  Two androgen-insensitive human PC cell lines, PC-3 and DU145, were assayed.  Cells were cultured in the presence of increasing concns. of 3-BI (5, 10, 30 and 50 μM) in the absence or presence of the chemotherapeutic drug docetaxel (DOCE) (1 and 2 nM).  The cytotoxic effects of these compds. were analyzed using the trypan blue exclusion assay at 24, 48 and 72 h.  Apoptosis and migration assays were also performed.  The results showed that 3-BI induced a dose-dependent cytotoxic effect on PC-3 cells at 24, 48 and 72 h.  These effects were significantly higher than those found with DOCE at 72 h of culture.  Moreover, 3-BI also potentiated the effects of DOCE in a dose-dependent manner.  Addnl., 3-BI showed inhibition of the migration of PC-3 cells.  Nevertheless, 3-BI was not effective in the DU145 PC cell line.  These results show a promising role for the 3-BI compd. as a co-adjuvant agent in DOCE-based therapy in certain types of PC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAXS5FOlVfK7Vg90H21EOLACvtfcHk0lh-HhiRrzbw4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjsFWltL8%253D&md5=d642aa510d0c68952c7f82ef93eb8d69</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.3892%2Fijo.2018.4545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.2018.4545%26sid%3Dliteratum%253Aachs%26aulast%3DN%25C3%25BA%25C3%25B1ez-Iglesias%26aufirst%3DM.%2BJ.%26aulast%3DNovio%26aufirst%3DS.%26aulast%3DGarc%25C3%25ADa-Santiago%26aufirst%3DC.%26aulast%3DCartea%26aufirst%3DM.%2BE.%26aulast%3DSoengas%26aufirst%3DP.%26aulast%3DVelasco%26aufirst%3DP.%26aulast%3DFreire-Garabal%26aufirst%3DM.%26atitle%3DEffects%2520of%25203-Butenyl%2520Isothiocyanate%2520on%2520Phenotypically%2520Different%2520Prostate%2520Cancer%2520Cells%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2018%26volume%3D53%26spage%3D2213%26epage%3D2223%26doi%3D10.3892%2Fijo.2018.4545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span> <span> </span><span class="NLM_article-title">SATB1 Is Overexpressed in Metastatic Prostate Cancer and Promotes Prostate Cancer Cell Growth and Invasion</span>. <i>J. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">111</span>, <span class="refDoi"> DOI: 10.1186/1479-5876-11-111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1186%2F1479-5876-11-111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=23642278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVSgsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=111&author=L.+Maoauthor=C.+Yangauthor=J.+Wangauthor=W.+Liauthor=R.+Wenauthor=J.+Chenauthor=J.+Zheng&title=SATB1+Is+Overexpressed+in+Metastatic+Prostate+Cancer+and+Promotes+Prostate+Cancer+Cell+Growth+and+Invasion&doi=10.1186%2F1479-5876-11-111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion</span></div><div class="casAuthors">Mao, Lijun; Yang, Chunhua; Wang, Junqi; Li, Wang; Wen, Rumin; Chen, Jiacun; Zheng, Junnian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Translational Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111</span>CODEN:
                <span class="NLM_cas:coden">JTMOBV</span>;
        ISSN:<span class="NLM_cas:issn">1479-5876</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Special AT-rich sequence binding protein 1 (SATB1) is a nuclear factor that functions as the global chromatin organizer to regulate chromatin structure and gene expression.  SATB1 has been shown to be abnormally expressed in various types of cancer.  However, the expression and role of SATB1 in prostate cancer remain unclear.  Methods: 120 cases of prostatic carcinoma and 60 cases of benign prostate hyperplasia were analyzed for SATB1 expression by immunohistochem.  LNCaP, DU-145, and PC3 prostate cancer cells were examd. for SATB1 expression by Western blot anal.  Cell proliferation and invasion was evaluated by CCK8 and transwell invasion assay, resp.  Results: SATB1 staining was stronger in prostatic carcinomas with metastasis than in those without metastasis, but was absent in benign prostate hyperplasia.  Furthermore, SATB1 expression was pos. correlated with bone metastasis and the Gleason score.  SATB1 overexpression promoted the proliferation and invasion of LNCaP cells while SATB1 knockdown inhibited the proliferation and invasion of DU-145 cells.  Conclusions: These findings provide novel insight into oncogenic role of SATB1 in prostate cancer, suggesting that SATB1 is a promising biomarker and therapeutic target for prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCHs8rj-fUDLVg90H21EOLACvtfcHk0lh-HhiRrzbw4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVSgsrc%253D&md5=8ff9872b9daf50d9b27684e030583762</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1186%2F1479-5876-11-111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1479-5876-11-111%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DWen%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DJ.%26atitle%3DSATB1%2520Is%2520Overexpressed%2520in%2520Metastatic%2520Prostate%2520Cancer%2520and%2520Promotes%2520Prostate%2520Cancer%2520Cell%2520Growth%2520and%2520Invasion%26jtitle%3DJ.%2520Transl.%2520Med.%26date%3D2013%26volume%3D11%26spage%3D111%26doi%3D10.1186%2F1479-5876-11-111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hejchman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taciak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowalski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maciejewska, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czajkowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borowska, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Śladowski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Młynarczuk-Biały, I.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Anticancer Activity of 7-Hydroxycoumarinyl Gallates</span>. <i>Pharmacol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">236</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1016/j.pharep.2014.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.pharep.2014.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=25712645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmt1SgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=236-244&author=E.+Hejchmanauthor=P.+Taciakauthor=S.+Kowalskiauthor=D.+Maciejewskaauthor=A.+Czajkowskaauthor=J.+Borowskaauthor=D.+%C5%9Aladowskiauthor=I.+M%C5%82ynarczuk-Bia%C5%82y&title=Synthesis+and+Anticancer+Activity+of+7-Hydroxycoumarinyl+Gallates&doi=10.1016%2Fj.pharep.2014.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and anticancer activity of 7-hydroxycoumarinyl gallates</span></div><div class="casAuthors">Hejchman, Elzbieta; Taciak, Przemyslaw; Kowalski, Sebastian; Maciejewska, Dorota; Czajkowska, Agnieszka; Borowska, Julia; Sladowski, Dariusz; Mlynarczuk-Bialy, Izabela</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">236-244</span>CODEN:
                <span class="NLM_cas:coden">PRHEDU</span>;
        ISSN:<span class="NLM_cas:issn">2299-5684</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The search for anti-cancer agents includes naturally occurring substances and theirs modifications.  Therefore we invented and designed compds. that represent fused derivs. of gallic acid with coumarins.  As a result, a series of 8 novel esters of gallic acid and 7-hydroxycoumarins were synthesized and evaluated for anticancer activity.  The structures of the compds. were established by IR, 1H, 13C NMR and HR MS spectra.  The esters were assayed for antiproliferative activity against human leukemia HL-60 and prostate cancer DU145 cell lines.  The activity of novel esters was evaluated by cell viability assays as well as by anal. of cell cycle and cell death mechanism.  The esters were found to be of similar or higher activity than gallic acid.  No pronounced harmful effect was obsd. in non-cancer cells.  The novel compds. represent an excellent starting point for the further optimization and the design of therapeutically effective anti-cancerous drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzVribZvviu7Vg90H21EOLACvtfcHk0lhqzjZpZAaY-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmt1SgsL0%253D&md5=2fcb78094a3979764719ff1f869a855c</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.pharep.2014.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharep.2014.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DHejchman%26aufirst%3DE.%26aulast%3DTaciak%26aufirst%3DP.%26aulast%3DKowalski%26aufirst%3DS.%26aulast%3DMaciejewska%26aufirst%3DD.%26aulast%3DCzajkowska%26aufirst%3DA.%26aulast%3DBorowska%26aufirst%3DJ.%26aulast%3D%25C5%259Aladowski%26aufirst%3DD.%26aulast%3DM%25C5%2582ynarczuk-Bia%25C5%2582y%26aufirst%3DI.%26atitle%3DSynthesis%2520and%2520Anticancer%2520Activity%2520of%25207-Hydroxycoumarinyl%2520Gallates%26jtitle%3DPharmacol.%2520Rep.%26date%3D2015%26volume%3D67%26spage%3D236%26epage%3D244%26doi%3D10.1016%2Fj.pharep.2014.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Härmä, V.</span>; <span class="NLM_string-name">Haavikko, R.</span>; <span class="NLM_string-name">Virtanen, J.</span>; <span class="NLM_string-name">Ahonen, I.</span>; <span class="NLM_string-name">Schukov, H.-P.</span>; <span class="NLM_string-name">Alakurtti, S.</span>; <span class="NLM_string-name">Purev, E.</span>; <span class="NLM_string-name">Rischer, H.</span>; <span class="NLM_string-name">Yli-Kauhaluoma, J.</span>; <span class="NLM_string-name">Moreira, V. M.</span>; <span class="NLM_string-name">Nees, M.</span>; <span class="NLM_string-name">Oksman-Caldentey, K.-M.</span></span> <span> </span><span class="NLM_article-title">Optimization of Invasion-Specific Effects of Betulin Derivatives on Prostate Cancer Cells through Lead Development</span>.  <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume">10</span> (). <span class="refDoi"> DOI: 10.1371/journal.pone.0126111</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1371%2Fjournal.pone.0126111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=25965345" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&author=V.+H%C3%A4rm%C3%A4&author=R.+Haavikko&author=J.+Virtanen&author=I.+Ahonen&author=H.-P.+Schukov&author=S.+Alakurtti&author=E.+Purev&author=H.+Rischer&author=J.+Yli-Kauhaluoma&author=V.+M.+Moreira&author=M.+Nees&author=K.-M.+Oksman-Caldentey&title=Optimization+of+Invasion-Specific+Effects+of+Betulin+Derivatives+on+Prostate+Cancer+Cells+through+Lead+Development&doi=10.1371%2Fjournal.pone.0126111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0126111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0126111%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25A4rm%25C3%25A4%26aufirst%3DV.%26atitle%3DOptimization%2520of%2520Invasion-Specific%2520Effects%2520of%2520Betulin%2520Derivatives%2520on%2520Prostate%2520Cancer%2520Cells%2520through%2520Lead%2520Development%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26doi%3D10.1371%2Fjournal.pone.0126111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrera-Abreu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohn, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Racine, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tajadura, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suryavanshi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bechtel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiemann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baum, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridley, A. J.</span></span> <span> </span><span class="NLM_article-title">Identification and Characterization of a Set of Conserved and New Regulators of Cytoskeletal Organization, Cell Morphology and Migration</span>. <i>BMC Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">54</span>, <span class="refDoi"> DOI: 10.1186/1741-7007-9-54</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1186%2F1741-7007-9-54" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=21834987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2gu7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=54&author=S.+Baiauthor=M.+Herrera-Abreuauthor=J.+L.+Rohnauthor=V.+Racineauthor=V.+Tajaduraauthor=N.+Suryavanshiauthor=S.+Bechtelauthor=S.+Wiemannauthor=B.+Baumauthor=A.+J.+Ridley&title=Identification+and+Characterization+of+a+Set+of+Conserved+and+New+Regulators+of+Cytoskeletal+Organization%2C+Cell+Morphology+and+Migration&doi=10.1186%2F1741-7007-9-54"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of a set of conserved and new regulators of cytoskeletal organisation, cell morphology and migration</span></div><div class="casAuthors">Bai, Siau Wei; Herrera-Abreu, Maria Teresa; Rohn, Jennifer L.; Racine, Victor; Tajadura, Virginia; Suryavanshi, Narendra; Bechtel, Stephanie; Wiemann, Stefan; Baum, Buzz; Ridley, Anne J.</div><div class="citationInfo"><span class="NLM_cas:title">BMC Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">54</span>CODEN:
                <span class="NLM_cas:coden">BBMIF7</span>;
        ISSN:<span class="NLM_cas:issn">1741-7007</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Cell migration is essential during development and in human disease progression including cancer.  Most cell migration studies conc. on known or predicted components of migration pathways.  Results: Here we use data from a genome-wide RNAi morphol. screen in Drosophila melanogaster cells together with bioinformatics to identify 26 new regulators of morphol. and cytoskeletal organization in human cells.  These include genes previously implicated in a wide range of functions, from mental retardation, Down syndrome and Huntington's disease to RNA and DNA-binding genes.  We classify these genes into 7 groups according to phenotype and identify those that affect cell migration.  We further characterize a subset of 7 genes, FAM40A, FAM40B, ARC, FMNL3, FNBP3/FBP11, LIMD1 and ZRANB1, each of which has a different effect on cell shape, actin filament distribution and cell migration.  Interestingly, in several instances closely related isoforms with a single Drosophila homolog have distinct phenotypes.  For example, FAM40B depletion induces cell elongation and tail retraction defects, whereas FAM40A depletion reduces cell spreading.  Conclusions: Our results identify multiple regulators of cell migration and cytoskeletal signaling that are highly conserved between Drosophila and humans, and show that closely related paralogs can have very different functions in these processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEUQp3NQF_0LVg90H21EOLACvtfcHk0lhqzjZpZAaY-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2gu7nF&md5=5a8e955c18176b5b1c0c9abf5c211672</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1186%2F1741-7007-9-54&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1741-7007-9-54%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DS.%26aulast%3DHerrera-Abreu%26aufirst%3DM.%26aulast%3DRohn%26aufirst%3DJ.%2BL.%26aulast%3DRacine%26aufirst%3DV.%26aulast%3DTajadura%26aufirst%3DV.%26aulast%3DSuryavanshi%26aufirst%3DN.%26aulast%3DBechtel%26aufirst%3DS.%26aulast%3DWiemann%26aufirst%3DS.%26aulast%3DBaum%26aufirst%3DB.%26aulast%3DRidley%26aufirst%3DA.%2BJ.%26atitle%3DIdentification%2520and%2520Characterization%2520of%2520a%2520Set%2520of%2520Conserved%2520and%2520New%2520Regulators%2520of%2520Cytoskeletal%2520Organization%252C%2520Cell%2520Morphology%2520and%2520Migration%26jtitle%3DBMC%2520Biol.%26date%3D2011%26volume%3D9%26spage%3D54%26doi%3D10.1186%2F1741-7007-9-54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, S. J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singletary, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venema, R. C.</span></span> <span> </span><span class="NLM_article-title">Sulforaphane Suppresses Angiogenesis and Disrupts Endothelial Mitotic Progression and Microtubule Polymerization</span>. <i>Vasc. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1016/j.vph.2006.06.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fj.vph.2006.06.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=16938492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFCitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=77-84&author=S.+J.+T.+Jacksonauthor=K.+W.+Singletaryauthor=R.+C.+Venema&title=Sulforaphane+Suppresses+Angiogenesis+and+Disrupts+Endothelial+Mitotic+Progression+and+Microtubule+Polymerization&doi=10.1016%2Fj.vph.2006.06.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Sulforaphane suppresses angiogenesis and disrupts endothelial mitotic progression and microtubule polymerization</span></div><div class="casAuthors">Jackson, Steven J. T.; Singletary, Keith W.; Venema, Richard C.</div><div class="citationInfo"><span class="NLM_cas:title">Vascular Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">77-84</span>CODEN:
                <span class="NLM_cas:coden">VPAHAJ</span>;
        ISSN:<span class="NLM_cas:issn">1537-1891</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sulforaphane (SUL), an isothiocyanate derived from broccoli and other cruciferous vegetables, is known to induce phase II detoxification enzymes, disrupt cancer cell microtubule polymn., and trigger cell cycle arrest in breast and colon cancer cells.  Here, we provide the first evidence that SUL also acts to inhibit angiogenesis via suppression of endothelial cell proliferation.  Bovine aortic endothelial (BAE) cells were exposed to concns. of up to 15 μM SUL prior to cell cycle anal. and mitotic index quantification.  Within 24 h, 15 μM SUL clearly induced G2/M accumulation and pre-metaphase arrest in BAE cells.  Moreover, immunofluorescence tubulin staining indicated that this same SUL concn. was efficacious in not only disrupting mitotic progression, but also in perturbing normal polymn. of mitotic (and cytoplasmic) microtubules.  Furthermore, daily administration of SUL (100 nmol/day, i.v. for 7 days) to female Balb/c mice bearing VEGF-impregnated Matrigel plugs strongly and significantly (P < 0.05) suppressed angiogenesis progression as measured by Hb concn.  Taken together, these findings suggest that the endothelial cell population is a novel target of SUL action both in vitro and in vivo.  This mechanism of SUL-induced endothelial microtubule disruption and early mitotic arrest may further discern a potential role of SUL as a chemopreventive agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeJtZdwJBhK7Vg90H21EOLACvtfcHk0lhqzjZpZAaY-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFCitw%253D%253D&md5=c8471b4b89ddb6698449854f4c1bb489</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.vph.2006.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vph.2006.06.015%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DS.%2BJ.%2BT.%26aulast%3DSingletary%26aufirst%3DK.%2BW.%26aulast%3DVenema%26aufirst%3DR.%2BC.%26atitle%3DSulforaphane%2520Suppresses%2520Angiogenesis%2520and%2520Disrupts%2520Endothelial%2520Mitotic%2520Progression%2520and%2520Microtubule%2520Polymerization%26jtitle%3DVasc.%2520Pharmacol.%26date%3D2007%26volume%3D46%26spage%3D77%26epage%3D84%26doi%3D10.1016%2Fj.vph.2006.06.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span> <i>Schrödinger</i>; <span class="NLM_publisher-name">Schrödinger
LLC</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schr%C3%B6dinger%3B+Schr%C3%B6dinger%0ALLC%3A+New+York%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchr%25C3%25B6dinger%26pub%3DSchr%25C3%25B6dinger%250ALLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piñeiro, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez-De-Terán, H.</span></span> <span> </span><span class="NLM_article-title">Molecular Dynamics Simulations Reveal Insights into Key Structural Elements of Adenosine Receptors</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">4194</span>– <span class="NLM_lpage">4208</span>, <span class="refDoi"> DOI: 10.1021/bi200100t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi200100t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVCksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=4194-4208&author=D.+Rodr%C3%ADguezauthor=%C3%81.+Pi%C3%B1eiroauthor=H.+Guti%C3%A9rrez-De-Ter%C3%A1n&title=Molecular+Dynamics+Simulations+Reveal+Insights+into+Key+Structural+Elements+of+Adenosine+Receptors&doi=10.1021%2Fbi200100t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Dynamics Simulations Reveal Insights into Key Structural Elements of Adenosine Receptors</span></div><div class="casAuthors">Rodriguez, David; Pineiro, Angel; Gutierrez-de-Teran, Hugo</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4194-4208</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The crystal structure of the human A2A adenosine receptor, a member of the G protein-coupled receptor (GPCR) family, is used as a starting point for the structural characterization of the conformational equil. around the inactive conformation of the human A2 (A2A and A2B) adenosine receptors (ARs).  A homol. model of the closely related A2BAR is reported, and the two receptors were simulated in their apo form through all-atom mol. dynamics (MD) simulations.  Different conditions were addnl. explored in the A2AAR, including the protonation state of crucial histidines or the presence of the cocrystd. ligand.  Our simulations reveal the role of several conserved residues in the ARs in the conformational equil. of the receptors.  The "ionic lock" absent in the crystal structure of the inactive A2AAR is rapidly formed in the two simulated receptors, and a complex network of interacting residues is presented that further stabilizes this structural element.  Notably, the obsd. rotameric transition of Trp6.48 ("toggle switch"), which is thought to initiate the activation process in GPCRs, is accompanied by a concerted rotation of the conserved residue of the A2ARs, His6.52.  This new conformation is further stabilized in the two receptors under study by a novel interaction network involving residues in transmembrane (TM) helixes TM5 (Asn5.42) and TM3 (Gln3.37), which resemble the conformational changes recently obsd. in the agonist-bound structure of β-adrenoreceptors.  Finally, the interaction between Glu1.39 and His7.43, a pair of conserved residues in the family of ARs, is found to be weaker than previously thought, and the role of this interaction in the structure and dynamics of the receptor is thoroughly examd.  All these findings suggest that, despite the commonalities with other GPCRs, the conformational equil. of ARs is also modulated by specific residues of the family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh0ijAwR8whbVg90H21EOLACvtfcHk0li3t8lrKd2L2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVCksrk%253D&md5=c095b25f0e1a5b190620e77a78364b26</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fbi200100t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi200100t%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DD.%26aulast%3DPi%25C3%25B1eiro%26aufirst%3D%25C3%2581.%26aulast%3DGuti%25C3%25A9rrez-De-Ter%25C3%25A1n%26aufirst%3DH.%26atitle%3DMolecular%2520Dynamics%2520Simulations%2520Reveal%2520Insights%2520into%2520Key%2520Structural%2520Elements%2520of%2520Adenosine%2520Receptors%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D4194%26epage%3D4208%26doi%3D10.1021%2Fbi200100t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Šali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, T. L.</span></span> <span> </span><span class="NLM_article-title">Comparative Protein Modelling by Satisfaction of Spatial Restraints</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>234</i></span>,  <span class="NLM_fpage">779</span>– <span class="NLM_lpage">815</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1993.1626</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1006%2Fjmbi.1993.1626" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=8254673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADyaK2cXnt1ylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=234&publication_year=1993&pages=779-815&author=A.+%C5%A0aliauthor=T.+L.+Blundell&title=Comparative+Protein+Modelling+by+Satisfaction+of+Spatial+Restraints&doi=10.1006%2Fjmbi.1993.1626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative protein modeling by satisfaction of spatial restraints</span></div><div class="casAuthors">Sali, Andrej; Blundell, Tom L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">234</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">779-815</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    </div><div class="casAbstract">The authors describe a comparative protein modeling method designed to find the most probable structure for a sequence given its alignment with related structures.  The three-dimensional (3D) model is obtained by optimally satisfying spatial restraints derived from the alignment and expressed as probability d. functions (pdfs) for the features restrained.  For example, the probabilities for main-chain conformations of a modelled residue may be restrained by its residue type, main-chain conformation of an equiv. residue in a related protein, and the local similarity between the two sequences.  Several such pdfs are obtained from the correlations between structural features in 17 families of homologous proteins which have been aligned on the basis of their 3D structures.  The pdfs restrain Cα-Cα distances, main-chain N-O distances, main-chain and side-chain dihedral angles.  A smoothing procedure is used in the derivation of these relationships to minimize the problem of a sparse database.  The 3D model of a protein is obtained by optimization of the mol. pdf such that the model violates the input restraints as little as possible.  The mol. pdf is derived as a combination of pdfs restraining individual spatial features of the whole mol.  The optimization procedure is a variable target function method that applies the conjugate gradients algorithm to positions of all non-hydrogen atoms.  The method is automated and is illustrated by the modeling of trypsin from two other serine proteinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC4wGhwZvib7Vg90H21EOLACvtfcHk0li3t8lrKd2L2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXnt1ylug%253D%253D&md5=d4a3c39b2205e36221dc187a3d1a478b</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1993.1626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1993.1626%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25A0ali%26aufirst%3DA.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26atitle%3DComparative%2520Protein%2520Modelling%2520by%2520Satisfaction%2520of%2520Spatial%2520Restraints%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1993%26volume%3D234%26spage%3D779%26epage%3D815%26doi%3D10.1006%2Fjmbi.1993.1626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez-de-Terán, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bello, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez, D.</span></span> <span> </span><span class="NLM_article-title">Characterization of the Dynamic Events of GPCRs by Automated Computational Simulations</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1042/BST20120287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1042%2FBST20120287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=23356284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1eitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=205-212&author=H.+Guti%C3%A9rrez-de-Ter%C3%A1nauthor=X.+Belloauthor=D.+Rodr%C3%ADguez&title=Characterization+of+the+Dynamic+Events+of+GPCRs+by+Automated+Computational+Simulations&doi=10.1042%2FBST20120287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the dynamic events of GPCRs by automated computational simulations</span></div><div class="casAuthors">Gutierrez-de-Teran, Hugo; Bello, Xabier; Rodriguez, David</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">205-212</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The recent advances in membrane protein crystallog. have provided extremely valuable structural information of the superfamily of GPCRs (G-protein-coupled receptors).  This has been particularly true for a few receptors whose structure was solved several times under different biochem. conditions.  It follows that the mechanisms of receptor conformational equil. and related dynamic events can be explored by computational simulations.  In the present article, we summarize our recent understanding of several dynamic features of GPCRs, accomplished through the use of MD (mol. dynamics) simulations.  Our pipeline for the MD simulations of GPCRs, implemented in the web service http://gpcr.usc.es, is updated in the present paper and illustrated by recent applications.  Special emphasis is put on the A2A adenosine receptor, one of the selected cases where crystal structures in several conformations and conditions exist, and on the dimerization process of the CXCR4 (CXC chemokine receptor 4).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSBHtH7UcGbLVg90H21EOLACvtfcHk0li3t8lrKd2L2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1eitbc%253D&md5=f3f75b95ae7cd34c91b9d39a72a567f7</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1042%2FBST20120287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20120287%26sid%3Dliteratum%253Aachs%26aulast%3DGuti%25C3%25A9rrez-de-Ter%25C3%25A1n%26aufirst%3DH.%26aulast%3DBello%26aufirst%3DX.%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520the%2520Dynamic%2520Events%2520of%2520GPCRs%2520by%2520Automated%2520Computational%2520Simulations%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2013%26volume%3D41%26spage%3D205%26epage%3D212%26doi%3D10.1042%2FBST20120287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hess, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutzner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Der
Spoel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindahl, E.</span></span> <span> </span><span class="NLM_article-title">GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">435</span>– <span class="NLM_lpage">447</span>, <span class="refDoi"> DOI: 10.1021/ct700301q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct700301q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVSqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=435-447&author=B.+Hessauthor=C.+Kutznerauthor=D.+Van+Der%0ASpoelauthor=E.+Lindahl&title=GROMACS+4%3A+Algorithms+for+Highly+Efficient%2C+Load-Balanced%2C+and+Scalable+Molecular+Simulation&doi=10.1021%2Fct700301q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation</span></div><div class="casAuthors">Hess, Berk; Kutzner, Carsten; van der Spoel, David; Lindahl, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">435-447</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. simulation is an extremely useful, but computationally very expensive tool for studies of chem. and biomol. systems.  Here, we present a new implementation of our mol. simulation toolkit GROMACS which now both achieves extremely high performance on single processors from algorithmic optimizations and hand-coded routines and simultaneously scales very well on parallel machines.  The code encompasses a minimal-communication domain decompn. algorithm, full dynamic load balancing, a state-of-the-art parallel constraint solver, and efficient virtual site algorithms that allow removal of hydrogen atom degrees of freedom to enable integration time steps up to 5 fs for atomistic simulations also in parallel.  To improve the scaling properties of the common particle mesh Ewald electrostatics algorithms, we have in addn. used a Multiple-Program, Multiple-Data approach, with sep. node domains responsible for direct and reciprocal space interactions.  Not only does this combination of algorithms enable extremely long simulations of large systems but also it provides that simulation performance on quite modest nos. of std. cluster nodes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrajjWdk6mUFrVg90H21EOLACvtfcHk0lhhn03vhdpIFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVSqurc%253D&md5=d53c94901386260221792ea30f151c5f</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fct700301q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct700301q%26sid%3Dliteratum%253Aachs%26aulast%3DHess%26aufirst%3DB.%26aulast%3DKutzner%26aufirst%3DC.%26aulast%3DVan%2BDer%2BSpoel%26aufirst%3DD.%26aulast%3DLindahl%26aufirst%3DE.%26atitle%3DGROMACS%25204%253A%2520Algorithms%2520for%2520Highly%2520Efficient%252C%2520Load-Balanced%252C%2520and%2520Scalable%2520Molecular%2520Simulation%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2008%26volume%3D4%26spage%3D435%26epage%3D447%26doi%3D10.1021%2Fct700301q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaminski, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirado-Rives, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span> <span> </span><span class="NLM_article-title">Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides</span>. <i>J. Phys. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">6474</span>– <span class="NLM_lpage">6487</span>, <span class="refDoi"> DOI: 10.1021/jp003919d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp003919d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BD3MXislKhsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2001&pages=6474-6487&author=G.+A.+Kaminskiauthor=R.+A.+Friesnerauthor=J.+Tirado-Rivesauthor=W.+L.+Jorgensen&title=Evaluation+and+Reparametrization+of+the+OPLS-AA+Force+Field+for+Proteins+via+Comparison+with+Accurate+Quantum+Chemical+Calculations+on+Peptides&doi=10.1021%2Fjp003919d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides</span></div><div class="casAuthors">Kaminski, George A.; Friesner, Richard A.; Tirado-Rives, Julian; Jorgensen, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">6474-6487</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1089-5647</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present results of improving the OPLS-AA force field for peptides by means of refitting the key Fourier torsional coeffs.  The fitting technique combines using accurate ab initio data as the target, choosing an efficient fitting subspace of the whole potential-energy surface, and detg. wts. for each of the fitting points based on magnitudes of the potential-energy gradient.  The av. energy RMS deviation from the LMP2/cc-pVTZ(-f)//HF/6-31G** data is reduced by ∼40% from 0.81 to 0.47 kcal/mol as a result of the fitting for the electrostatically uncharged dipeptides.  Transferability of the parameters is demonstrated by using the same alanine dipeptide-fitted backbone torsional parameters for all of the other dipeptides (with the appropriate side-chain refitting) and the alanine tetrapeptide.  Parameters of nonbonded interactions have also been refitted for the sulfur-contg. dipeptides (cysteine and methionine), and the validity of the new Coulombic charges and the van der Waals σ's and ε's is proved through reproducing gas-phase energies of complex formation heats of vaporization and densities of pure model liqs.  Moreover, a novel approach to fitting torsional parameters for electrostatically charged mol. systems has been presented and successfully tested on five dipeptides with charged side chains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSHwmffIQePbVg90H21EOLACvtfcHk0lhhn03vhdpIFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXislKhsLk%253D&md5=3ff059626977ee7f6342466f5820f5b7</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Fjp003919d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp003919d%26sid%3Dliteratum%253Aachs%26aulast%3DKaminski%26aufirst%3DG.%2BA.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26atitle%3DEvaluation%2520and%2520Reparametrization%2520of%2520the%2520OPLS-AA%2520Force%2520Field%2520for%2520Proteins%2520via%2520Comparison%2520with%2520Accurate%2520Quantum%2520Chemical%2520Calculations%2520on%2520Peptides%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2001%26volume%3D105%26spage%3D6474%26epage%3D6487%26doi%3D10.1021%2Fjp003919d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berger, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edholm, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jähnig, F.</span></span> <span> </span><span class="NLM_article-title">Molecular Dynamics Simulations of a Fluid Bilayer of Dipalmitoylphosphatidylcholine at Full Hydration, Constant Pressure, and Constant Temperature</span>. <i>Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">2002</span>– <span class="NLM_lpage">2013</span>, <span class="refDoi"> DOI: 10.1016/S0006-3495(97)78845-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2FS0006-3495%2897%2978845-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=9129804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADyaK2sXivVOjsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1997&pages=2002-2013&author=O.+Bergerauthor=O.+Edholmauthor=F.+J%C3%A4hnig&title=Molecular+Dynamics+Simulations+of+a+Fluid+Bilayer+of+Dipalmitoylphosphatidylcholine+at+Full+Hydration%2C+Constant+Pressure%2C+and+Constant+Temperature&doi=10.1016%2FS0006-3495%2897%2978845-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular dynamics simulations of a fluid bilayer of dipalmitoylphosphatidylcholine at full hydration, constant pressure, and constant temperature</span></div><div class="casAuthors">Berger, Oliver; Edholm, Olle; Jahnig, Fritz</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Journal</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2002-2013</span>CODEN:
                <span class="NLM_cas:coden">BIOJAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3495</span>.
    
            (<span class="NLM_cas:orgname">Biophysical Society</span>)
        </div><div class="casAbstract">Mol. dynamics simulations of 500 ps were performed on a system consisting of a bilayer of 64 mols. of the lipid dipalmitoylphosphatidylcholine and 23 water mols. per lipid at an isotropic pressure of 1 atm and 50°.  Special attention was devoted to reproduce the correct d. of the lipid, because this quantity is known exptl. with a precision better than 1%.  For this purpose, the Lennard-Jones parameters of the hydrocarbon chains were adjusted by simulating a system consisting of 128 pentadecane mols. and varying the Lennard-Jones parameters until the exptl. d. and heat of vaporization were obtained.  With these parameters the lipid d. resulted in perfect agreement with the exptl. d.  The orientational order parameter of the hydrocarbon chains agreed perfectly well with the exptl. values, which, because of its correlation with the area per lipid, makes it possible to give a proper est. of the area per lipid of 0.61±0.1 nm2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYuDXgD7e9r7Vg90H21EOLACvtfcHk0lhhn03vhdpIFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivVOjsL4%253D&md5=984ea49ced9d0e2ce912bf99220fd228</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2FS0006-3495%2897%2978845-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3495%252897%252978845-3%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DO.%26aulast%3DEdholm%26aufirst%3DO.%26aulast%3DJ%25C3%25A4hnig%26aufirst%3DF.%26atitle%3DMolecular%2520Dynamics%2520Simulations%2520of%2520a%2520Fluid%2520Bilayer%2520of%2520Dipalmitoylphosphatidylcholine%2520at%2520Full%2520Hydration%252C%2520Constant%2520Pressure%252C%2520and%2520Constant%2520Temperature%26jtitle%3DBiophys.%2520J.%26date%3D1997%26volume%3D72%26spage%3D2002%26epage%3D2013%26doi%3D10.1016%2FS0006-3495%2897%2978845-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marelius, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolmodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feierberg, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Åqvist, J.</span></span> <span> </span><span class="NLM_article-title">Q: A Molecular Dynamics Program for Free Energy Calculations and Empirical Valence Bond Simulations in Biomolecular Systems</span>. <i>J. Mol. Graphics Modell.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">225</span>, <span class="refDoi"> DOI: 10.1016/s1093-3263(98)80006-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2Fs1093-3263%2898%2980006-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10522241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADyaK1MXmsVWmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1998&pages=213-225&author=J.+Mareliusauthor=K.+Kolmodinauthor=I.+Feierbergauthor=J.+%C3%85qvist&title=Q%3A+A+Molecular+Dynamics+Program+for+Free+Energy+Calculations+and+Empirical+Valence+Bond+Simulations+in+Biomolecular+Systems&doi=10.1016%2Fs1093-3263%2898%2980006-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Q: a molecular dynamics program for free energy calculations and empirical valence bond simulations in biomolecular systems</span></div><div class="casAuthors">Marelius, J.; Kolmodin, K.; Feierberg, I.; Aqvist, J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4/5/6</span>),
    <span class="NLM_cas:pages">213-225</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A new mol. dynamics program for free energy calcns. in biomol. systems is presented.  It is principally designed for free energy perturbation simulations, empirical valence bond calcns., and binding affinity estn. by linear interaction energy methods.  Evaluation of ligand-binding selectivity and free energy profiles for nucleophile activation in two protein tyrosine phosphatases as well as abs. binding affinity estn. for a lysine-binding protein are given as examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK9PQiYqiBIrVg90H21EOLACvtfcHk0ljL41znw_yEkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsVWmtL0%253D&md5=e89a1cff3b31988baec5cd9759326b72</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fs1093-3263%2898%2980006-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs1093-3263%252898%252980006-5%26sid%3Dliteratum%253Aachs%26aulast%3DMarelius%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DFeierberg%26aufirst%3DI.%26aulast%3D%25C3%2585qvist%26aufirst%3DJ.%26atitle%3DQ%253A%2520A%2520Molecular%2520Dynamics%2520Program%2520for%2520Free%2520Energy%2520Calculations%2520and%2520Empirical%2520Valence%2520Bond%2520Simulations%2520in%2520Biomolecular%2520Systems%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D1998%26volume%3D16%26spage%3D213%26epage%3D225%26doi%3D10.1016%2Fs1093-3263%2898%2980006-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jespers, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esguerra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Åqvist, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez-de-Terán, H.</span></span> <span> </span><span class="NLM_article-title">Qligfep: An Automated Workflow for Small Molecule Free Energy Calculations in Q</span>. <i>J. Cheminf.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1186/s13321-019-0348-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1186%2Fs13321-019-0348-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpslagsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=1-16&author=W.+Jespersauthor=M.+Esguerraauthor=J.+%C3%85qvistauthor=H.+Guti%C3%A9rrez-de-Ter%C3%A1n&title=Qligfep%3A+An+Automated+Workflow+for+Small+Molecule+Free+Energy+Calculations+in+Q&doi=10.1186%2Fs13321-019-0348-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">QligFEP: an automated workflow for small molecule free energy calculations in Q</span></div><div class="casAuthors">Jespers, Willem; Esguerra, Mauricio; Aaqvist, Johan; Gutierrez-de-Teran, Hugo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cheminformatics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>CODEN:
                <span class="NLM_cas:coden">JCOHB3</span>;
        ISSN:<span class="NLM_cas:issn">1758-2946</span>.
    
            (<span class="NLM_cas:orgname">SpringerOpen</span>)
        </div><div class="casAbstract">The process of ligand binding to a biol. target can be represented as the equil. between the relevant solvated and bound states of the ligand.  This which is the basis of structure-based, rigorous methods such as the estn. of relative binding affinities by free energy perturbation (FEP).  Despite the growing capacity of computing power and the development of more accurate force fields, a high throughput application of FEP is currently hampered due to the need, in the current schemes, of an expert user definition of the "alchem." transformations between mols. in the series explored.  Here, we present QligFEP, a soln. to this problem using an automated workflow for FEP calcns. based on a dual topol. approach.  In this scheme, the starting poses of each of the two ligands, for which the relative affinity is to be calcd., are explicitly present in the MD simulations assocd. with the (dual topol.) FEP transformation, making the perturbation pathway between the two ligands univocal.  We show that this generalized method can be applied to accurately est. solvation free energies for amino acid sidechain mimics, as well as the binding affinity shifts due to the chem. changes typical of lead optimization processes.  This is illustrated in a no. of protein systems extd. from other FEP studies in the literature: inhibitors of CDK2 kinase and a series of A2A adenosine G protein-coupled receptor antagonists, where the results obtained with QligFEP are in excellent agreement with exptl. data.  In addn., our protocol allows for scaffold hopping perturbations to identify the binding affinities between different core scaffolds, which we illustrate with a series of Chk1 kinase inhibitors.  QligFEP is implemented in the open-source MD package Q, and works with the most common family of force fields: OPLS, CHARMM and AMBER.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkmg7__Ub7KbVg90H21EOLACvtfcHk0ljL41znw_yEkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpslagsrw%253D&md5=a476389264078fd32cd0d040596e165c</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1186%2Fs13321-019-0348-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13321-019-0348-5%26sid%3Dliteratum%253Aachs%26aulast%3DJespers%26aufirst%3DW.%26aulast%3DEsguerra%26aufirst%3DM.%26aulast%3D%25C3%2585qvist%26aufirst%3DJ.%26aulast%3DGuti%25C3%25A9rrez-de-Ter%25C3%25A1n%26aufirst%3DH.%26atitle%3DQligfep%253A%2520An%2520Automated%2520Workflow%2520for%2520Small%2520Molecule%2520Free%2520Energy%2520Calculations%2520in%2520Q%26jtitle%3DJ.%2520Cheminf.%26date%3D2019%26volume%3D11%26spage%3D1%26epage%3D16%26doi%3D10.1186%2Fs13321-019-0348-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">King, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warshel, A.</span></span> <span> </span><span class="NLM_article-title">A Surface Constrained All-Atom Solvent Model for Effective Simulations of Polar Solutions</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">3647</span>– <span class="NLM_lpage">3661</span>, <span class="refDoi"> DOI: 10.1063/1.456845</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1063%2F1.456845" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADyaL1MXmsVWntrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1989&pages=3647-3661&author=G.+Kingauthor=A.+Warshel&title=A+Surface+Constrained+All-Atom+Solvent+Model+for+Effective+Simulations+of+Polar+Solutions&doi=10.1063%2F1.456845"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">A surface constrained all-atom solvent model for effective simulations of polar solutions</span></div><div class="casAuthors">King, Gregory; Warshel, Arieh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3647-61</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">A surface constrained all-atom solvent (SCAAS) model was developed in order to consistently treat the surface polarization effects in all-atom mol. dynamics simulations.  The SCAAS model introduces surface constraints as boundary conditions in order to make the necessarily finite system behave as if it was part of an infinite system.  The performance of the model with regard to various properties of bulk water is examd. by comparing its results to those obtained by PBC simulations.  The results obtained from SCAAS models of different sizes are found to be similar to each other and to the corresponding PBC results.  The performance of the model in simulations of solvated ions is emphasized and a comparison of the results obtained with spheres of different sizes demonstrates that the model does not possess significant size dependence.  This indicates that the model can be used with a relatively small no. of solvent mols. for convergent simulation of structure, energetics, and dynamics of polar solns.  The much simpler fixed center Langevin dipoles model was also examd. and found to provide a powerful tool for estg. solvation free energies.  Finally, a preliminary study of the dielec. properties of the SCAAS model is reported and the potential of this model for exploring the correct implementation of the solvent reaction field is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa1aigs5xWZrVg90H21EOLACvtfcHk0ljL41znw_yEkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXmsVWntrw%253D&md5=ae548b312d7b9b3c57a1b0fba27ec702</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1063%2F1.456845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.456845%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DG.%26aulast%3DWarshel%26aufirst%3DA.%26atitle%3DA%2520Surface%2520Constrained%2520All-Atom%2520Solvent%2520Model%2520for%2520Effective%2520Simulations%2520of%2520Polar%2520Solutions%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1989%26volume%3D91%26spage%3D3647%26epage%3D3661%26doi%3D10.1063%2F1.456845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warshel, A.</span></span> <span> </span><span class="NLM_article-title">A Local Reaction Field Method for Fast Evaluation of Long-Range Electrostatic Interactions in Molecular Simulations</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">3100</span>– <span class="NLM_lpage">3107</span>, <span class="refDoi"> DOI: 10.1063/1.462997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1063%2F1.462997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADyaK38Xlslykt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1992&pages=3100-3107&author=F.+S.+Leeauthor=A.+Warshel&title=A+Local+Reaction+Field+Method+for+Fast+Evaluation+of+Long-Range+Electrostatic+Interactions+in+Molecular+Simulations&doi=10.1063%2F1.462997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">A local-reaction-field method for fast evaluation of long-range electrostatic interactions in molecular simulations</span></div><div class="casAuthors">Lee, Frederick S.; Warshel, Arieh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">3100-7</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">This work introduces a simple and very effective approach for treating the long-range electrostatic forces.  The present method, which is referred to as the local reaction field method, follows some of the ideas of the previously developed generalized Ewald method but then develops into a much simpler method.  This is done by dividing the system into M groups of atoms and evaluating sep. the short- and long-range contributions to the potential of each group.  The short-range potential is evaluated explicitly as in any std. truncation method, while the long-range potential is approximated by the first four terms in a multipole expansion.  In addn., the long-range potential is updated only once in every L time steps leading to a method of the order of N × M × q/L + N × P where q is related to the no. of expansion terms and P is the av. no. of atoms inside the cutoff range.  The speed, accuracy, and precision of the present method is assessed by evaluating the self-energy of a sodium ion in water and the self-energies of the acidic residues of bovine pancreatic trypsin inhibitor using an adiabatic charging free-energy perturbation approach.  The present method reproduces accurately the corresponding results obtained without any cutoff but an order of magnitude faster.  Furthermore, at the limit of very large systems, the speed of this method can be 2 orders of magnitude faster than that of the no-cutoff method even when each group contains only a small no. of atoms.  The method gives much better results for electrostatic energies in proteins than those obtained by truncation methods.  The stability and speed of the local reaction field method provides a powerful tool for the microscopic evaluation of electrostatic energies in macromols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouTs-m9qDIu7Vg90H21EOLACvtfcHk0ljL41znw_yEkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xlslykt7c%253D&md5=f5ac55192f5da7dc896470ec208bf79c</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1063%2F1.462997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.462997%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DF.%2BS.%26aulast%3DWarshel%26aufirst%3DA.%26atitle%3DA%2520Local%2520Reaction%2520Field%2520Method%2520for%2520Fast%2520Evaluation%2520of%2520Long-Range%2520Electrostatic%2520Interactions%2520in%2520Molecular%2520Simulations%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1992%26volume%3D97%26spage%3D3100%26epage%3D3107%26doi%3D10.1063%2F1.462997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryckaert, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciccotti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berendsen, H. J. C.</span></span> <span> </span><span class="NLM_article-title">Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes</span>. <i>J. Comput. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1016/0021-9991(77)90098-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2F0021-9991%2877%2990098-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADyaE2sXktVGhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1977&pages=327-341&author=J.-P.+Ryckaertauthor=G.+Ciccottiauthor=H.+J.+C.+Berendsen&title=Numerical+Integration+of+the+Cartesian+Equations+of+Motion+of+a+System+with+Constraints%3A+Molecular+Dynamics+of+n-Alkanes&doi=10.1016%2F0021-9991%2877%2990098-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Numerical integration of the Cartesian equations of motion of a system with constraints:  molecular dynamics of n-alkanes</span></div><div class="casAuthors">Ryckaert, Jean Paul; Ciccotti, Giovanni; Berendsen, Herman J. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Physics</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">327-41</span>CODEN:
                <span class="NLM_cas:coden">JCTPAH</span>;
        ISSN:<span class="NLM_cas:issn">0021-9991</span>.
    </div><div class="casAbstract">A numerical algorithm integrating the 3N Cartesian equation of motion of a system of N points subject to holonomic constraints is applied to mol. dynamics simulation of a liq. of 64 butane mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYPlhG1U3Uw7Vg90H21EOLACvtfcHk0ljksyaL8gFJXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXktVGhsL4%253D&md5=b4aecddfde149117813a5ea4f5353ce2</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2F0021-9991%2877%2990098-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0021-9991%252877%252990098-5%26sid%3Dliteratum%253Aachs%26aulast%3DRyckaert%26aufirst%3DJ.-P.%26aulast%3DCiccotti%26aufirst%3DG.%26aulast%3DBerendsen%26aufirst%3DH.%2BJ.%2BC.%26atitle%3DNumerical%2520Integration%2520of%2520the%2520Cartesian%2520Equations%2520of%2520Motion%2520of%2520a%2520System%2520with%2520Constraints%253A%2520Molecular%2520Dynamics%2520of%2520n-Alkanes%26jtitle%3DJ.%2520Comput.%2520Phys.%26date%3D1977%26volume%3D23%26spage%3D327%26epage%3D341%26doi%3D10.1016%2F0021-9991%2877%2990098-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirado-Rives, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span> <span> </span><span class="NLM_article-title">Improved Peptide and Protein Torsional Energetics with the OPLS-AA Force Field</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3499</span>– <span class="NLM_lpage">3509</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.5b00356</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00356" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsFOlsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=3499-3509&author=M.+J.+Robertsonauthor=J.+Tirado-Rivesauthor=W.+L.+Jorgensen&title=Improved+Peptide+and+Protein+Torsional+Energetics+with+the+OPLS-AA+Force+Field&doi=10.1021%2Facs.jctc.5b00356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Improved Peptide and Protein Torsional Energetics with the OPLS-AA Force Field</span></div><div class="casAuthors">Robertson, Michael J.; Tirado-Rives, Julian; Jorgensen, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3499-3509</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development and validation of new peptide dihedral parameters are reported for the OPLS-AA force field.  High accuracy quantum chem. methods were used to scan φ, ψ, χ1, and χ2 potential energy surfaces for blocked dipeptides.  New Fourier coeffs. for the dihedral angle terms of the OPLS-AA force field were fit to these surfaces, utilizing a Boltzmann-weighted error function and systematically examg. the effects of weighting temp.  To prevent overfitting to the available data, a minimal no. of new residue-specific and peptide-specific torsion terms were developed.  Extensive exptl. soln.-phase and quantum chem. gas-phase benchmarks were used to assess the quality of the new parameters, named OPLS-AA/M, demonstrating significant improvement over previous OPLS-AA force fields.  A Boltzmann weighting temp. of 2000 K was detd. to be optimal for fitting the new Fourier coeffs. for dihedral angle parameters.  Conclusions are drawn from the results for best practices for developing new torsion parameters for protein force fields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxE-hNg6xKqLVg90H21EOLACvtfcHk0ljksyaL8gFJXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsFOlsbc%253D&md5=b9836b19acadc1a86369bca744ca9b13</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00356%26sid%3Dliteratum%253Aachs%26aulast%3DRobertson%26aufirst%3DM.%2BJ.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26atitle%3DImproved%2520Peptide%2520and%2520Protein%2520Torsional%2520Energetics%2520with%2520the%2520OPLS-AA%2520Force%2520Field%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2015%26volume%3D11%26spage%3D3499%26epage%3D3509%26doi%3D10.1021%2Facs.jctc.5b00356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, C. H.</span></span> <span> </span><span class="NLM_article-title">Efficient Estimation of Free Energy Differences from Monte Carlo Data</span>. <i>J. Comput. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.1016/0021-9991(76)90078-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;key=10.1016%2F0021-9991%2876%2990078-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1976&pages=245-268&author=C.+H.+Bennett&title=Efficient+Estimation+of+Free+Energy+Differences+from+Monte+Carlo+Data&doi=10.1016%2F0021-9991%2876%2990078-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2F0021-9991%2876%2990078-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0021-9991%252876%252990078-4%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DC.%2BH.%26atitle%3DEfficient%2520Estimation%2520of%2520Free%2520Energy%2520Differences%2520from%2520Monte%2520Carlo%2520Data%26jtitle%3DJ.%2520Comput.%2520Phys.%26date%3D1976%26volume%3D22%26spage%3D245%26epage%3D268%26doi%3D10.1016%2F0021-9991%2876%2990078-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EIY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EIY','PDB','4EIY'); return false;">PDB: 4EIY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EML" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EML','PDB','3EML'); return false;">PDB: 3EML</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i47"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01431">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_36018"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01431?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01431</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01431/suppl_file/jm0c01431_si_001.csv">CSV</a>)</p></li><li><p class="inline">Peak summary report (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01431/suppl_file/jm0c01431_si_002.pdf">PDF</a>)</p></li><li><p class="inline">Computational chemistry; general information; general procedure for Biginelli synthesis; spectroscopic and analytical data for all compounds described; and analytical HPLC chromatograms of AF80 (38) and AF80 (47) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01431/suppl_file/jm0c01431_si_003.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01431/suppl_file/jm0c01431_si_001.csv">jm0c01431_si_001.csv (7.67 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01431/suppl_file/jm0c01431_si_002.pdf">jm0c01431_si_002.pdf (1.24 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01431/suppl_file/jm0c01431_si_003.pdf">jm0c01431_si_003.pdf (697.88 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01431&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01431%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-1%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01431" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                10MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a7bad4a7d2290","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
